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Welcome Message 
The Centers for Disease Control and Prevention (CDC) is pleased to present the 2016-2017 Presidential 
Transition Owner's Manual. CDC is the nation's health protection agency. CDC works 24/7 to conduct critical 
science and provides health information that protects our nation against dangerous health threats, and 
responds when these arise. CDC promotes quality of life and prevents the leading causes of disease, injury, 
disability, and death. CDC is committed to maximizing the impact of every dollar entrusted to the agency and 
continuing critical work to increase public health capacity at local, state, national, and global levels. 
CDC's pledge to the American people is to: 
1. Be a diligent steward of the funds entrusted to the agency 
2. Provide an environment for intellectual and personal growth and integrity 
3. Base all public health decisions on the highest quality scientific data that is derived openly and 
objectively 
4. Place the benefits to society above the benefits to this institution 
5. Treat all persons with dignity, honesty, and respect 
Briefing Schedule 
CDC staff are pleased to provide additional materials or briefings, as requested. All requests should be routed 
through Department of Health and Human Services Transition Director John Gentile. 
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Organizational Overview 
CDC is the nation's first line of defense to protect Americans from health threats. 
Mission 
CDC works 24/7 to protect America from health, safety, and security threats, originating within and outside the 
United States. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, or the 
result of human error or deliberate attack, CDC fights disease—and supports communities and citizens to do the 
same. As the Nation's health protection agency, CDC increases the health security of the Nation, saves lives, and 
protects people from health threats. To accomplish this mission, CDC conducts critical science, provides health 
information, tools, and resources that protect our nation against expensive and dangerous health threats, and 
responds when these arise. 
History and the Agency Today 
On July 1, 1946, the originally-named Communicable Disease Center opened its doors and occupied one floor of 
a small building in Atlanta. Its primary mission was simple, yet highly challenging: to prevent malaria from 
spreading across the nation. Armed with a budget of $10 million and fewer than 400 employees, the agency's 
early challenges included obtaining enough trucks, sprayers, and shovels necessary to wage war on mosquitoes. 
Today, CDC is one of the major operating components of the Department of Health and Human Services (HHS), 
and is recognized as the nation's premier public health, health promotion, prevention, and preparedness 
agency. 
CDC is: 
• On the cutting edge of health security: Confronting global disease threats through advanced computing 
and lab analysis of huge amounts of data to quickly find solutions 
• Putting science into action: Tracking disease, finding out what is making people sick and the most 
effective ways to prevent it 
• Improving medical care: Bringing new knowledge to individual health care and community health to 
save more lives and reduce waste 
• Fighting diseases globally before they reach our borders: Detecting and confronting new germs and 
diseases around the globe to increase our national security 
• Nurturing public health: Building on CDC's significant contribution to have strong, well-resourced public 
health leaders and capabilities at national, state, and local levels to protect Americans from health 
threats 
CDC's role is: 
• Detecting and responding to new and emerging health threats 
• Tackling the biggest health problems causing death and disability for Americans 
• Putting science and advanced technology into action to prevent disease 
• Promoting healthy and safe behaviors, communities, and environments 
• Developing leaders and training the public health workforce 
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Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 
Health Information and Health Promotion 
Vaccines 
Subtitle C, Sec. 	National All-Hazards Preparedness for Public Health 
Agency for Toxic Substances and Disease Registry 
The director of CDC is also the Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR). 
Superfund legislation created ATSDR in 1985 as an advisory, non-regulatory agency. Although ATSDR is an 
independent operating division within the Department of Health and Human Services, CDC performs its 
administrative functions. ATSDR has a joint Office of the Director with the National Center for Environmental 
Health (NCEH). ATSDR headquarters are in Atlanta, Georgia, at CDC's Chamblee Campus. 
Today, congressional mandate directs ATSDR to perform specific functions concerning the effect of hazardous 
substances in the environment on public health. These functions include public health assessments of waste 
sites, health consultations concerning specific hazardous substances, health surveillance and registries, response 
to emergency releases of hazardous substances, applied research in support of public health assessments, and 
education and training concerning hazardous substances. 
The Organization 
• CDC's organizational chart (Attachment A) 
• Fact sheets for CDC's centers, institute, and offices (Attachment B) 
• CDC's senior leadership team (Attachment C) 
Strategic Plan and Performance Documentation 
• CDC's strategic guidance framework (Attachment D) 
• CDC's performance overview from the FY 2017 Congressional Justification (Attachment E) 
• The CDC Winnable Battle Progress Report 2014 — published April 2015 (Attachment F) 
• The CDC National Health Report 2006-2012 (Attachment G) 
Authorizing Legislation 
CDC's authorizing legislation provided through Appropriations (H.R. 2029— Consolidated Appropriations Act, 
2016) can be found in the following two tables. 
Legislative Citation (Public 
Health Service Act, unless 	Subdivision 	 Function 
otherwise indicated) 
2821 	 Emergencies 
Strengthening Public Health Surveillance Systems 
Immigration and Nationality Act 
Title II 
Immigration and Nationality Act 
Title IV 
Epidemiology-Laboratory Capacity Grants 
Immigration 
Refugee Assistance and Miscellaneous 
Ie , 
Legislative Citation (Public 
Health Service Act, unless 	Subdivision 	 Function 
otherwise indicated) 
Provisions Relating to Cuban and Haitian Entrants, Authorities 
for Other Programs and Activities 
Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 
Health Information and Health Promotion 
Research with Respect to Acquired Immune Deficiency 
Syndrome 
Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 
Health Information and Health Promotion 
Refugee Education Assistance 
	
Sec. 501 
Act Title V 














Strengthening Public Health Surveillance Systems 
Epidemiology-Laboratory Capacity Grants 
Immigration and Nationality Act 	 Immigration 
Title II 
Immigration and Nationality Act 
Title IV 
Refugee Education and 	 Sec. 501 
Assistance Act Title V 
Chronic Disease Prevention and Health Promotion 
Refugee Assistance and Miscellaneous 
Provisions Relating to Cuban and Haitian Entrants, Authorities 
for Other Programs and Activities 
Title II 	 Administration and Miscellaneous Provisions 
Title III General Powers and Duties of Public Health Service 






Preventive Health Measures with Respect to Breast and 
Cervical Cancers 
Requirements with Respect to Type and Quality of Services 
Requirement of Provision of All Services by Date Certain 
(Proportional funding requirements will not apply to funds 
made available through the Chronic Disease Prevention and 
Health Promotion account) 
Title XV 	 Sec. 1509 	 Preventive Health Measures with Respect to Breast and 
Cervical Cancers (Funds may be available for making grants for 
not less than 21 States, tribes, or tribal organizations) 
Title XVII 
Title XIX 




Title XVII  
Health Information and Health Promotion 
Block Grants 
Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 
Genetic Diseases, Hemophilia Programs, and Sudden Infant 
Death Syndrome 
Health Information and Health Promotion 
Title XVII 








Federal Mine Safety and Health 	101 
Act Title I 
Federal Mine Safety and Health 
	
102 
Act Title I 
Federal Mine Safety and Health 	103 
Act Title I 
Federal Mine Safety and Health 	201 
Act Title II 
Legislative Citation (Public 










     
   
Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 
Health Information and Health Promotion 
   
Public Health Scientific Services 
    
Title II 
   
Administration and Miscellaneous Provisions 
Title III 	 General Powers and Duties of Public Health Service 
Health Information and Health Promotion 
Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 
Health Information and Health Promotion 
Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 
Health Information and Health Promotion 
General 




Inspections, Investigations, and Recordkeeping 
Interim Mandatory Health Standards 
Coverage 
Federal Mine Safety and Health 
Act Title II 
Federal Mine Safety and Health 
Act Title II 
Federal Mine Safety and Health 
Act Title III 
202 	 Interim Mandatory Health Standards 
Dust Standard and Respiratory Equipment 
203 
	
Interim Mandatory Health Standards 
Medical Examinations  
301 	 Interim Mandatory Safety Standards for Underground Coal 
Mines 
Coverage 
Federal Mine Safety and Health 




Public Law 106-554 Title I 
	
Div. B, Sec. 151(b) 
	
Pursuant to the Balanced Budget and Emergency Deficit 
Control Act of 1985 (Amounts used for the Energy Employees 
Occupational Illness Compensation Program will be in the 




Administration and Miscellaneous Provisions 
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Legislative Citation (Public 
Health Service Act, unless 
otherwise indicated) 
Subdivision Function 
Health Information and Health Promotion Title XVII 
Public Health Preparedness and Response 
Title II Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 








Subtitle C, Sec. 
2821 
Subtitle C, Sec. 
2821, Subsec. (b), 
Paragraphs (1) 
through (3) 
Administration and Miscellaneous Provisions 
General Powers and Duties of Public Health Service 
Health Information and Health Promotion 
Block Grants 
National All-Hazards Preparedness for Public Health 
Emergencies 
Strengthening Public Health Surveillance Systems 
Epidemiology-Laboratory Capacity Grants 
The specific amounts for activities under this authority were 
only valid for the years 2010-2013 
Allocation Methods 
Enabling Legislation 
Status Enabling Legislation Citatkin3 
Title III 	 General Powers and Duties of Public Health Service 
Buildings and Facilities 
CDC-Wide Activities and Program Support 
Immunization and Respiratory Diseases 
PHSA Title II, §§ 301, 307, 310, 311, 317, 317N, 317S, 319, 	Permanent 
319C, 319E, 319F, 322, 325, 327, 340C, 352, Title XVII*, Indefinite 
2102(a)(6), 2102(a)(7), 2125, 2126, 2127, 2821; Immigration 
and Nationality Act §§ 212 (8 U.S.C. 1182), 232 (8 U.S.C. 




Formula Grants; Contracts; and 
Other 
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 
PHSA Title II, §§ 301, 306(a-I), 306(n)*, 307, 308(d), 310, 
311, 317, 317E(a-f)*, 317E(g)*, 317N(a-b), 317N(c)*, 
317P(a-c), 318(a-d), 318(e)*, 318(f), 318B*, 322, 325, 327, 







Contracts, and Other 
Emerging and Zoonotic Infectious Diseases 
PHSA §§ 252, 264, 301, 304, 307, 308(d), 310, 311, 317, 	Permanent 
	
Direct Federal/Intramural, 
317P, 317R, 317S, 319, 319D, 319E*, 319F, 319G, 321, 322, 	Indefinite Contracts, and Competitive 
325, 327, 352, 353, 361-369, 1102, Title XVII*, 2821*; P.L. Grants/Cooperative Agreements 
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96-517; P.L. 111-5; Immigration and Nationality Act §§ 212, 
232 (8 U.S.C. 1182, 8 U.S.C. 1222, 8 U.S.C. 1252) 
Chronic Disease Prevention and Health Promotion 
PHSA Title II §§ 301, 307, 310, 311, 317*, 317D*, 317H, 
317K*, 317L*, 317M*, 317P*, 330E, 399B*-399D, 399E, 
399NN*, 399Q*, 399V-3*-399Z*, 1501-1509*, Title XVII*, 
Fertility Clinic Success Rate And Certification Act of 1992 
(P.L. 102-493); Comprehensive Smoking Education Act of 
1984, P.L. 98-474 (15 U.S.C. 1335(a) and 15 U.S.C. 1341); 
Comprehensive Smokeless Tobacco Health Education Act of 
1986 (P.L. 99-252); The Patient Protection and Affordable 
Care Act of 2010,§ 4201* (Pl. 111-148) 
Birth Defects and Developmental Disabilities 
PHSA Title II §§ 301, 304, 307, 308(d), 310, 311, 317, 
317C(a)*, 317.1*, 317K*, 317L*, 3170, 327, 352, 399M, 
399Q*, 399S, 399T, 399V-2*, 399AA*, 399BB, 399CC; 
1102,1110, 1112-1114, Title XI, Title XVII*; The Prematurity 
Research Expansion And Education For Mothers Who 
Deliver Infants Early Act §§ 3,5 (42 U.S.C. 247b-4f* and 42 
U.S.C. 247b-4g) 
Environmental Health 
PHSA Title II §§ 301, 307, 310, 311, 317*, 317A*, 31713*, 
3171*, 327, 352, 361, 366, 1102; Title XVII* 
Injury Prevention and Control 
Permanent 
Indefinite 
Direct Federal Intramural; 
Competitive Cooperative 
Agreements/Grants, including 





Indefinite Competitive Grants, Cooperative 
Agreements and Contracts 
Permanent 
	
PHSA Title II §§ 301, 307, 310, 311, 
Indefinite 317*, 317A*, 317B*, 3171*, 327, 




Formula Grants; and Competitive 
Contracts 
PHSA Title II §§ 214, 215, 301, 304, 307, 308, 310, 311, 317, 	Permanent 
319, 319D*, 327, 352, 391*, 392*, 393*, 393A*, 393B*, 	Indefinite 
393C*, 393D*, 394*, 394A*, 399P*, 1102; Title XVII*, Bayh-
Dole Act of 1980 (P.L. 96-517); Safety of Seniors Act of 2007 
(P.L. 110-202); Traumatic Brain Injury Reauthorization Act of 
2014 (Pl. 113-196); Family Violence Prevention and 
Services Act §§ 303 (42 U.S.C. 10403)*, 314 (42 U.S.C. 
10414)* 
Public Health Scientific Services 
PHSA Title II §§ 241, Title III 301, 304, 306*, 307, 308, 310, 	Permanent 
317, 317G, 318, 319, 319A, 353, 391, 399V, 778*, 1102, Indefinite 
Title XVII*, 2315, 2341, 2521*; P.L. 107-347, Title V (44 
U.S.C. 3501 note); Intelligence Reform and Terrorism 
Prevention Act of 2004 § 7211* (P.L. 108-458); Food, 
Conservation, And Energy Act of 2008 § 4403 (7 U.S.C. 
5311a); P.L. 101-445 § 5341 (7 U.S.C. 5341); The Patient 
Protection and Affordable Care Act of 2010 (P.L. 111-148) 
Occupational Safety and Health 
PHSA Title II §§ 301, 304, 306, 307, 308(d), 310, 311, 317, 	Permanent 
317A, 317B, 319, 327, 352, 399MM, 1102, Title XVII, 2695; Indefinite 
Occupational Safety and Health Act of 1970 §§20-22, P.L. 
91-596 as amended by P.L. 107-188 and 109-236 (29 U.S.C. 
669-671); Federal Mine Safety and Health Act of 1977, P.L. 
91-173 as amended by P.L. 95-164 and P.L. 109-236 (30 
U.S.C. 811-813, 842, 843-846, 861, 951-952, 957, 962, 963, 






Agreements, Contracts, Other 
I 	11 
239 (30 U.S.C. 902); Bureau of Mine Act, as amended by P.L. 
104-208 (30 U.S.C. 1 note, 3, 5); Radiation Exposure 
Compensation Act, §§ 6 and 12 (42 U.S.C. 2210 note); 
Energy Employees Occupational Illness Compensation 
Program Act of 2000, as amended (42 U.S.C. §57384, et 
seq.); Floyd D. Spence National Defense Authorization Act 
for Fiscal Year 2001 §§ 3611, 3612, 3623, 3624, 3625, 3626, 
3633 of P.L. 106-398; National Defense Authorization Act 
for Fiscal Year 2006, P.L. 109-163; Toxic Substances Control 
Act, P.L. 94-469 as amended by 102-550, (15 U.S.C. 2682, 
2685); Ryan White HIV/AIDS Treatment Extension Act of 
2009 § 2695, P.L. 111-87 (42 U.S.C. 300ff-131); James 
Zadroga 9/11 Health And Compensation Reauthorization 
Act (2015), Division 0, Title III, P.L 114-113 
Global Health 
PHSA Title II §§ 301, 304, 307, 310, 319*, 327, 340C, 361- 	Permanent 
369*, Title VVII*, 2315, 2341; Foreign Assistance Act of Indefinite 
1961 §§ 104, 627, 628; Federal Employees International 
Organization Service Act § 3 (5 USC 3343); International 
Health Research Act of 1960 § 5; Agriculture Trade 
Development and Assistance Act of 1954 § 104; 38 U.S.C. § 
3968; Foreign Employees Compensation Program (22 U.S.C. 
3968); Tom Lantos and Henry J. Hyde United States Global 
Leadership Against HIV/AIDS, Tuberculosis, and Malaria 
Reauthorization Act of 2008 (P.L.110-293); PEPFAR 
Stewardship & Oversight Act of 2013 (P.L. 113-56); Section 
212 of the Consolidated Appropriations Act, 2016 (P.L. 114-
113, Division H) 
Public Health Preparedness and Response 






PHSA Title 1155 301, 307, 310, 311, 319, 319C-1, 319D, 
319F, 319F-2, 319G*, 351A*, 361, Title XVII*, 2801, 2812 
Buildings and Facilities 
Consolidated Appropriations Act of 2016, PL 114-113 
CDC-Wide Activities and Program Support 
PHSA Title 11 55 301, 304, 306*, 307, 308, 310, 311, 317, 
317F*, 319, 319A, 3190, 322, 325, 327, 352, 361-369, 
391*,Title XVII*, 2821 
Direct Federal/Intramural, 
Competitive Grants/Cooperative 
Agreements, Direct Contracts, 
Interagency Agreements 















Order of Succession 
CDC Order of Succession 
1. Principal Deputy Director, CDC 
2. Deputy Director for Infectious Diseases 
3. Associate Director for Science 
4. Deputy Director for Noncommunicable Diseases, Injury, and Environmental Health 
ATSDR Order of Succession 
1. Administrator, ATSDR 
2. Principal Deputy Administrator, ATSDR 
3. Assistant Administrator, ATSDR 




Workforce Data and Trends 
CDC's workforce, as of September 30, 2016, included 11,842 permanent full-time equivalent (FTE) employees, 
commissioned corps, and temporary/term appointees. As the only Federal agency headquartered outside 
Washington, D.C., 75 percent of CDC employees are located in Atlanta. Other CDC staff are stationed at CDC 
campuses outside Atlanta and in quarantine stations, and embedded in state and local health departments 
across the United States. CDC also has more than 2,000 staff (including locally employed staff) working in more 
than sixty countries outside the United States. 
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Length of Federal Service 
1,200 
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Average Years in Service = 13 years 
<1 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50 
Years in Service 
About 14 percent of the CDC workforce is currently eligible to retire, and nearly a third of the CDC 




























Eligible Within 12 
	































2011 	 2016 







I I I I III I I II • . 0 
..c,1\4.. 	 •'k-N 	4".\ 	etkk. 	• .\ 	(§:'\ 	4" ¢..\ 	e 	c'i> 	--c-k\  * 
,z..





e •'?" ..kot's 
 
e * 	* Oc° 
, 
oe 	e?) o 
is 2011 Population al Increase III Decrease 
Note: Data limited to occupational series with at least 200 FTEs in 2016. 
Page 17 
Organizational Culture 
The Best Places to Work in the Federal Government® rankings group 75 Federal organizations into six mission 
areas: public health, law enforcement, national security, energy and environment, financial regulation and 
oversight. In 2015, CDC was ranked first in the public health mission area (70.9 Best Places to Work index score) 
and is consistently among the top tier of public health agencies when it comes to employee satisfaction and 
commitment. According to the Partnership for Public Service, which produces the Index, CDC's ranking is "in 
large part because of because of efforts by their leaders to improve the work environment and a generally high 
level of employee dedication to their jobs." 
The Best Places to Work index is based largely on data from the Federal Employee Viewpoint Survey (EVS). CDC's 
EVS results show employee opinions about CDC are consistently higher than HHS and other Federal agencies. 
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Public Opinion 
The 2015 Harris poll found 89 percent of Americans understand what CDC does, and of those who understand, 
69 percent feel positively about CDC. 
The Pew Research Center also found CDC is the third most favorably viewed Federal agency (71 percent). 
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Important Relationships with Other Federal Agencies 
CDC works collaboratively with virtually every Federal agency on a wide variety of critical issues. Listed below 
are examples of the type of work CDC does with outside agencies: 
• CDC works closely with the Department of Justice, to address risk factors for violence. With partners, 
CDC implements violence prevention interventions to improve the ability to track trends, implement 
effective interventions, and share successes. The Department of Education is another partner CDC 
works with to gather and analyze data from a variety of sources to gain a more complete understanding 
of school violence. 
• CDC emphasizes primary prevention of lead poisoning through the elimination and control of lead 
hazards before children are exposed. Working with the Department of Housing and Urban 
Development and the Environmental Protection Agency, CDC data help identify housing properties 
where multiple children have been lead poisoned and target lead hazard reduction enforcement actions. 
• Building on efforts to establish Antibiotic Resistance tracking, CDC works with the Department of 
Defense and the Department of Veterans Affairs to facilitate antibiotic use reporting from their 
healthcare facilities to better prevent the spread of potentially untreatable infections in these settings. 
• CDC works closely with the Federal Drug Administration and the United States Department of 
Agriculture on food safety issues recalls, in order to prevent and control foodborne outbreaks. 
• CDC partners with the Animal and Plant Health Inspection Service of the United States Department of 
Agriculture to administer the Federal Select Agent Program. The program oversees the possession, use, 
and transfer of biological select agents and toxins that have the potential to pose a severe threat to 
public, animal, or plant health or to animal or plant products. 
• CDC developed methods for testing and rating hearing protector performance and assessing exposure 
risk included in the Department of Defense noise limit criteria acquisition standard released April 2015. 
This new standard sets the maximum permissible noise levels for military systems, facilities, and 
equipment. 
• CDC's Energy Employees Occupational Illness Compensation Program Act is a mandatory Federal 
program that provides compensation to Department of Energy employees or survivors of employees 
who have been diagnosed with a radiation-related cancer, beryllium-related disease, or chronic silicosis 
because of their work in producing or testing nuclear weapons. 
• CDC receives interagency funding from the Department of State to implement President's Emergency 
Plan for AIDS Relief to accelerate progress toward achieving an AIDS-free generation and create a lasting 
infrastructure that allows partner countries to respond to a range of health challenges and threats. CDC 
works with many implementing partners overseas, including the United States Agency for International 
Development, Peace Corps, and the Department of Defense. 
• CDC collaborated with the Department of Defense to expand the number of Laboratory Response 
Network laboratories that could quickly and accurately test for the Ebola virus in 2015. 
• CDC's surveillance system for the timely exchange of syndromic data are accessed by Federal agencies 
including the Department of Defense and the Department of Veterans Affairs to improve nationwide 
situational awareness and enhance responsiveness to hazardous events and disease. 
• CDC works with the Department of Veterans Affairs on research and surveillance studies on the health 
of veterans. The data and research findings from these studies help Veteran Affairs health professionals 
improve healthcare practices for veterans. 
• CDC works with the United States Agency for International Development on various activities, including 
the Emerging Pandemic Threats program, which emphasizes early identification of, and response to, 
dangerous pathogens in animals before they can become significant threats to human health. These 
efforts are critical to the sustainability of long-term pandemic prevention and preparedness. 
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• CDC's HIV surveillance systems provide other Federal programs—including those at the Health 
Resources and Services Administration and the Department of Housing and Urban Development—with 
data to guide the allocation of Federal funding for HIV care, treatment, and housing programs. 
• Through funding from the Centers for Medicare & Medicaid Services, CDC implements the Vaccines for 
Children program to provide immunization services for uninsured and underinsured populations in the 
United States and supports the scientific evidence base for vaccine policy and practices. 
• CDC, in collaboration with the Department of Homeland Security, has implemented Federal travel 
restriction procedures to protect travelers and the public from communicable diseases that constitute a 
public health threat. 
• CDC works with virtually every component of the National Institutes of Health. In the area of diagnostic 
innovation, CDC is working with the National Institutes of Health to evaluate a multiplex diagnostic assay 
that can detect exposure to multiple pathogens. 
• CDC coordinates with the Substance Abuse and Mental Health Services Administration on opioid 
overdose prevention and suicide prevention. 
• CDC collaborates with the Administration on Children and Families and the Health Resources and 
Services Administration to reach very young children in Federal early childhood services such as Early 
Head Start and Healthy Start with CDC's Legacy for ChildrenTM parenting program. 
• Million Hearts® is a national initiative co-led by CDC and the Centers for Medicare & Medicaid Services 
to coordinate and enhance cardiovascular disease prevention activities across the public and private 
sectors in an effort to change the environment to help prevent cardiovascular disease. 
• CDC is providing support for full implementation of its surveillance, prevention, and stewardship 
activities to advance the goals of the White House's National Strategy for Combating Antibiotic-Resistant 
Bacteria. The interagency Combating Antibiotic-Resistant Bacteria Task Force, co-chaired by the 
secretaries of Defense, Agriculture, and Health and Human Services, coordinates implementation of the 
National Action Plan. Within HHS, CDC works with the Centers for Medicare & Medicaid Services, 
National Institutes of Health, Food and Drug Administration, and Agency for Healthcare Research and 
Quality. 
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Top Issues for New Leadership 
Quick Wins 
In the coming months, there will be a number of opportunities for the new Administration to enhance CDC's 
ability to meet its mission and increase the health security of Americans. These include: 
Rapid Response Reserve for Public Health Emergencies 
Need: Establishment of a funding mechanism, with authorities that allow CDC to engage and obligate dollars 
quickly, to better position the agency to save lives and money. 
Timing: Several Congressional proposals have been introduced, including $300 million for an Infectious Disease 
Rapid Response Reserve Fund in the House Labor-HHS-Education appropriations bill, a $2 billion fund in the 
Centers for Disease Control and Prevention Emergency Response Act of 2016, and a fund containing an average 
of the costs prior emergencies in the Public Health Emergency Response and Accountability Act. These proposals 
differ in their purposes, with the $300 million fund providing a head start on large responses, and the larger 
funds supporting full responses. They also propose various triggers for use of the fund and a range of 
administrative flexibilities. The Administration will have the opportunity to include a reserve in the FY 2018 
budget process, and Congress could promote a standalone bill, or include the reserve in proposed legislation, at 
any time. 
Background: Public health emergencies are unpredictable and can be costly. The costs of the Severe Acute 
Respiratory Syndrome (SARS) epidemic in 2003 have been estimated at over $50 billion. In 2008, the World Bank 
estimated that a severe influenza pandemic could result in $3 trillion in global economic losses, which is 
equivalent to 4.8 percent of gross domestic product. The World Bank estimates the regional economic damage 
of West Africa's Ebola outbreak to have been $2.2 billion between 2014 and 2015. The World Bank has 
mobilized around $1.6 billion for Ebola response and recovery efforts, some of which could have likely been 
avoided with swifter action to contain the outbreak. Unlike the Federal Emergency Management Agency's 
Disaster Relief Fund, which they can use to direct, coordinate, manage, and fund eligible response and recovery 
efforts associated with domestic major disasters and emergencies, there is no readily available funding 
mechanism to quickly respond to public health emergencies, domestic or international. If U.S. government 
response capabilities were oriented toward public health emergencies, implementation of appropriate and 
immediate early interventions could prevent an aggressive outbreak from becoming an epidemic, and prevent 
an epidemic in a country or region from developing into a world-wide pandemic. A true contingency funding 
mechanism, with authorities that support rapid response, is an important opportunity to achieve better results 
during the early stages of a public health emergency. 
Zika Virus 
Need: Continued leadership focus and support for CDC's ongoing efforts to stop the spread of the Zika virus and 
to increase knowledge of the health effects of Zika virus, discover new tools to reduce the mosquito populations 
that can spread Zika and other diseases, and begin to rebuild the eroded capacity for vector surveillance in 
states and territories. 
Timing: Since early 2016, CDC has been directly engaged with the U.S. response to the Zika virus and 
approximately 1,900 CDC staff members have provided support to date. 
Background: CDC managed the response in fiscal year (FY) 2016 with reprogrammed resources. As of September 
30, 2016, CDC obligated approximately $217 million in the United States and territories, and more than $56 
million internationally (international funds from an interagency agreement with United States Agency for 
International Development). A Zika supplemental funding bill provided CDC with an additional $350 million 
through September 30, 2017. The majority of this funding will be provided to states, territories, localities, and 
universities in the first half of FY 2017 through cooperative agreements. Zika has been an unprecedented and 
complex response, and the world will be dealing with implications from this disease for years to come. CDC's key 
priority in responding to this epidemic is to reduce the risk of Zika virus infection for pregnant women. CDC is 
working intensively with Puerto Rico and other areas with local transmission of the virus to provide information 
to women who are or who may become pregnant (and their partners) to reduce the threat of Zika to the 
developing fetus. Knowledge of the health effects of Zika virus is continuing to evolve. Funding supports 
maximizing use of current tools to reduce the mosquito populations that can spread Zika and other diseases, 
beginning to rebuild the eroded capacity for vector surveillance in states and territories, and advancing 
innovative mosquito control tools that may be safer and more effective than today's methods. Puerto Rico is a 
particular focus for vector surveillance and control, and CDC has funded a partner to create a Puerto Rico Vector 
Control Unit. CDC's focus is protecting the health, safety, and security of Americans; learning more about Zika 
and fighting it is a top priority for the agency. 
Non-recurring Expenses Fund and CDC's Buildings and Facilities 
Need: HHS continued support for CDC's request for additional funds in FY 2017 and beyond from the Non-
recurring Expense Fund (NEF) to complete critical infrastructure projects. 
Timing: In early 2017, HHS leadership will consider how to allocate remaining FY 2017 NEF funds and begin the 
FY 2018 allocation process. 
Background: NEF permits HHS to transfer unobligated balances of expired discretionary funds from FY 2008 and 
subsequent years into the NEF account. Congress authorized use of the funds for capital acquisitions including 
information technology and facilities infrastructure. CDC relies heavily on these funds to support critical 
infrastructure, including replacement of aging facilities. 
Most urgently, current infrastructure at CDC's Roybal Campus headquarters is inadequate to support the 
intensive demands of ongoing laboratory work and the campus population of over 5,000 staff. Infrastructure 
improvements are necessary to support existing and planned laboratory facilities, which draw greatly on 
utilities, and require intricate and reliable support systems to maintain a safe and scientifically-advanced 
research environment. In addition, the parking demand on the Roybal campus exceeds capacity due to lack of 
public transportation in the surrounding area and increased space utilization requirements. Roybal 
infrastructure improvements are estimated at close to $100 million. This lack of support for the basic needs of 
CDC's infectious disease workforce and laboratory scientists inhibits scientific productivity and collaboration. 
A lack of investment in facilities improvements has resulted in a nationwide decline in the condition of CDC 
facilities. CDC's buildings portfolio includes 192 buildings and 27 support facilities in metro Atlanta, Anchorage, 
Cincinnati, Morgantown, Pittsburgh, San Juan, Fort Collins, and Spokane. Of CDC's 192 buildings, only 33 are less 
than 10 years old. Forty-three percent are more than 40 years old. CDC's current backlog for repairs and 
improvements, as well as infrastructure projects, is well over hundreds of millions of dollars. Yet, CDC's FY 2016 
appropriation for buildings and facilities was only $10 million. 
Fiscal Year 2017 Continuing Resolution 
Need: Engage with Congress to ensure support for CDC's top priorities in the FY 2017 President's Budget 
request. 
Timing: CDC is currently operating under a continuing resolution (through December 9, 2016). 
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Background: Please refer to the section titled Implications of Continuing Resolutions for more information. 
(b)(5) 
Lead Poisoning Prevention Efforts across the United States 
Need: Additional funding for CDC to enhance the on-going lead prevention activities and establish a registry for 
children who were exposed to lead in Flint, Michigan. 
Timing: In FY 2016, the Senate passed the Water Resources Development Act, which included $30 million in 
mandatory spending for CDC for a registry, an advisory committee ($20 million), and an increase for the 
Childhood Lead Prevention Program ($10 million over 2 years). While the House-passed version does not include 
this funding, it is likely the House and Senate will agree to the Senate-passed version of these provisions. 
Background: CDC's National Center for Environmental Health and the Agency for Toxic Substances and Disease 
Registry led CDC's response to the lead crisis in Flint, Michigan. As part of those efforts, the agency educated 
Congressional offices regarding the lead surveillance program that was eliminated by Congress in FY 2012. This 
funding was restored in FY 2014, however, at a considerably reduced level. With passage of the Water 
Resources Development Act in the Senate, there is support for further increasing program funding and 
expanding the program to additional states. Assuming funding is provided in late 2016, CDC will be well 
positioned to launch a revitalized national lead prevention program, while establishing a registry of affected 
children in Flint, Michigan. 
Opportunities for Public Health Modernization 
Looking beyond the first 90 days, the Administration will have the opportunity to promote CDC's unique role 
protecting America's health security by investing in the nation's public health infrastructure. A few key examples 
of these opportunities are listed below. 
Public Health Innovation and Infrastructure 
CDC supports public health innovation and makes investments in nationwide infrastructure, including 
laboratories, surveillance, and the public health workforce. These investments strengthen the nation's public 
health system. However, efforts by federal, state, and local public health departments around the country to 
q.0 
build a resilient public health system have been limited by funding and a shrinking public health workforce. A 
robust and well-trained public health workforce is critical to protecting America's health and successfully 
safeguarding our population. Enhancing the public health infrastructure will ensure the nation has the ability to 
prevent, detect, and respond to emerging health threats. 
Advanced Molecular Detection: CDC can improve pathogen identification and detection, continue to develop 
next-generation diagnostics to meet evolving public health needs, implement sustainable and integrated 
laboratory information systems, and develop tools for prediction, modeling, and early recognition of emerging 
infections. Imagine doing a 10,000-piece jigsaw puzzle in the time it takes to finish a 100-piece puzzle. Apply that 
to infectious disease control, and that's Advanced Molecular Detection (AMD) at work. Now imagine putting 
together that 10,000-piece puzzle when key pieces are missing, disease is spreading, and people are dying. AMD 
gives CDC scientists the "key pieces" they need to protect people from ever-changing infectious disease threats. 
CDC received Congressional support in FY 2014 to launch AMD. AMD has allowed CDC to identify more precise 
methods of diagnosing known and emerging infections, detecting and responding to outbreaks, understanding, 
characterizing, and controlling antibiotic resistance, and developing and targeting health prevention measures, 
including vaccines. 
Buildings and Facilities: For CDC's public health work to protect the health and safety of the nation, CDC must 
invest in buildings and facilities that support a safe, world-class research environment. Both major capital 
investment and repair of current buildings and facilities are essential to ensure that CDC is able to maintain its 
ability to respond to the public health needs in the next decade. 
(b)(5) 
• 
• Current intrastructure at CDC's Roybal Campus headquarters is Inadequate to support the intensive 
demands of ongoing laboratory work and the campus population of over 5,000 staff. Infrastructure 
improvements are necessary to support existing and planned laboratory facilities, which draw greatly on 
utilities and require intricate and reliable support systems to maintain a safe and scientifically-advanced 
research environment. Furthermore, the parking demand on the Roybal campus exceeds capacity due to 
lack of public transportation in the surrounding area and increased space utilization requirements. 
• In addition, there are opportunities to construct, renovate, or expand laboratories and office space 
around the United States: 
o High containment and special pathogen laboratory capacity in Atlanta, Georgia (Roybal campus) 
o Environmental health laboratory and office space in Atlanta, Georgia (Chamblee campus) 
(b)(7)(E) 
o Pittsburgh, Pennsylvania Research Center 
o Occupational health laboratories in Morgantown, West Virginia 
o Lake Lynn Laboratory and underground research mine replacement (new location TBD) 
o Vector-borne laboratory and insectary capacity in San Juan, Puerto Rico 
• Vector-borne viral and bacterial laboratory capacity in Ft. Collins, Colorado 
Page 25 
Laboratory Response Network: The Laboratory Response Network (LRN) was established by CDC in accordance 
with Presidential Decision Directive 39, which outlined national anti-terrorism policies and assigned specific 
missions to Federal departments and agencies, to ensure an effective laboratory response to bioterrorism by 
helping to improve the nation's public health laboratory infrastructure, which had limited ability to respond to 
bioterrorism. Today, the LRN maintains an integrated network of state and local public health, Federal, military, 
and international laboratories that can respond to bioterrorism, chemical terrorism, and other public health 
emergencies. LRN is a unique asset in the nation's growing preparedness for biological and chemical terrorism. 
The linking of state and local public health laboratories, veterinary, agriculture, military, and water- and food-
testing laboratories is unprecedented. LRN plays an instrumental role in improving the public health 
infrastructure by helping to boost laboratory capacity. 
Integrated Public Health Surveillance Platform: Modernization of informatics and information technology is 
critical for CDC to respond to new public health threats and effectively make use of growing health care data 
and information relevant to public health. By developing an integrated public health surveillance platform, CDC 
will enable public health programs to focus on practice and science using the effective technology, tools, and 
services developed on the platform. An integrated CDC surveillance platform will provide the environment and 
infrastructure to create shared services for public health surveillance functions. Modernization of the 
surveillance platform will enhance CDC's ability to fulfill its mission through: 
• Improving the timeliness and quality of data received electronically by CDC and made available to public 
health programs 
• Improving the cost efficiency of developing and maintaining surveillance activities 
• Improving the bidirectional interoperability of CDC surveillance activities with electronic health records 
and other health information technology systems 
• Reducing the number of independent, stand-alone systems 
• Reducing the reporting burden on external partners to share public health data and information with 
CDC 
• Reducing the length of time between determining surveillance data of interest, receiving data 
electronically, sharing with programs, and using the data to impact public health 
Public Health Workforce Training Programs: The public health workforce must have the capacity to confront 
emerging communicable diseases, prevent chronic diseases and health effects from environmental hazards, 
assist communities in preparing for natural and man-made disasters, and be prepared to handle health threats 
that arise from outside our borders. The United States has seen a dramatic decline in the state and local public 
health workforce. CDC is a world-renowned leader in the field of workforce development. CDC sponsors a 
variety of workforce programs to help fill this gap. Examples include: 
• Epidemic Intelligence Service (EIS) is a hands-on, two-year postgraduate training program in 
epidemiology, with a focus on field work. For more than 60 years, EIS officers have been ready 
responders, identifying causes of disease outbreaks, recommending prevention and control measures, 
and implementing strategies to protect people from injury, disability, illness, and death. As CDC's 
"disease detectives," EIS officers have significant impact on improving the public's health. When disease 
outbreaks or other threats emerge, EIS officers are on the scene. They support over 100 public health 
investigations each year in the U.S. and worldwide. 
• Field Epidemiology Training Program (FETP) trains a global workforce of field epidemiologists to create a 
cadre of well-trained "disease detectives" with the necessary skills to collect, analyze, and interpret 
public health data and turn it into action. FETP residents and graduates are CDC's global "boots on the 
ground" in the ongoing battle against infectious diseases, environmental hazards, and chronic diseases. 
• Public Health Associate Program (PHAP) is a competitive, two-year, paid training program to provide 
experiential learning to early career professionals. PHAP associates are assigned to public health 
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agencies and nongovernmental organizations and work alongside other professionals in a variety of 
public health settings. After completing the program, PHAP graduates are qualified to apply for jobs 
with public health agencies and organizations. 
• Laboratory Leadership Service (LLS) is a two-year laboratory fellowship that provides early career 
laboratory scientists with a strong foundation for future leadership and management positions in 
laboratories conducting public health research or providing clinical or environmental testing services. 
The program provides high-quality training that focuses on biosafety, quality management systems, and 
management and leadership competencies. 
Global Health 
CDC could better protect Americans from diseases and other health threats that begin overseas by stopping 
them before they spread to our shores. 
CDC leverages its core strengths to advance four overarching global health goals: improving the health and well-
being of people around the world, improving capabilities for preparing and responding to infectious diseases 
and emerging health threats, building country public health capacity, and maximizing organizational capacity. 
CDC stations staff in more than 60 countries, many embedded in ministries of health (MOH) and at the World 
Health Organization, and deploys others from the United States to provide technical assistance, mentoring, and 
broad support to build national and regional capacity. These technical exchanges offer expertise from CDC to 
partners, but also create opportunities for CDC to learn from partners and communities from direct in-country 
engagement. 
These important global health outcomes would protect Americans at home and abroad, and could be advanced 
with increased funding for CDC's work in malaria and tuberculosis (TB): 
• The World Health Organization estimates that more than 6.2 million malaria deaths were averted 
worldwide between 2000 and 2015. Success in reducing prevalence, as well as the emergence of drug 
and insecticide resistance, is creating a different malaria landscape. New tools and approaches to reduce 
transmission completely and to overcome technical challenges are needed to support elimination. These 
include diagnostics, strategic use of treatment drugs, surveillance methods, vector control strategies, and 
vaccines. Malaria can be eliminated. Additional investment in CDC's programs will help the world meet 
this achievable target, in coordination with the global health community. 
• Although tuberculosis is nearly 100 percent curable, it is still one of the world's deadliest diseases and 
the leading cause of death among people with HI . There were nearly 500,000 cases of new multi-drug 
resistant (MDR) TB in 2015, and MDR-TB is now found in every country in the world. In addition, nearly 
50,000 cases of extremely drug resistant ( DR) TB have been identified in more than 90 countries. Even 
in countries with relatively low TB burden, such as the United States, TB and drug-resistant TB strain 
public health systems that must maintain a supply of expensive drugs and provide health services for 
patients that can stretch from six months to two years. Additional funding will strengthen the 
tuberculosis prevention program, including drug resistance, prevention of the spread of tuberculosis to 
patients and health care workers in hospitals and other health care facilities, better mapping the spread 
of tuberculosis, and ensuring complete treatment in order to save lives and prevent drug resistant TB. 
Environmental Health 
CDC has an opportunity to strengthen its environmental health research and public health program that 
monitors environmentally-related disease trends, and apply scientific evidence to address public health 
problems. 
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Investments in environmental public health infrastructure will improve health through the elimination of 
childhood lead exposure and improvement in asthma, cardiovascular disease, and other respiratory conditions. 
In FY 2012, Congress decreased funding for CDC's Lead Poisoning Prevention Program by 93 percent, from 
$29.2 million to $2 million. Congress limited CDC's role in supporting data systems that track lead exposures in 
children, conducting laboratory proficiency testing, and working on evidence-based healthy homes policies. 
CDC was unable to support its dedicated network of state and local lead poisoning prevention programs in 
delivering critical services to children exposed to lead, such as screenings and environmental inspections. 
Additionally, CDC could not provide technical assistance in developing state and local lead poisoning 
prevention laws, conducting trainings, or assisting over 180,000 locations in need of lead remediation. 
Childhood lead exposure continues to be a major concern and remains widespread in the United States. At 
least 4 million households have children who are being exposed to high levels of lead. The lead exposure in 
Flint, Michigan is a stark reminder of the damage that environmental health threats can cause. Specific 
environmental health threats include drinking water contamination, environment-related food hazards, 
expansion of infectious disease, radiation emergencies, and the decline of the state, local, and tribal 
environmental health workforce, which is the frontline defense for environmental health in our communities. 
With additional funds, CDC would support a comprehensive lead poisoning prevention program in all 50 states 
and major cities, including: 
• Robust detection (surveillance) systems to provide early warning of lead exposure 
• Dissemination of best practices to reduce lead exposure through partnership development at the local 
and state levels 
• Systems to ensure lead-exposed children receive appropriate follow-up services 
Alzheimer's Disease and the Healthy Brain Initiative 
CDC has an opportunity to strengthen public health's role in maintaining cognitive health, a vital part of healthy 
aging and quality of life. 
Alzheimer's disease is the most common form of dementia. Dementias are irreversible and progressive brain 
diseases that begin with mild memory loss leading to an inability to care for themselves and to remain 
independent. Alzheimer's disease involves parts of the brain that control thought, memory, and language and 
can seriously impair a person's ability to carry out daily activities. Scientists do not yet understand what causes 
Alzheimer's disease. In 2016, as many as 5.4 million Americans were living with Alzheimer's disease. The 
symptoms of the disease typically first appear after age 60 and the risk increases with age, although changes in 
the brain can begin years before the first symptoms appear. By 2050, 14 million Americans are expected to 
have Alzheimer's disease, a nearly three-fold increase. Efforts are needed to better understand both the 
national prevalence and trends of Alzheimer's disease, as well as risk and protective factors. 
The need for a clearly delineated public health role comes at a critical time given the dramatic aging of the 
United States population, scientific advancements in knowledge about risk behaviors (e.g., lack of physical 
activity, uncontrolled high blood pressure) related to cognitive decline, and the growing awareness of the 
significant health, social, and economic burdens associated with cognitive decline. Cognitive decline, ranging 
from mild cognitive impairment to dementia, can have profound implications for an individual's overall health 
and well-being. Older adults and others experiencing cognitive decline may be unable to care for themselves or 
conduct routine activities of daily living, such as meal preparation and money management. Limitations in the 
ability to effectively manage medications and existing medical conditions are particular concerns when an 
individual is experiencing cognitive decline or dementia. Informal or unpaid caregivers are the backbone of 
long-term care provided in people's homes. According to data from the Behavioral Risk Factor Surveillance 
System, about 25 percent of United States adults reported providing care or assistance to a person with a long-
term illness or disability. The value of this unpaid care is an estimated $221 billion. 
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Opportunities for maintaining optimal cognitive health are growing as public health professionals gain a better 
understanding of cognitive decline risk factors. CDC's Healthy Brain Initiative improves understanding of 
cognitive aging as a central part of public health practice. The initiative creates and supports partnerships, 
collects and reports data, increases awareness of cognitive aging, and promotes the use of The Healthy Brain  
Initiative: The Public Health Road Map for State and National Partnerships, 2013-2018. An Interim Progress 
Report highlights the Healthy Brain Initiative's accomplishments from 2013 to 2015. 
Calendar 
CDC uses an agency-wide tool to monitor and report upcoming high profile and significant activities. These 
activities are regularly reported, for awareness, to HHS, through CDC's Office of the Chief of Staff. Information is 
available upon request. 
Key Management Initiatives and Mandates 
CDC improved a number of critical management processes in the past eight years to enhance efficiency and 
effectiveness. For example: 
• Laboratory science and safety 
• Emergency preparedness and response activities 
• Working Capital Fund 
• Grant optimization 
• Buildings and facilities management 
• Enterprise risk management 
Laboratory Science and Safety 
CDC's guiding principles for laboratory work are to ensure the safety of all staff and the community and be as 
transparent as possible about our work as we conduct high-quality scientific research to protect people in this 
country and around the world. CDC established the position and Office of the Associate Director for Laboratory 
Science and Safety (OADLSS) reporting to the CDC director. OADLSS provides scientific, technical, and managerial 
expertise and leadership in the development and enhancement of laboratory safety programs; and oversees and 
monitors the development, implementation, and evaluation of the laboratory safety and quality management 
programs across CDC. OADLSS functions include: 
• Program Management: Managing, directing, and evaluating laboratory science and safety initiatives 
• Policy Development and Implementation: Developing, reviewing, and ensuring compliance with 
agency-level policies for laboratory science, safety, quality and training 
• Risk Management: Advising on CDC's portfolio of laboratory risk management procedures and 
strategies 
• Communications: Providing transparent flow of information across the laboratory community regarding 
laboratory science, safety, and quality; and sharing of best practices 
• Data and Information Management: Collecting and synthesizing data to inform laboratory safety and 
quality improvements 
Emergency Preparedness and Response Activities 
Since 2008, CDC has continued to improve emergency management processes, most recently enabling 
historically successful responses to the Ebola and Zika virus outbreaks. These process improvements specifically 
helped CDC to: 
• Address state and local workforce gaps and strengthen field staff operations through initiatives such as 
the Career Epidemiology Field Officers program, and Public Health Associate Program rotations with 
state and local public health preparedness teams. 
• Establish a new medical countermeasure (MCM) operational readiness review process to evaluate a 
jurisdiction's ability to plan and successfully execute large-scale responses requiring distribution and 
dispensing of medical countermeasures. 
• Achieve programmatic and administrative alignment of the Hospital Preparedness Program (HPP) and 
Public Health Emergency Preparedness (PHEP) cooperative agreements. As part of this, CDC developed a 
joint HPP-PHEP funding opportunity, funding application, and grant award; aligned grant cycle and 
reporting requirements and created a single grants management organization; aligned public health and 
healthcare system capabilities; and developed joint metrics, joint technical assistance planning and site 
visits, and a joint capabilities gap assessment tool. 
• Develop automated data sharing between HHS and the Defense Threat Reduction Agency; this supports 
secure sharing of emergency management and public health information. 
• Earn National Emergency Management Accreditation for CDC's Emergency Management Program; CDC 
remains the only Federal agency with this distinction. 
• Execute the largest full-scale deployments of MCMs in history by successfully deploying 25 percent of 
stockpiled influenza countermeasures to 62 project areas in 7 days during the 2009 H1N1 pandemic, as 
well as distribution of 126 million doses of monovalent H1N1 vaccine to more than 67,000 provider sites 
once product became available October-December 2009. 
• Improve the Vaccines for Children information technology system, VTrckS, which serves as a central 
distribution system pandemic module (option that can be exercised for a pandemic) as a result of CDC's 
response the 2009 H1N1 pandemic. 
Working Capital Fund 
In the FY 2012 appropriation bill, Congress authorized CDC to establish a Working Capital Fund (WCF). The 
impetus was to increase transparency, improve efficiency, and increase accountability in agency-wide business 
support services provision. 
WCF, led by the CDC Chief Operating Officer, is a mechanism for providing business services that support CDC 
programs on a fee-for-service basis. Through WCF, CDC creates operational efficiencies and encourages resource 
conservation, cost awareness, and performance measurement. Additionally, WCF increases transparency by 
making the cost of the services visible to programs. Participating programs have the ability to monitor the 
amount of services they require to complete work, and to make necessary adjustments. WCF-provided services 
are performed at pre-established rates that cover the full cost of operations. WCF operates on fees collected for 
WCF services, rather than from the direct business services appropriation. This creates market-like incentives for 
both customers and service providers, and maximizes efficiency. 
Implementation of WCF: 
• Allows Center directors, as the majority voting members on the governance board, to have more 
ownership of business services provided to programs 
• Promotes effective cost control within programs and service organizations 
• Achieves greater transparency with a standard process for developing and reviewing rates and reporting 
on the actual costs of services 
• Enables CDC to finance long-term capital investments, while avoiding cyclical funding spikes 
Grant Optimization 
Starting in October 2011, sparked in part by CDC's Advisory Committee to the Director recommendations to 
improve grants processes and procedures, CDC embarked on a grants optimization effort that has led to 
significant changes in the way the agency develops and announces funding opportunities. Beginning October 1, 
2013, CDC instituted a new Funding Opportunity Announcement development process that helped standardize 
and improve the quality of FOAs. The Funding Opportunity Announcement planning process now begins 12-18 
months prior to Funding Opportunity Announcement release and is used to review current program progress 
and plan program strategy. CDC now uses standard templates with guidance for both non-research and research 
Funding Opportunity Announcements that streamline and clarify guidance for external stakeholders. CDC also 
implemented GrantSolutions, a new grants management system that incorporates the entire lifecycle of the 
grants process. Once fully implemented, this comprehensive system will increase transparency, enable real-time 
updates on the status of requests, improve the consistency of decisions and actions, and increase efficiency. 
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Buildings and Facilities 
CDC implemented several measures over the past eight years to enhance efficiency, accountability, and mission 
support for agency facilities, these include: 
• Function Alignment: In 2013, CDC established a single office within the Office of the Chief Operating 
Officer to better align work in safety, security, buildings and facilities, property accountability, 
transportation, health and wellness, public health intelligence, and sustainability. This new approach 
improved coordination, collaboration, and efficiency. 
• CDC Capital Investment Review Board: In 2012, CDC established the CDC Capital Investment Review 
Board (CCIRB), chaired by the chief operating officer. Leaders from CDC's centers, institute, and offices 
serve on the board, and they direct major facilities investments and guide a strategic direction for 
capital investment on campuses nationwide. The board ensures agency facility investments are made in 
the best interest of public health. 
• Space Consolidation: CDC consolidated its leased space portfolio and reduced its space utilization rate 
(UR). Almost 2,000 staff have moved from leased to owned space, reducing operational costs from $44.3 
million to $32.4 million. The agency has implemented widespread space-sharing practices to reduce the 
amount of office space needed and decrease costs. Since 2010, the agency has reduced leased rentable 
square footage by 461,521 square feet. Leased space has moved from a UR of 233 square feet per 
person to 215 square feet per person. 
Enterprise Risk Management 
The Office of Management and Budget released guidance on Federal enterprise risk management with 
instructions for all Federal agencies to implement enterprise risk management (ERM). ERM is coordinated and 
strategic risk management applied across an organization that addresses all types of risk (strategic, reputational, 
operational, financial, and compliance). ERM is the next step in the evolution of risk management, which in the 
past has focused mainly on finance and compliance. Some of the benefits of ERM include standardizing risk 
information to inform strategic decision-making, identifying crosscutting risks and root causes, and empowering 
employees at all levels to manage risk. With leadership from the Office of the Chief Operating Officer, CDC is in 
the process of implementing the ERM framework. Once the process is fully integrated into CDC operations, the 
framework will promote a holistic view of risk, including proactive risk assessment and management and a more 
transparent and risk-aware culture. The program will follow three guiding principles: promote transparency 
throughout the organization, raise risk awareness among leadership and staff, and use quality risk information 
to support better decision-making. 
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Budget Overview 
In fiscal year (FY) 2016, Congress appropriated CDC just over $7 billion, more than $100 million over the 
President's Budget request. The FY 2017 President's Budget request significantly reduced CDC's overall program 
level. 
Centers for Disease Control and Prevention 




President's Budget Request Program Level 
	
$7,010,103 
Budget Authority $6,095,803 
Public Health Service (PHS) Evaluation Funds $0 
Prevention and Public Health Funds (PPHF) $914,300 






Final Program Level 
	
$7,178,045 	 TBD 
Budget Authority $6,270,745 TBD 
Public Health Service (PHS) Evaluation Funds $0 	 TBD 
Prevention and Public Health Funds (PPHF) $892,300 	 TBD 
Public Health and Social Services Emergency Fund (PHSSEF) $15,000 TBD 
Increase Above the President's Budget Request 	 $167,942 	 TBD 
Top Budget Opportunities and Challenges 
As presented in the Top Issues for New Leadership, CDC has a number of opportunities under the new 
Administration to improve the nation's health security by increasing investments in public health programs, both 
domestic and abroad. CDC faces a number of budget-related challenges, which are also highlighted below. 
Public Health Emergency Response 
Public health emergencies are unpredictable and can be costly. The global costs of the Severe Acute Respiratory 
Syndrome (SARS) epidemic in 2003 have been estimated at over $50 billion, and in 2008, the World Bank 
estimated that a severe flu pandemic could result in $3 trillion in global economic losses. The World Bank 
estimated the regional economic damage of the Ebola outbreak in West Africa to have been $2.2 billion in 2014-
2015. The World Bank has mobilized around $1.6 billion for Ebola response and recovery efforts—some of which 
would likely have been avoided with swifter action to contain the outbreak. CDC needs to detect and analyze the 
threat, and develop, evaluate, and adjust public health strategies in real-time. However, CDC does not have a 
funding mechanism to respond to domestic or foreign public health emergencies. Such a fund will allow for 
appropriate and immediate interventions that could prevent an aggressive or fast-moving outbreak in the early 
stages from becoming an epidemic, and prevent an epidemic in a country or region from spreading to a world-
wide pandemic. 
Buildings and Facilities 
Investments in buildings and facilities are needed to support a safe, world-class research environment. Both 
major capital investment and repair of current buildings and facilities are essential to ensure that CDC is able to 
maintain its ability to respond to the public health needs in the next decade. Most urgently, current 
infrastructure at CDC's Roybal Campus headquarters is inadequate to support the intensive demands of ongoing 
laboratory work and the campus population of over 5,000. Infrastructure improvements are necessary to 
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support existing and planned laboratory facilities, which draw greatly on utilities, and require intricate and 
reliable support systems to maintain a safe and scientifically-advanced research environment. The Roybal 
infrastructure improvement project is one of CDC's many facility improvement proposals requiring significant 
funding to meet the demands of the public health workforce and provide safe and secure laboratories and office 
space. The current lack of support for the basic needs of CDC's infectious disease workforce and laboratory 
scientists inhibits scientific productivity and collaboration. The situation at CDC's Pittsburgh Research Campus is 
worse, which is hampering occupational safety and health research—especially in mining. 
Global Health 
The most effective and least expensive way to protect Americans from diseases and other health threats that 
begin overseas is to stop them before they spread to our shores. CDC leverages its core strengths to advance 
four overarching global health goals: improving the health and well-being of people around the world, improving 
capabilities for preparing and responding to infectious diseases and emerging health threats, building country 
public health capacity and maximizing organizational capacity. CDC assigns staff in countries, many embedded in 
ministries of health (MOH) and the World Health Organization, and deploys others from the United States to 
provide technical assistance, mentoring, and broad support to build national and regional capacity. These 
technical exchanges offer technical expertise from CDC to partners, but also create opportunities for CDC to 
learn from partners and communities from direct in-country engagement. CDC recognizes the central role 
played by MOHs and understands that long-term sustainability for in-country health activities is contingent on 
country ownership and MOH programmatic and management capacity to plan, implement, monitor, and 
evaluate programs. 
Environmental Health 
Environmental health challenges are re-emerging threats for the United States and the world. Americans cannot 
be truly secure if basic, life-sustaining necessities are under threat. Threats against the water we drink, the air 
we breathe, the food we eat in restaurants, and the environments where we live, work, and play are reemerging 
and evolving as society changes. World Health Organization estimates that, overall, 13 percent of the disease 
burden in the United States is due to environmental factors. The Agency for Toxic Substances and Disease 
Registry estimated that 5.6 million disability-adjusted life years and 398,000 deaths annually can be attributed to 
environmental factors in America. To help ensure the security of the American people, CDC has an opportunity 
to strengthen its environmental health research and programs that monitor environmentally-related disease 
trends, and apply scientific evidence to address public health problems. CDC also identifies the environmental 
exposures that make people sick, investigates how the environment transmits those exposures, and finds ways 
to eliminate the threat to people's health—thereby saving money and lives. 
Constraints within CDC Budget Structure; Need for Transfer Authority and Two-Year Fund Availability 
CDC's appropriation includes 13 separate accounts and over 160 programs, projects, and activities that Congress 
determines in the annual appropriations bill. CDC's programs, projects, and activities range from $475,000 for 
the Cancer Survivorship Resource Center to $660 million for the Public Health Emergency Preparedness 
program. This structure is extremely complicated to manage and provides little to no flexibility to direct funds to 
emerging public health threats. 
The majority of CDC's funding is appropriated for a one-year period of availability (POA). Appropriations delays 
make it difficult for CDC to award thousands of grants and contracts annually. This is particularly challenging for 
international programs or those that require coordination across CDC. Other international program agencies have 
two-year or no-year POAs for most international program accounts. With an expansion of the POA in CDC's 
accounts to two years, CDC could plan and execute its extramural programs more effectively. 
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The CDC director is unable to effectively use public health science to direct investment in an unanticipated 
priority or rapidly respond to a public health emergency. Constraints within CDC's budget structure and the 
limited POA prevent adjustments in spending when program priorities change. CDC also lacks authority to move 
funds between accounts, if needed. When priority issues emerge or there is an emergency, the CDC director has 
only two options: 
• Reprogramming: Moving funds within an appropriations account. CDC must notify Congress if the 
reprogramming exceeds the lessor of 10 percent of the relevant programs, projects, and activities or 
$500,000. 
• Transfer: Moving funds across appropriations accounts. CDC must use HHS's statutory transfer 
authority, which is limited to 1 percent of any current discretionary appropriations and cannot increase 
the receiving account by more than 3 percent. 
CDC requested agency-level transfer authority in the FY 2017 President's Budget request. If enacted, this would 
allow the CDC director to leverage up to 3 percent from any account across the agency, with congressional 
notification, and ensure the timeliest response to immediate health threats either domestically or 
internationally. 
Erosion of CDC's Budget Authority and the Prevention and Public Health Fund 
Since FY 2010, Congress has used the Prevention and Public Health Fund (PPHF) to supplant budget authority. 
PPHF funding is now integral to CDC programs, and these funds currently support a range of CDC's base 
activities. PPHF funding has grown from 2.8 to 12.4 percent of CDC's total program budget. As the incoming 
Administration finalizes the FY 2018 President's Budget request, support for CDC's overall program level and 
increase in budget authority will be crucial. 
CDC's Prevention and Public Health Fund 
FY 2010-FY 2016 











FY 2010 	FY 2011 	FY 2012 	FY 2013 	FY 2014 	FY 2015 	FY 2016 
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At CDC, a $119 million reduction in budget authority and the elimination of PHS Evaluation Transfers (-$352 
million) has accompanied an increase in PPHF funding since FY 2010. The majority of these funds support five of 
CDC's existing state and local programs: 
• Preventive Health and Health Services Block Grant: Funded entirely by PPHF, this program provides 
flexible funds to State health departments to address their unique public health needs in innovative 
and locally-defined ways. 
• Immunization: PPHF funds more than 50 percent of this program, which protects individuals and 
communities from vaccine-preventable diseases through purchase vaccine, financial support of 
immunization state programs, provider and public education, and evaluation and research. 
• Racial and Ethnic Approaches to Community Health (REACH): Funded entirely by PPHF, CDC partners 
use community-based, participatory approaches to identify, develop, and disseminate effective 
strategies for addressing health disparities across a wide range of chronic disease priority areas. 
• Tobacco: PPHF funds more than 50 percent of this program, which supports the lifesaving TIPS from 
Former Smokers advertising campaign and tobacco uitline, two proven interventions for smoking 
cessation. 
• Childhood Lead Poisoning Prevention: Funded entirely by PPHF, this program is committed to the 
Healthy People 2020 goals of eliminating blood lead levels 10 g dL and differences in average risk 





















686 $7,252,736 $7,088,537 $7,858,135 $7,134,439 
Less PHS Eval $(325,673) $ 	- $(72,000) $ 	- 
Less PPHF $ $(892,300) $(944,470) $(908,300) $(891,300) 
Less PHSSEF $ 	- I 	$(15,000) < 	- $(15,000) 
Total Budget 
Authority 
$6,124,013 $6,345,436 $6,072,067 $6,949,835 $6,228,139 
FTE $8,951 $10,886 $10,886 $10,886 $10,886 
(b)(5) 
)(5) (b 
Fiscal Year 2018 Current Services Budget 
FY 
No. of 





Project Category Projects Cost Projects Cost 
Emergency 1 $1,000,000 $1,000,000 
Fire & Life Safety 15 $5,364,000 42 $7,680,446 
Security 5 $617,500 4 $2,150,500 
Condition Index 68 $19,109,000 27 $16,059,054 
Program Support 14 $4,935,000 13 $1,385,000 
Space Utilization 2 $675,000 N/A N/A 
Other 8 $4,145,000 12 $2,725,000 








Centers for Disease Control and Prevention and ATSDR 
OMB Current Services Baseline All-Purpose Table 
(Dollars in Thousands) 
Activity 















HIV/AIDS, Viral Hepatitis, STI and TB 
Prevention 
$1,002,130 $1,122,278 $1,127,278 $1,122,278 $1,112,278 
Emerging and Zoonotic Infectious Diseases $217,771 $579,885 $629,485 $677,522 $578,885 
Chronic Disease Prevention and Health 
Promotion 
$833,827 $1,177,096 $1,117,145 $1,097,821 $1,064,646 
Birth Defects, Developmental Disabilities, 
Disability and Health 
$127,366 $135,610 $135,610 $135,310 $137,560 
Environmental Health $154,486 $182,303 $182,303 $160,800 $182,303 
Injury Prevention and Control $134,837 $236,059 $298,629 $261,059 $264,059 
Public Health Scientific Services $276,778 $491,597 $500,631 $485,397 $485,000 
Occupational Safety and Health $381,954 $339,121 $285,621 $329,100 $334,121 
Global Health $302,371 $427,121 $442,121 $556,721 $432,121 
Public Health Preparedness and Response $1,479,455 $1,405,000 $1,402,166 $1,485,800 $1,396,800 
Cross-Cutting Activities and Program 
Support23  
$725,016 $273,570 $113,570 $713,570 $273,570 
Building and Facilities $55,022 $10,000 $31,221 $10,000 
ATSDR $74,039 $74,691 $74,691 $74,691 $74,691 
Total Program Level $6,449,686 $7,252,736 $7,088,537 $7,858,135 $7,134,439 
Less PHS Evaluation $(325,673) $ 	- $(72,000) $ 	- $ 	- 
Less PPHF $ 	- $(892,300) $(944,470) $(908,300) $(891,300) 
Less PHSSEF $ 	- $(15,000) $ 	- $ 	- $(15,000) 
Total Budget Authority $6,124,013 $6,345,436 $6,072,067 $6,949,835 $6,228,139 
FTE $8,951 $10,886 $10,886 $10,886 $10,886 
Budget Trends 
Since FY 2011, the President's Budget request for CDC has been below the average HHS-wide request. 
President's Budget Request by Fiscal Year 
FY 2011 FY 2012 FY 2013 FY 2014 FY 2015 FY 2016 FY 2.017 
HHS Average for all OPDIVS 9.5% 9.2% 
3.2% 
(5.9%) 














(7.1%) CDC Variance from HHS average (11.6%) 
Despite this challenge, in 5 of the past 7 years, Congress has appropriated more than the Administration 
requested for CDC. 












$6,611,478 $7,090,384 $6,660,061 $6,589,283 $6,606,361 $7,010,103 
$6,837,086 $6,866,027 $6,286,547* $6,833,158 $6,900,418 $7,178,045 
$225,608 ($224,357) ($373,514) $243,875 $294,057 $167,942 
*FY 2013 operating level includes reductions from sequestration and the Prevention and Public Health Fund reallocation. 
Since FY 2010, Congress has used the Prevention and Public Health Fund to supplant budget authority. 
Prevention and Public Health Fund funding is now integral to CDC programs, and these funds currently support a 
range of CDC's base activities. The biggest risk to CDC's budget, as a result of the changes that have occurred 
over the past eight years, is the erosion of budget authority: 
• Since the Prevention and Public Health Fund inception in FY 2010, these funds have grown from 2.8 
percent to 12.4 percent of CDC's budget. 
• Prevention and Public Health Fund funding has been accompanied by a $119 million reduction in budget 
authority and the elimination of Public Health Service (PHS) Evaluation Transfers (-$352 million). 
• While CDC has seen a $244 million net increase in funding; this increase has almost entirely come from 
Prevention and Public Health Fund at the expense of budget authority and PHS Evaluation funds. 
Source 
Fiscal Year 2010 
Funding Amount 
Fiscal Year 2016 
% of Total Funding Amount 	% of Total 
Budget Authority $6,389,442 92.2% $6,270,745 87.4% 
PHS Evaluation $352,357 5.1% $ 	- 0.0% 
PHSSEF $ 	- 0.0% $15,000 0.2% 
PPHF $191,800 2.8% $892,300 12.4% 
Total $6,933,599 100% $7,178,045 100% 







Since 2008, CDC has received funding from various sources: 
• American Recovery and Reinvestment Act (ARRA): AARA of 2009 (P.L. 111-5), commonly referred to as 
The Stimulus or The Recovery Act, was a stimulus package that the 111th United States Congress 
enacted and that President Obama signed into law in February 2009. 
• Budget Authority (BA): Broad responsibility conferred by Congress that empowers government agencies 
to spend Federal funds. Congress can specify criteria for how agencies spend these funds. For example, 
Congress may stipulate that a given agency must spend funds by any time in the future such as within a 
specific year or number of years. 
• Cooperative Research and Development Agreement (CRADA): CRADA makes government facilities, 
intellectual property, and expertise available for collaboration to promote development of 
commercialized products that meet a public health need. CRADA offers collaborators an option to 
license any CDC-developed intellectual property that results from the agreement. 
• Energy Employees Occupational Illness and Compensation Program Act (EEOICPA): EEOICPA was 
enacted in October 2000 to provide compensation and medical benefits to employees who worked at 
certain Department of Energy facilities, including contractors, subcontractors, and certain vendors. 
• Non-recurring Expenses Fund (NEF): NEF permits HHS to transfer unobligated balances of expired 
discretionary funds from FY 2008 and subsequent years into the NEF account. Congress authorized use 
of the funds for capital acquisitions including information technology and facilities infrastructure. 
• President's Emergency Plan for AIDS Relief (PEPFAR): PEPFAR is an initiative to address the global 
HIV/AIDS epidemic and help save the lives of those suffering from the disease (primarily in Africa). 
• President's Malaria Initiative (PMI): President George W. Bush created PM! in 2005 and 
President Barack Obama continued the Initiative. PMI's mission is to reduce malaria-related mortality by 
50 percent across 15 high-burden countries in sub-Saharan Africa. 
• Prevention and Public Health Fund (PPHF): Section 4002 of the Patient Protection and Affordable Care 
Act of 2010 established PPHF. PPHF is the nation's first mandatory funding stream dedicated to 
improving our nation's public health system. 
• Public Health and Social Services Emergency Fund (PHSSEF): PHSSEF is an account HHS uses to provide 
annual or emergency supplemental appropriations for one-time or short-term public health activities in 
a variety of agencies and offices. 
• Public Health Service Evaluation Funds (PHS Evaluation): Section 241 of the Public Health Service Act 
(PHSA) authorizes the HHS Secretary, with the approval of congressional appropriators, to use a portion 
of the funds appropriated for programs authorized by PHSA to evaluate their implementation and 
effectiveness. This long-standing budgeting authority is known as the PHS Program Evaluation Set-Aside. 
• Vaccines for Children (VFC): VCF is a Federally-funded program providing no-cost vaccines to children 
who lack health insurance or who cannot otherwise afford vaccination costs. The Omnibus Budget 
Reconciliation Act of 1993 created the VFC program and required VCF to be a new entitlement of each 
State's Medicaid plan. 
• Working Capital Fund (WCF): WCF is a revolving fund that allows an agency to provide business services 
on a fee-for-service basis. CDC's WCF finances organizations that provide administrative and business 
services support to CDC programs. WCF refers to these organizations, commonly known as CDC's 
Business Services Offices (BS0s), as "service providers." WCF launched in the beginning of FY 2014. 
• World Trade Center Health Program (WTCHP): WTCHP provides medical benefits to individuals affected 
by the September 11,2001 terrorist attacks on the United States. Title I of the James Zadroga 9/11 
Health and Compensation Act of 2010 (P.L. 111-347), which amended the Public Health Service Act, 
established WTCHP. 
Expenditures 
Personnel and non-personnel expenses by program can be found in Attachment H. 
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Oversight 
The Office of the Chief of Staff and has responsibility for CDC program reviews performed by the Government 
Accountability Office and audits or program evaluations conducted by the Office of Inspector General. The 
following table lists engagements with CDC since 2009. 




	 Title 	 Status 
Date 
2/18/2016 	3/2/2016 Zika Virus http://www.gao.gov/products/GA0-16-470T Closed; No Recommendations 
5/5/2015 9/14/2015 E-cigarette Data and Revenue Implications 
http://www.gao.gov/products/GA0-15-771  
Closed; No Recommendations 
3/30/2015 	7/30/2015 Federal Autism Research Closed; No Recommendations 
http://www.gao.gov/search?q=GA0-15- 
583R&Submit=Search 
3/2/2015 	2/25/2016 Patient Safety Practices in Hospitals 
http://www.gao.gov/products/GA0-16-308  
Closed; No Recommendations 
2/19/2015 	6/20/2016 Federal Autism Efforts 
http://www.gao.gov/products/GA0-16-446 
Closed; No Recommendations 
2/3/2015 	1/13/2016 EBOLA, DHS, OIG Pandemic Planning and Response Closed; No Recommendations 
(Report not on the Web, hard copy available only) 
11/21/2014 	12/17/2015 	Preparedness of U.S. Aviation System to React to 	Closed; No Recommendations 
Health Threats from Infectious Diseases 
http://www.gao.gov/products/GA0-16-127  
10/27/2014 	1/22/2016 Oversight and Costs of the Oak Ridge Institute for Closed; No Recommendations 
Science and Education Fellowship Program 
http://www.gao.gov/products/GA0-16-128  
10/16/2014 	5/13/2015 Illicit Tobacco Imports and E-Cigarettes 
http://www.gao.gov/prerelease/Pkt2 
Closed; No Recommendations 
10/2/2014 1/20/2016 OIG Preliminary Research into Select Agents Closed; No Recommendations 
(No report issued) 
7/8/2014 	8/1/2014 	High-Containment Laboratories: Incident at CDC 	Closed; No Recommendations 
Laboratories 
http://www.gao.gov/assets/670/664799.pdf  
4/7/2014 Audit of CDC Grants and Cooperative Agreements Follow-up on 
Funded by the Prevention and Public Health Fund 
http://go.usa.gov/cPfGz 
Recommendations Underway 




2/13/2014 Review of Centers for Disease Control and Prevention's Follow-up on 
Accountability for Property 
https://oig.hhs.gov/oas/reports/region4/41403546.asq 
Recommendations Underway 
1/14/2014 Audit of the CDC's Award Process for President's Follow-up on 
Emergency Plan for AIDS Relief Cooperative Agreement 
http://go.usa.gov/c.JzgP 
Recommendations Underway 
8/27/2013 	12/30/2015 Project Bioshield: Anthrax Vaccine and Stockpile Closed 
License http://www.gao.gov/products/GA0-08-88  




2/13/2012 7/20/2012 U.S. Global Health Program Drug Procurement and Closed; No Recommendations 














8/19/2011 Review of Evaluations of PEPFAR Programs 
Implemented by CDC and USAID 
http://www.gao.gov/products/GA0-12-673  
Closed; No Recommendations 
8/4/2011 Review of World Trade Center Health Program 
http://go.usa.gov/B4p5  
Closed; No Recommendations 
5/17/2011 10/19/2015 Duplication of Federal Inspections of High Containment 
Laboratories (HCL) 
http://www.gao.gov/products/GA0-13-154 
Closed; No Recommendations 
2/18/2011 	8/4/2011 World Trade Center (WTC) Health Programs 
http://www.gao.gov/products/GA0-11-735R 
Closed; No Recommendations 
2/18/2011 7/15/2011 Timely Submission of Claims Data for World Trade 
Center Health Program 
http://www.gao.gov/products/GA0-11-793R 
Closed; No Recommendations 
1/13/2011 	8/17/2011 Shelf Life Extension Program at the Centers for Disease 
Control and Prevention 
https://oig.hhs.gov/oas/reports/region4/41101001.asp 
Closed; No Recommendations 
8/16/2010 5/18/2011 High-Containment Laboratories: Duplication of Federal 
Oversight (No report issued) 




CDC's Policies and Practices Related to its Published 
Public Health Products, to Include CDC's Work on D.C.'s 
Lead in Water Crisis 
http://www.gao.gov/products/GA0-11-279  
Closed 
3/11/2010 High-Containment Laboratories: GAO Assessment of 
Federal reports of Biosafety and Biosecurity 
http://www.gao.gov/products/GA0-13-466R 
Closed; No Recommendations 
7/2/2009 Review of CDC's Resolution of Audit Recommendations 
https://oig.hhs.gov/oas/reports/region7/70903131.asp 
Closed 
Closed 4/15/2009 6/30/2011 ATSDR Policies and Procedures for Developing Public 




Key Structures and Decision-Making Processes 
Meeting Calendar 
Leadership Group 	 Regular Meeting Occurrences 
 
Senior Leadership 
CDC Management Board 
Working Capital Fund Board 
 
Every other Monday, 9:00 — 10:30 a.m. 
First Tuesday of every month, 1:30 — 3:00 p.m. 
Quarterly. Upcoming dates: 
• December 5, 2016 
• March 13, 2017 
• June 5, 2017 
• December 18, 2017 
Twice a year, in April and October. Upcoming dates: 
• April 20, 2017 
• October 19, 2017 
• April 26, 2018 
• October 25, 2018 
 
Advisory Committee to the Director 
Senior Leadership Team 
 
CDC's senior leadership team governs the agency's overall direction. A wide array of specific topic, functional, 
and project leadership boards work together to network, coordinate, and move the agency's agenda forward. 
The CDC Director manages the agency's primary leadership group, the senior leadership team. 
CDC Management Board 
The CDC Chief Operating Officer leads the CDC Management Board, which governs CDC's management practices 
in support of the agency's goals and strategic direction. The board is accountable for: 
• Ensuring the health, welfare, morale, and development of an increasingly diverse workforce 
• Improving management within CDC 
• Providing cost-effective and efficient business services 
• Communicating significant decisions and the associated rationales 
Working Capital Fund Governance Board 
The Working Capital Fund (WCF) is a revolving fund that allows an agency to provide business services on a fee-
for-service basis. CDC's WCF finances organizations that provide administrative and business services support to 
CDC programs. A board presides over the WCF and approves the scope of services, associated rates, and service 
levels. The chief operating officer chairs the board, which is comprised of the CDC center directors, chief 
information officer, and chief financial officer. 
Tribal Advisory Committee 
The Tribal Advisory Committee provides CDC with input and guidance on policies, guidelines, and programmatic 
issues affecting the health of American Indian Alaska Native (Al AN) tribes. The TAC is composed of 16 
delegates (and authorized representatives) from federally recognized tribes to provide specific representation 
for the regional and national concerns of tribal governments. 
Advisory Committee to the Director 
Federal advisory committees are a key component of CDC's overall strategy to achieve stakeholder and public 
engagement in its efforts and commitment to improve people's health. The Federal Advisory Committee Act 
(P.L. 92-463) provides a mechanism for experts and stakeholders to participate in the decision-making process, 
and to offer advice and recommendations to the Federal government. 
The CDC Advisory Committee to the Director advises the CDC director on policy and broad strategies that enable 
CDC to fulfill its mission of protecting health through health promotion, prevention, and preparedness. The 
Advisory Committee to the Director recommends ways to prioritize CDC's activities, improve results, and 
address health disparities. It also provides guidance to help CDC work more effectively with its various private 
and public sector constituents to make health protection a practical reality. 
Current membership: 
• Jonathan E. Fielding, MD, MPH (chair) 
• Dileep G. Bal, MD, MS, MPH 
• Kenneth Berns, MD, PhD 
• Benjamin K. Chu, MD, MPH, MCAP 
• Christopher J. Elias, MD, MPH 
• Thomas A. Farley, MD, MPH 
• David W. Fleming, MD 
• Lynn R. Goldman, MD, MS, MPH 
• Anthony B. Iton, MD, JD, MPH 
• Joseph A. Kanabrocki, PhD 
• LaQuandra Sherese Nesbitt, MD, MPH 
• Lynne D. Richardson, MD, FACEP 
• Sara Rosenbaum, JD 
• Wilma J. Wooten, MD, MPH 
Other CDC Federal Advisory Committees 
Currently, 21 Federal advisory committees provide advice and recommendations on a broad range of public 
health issues to help CDC achieve its mission to promote health and quality of life by preventing and controlling 
disease, injury, and disability. 
• Advisory Board on Radiation and Worker Health 
• Advisory Committee on Breast Cancer in Young Women 
• Advisory Committee on Immunization Practices 
• Advisory Committee to the Director, Centers for Disease Control and Prevention 
• Advisory Council for the Elimination of Tuberculosis 
• Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances 
and Disease Registry 
• Board of Scientific Counselors, National Center for Health Statistics 
• Board of Scientific Counselors, National Center for Injury Prevention and Control 
• Board of Scientific Counselors, National Institute for Occupational Safety and Health 
• Board of Scientific Counselors, Office of Infectious Diseases 
• Board of Scientific Counselors, Office of Public Health Preparedness and Response 
• Breast and Cervical Cancer Early Detection and Control Advisory Committee 
• CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment 
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• Clinical Laboratory Improvement Advisory Committee 
• Disease, Disability, and Injury Prevention and Control Special Emphasis Panel 
• Healthcare Infection Control Practices Advisory Committee 
• Interagency Committee on Smoking and Health 
• Mine Safety and Health Research Advisory Committee 
• National Committee on Vital and Health Statistics 
• Safety and Occupational Health Study Section 
• World Trade Center Health Program —Scientific Technical Advisory Committee 
Participation in Enterprise Government Activities 
CDC is an active participant with many HHS and government-wide committees and working groups. These range 
from scientific, cross-cutting activities such as Combating Antibiotic-Resistant Bacteria to management and 
operations, such as the HHS Service and Supply Fund. 
Piq.c. 
Policies and Regulations 
For more information about CDC's regulations, please visit www.cdc.gov/regulations.  
Historical Overview (2009-Present) 
The majority of CDC's regulatory activities each year are revisions to current regulations. Since 2009: 
• One new regulation has been added to the Code of Federal Regulations (CFR), the World Trade Center 
Health Program in 2011 (42 CFR 88). 
• One regulation has been rescinded from the CFR, the Administrative Functions, Procedures, and 
Practices (42 CFR 80). 
• Number of new rulemakings added to the Unified Agenda of Regulatory and Deregulatory Actions per 
year: 4 (average); 1-7 (range); 33 (total). 
• Published regulations: 56. 
• Percentage deemed significant by the Office of Management and Budget's Office of Information and 
Regulatory Affairs (OIRA): 39.2 percent (22 of 56). 
Recently Adopted or Pending Policies and Regulations 
Pending Regulations 
Since 2009, CDC has published as few as 1 and as many as 14 new regulations per year. CDC's average is seven 
regulations per year. 
• Biennial Review of Select Agents and Toxins Final Rule (0920-AA53), estimated publication late October 
to early November, 2016 (30-day effective date). 
• World Trade Center Health Program Final Rule (0920-AA56), estimated publication mid-December 2016 
(30-day effective date). 
• Control of Communicable Diseases Final Rule (0920-AA63), estimated publication mid-December 2016. 
Final Rules 
• Addition of highly pathogenic avian influenza (HPAI) H5N1 Influenza strains to the List of HHS Select 
Agents and Toxins (42 CFR 73): notice of proposed rulemaking (NPRM) published July 16, 2015. 
• Addition of Bacillus cereus Biovar anthracis to the List of HHS Select Agents and Toxins (42 CFR 73): IFR 




Existing Regulatory Practice 
Rulemaking identified through CDC's annual retrospective review of its regulations: 
• Grants for Educational Programs in Occupational Safety and Health (42 CFR 86) 
• National Institute for Occupational Safety and Health Research and Demonstration Grants (42 CFR 87) 
Response to World Trade Center Health Program petitions: 
• Response to one petition is in development; response should be published by December 31, 2016. The 
response will not require rulemaking 
• At this time, it is unknown if other petitions will be submitted in the new Administration's first year 
Request for comments: 
• CDC routinely publishes requests for comments and requests for information on various draft scientific 
documents, vaccine information materials, and strategic plans 
• CDC currently has no requests for comments and requests for information under review 
Office of Information and Regulatory Affairs Relations 
Relations between CDC employees and the Office of Information and Regulatory Affairs (OIRA) career staff: 
• CDC works through policy coordinators in HHS's Office of the Executive Secretariat 
• Within CDC, the Office of the Chief of Staff serves as the liaison for all regulatory matters 
CDC's principal contacts on °IRA's career staff: 
• CDC's desk officer at OIRA is Dr. Stephanie Mok 
• CDC works with other OIRA staff as needed, including OIRA policy analysts, health statisticians, and 
health economists 
• On select agent rulemaking, CDC works with Cortney Higgins, desk officer for the United States 
Department of Agriculture's Animal and Plant Health Inspection Service 
The review process for regulations within CDC: 
• CDC programs submit regulatory documents to the Office of the Chief of Staff for review 
• Documents are disseminated to key CDC offices for review including: 
o Office of Associate Directors for Science, Policy, and Communications 
o Office of the General Counsel 
o Office of the Chief Operating Officer 
o Program Planning and Evaluation 
o CDC Washington Office 
o CDC privacy officer 
o CDC Information Collection Review Office (Paperwork Reduction Act) 
o Other CDC units as necessary 
• After comments are resolved, the chief regulatory officer approves the regulation 
• After approval by the chief regulatory officer, the chief of staff and the CDC director approve the rule for 
transmittal to HHS Office of the Executive Secretariat 
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CDC employees responsible for managing the regulatory process and assembling the CDC section of the Unified 
Agenda: 
• Cynthia K. Clark, director, Division of Issues Management, Analysis, and Coordination, Office of the Chief 
of Staff 
• Anne E. O'Connor, senior regulations issues manager, Division of Issues, Management, Analysis, and 
Coordination, Office of the Chief of Staff 
Enforcement Issues 
Foreign Quarantine Regulations: Human Remains (42 CFR 71.55) 
• Current regulations require that remains are: a) properly embalmed and placed in a hermetically sealed 
casket; b) cremated; or c) accompanied by a permit signed by the director. 
• Body brokers repeatedly import body parts in containers that are considered unsafe and without 
appropriate documentation. 
• Current regulations only pertain to quarantinable diseases, but have no requirements for human 
remains of an individual infected with other infectious diseases such as Hepatitis B or C. 
• Current regulations need revision to clarify requirements for family members who are repatriating 
remains for final burial. 
• Current regulations need revision regarding repatriating remains of an individual who has died from a 
viral hemorrhagic fever. 
Foreign Quarantine Regulations: Cats, Dogs, Ferrets (42 CFR 71.51) 
• CDC has little oversight or control of an animal after it enters the United States—especially a dog in 
confinement due to inadequate vaccination for rabies. 
• There are no vaccination requirements for cats or ferrets. And current regulations do not require a valid 
health certificate for any animal entering the United States. 
Foreign Quarantine Regulations: African Rodents (42 CFR 71.56) 
• Revised regulations would ban the importation of all rodents, except for science, education, or 
exhibition. 
Foreign Quarantine Regulations: All Imports (42 CFR 71, Section F) 
• Current regulations contain no provisions regarding the treatment of animal products to render them 
non-infectious for all imports. 
• Revised regulations would require that the animal or product is no longer capable of introducing, 
transmitting, or spreading a communicable disease to humans. It would also detail several specific 
methods and include new options at the discretion of the CDC director. 
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Title of Regulation Regulatory Authority Statutory Authority 
42 CFR Part 7 
42 CFR Part 34 
42 CFR Part 37 
42 CFR Part 70 
42 CFR Part 71 
42 CFR Part 73 
42 CFR Part 81 
42 CFR Part 82 
42 CFR Part 83 
42 CFR Part 84 
42 CFR Part 85 
42 CFR Part 85a 
42 CFR Part 86 
42 CFR Part 87 
42 CFR Part 88 
42 CFR Part 90 
42 CFR Part 493 
Sec. 215, 58 Stat. 690, as amended (42 U.S.C. 
216); title V of the Independent Offices 
Appropriations Act of 1952 (31 U.S.C. 9701); and 
secs. 301(a) and 352 of the Public Health Service 
Act, as amended (42 U.S.C. 241(a) and 263). 
42 U.S.C. 252; 8 U.S.C. 1182 and 1222 
Sec. 203, 83 Stat. 763; 30 U.S.C. 843. 
Secs. 215 and 311 of the Public Health Service 
(PHS) Act, as amended (42 U.S.C. 216, 243); 
section 361-369, PHS Act, as amended (42 U.S.C. 
264-272); 31 U.S.C. 9701. 
Secs. 215 and 311 of Public Health Service (PHS) 
Act as amended (42 U.S.C. 216, 243); secs. 361-
369, PHS Act, as amended (42 U.S.C. 264-272). 
42 U.S.C. 262a; sections 201-204, 221 of Title II of 
Public Law107-188; 116 Stat.637 
42 U.S.C. 7384n(c); EO 13179, 65 FR 77487, 3 CFR, 
2000 Comp., p. 321 
42 U.S.C. 7384n(d) and (e); EO 13179, 65 FR 
77487, 3 CFR, 2000 Comp., p. 321 
42 U.S.C. 7384q; EO 13179, 65 FR 77487, 3 CFR, 
2000 Comp., p. 321 
29 U.S.C. 651 et seq.; 30 U.S.C. 3, 5, 7, 811, 842(h), 
844. 
Sec. 8(g), 84 Stat. 1600; 29 U.S.C. 657(g) and sec. 
508, 83 Stat. 803; 30 U.S.C. 957 
Sec. 8(g), 84 Stat. 1600; 29 U.S.C. 657(g) and sec. 
508, 83 Stat. 803; 30 U.S.C. 957 
Sec. 8(g), 84 Stat. 1600, 29 U.S.C. 657(g); sec. 
21(a), 84 Stat. 1612, 29 U.S.C. 670(a) 
Sec. 8(g), 84 Stat. 1600 (29 U.S.C. 657(g), sec. 508, 
83 Stat. 803 (30 U.S.C. 957) 
42 U.S.C. 300mm-300mm-61, Pub. L. 111-347, 124 
Stat. 3623, as amended by Pub. L. 114-113, 129 
Stat. 2242. 
42 U.S.C. 9604(i); 42 U.S.C. 6939a(c) 
Sec. 353 of the Public Health Service Act, (42 
U.S.C. 263a) 
Distribution of Reference Biological 
Standards and Biological Preparations 
Medical Examination of Aliens 




Select Agents and Toxins 
Guidelines for the Probability of Causation 
under the Energy Employees Occupational 
Illness Compensation Program Act 
(EEOICPA) of 2000 
Methods for Conducting Dose 
Reconstruction under EEOICPA 2000 
Procedures for Designating Classes of 
Employees as members of the Special 
Exposure Cohort under EEOICPA 2000 
Approval of Respiratory Protective Devices 
Requests for Health Hazard Evaluations 
Occupational Safety and Health 
Investigations of Places of Employment 
Grants for Educational Programs in 
Occupational Safety and Health 
NIOSH Research and Demonstration 
Project 
World Trade Center Health Program 
Health Assessments and Health Effects 
Studies of Hazardous Substances, Releases 
and Facilities 
Clinical Laboratory Improvement 
Amendments of 1988: Laboratory 
Requirements 
The following table outlines CDC's regulatory authorities. 
Summary of Litigation 
For the latest information about litigation, please contact the HHS's Office of the General Counsel. 
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Lamar Alexander (R-TN), Chairman 
	
Patty Murray (D-WA), Ranking 
Ed Royce (R-CA 
Bob Corker (R-TN), Chairman 
Bill Shuster (R-PA), Chairman 
Chairman John Kline (R-MN) 
Eliot Engel (D-NY) 
Ben Cardin (D-MD) 
Peter DeFazio (D-OR), Ranking 
Member 
Bobby Scott (D-VA) 
Tim Walberg (R-MI), Chairman Joe Courtney (D-CT), Ranking 










House Energy and Commerce Subcommittee 
on Oversight and Investigations 
House Committee on Oversight and 
Government Reform 
Senate Homeland Security and 
Governmental Affairs 
Tim Murphy (R-PA), Chairman 
Jason Chaffetz (R-UT), Chairman 
Ron Johnson (R-WI), Chairman 
Diana DeGette (D-CO), Ranking 
Elijah Cummings (D-MD), Ranking 
Thomas Carper (D-DE), Ranking 






House Energy and Commerce Committee 
	
Fred Upton (R-MI), Chairman 
	
Frank Pallone (D-NJ), Ranking 
Subcommittee on Health 
Joe Pitts (R-PA), Chairman 
	
Gene Green (R-TX), Ranking 
Senate Health, Education, Labor and 
Pensions 
House Committee on Foreign Affairs 
(Global Health) 
Senate Committee on Foreign Relations 
(Global Health) 
House Transportation and Infrastructure 
Committee (ATSDR) 
House Education and the Workforce 
Committee 
Subcommittee on Workforce Protections 
(NIOSH) 
Senate Environment and Public Works 
Committee (ATSDR) 
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Harold Rogers (R-KY), Chairman 
	
Nita Lowey (D-NY), Ranking Member 
Thad Cochran (R-MS), Chairman 
Roy Blunt (R-MO), Chairman 
Barbara Mikulski (D-MD), Vice 
Chairwoman 
Patty Murray (D-WA), Ranking 
Member 
Tom Cole (R-OK), Chairman Rosa DeLauro (D-CT), Ranking 
Member 
Lindsey Graham (R-SC), Chairman 	Patrick Leahy (D-VT), Ranking 
Member 
Kay Granger (R-TX), Chairwoman 
	
Nita Lowey (D-NY), Ranking Member 
(see Appropriations, above) 
Lisa Murkowski (R-AK), Chairwoman Tom Udall (D-NM), Ranking Member 
Appropriations Committees and Leadership (as of October 2016) 
Majority Leadership 	 Minority Leadership 
House of Representatives Appropriations 
Committee 
Senate Appropriations Committee 
Senate Appropriations Subcommittee on 
Labor, Health and Human Services, 
Education, and Related Agencies 
House of Representatives Appropriations 
Subcommittee on Labor, Health and Human 
Services, Education, and Related Agencies 
Senate Appropriations Subcommittee on 
State, Foreign Operations, and Related 
Programs 
House of Representatives Appropriations 
Subcommittee on State, Foreign 
Operations, and Related Programs 
Senate Appropriations Subcommittee on 
Interior, Environment, and Related 
Agencies 
House of Representatives Appropriations 
Subcommittee on Interior, Environment, 
and Related Agencies 
Ken Calvert (R-CA), Chairman 
	
Betty McCollum (D-MN), Ranking 
Member 
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Membership and Key Issues 
Key CDC staff 
• The CDC Washington Office manages relations with oversight and authorization committees 
• CDC's Office of the Chief Operating Officer manages relations with appropriations committees 
Overview of previous hearings 
• Attachment I contains a list of CDC's hearings since 2009. 
Current inquiries 
• House Committee on Oversight and Government Reform: Vaccine Safety 
• House Energy and Commerce Committee: Laboratory Safety and Select Agents 
• House Energy and Commerce Committee: Prescription Drug Overdose 
Members with Special Interest or Subject Matter Expertise 
House Members 
• Rep. Rosa DeLauro (D-CT): Food Safety 
• Rep. Charles Dent (R-PA): HIV/AIDS, Viral Hepatitis, STD and TB, Polio 
• Rep. Kay Granger (R-TX): Cancer Survivorship 
• Rep. Kevin McCarthy (R-CA): Mycotics/Valley Fever 
• Rep. Martha Roby (R-AL): Diabetes 
• Rep. Lucille Roybal-Allard (D-CA): Alzheimer's Disease, Women's Health 
• Rep. Chris Smith (R-N.1): Global Public Health 
Senate Members 
• Sen. Susan Collins (R-ME): Lyme Disease, Tobacco, Diabetes 
• Sen. Dick Durbin (D-IL): Tobacco, Global Public Health, Prescription Drug Overdose, Food Safety, 
Congenital Heart Disease 
• Sen. Dianne Feinstein (D-CA): Cancer Survivorship, Antibiotic Resistance, Prescription Drug Overdose, 
Food Safety 
• Sen. Brian Schatz (D-HI): Infectious and Vector-borne Diseases, Tobacco 
Implications of Continuing Resolutions 
CDC provides billions of dollars to state, local, tribal, and territorial agencies on an annual basis. The uncertainty 
of funding levels during a continuing resolution can have significant impact on CDC and its partners' ability to 
meet critical program goals. 
Similar to prior continuing resolutions, the FY 2017 continuing resolution poses a problem to perform fiscal 
planning and impacts a number of high-priority program decisions. Examples of FY 2017 priorities that will not 
be met under a continuing resolution include: 
Antibiotic Resistance 
CDC's request for $200 million in FY 2017 (+$40 million over FY 2016) will expand the nation's ability to detect, 
respond to, and prevent antibiotic resistant (AR) infections across healthcare settings and in the community in 
up to 50 states, 6 large cities, and Puerto Rico. Without this funding, CDC will not be able to work with HHS to 
build on existing critical investments to launch a department-wide response to all threats identified in CDC's 
Antibiotic Resistance Threat Report. 
CDC will not be able to fully implement the surveillance, prevention, and stewardship activities outlined in the 
Combating Antibiotic-Resistant Bacteria National Strategy to reach the goals and prevention targets. CDC will 
not be able to expand programs reducing inappropriate antibiotic use and preventing the spread of AR threats 
across all healthcare settings, including inpatient, outpatient, and long-term care settings. In addition, CDC will 
not be able to expand programs that will help prevent the spread of other AR threats included in CDC's AR 
Threat Report such as: multidrug-resistant Acinetobacter, fluoconozale-resistant Candida, extended-spectrum 13-
lactamase (ESBL)-producing Enterbacteriaceae, and vancomyocin-resistant Enterococcus. Without the increase, 
CDC will not be able to expand state public health laboratory capacity from 10 States in FY 2016 to all 50 states, 
6 large cities, and Puerto Rico to rapidly screen enteric bacteria for resistance. This expansion would have 
ensured the nation's ability to rapidly detect and investigate AR across the country and in more enteric 
pathogens, specifically Campylobacter and Shiga toxin-producing E. coli. CDC will not be able to expand the 
Emerging Infections Program, neither in the scope of AR activities in current sites nor by potentially adding one 
to two additional sites to the network. 
Building and Facilities Improvements 
The FY 2017 budget request included an increase of $21.2 million for CDC's Buildings and Facilities for repair and 
improvement of CDC's existing facilities portfolio in Atlanta and other locations across the United States. 
Without this funding for life safety and mission-support repair and improvement projects, CDC will not be able 
to ensure facilities are safe and support the public health mission needs. The functional replacement value of 
CDC's 188 buildings and 22 support and infrastructure facilities is $3.8 billion. As many of CDC's non-Atlanta 
campuses are approaching or are beyond a half century or more in age—including the Pittsburgh Research 
Campus—not only do requirements for routine repair and improvement continue to increase, but so do 
demands for asset demolition and/or disposal to improve CDC's overall condition index to 90 or above. 
Prescription Drug Overdose 
The FY 2017 budget request included an increase of $10 million to fully expand efforts to promote opioid 
prescribing guideline dissemination and uptake. Without this funding, CDC will not be able to further support, 
pilot test, evaluate and adapt the comprehensive translation and dissemination of prescribing guidelines into 
succinct, usable formats accessible to providers across the country. CDC will not be able to fully develop, 
evaluate, and publicly disseminate clinical decision support tools derived from the opioid prescribing guidelines. 
5!• 
Good Health and Wellness in Indian Country 
In FY 2017, CDC requested $15 million to expand its current investment in Indian Country. American Indians and 
Alaska Natives (Al/ANs) bear a disproportionate burden of death, disease, disability, and injury compared to 
other racial and ethnic groups in the United States. Currently, CDC supports a five-year, $14 million per year 
cooperative agreement that aims to prevent diabetes, heart disease and stroke, and associated risk factors 
through a holistic approach to population health and wellness with funding from several areas of the Chronic 
Disease Prevention and Health Promotion budget. Without this funding, CDC will not be able to build on its 
existing program to more comprehensively address the leading causes of death and their associated risk factors, 
and further incorporate the culturally driven wellness practices that build resilience and strengthen social and 
emotional well-being. CDC will not be able to more effectively address chronic diseases, as well as depression 
and mental health, suicide, substance use, and alcohol-related motor vehicle injuries. 
Page 57 
External Stakeholders 
CDC alone cannot protect the health of the American people. By engaging with others—from state and local 
health departments and private corporations, to media outlets and the general public—the agency can achieve 
the vision of a better world, with safer, healthier people. 
State, Tribal, Local and Territorial Health Departments 
Annually, CDC awards billions of dollars to support the nation's public health system, which includes state, local, 
tribal, and territorial entities. CDC's Office for State, Tribal, Local, and Territorial Support (OSTLTS) plays a vital 
role in helping health agencies work to enhance their capacity and improve their performance to strengthen the 
public health system on all levels. CDC provides an online interactive data tool to get information since FY 2010 
about grant funding to recipients in states, the District of Columbia, and territories. The tool allows users to 
view, sort, and analyze data by funding opportunity announcement, funding source, and recipient. In addition to 
financial support, CDC provides technical assistance to public health officials by: 
• Serving as an informal sounding board and consultation 
• Sharing data to support health departments for decision making 
• Distributing toolkits and other resources for conducting epidemiologic investigations 
• Developing materials for communicating with the public in regards to emerging issues of concern 
• Convening discussions with stakeholders to increase awareness and discuss solutions 
• Connecting partners to other jurisdictions with similar issues 
• Assigning staff to work in the field 
CDC can also conduct an Epi-Aid, if requested. An Epi-Aid is an investigation of an urgent public health problem, 
such as infectious or noncommunicable disease outbreaks, unexplained illnesses, or natural or manmade 
disaster. When a public health authority requests assistance from CDC, an Epi-Aid provides rapid, short-term 
support by Epidemic Intelligence Service officers and other CDC subject matter experts. The Epi-Aid investigation 
team helps partners make timely decisions to control the public health problem. The CDC team joins local staff 
in the community, while the requesting public health authority provides overall leadership for the investigation. 
CDC is available to provide other support services to health officials: 
• Health Hazard Evaluation (HHE): The program provides services to assess potential health hazards in 
workplaces. 
• Community Assessment for Public Health Emergency Response (CASPER): Health officials can request 
assistance in conducting a rapid needs assessment to determine the health status, basic needs, or 
knowledge, attitudes, and practices of a community in a quick and low-cost manner. 
• Assessment of Chemical Exposures (ACE): Health officials can use ACE tools to conduct, or can request 
assistance from the ACE program in performing an epidemiologic assessment after a chemical incident. 
The ACE Toolkit contains materials that can quickly be modified to meet the needs of a local team 
performing an epidemiologic assessment, including surveys, consent forms, medical chart abstraction 
form, training manual, and Epi InfoTM databases to enter and analyze the data. 
• Customized Support for Health Officials (CSHO): The program provides customized support for health 
officials to improve population health in their communities by connecting them with world-class subject 
matter experts, developing customized data and resource packages, and coordinating peer-to-peer 
networking opportunities. 
International Partners 
Additionally, CDC works in close partnership with a wide array of international agencies and institutions to shape 
global health policies and to fund, implement, and evaluate programs. CDC's partnerships with international and 
multinational organizations include the World Health Organization and its regional offices, other United Nations 
agencies (such as UNICEF) and affiliated agencies (such as the United Nations Foundation), the World Bank, 
other Federal agencies within the U.S. Government, private foundations, universities, and global health 
organizations. CDC works closely with Ministries of Health and other partners to maintain strong programs 
overseas. 
Health Professionals 
CDC is the key source of information for health professionals around the world. Ranging from recommendations 
from the Advisory Committee on Immunization Practices to clinical guidance on emerging health threats like 
Zika virus and Ebola, health professionals count on CDC for accurate and timely guidance and breaking news. 
Some of CDC's key publications and information sources: 
• Health Alert Network (HAN): HAN is CDC's primary method of sharing cleared information about urgent 
public health incidents with public information officers. CDC's HAN collaborates with Federal, state, 
territorial, and city/county partners to develop protocols and stakeholder relationships to ensure a 
robust interoperable platform for the rapid distribution of public health information. 
• Morbidity and Mortality Weekly Report (MMWR): MMWR is often called "the voice of CDC." The 
MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, 
accurate, objective, and useful public health information and recommendations. MMWR readership 
predominately consists of physicians, nurses, public health practitioners, epidemiologists and other 
scientists, researchers, educators, and laboratorians. The data in the weekly MMWR are provisional, 
based on weekly reports to CDC by state health departments. 
• Vital Signs: CDC Vital Signs monthly report was launched in 2010. It includes an MMWR Early Release, a 
fact sheet and media release, and social media tools. Most materials are available in English and 
Spanish. Vital Signs is released the first Tuesday of each month. CDC Vital Signs links science, policy, and 
communications with the intent of communicating a call-to-action for the public action. 
• Epi-X: Epi-X supports postings and discussions about disease outbreaks and other public health events 
that potentially involve multiple jurisdictions. Epi-X was created to provide public health officials with a 
single source for up-to-the-minute alerts, reports, discussions, and comments to respond to public 
health emergencies, and encourage professional growth and exchange of information. The reports are 
contributed by health professionals and moderated by medical epidemiologists and laboratorians at 
CDC. 
Non-Governmental Organizations 
The US public health system is most effective when government teams up with national nonprofit organizations 
to address emerging epidemics, develop the public health workforce, communicate public health information, 
translate science to practice, and evaluate effective public health services. National public health partners with 
their memberships and associations have the reach, influence, access, and capabilities for an effective public 
health response. A key role for national public health partners is to provide capacity-building assistance to 
ensure a capable and efficient public health workforce. 
o 
Private Sector Partners 
CDC works with business to successfully carry out its mission. Engaging business can improve workforce and 
community well-being, lead to innovative strategies, and change the way CDC conceptualizes and solves 
problems. Opportunities for both formal and informal collaborations may lead to valuable, mutual benefits. For 
example, CDC partners with industry, academia, non-profits, and other government agencies to transfer its 
research portfolio into products and services to improve public health and facilitate the use of Cooperative 
Research and Development Agreements. 
The 6118 Initiative is a partnership between CDC and health care purchasers, payers, and providers to improve 
health and control health care costs. CDC provides rigorous evidence about six common and costly health 
conditions — tobacco use, high blood pressure, healthcare-associated infections, asthma, unintended 
pregnancies, and diabetes — and 18 proven specific interventions to inform decisions to have the greatest health 
and cost impact. This initiative offers proven interventions that prevent chronic and infectious diseases by 
increasing coverage, access, utilization and quality. Additionally, the initiative aligns evidence-based preventive 
practices with emerging value-based payment and delivery models. 
Labor-Management Partnership Council 
The Labor-Management Partnership Council fosters partnerships that create and maintain a strong, cooperative 
relationship between labor and management at all levels of CDC. The council: 
• Makes decisions on agency-wide issues affecting management, labor, and mission achievement (at the 
director or a designee's request). 
• Exchanges facts and information about agency-wide issues affecting management, labor, and mission 
achievement. 
• Serves as a forum for discussions and guidance on agency-wide issues affecting management, labor, and 
mission achievement. 
• Promotes and facilitates labor-management relationships at all appropriate levels. 
• Provides guidance and support to any cooperation councils that form at other levels of CDC. 
Local councils in Atlanta, Cincinnati, Morgantown, Pittsburgh, Research Triangle Park, and Hyattsville help 
improve and maintain good relations between union and management at all levels to promote outcomes that 
are in the best interests of employees and CDC. 
The council includes 14 primary members (7 management and 7 union) and 14 alternates (7 management and 7 
union). Unions include: 
• American Federation of Government Employees (AFGE) — Locals 1916, 2883, 2923, 3430, 3840 
• National Treasury Employees Union (NTEU) — Chapter 287 
• National Alliance of Postal and Federal Employees (NAPFE) — Local 303 
i3(.1 
Crisis Management and Emergency Response 
Emergency Response Plan 
• CDC develops and implements internal emergency response planning for the agency. 
• Planning occurs under the umbrella of the Occupant Emergency Program. CDC's Occupant Emergency 
Program is an all-hazards approach that ensures that CDC is capable of responding to and managing any 
incident that may impact CDC staff or facilities. 
• CDC's current major focus is on improving the emergency response capacity at CDC's Atlanta-area 
facilities through the redevelopment of CDC's Occupant Emergency Plan, and through a series of nine 
emergency response exercises, including seminars, tabletop exercises, and full-scale exercises. 
• Activities in the coming year will focus on continuing to build capacity within the Atlanta area, and on 
working with CDC facilities outside of the Atlanta area to update their response plans, and bring them 
into better alignment with CDC's Occupant Emergency Program. 
Continuity of Operations Information 
• CDC develops and implements continuity of operations planning (COOP). 
• CDC maintains a COOP plan designed to ensure the continuation of pre-identified essential functions. 
CDC also maintains two alternate operating facilities to assist in the continuation of CDC's essential 
functions. 
• COOP activities in the coming year will focus on continuing to meet or exceed the requirements that the 
Federal Government will identify in its upcoming continuity planning guidance. 
Primary Points of Contact 




Division Transition Team Contacts 
HHS Presidential Transition Council Representative 
Sherri Berger, MSPH 
Chief Operating Officer 
Centers for Disease Control and Prevention 
(404) 639-7846 
sberger@cdc.gov   
Security Procedures, Transportation, and Parking Information 
CDC's headquarters are located in Atlanta, Georgia. The main address: 1600 Clifton Road NE, Atlanta, Georgia 
30333. CDC has a number of additional locations in the Atlanta area. CDC can reserve visitor parking on campus 
with advance notice. 
For more information: 
Joe Henderson 
Director, Office of Security, Safety, and Asset Management 
Centers for Disease Control and Prevention 
(404) 639-7131 
jfh0@cdc.gov  
Information Technology and Computer Access 
CDC's cybersecurity infrastructure plan and procedures, as well as privacy infrastructure, is under the chief 
information officer. 
CDC will provide Wi-Fi and computer access to on-site visitors, using the government-issued Ply card. 
For more information: 
Jim Seligman 
Chief Information Officer 
Centers for Disease Control and Prevention 
(404) 639-7601 
idsl@cdc.gov  
Map of Organization Facilities 
Attachment., contains maps for all CDC locations across the United States. 
Attachments 
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Office for State, Tribal, 
Local, and Territorial 
Support 
National Center for Injury 
Prevention and Control 
Debra Houry, MD, MPH 
Centers for Disease 
Control and Prevention 
Office of the Director 
ORGANIZATIONAL CHART 
Chief Operating Officer 
Sherri A. Berger, MSPH 
Office of Equal 
Employment Opportunity 
Reginald R. Mebane, MS 
Office of Minority Health 
and Health Equity 
Leandris Liburd, PhD, MPH, MA 
Associate Director for Science 
Harold W. Jaffe, MD, MA 
Associate Director 
for Communication 
Katherine Lyon Daniel, PhD 
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Associate Director for Policy 
John Auerbach, MBA 
Associate Director for Laboratory 
Science and Safety 
Steve Monroe, PhD 
11 CDC Washington Director Dena S. Morris, MPP Ii 
Chief of Staff 
Carmen Villar, MSW 
OFFICE OF THE DIRECTOR 
Director 
Thomas R. Frieden, MD, MPH 
Principal Deputy Director 
Anne Schuchat, MD 
(RADM, USPHS) 
I.  
Office of Public Health 
Preparedness and Response 
Stephen C. Redd, MD 
(RADM, USPHS) 
National Institute for 
Occupational Safety and Health 
- John Howard, MD, MPH, JD, LLM 
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Office of Public Health 
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Chesley Richards, MD, MPH, FACP 
L.  National Center for Health Statistics . ...- Charles J. Rothwell, MBA, MS 
Office of Noncommunicable 
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National Center for Emerging 
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Beth P. Bell, MD, MPH 
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ORGANIZATIONAL CHART: TEXT VERSION 
Centers for Disease Control and Prevention 
o Thomas R. Frieden, MD, MPH 
• Principal Deputy Director Anne Schuchat, MD (RADM, USPHS) 
The following offices report directly to the Director: 
• CDC Washington Office 
o Dena Morris, MPP 
• Chief Operating Officer 
o Sherri A. Berger, MSPH 
• Associate Director for Laboratory Science and Safety 
o Stephan Monroe, PhD 
• Associate Director for Policy 
o John Auerbach, MBA 
• Associate Director for Science 
o Harold W. Jaffe, MD, MA 
• Chief of Staff 
o Carmen H. Villar, MSW 
• Associate Director for Communication 
o Katherine Lyon Daniel, PhD 
• Office of Equal Employment Opportunity 
o Reginald R. Mebane, MS 
• Office of Minority Health and Health Equity 
o Leandris Liburd, PhD, MPH, MA 
• Office of Public Health Scientific Services (CDC Deputy Director) 
o Chesley L. Richards, MD, MPH, FACP 
• Office of Noncommunicable Diseases, Injury, and Environmental Health (CDC Deputy Director) 
o Robin M. Ikeda, MD, MPH (RADM, USPHS) 
• Office of Infectious Diseases (CDC Deputy Director) 
o Rima F. Khabbaz, MD 
• Office for State, Tribal, Local and Territorial Support (CDC Deputy Director) 
o John Auerbach, MBA (Acting) 
• Office of Public Health Preparedness and Response 
o Stephen C. Redd, MD (RADM, USPHS) 
• National Institute for Occupational Safety and Health 
o John Howard, MD, MPH, JD, LLM 
• Center for Global Health 
o Rebecca Martin, PhD 
The following offices report to the CDC Deputy Director, Office of Public Health Scientific Services: 
• National Center for Health Statistics 
o Charles J. Rothwell, MS, MBA 
• Center for Surveillance, Epidemiology and Laboratory Services 
o Michael F. lademarco, MD, MPH (CAPT, USPHS) 
The following offices report to the CDC Deputy Director, Office of Noncommunicable Diseases, Injury, and 
Environmental Health: 
• National Center on Birth Defects and Developmental Disabilities 
o Coleen A. Boyle, PhD, MS hyg 
• National Center for Chronic Disease Prevention and Health Promotion 
o Ursula Bauer, PhD, MPH 
• National Center for Environmental Health/Agency for Toxic Substances and Disease Registry* 
o Patrick Breysee, PhD, CIH 
• National Center for Injury Prevention and Control 
o Debra Houry, MD, MPH 
The following offices report to the CDC Deputy Director, Office of Infectious Diseases: 
• National Center for Immunization and Respiratory Diseases 
o Nancy Messonnier, MD (CAPT, USPHS) 
• National Center for Emerging and Zoonotic Infectious Diseases 
o Beth P. Bell, MD, MPH 
• National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention 
o Jonathan H. Mermin, MD, MPH (RADM, USPHS) 
*ATSDR is an OPDIV within HHS, but is managed by a common director's office 
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CDC's Work in Global Health 
Disease knows no borders. A health threat anywhere is a health threat 
everywhere. By ensuring that countries have the capacity to prevent, detect, 
and respond to threats within their borders, the Center for Global Health (CGH) 
helps prevent regional and global health crises that affect health, security, 
and economic stability abroad and at home. We provide a global safety 
net by monitoring for disease outbreaks 24/7 around the world. CGH uses 
scientific data to track diseases and other health threats and target services 
to those who need them most across a variety of programs, including global 
immunization, HIV/AIDS, tuberculosis, parasitic diseases and malaria, and 
disease detection and response, as well as health systems and laboratories. 
Nearly 80% 
of CDC's Reid 
Epidemiology Training 
Program (FO-P) 
graduates continue to 
serve in public health 
programs in their 
home countries. 
How We Work 
Respond quickly to threats posed by infectious diseases like Ebola, Zika, 
MERS-CoV, avian influenza, and others. 
Implement proven prevention and treatment programs for global 
epidemics like HIV, malaria, and tuberculosis. 
Train public health leaders and health workers to build a ready workforce 
and enhance global capacity to identify and report outbreaks from 
leading disease threats. 
Increase epidemiology and laboratory capacity within ministries of health 
around the world. 
Provide assistance to ministries of health to develop emergency 
operations centers and catch outbreaks faster. 
Build health infrastructure and strengthen information systems needed 
for data-driven decision-making for faster local action. 
Countries Participating in FETPs 
Atit 
Learn more about where we work, 
http://www.cdc.gov/globalhealth/healthprotectionfietpAndex.htm 
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CENTER FOR GLOBAL HEALTH 
SNAPSHOT 
MISSION 
To protect and improve health globally 
through science, policy, partnership, and 
evidence-based public health action. 
ORGANIZATION 
Division of Global Health Protection 
Division of Global HIV and TB 
Division of Parasitic Diseases and Malaria 
Global Immunization Division 
PRIORITIES 
One CDC: Bring cohesiveness to CDC's 
global health work to improve the 
health and well-being of people 
around the world. 
Global health is local health: CDC 
cannot protect the health of people 
living in the United States without 
addressing infectious disease problems 
that are occurring elsewhere in the world. 
Helping other countries to control disease 
outbreaks prevents those diseases from 
spreading to the United States, saving lives 
and dollars. 
Sustain, intensify, and accelerate CDC's 
global health work: We must increase 
and expand the proven interventions 
to prevent, detect, and respond to 
disease threats. 
Key Accomplishmell7ts  
Training a Ready Workforce: In 
2014, Field Epidemiology Training 
Program graduates and residents 
participated in more than 400 
outbreak investigations. Their 
response was critical in controlling 
the 2014 Ebola outbreak as well 
as more recent yellow fever and 
cholera outbreaks. 
Eradicating Polio: Since 1988, 
polio cases have dropped by more 
than 99%, and 80% of the world's 
population now live in polio-free 
regions. 
Helping Provide Anti-retroviral 
Treatment (ART): By the end of 
2015, as a result of CDC's support 
of HIV care and treatment, 
5,841,782 patients were on ART. 
This is over half the 2015 PEPFAR 
achievement of 9.5 million. 
Eliminating Parasitic Diseases: 
CDC helped make significant 
progress toward wiping out 
Lymphatic filariasis in Haiti; 94% 
of the 48 communities assessed 
(representing 2 million people) no 
longer need to provide preventive 
treatment drugs to their residents. 
Reducing Deaths from Malaria: 
CDC, working in collaboration 
with partners, saved an estimated 
6.2 million lives during 2001-2015 
as a result of proven malaria 
interventions like vector control, 
use of treated bed nets, and 
strategic use of antimalarial drugs. 




10 Global Disease Detection 
	
Tracked over 140 unique 
	
Discovered 12 pathogens that 
Centers around the world diseases globally. were identified for the first 
support over 50 countries. 	 time anywhere in the world. 
What's Needed 
CGH's top challenges to program success include: 
Challenging environments: We often work to build and sustain health 
security in unstable, high-risk areas. 
Low levels of preparedness: We live in a world where two thirds of all 
countries remain unprepared to handle a public health emergency. 
Disease control: We face many remaining challenges to prevent the 
leading causes of death and disease globally. 
Intensify and accelerate: We have proven, successful interventions 
that must scale up significantly to reduce disease rates and improve 
public health. 
Disease elimination and eradication initiative: We need to know more 
than we know now in order to develop new tools to face these challenges 
and intensify and accelerate gains in global health. 
Greater momentum: With additional resources, CDC stands ready to meet 
these challenges and ensure that the health and economic prosperity 
of the United States continues to flourish while mitigating health and 
instability threats around the world. 
Long-Term Opportunities 
Global Health Safety Net - Strengthen our rapid response workforce, 
global disease monitoring, and regional disease detection centers. 
Safe and Prepared Global Community - Support the development and 
sustainability of the underlying public health systems in countries around 
the world so they are able to detect and diagnose disease and efficiently 
respond with a ready, trained workforce. 
End Polio Transmission - Use life-saving scientific research to interrupt 
transmission of polio in countries where it continues and move toward 
global eradication by 2019. 
Intensify, Sustain, and Accelerate - Scale up known, proven 
interventions and advance the science base to develop the public health 
tools to continue the fight against HIV, TB, malaria, parasitic, and vaccine-
preventable diseases. 
For more information visit htto://www cdc gov/globalhealth or call 1-800-CDC-INFO. 
1 -* 
NIOSH developed "Mini Bag House" control technology to reduce 
harmful silica dust exposure. Data have shown a 98% reduction 
in respirable silica dust emissions during hydraulic tracturing. 
How We Work 
NATIONAL INSTITUTE FOR 
OCCUPATIONAL SAFETY AND HEALTH 
SNAPSHO1 Why We're Here 
 
MISSION 
To generate new knowledge in the field 
of occupational safety and health and to 
transfer that knowledge into workplace 
practice to prevent work-related injury, 
illness, and death. 
ORGANIZATION 
Education and Information Division 
Division of Applied Research 
and Technology 
Division of Compensation Analysis 
and Support 
Division of Safety Research 
Division of Surveillance, Hazard 
Evaluations, and Field Studies 
Health Effects Laboratory Division 
National Personal Protective 
Technology Laboratory 
Pittsburgh Mining Research Division 
Respiratory Health Division 
Spokane Mining Research Division 
Western States Division 
World Trade Center Health Program 
PRIORITIES 
Implement the third decade of the 
National Occupational Research Agenda 
with partners and stakeholders. 
Implement a systematic burden, need, 
and impact framework to set 
research priorities. 
Advance translation research in 
occupational safety and health. 
The Occupational Safety and Health Act of 1970 established the National 
Institute for Occupational Safety and Health (NIOSH) with the mandate to 
provide"every man and woman in the Nation safe and healthful working 
conditions and to preserve our human resources." NIOSH is the only federal 
entity responsible for conducting research and making recommendations 
for the prevention of work-related injury and illness. NIOSH works closely 
with the Occupational Safety and Health Administration and the Mine 
Safety and Health Administration in the U.S. Department of Labor to 
protect American workers and miners. NIOSH also administers the World 
Trade Center Health Program, which provides medical monitoring and 
treatment for eligible 9/11 responders and survivors and funds research 
into health conditions associated with the September 11, 2001, 
terrorist attacks. 
NIOSH's research efforts are aligned under the National Occupational 
Research Agenda, which partners with industry, labor, government, 
academia, professional associations, and others to maximize the impact of 
occupational safety and health research. 
• Conduct innovative, multidisciplinary scientific research based on 
surveillance information to prevent worker injury, illness, and death. 
• Perform on-site investigations to determine if workers are being 
exposed to hazardous materials or harmful conditions. 
• Disseminate new scientific knowledge to reduce risks of workplace 
injury and death. 
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Current Intelligence Bulletin on 
carbon nanotubes and nanofibers: 
This publication contains the first 
government-issued recommended 
exposure limits for a major class 
of nanomaterials. 
Mini-baghouse Retrofit Assembly: 
NIOSH developed and patented this 
control technology to protect workers 
from harmful exposures during 
hydraulic fracturing. Recent data 
show a 98% reduction in respirable 
silica dust emissions from 
sand movers. 
Update of the NIOSH hazardous 
drugs list: Provides guidance on 
using personal protective equipment 
in healthcare settings to prevent 
mishandling of hazardous drugs. 
Stand-alone respirable coal mine 
dust collector: Partnered with a 
manufacturer to develop this device 
to reduce worker respirable dust 
exposures and help eliminate black 
lung disease. 
Development of the NIOSH Ladder 
Safety Smartphone app: This app 
has been downloaded more than 
50,000 times. It provides graphical 
guidance on safe ladder use and 
includes a patented innovation that 
allows users to set safe ladder angles 




• Pittsburgh - most of the site and utility infrastructure at the NIOSH 
campus in Pittsburgh, Pennsylvania, is obsolete and failing, which has 
resulted in frequent utility outages, delays in research activities, lost time 
for employees, and other problems. 
• Cincinnati - the two aging NIOSH facilities should be merged into one 
updated, consolidated building. CDC is working with GSA on acquiring 
an appropriate property in Cincinnati for NIOSH to continue its important 
research activities. 
Human Capital Management and IT Support 
• Multidisciplinary workforce needs across eight cities must be addressed. 
• Varied IT needs, including diverse data management needs, must be 
supported and addressed across these eight cities. 
NIOSH Locations 
Long-Term Opportunities 
• Reduce oil and gas extraction worker fatality rates. 
• Increase the dissemination of guidance documents on how to use 
engineered controls and personal protective equipment to mitigate 
exposure to nanomaterials. 
• Reduce the percentage of respirable coal mine dust overexposures for 
the tailgate shearer operator. 
• Reduce the number of fatalities from falls in construction. 
• Reduce the rate of work-related assaults. 
• Increase the proportion of employees who have access to workplace 
programs that prevent or reduce employee stress. 











Centers for Disease Control and Prevention 
OFFICE FOR STATE, TRIBAL, LOCAL, 
AND TERRITORIAL SUPPORT 
SNAPSHOT 
MISSION 
To advance U.S. public health 
agency and system performance, 
capacity, agility, and resilience. 
ORGANIZATION 
Why We're Here 
The public counts on accessible, timely, high-quality, and sustainable 
public health services for their health and safety—every day and in times 
of crisis. Prolonged under-resourcing of public health infrastructure and 
capacity has resulted in a less agile, less resilient public health system, 
putting the health of Americans at risk. State, tribal, local, and territorial 
(SILT) health departments need tools, resources, and a sustainable, well-
trained workforce to work better, faster, and smarter. OSTLTS helps health 
departments improve delivery of services to the public, reduce costs, and 
improve health in a cross-cutting way that maximizes other investments in 
public health. 
Division of Public Health Performance 
Improvement 
Partnership Support Unit 
Public Health Associate Program 
Public Health Law Program 
Tribal Support Unit 
Maximizes 
Investments 
Leads to Better Service and 
Improved Health Outcomes 
How We Work 
PRIORITIES 
Improve health department 
performance and services. 
Build the public health workforce. 
Strengthen CDC program and STLT 
agency relationships. 
Collaborate with national partners on 
system-wide improvements. 
Build capacity to use public 
health law. 
Administer the Preventive Health and 
Health Services (PHHS) Block Grant. 
Improve collaboration with and 
support to tribes. 
• Administer the Preventive Health and Health Services Block Grant (PHHS), 
a flexible source of funding for all 50 states, D.C., 8 U.S. territories, and 
2 tribes. 
• Build capacity to use public health law. 
• Build the public health workforce through the Public Health Associate 
Program (PHAP). 
• Diffuse public health knowledge and resources across the health system. 
• Help health departments improve their performance based on national 
standards and advance toward national accreditation. 
• Collaborate with national partners on system-wide improvements. 
• Monitor state use of evidence-based policies and practices to address 
priority public health problems. 
• Coordinate CDC activities to improve service and support for health 
departments, including facilitating joint planning and problem solving. 
• Coordinate CDC/ATSDR government-to-government Tribal Advisory 
Committee and consultations with American Indians/Alaska Natives. 
AM= 
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Division of Public Health 
Performance Improvement: As 
of September 2016, 55% of the 
U.S. population is being served by 
an accredited health department 
(19 state, 1 tribal, 130 local, and 
1 centralized state integrated 
system of 67 local health 
departments). 
Public Health Law Program: 
Trained nearly 23,200 people 
since 2011, including 2,528 at the 
Zika Action Plan Summit. 
Public Health Associate 
Program: As of May 2016, 
310 associates are supporting 
the capabilities of state, tribal, 
local, and territorial public health 
agencies, nongovernmental 
organizations, and CDC 
quarantine stations across 
43 states, Puerto Rico, and the 
District of Columbia. 
Tribal Support Unit: Held 
13 meetings of the CDC/ATSDR 
Tribal Advisory Committee 
(January 2010 to present) with 
tribal consultation. 
Partnership Support Unit: In 
FY16, managed cooperative 
agreements with 25 national 
nonprofit organizations to 




Cumulative Growth in Accredited Health Departments 
(State, Tribal, Local, and Locals in Centralized State System)* 
2013 	 201%1 	 20' 	 2(116 
'By 2016, the grand total includes 19 state, 1 tribal, 130 local, and 1 integrated state system 


























Key Accomplishments' What's Needed 
• A next-generation cooperative agreement program based on national 
public health accreditation standards that provides health departments 
with flexible resources to sustain and improve infrastructure and service 
delivery to the public. 
• Flexible and sustainable funding for PHAP to support public health 
workforce infrastructure across the United States and its territories. 
• Sustainable funding and an improved funding formula for the PHHS 
Block Grant. 
• Increased direct CDC support to tribes, including more funding, 
technical assistance, and data for action. 
• Greater attention and support through partnerships for improving 
public health infrastructure in U.S. territories. 
• Expanded legal evaluation studies, including those that compare legal 
trends with trends in public health outcomes. 
Long-Term Opportunities 
• In FY18, release a new funding opportunity announcement for the 
national partnership cooperative agreement on behalf of CDC. 
• Identify sustainable and flexible funding strategies to establish and 
safeguard the delivery of basic and core public health services in 
all communities. 
• Develop or support emerging initiatives to revitalize and transform 
population health. 
• Expand support for accreditation readiness to help more health 
departments meet national accreditation standards. 
• Revisit formula for awardee allocations under the PHHS Block Grant 
to reduce funding disparities and enable completion of impactful and 
measurable activities. 
• Work with program partners to facilitate more job opportunities for 
PHAP graduates. 
For more information visit http://www.cdc.gov/stltpublichealth or call 1-800-CDC-INFO. 
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OFFICE OF INFECTIOUS DISEASES 
Why We're Here 
The Office of Infectious Diseases (OID) was established to advise the 
CDC director and help set agency strategic priorities, as well as to lead 
CDC's three infectious disease national centers and support their work to 
prevent and control infectious diseases. OID's vision is a world safe from 
infectious diseases. 
g CDC'S INFECTIONS DISEASE NATIONAL CENTERS 
BOARD OF SCIENTIFIC 




How We Work 
OID is led by CDC's Deputy director for Infectious Diseases. OID's Office 
of the Director (OD) consists of a small team of senior staff who provide 
strategic leadership to CDC's infectious disease national centers—the 
National Center for Emerging and Zoonotic Infectious Diseases; the 
National Center for HIV, Viral Hepatitis, STD, and TB Prevention; and the 
National Center for Immunization and Respiratory Diseases—including 
setting priorities, developing and implementing infectious disease goals 
and objectives, and evaluating and adjusting activities to ensure optimal 
effectiveness and efficiency. 
OID leadership works with internal and external partners to advance 
infectious disease prevention programs and priorities. OID collaborates 
with CDC's infectious disease centers and other CDC/OD offices on 
cross-cutting issues, including policy development and coordination, 
budget, program, personnel, scientific priorities, and informatics activities. 
OID actively identifies opportunities to strengthen CDC capacities and 
connect programs. 
MISSION 
To lead, promote, and facilitate 
science, programs, and policies 
to reduce the burden of infectious 
diseases in the United States 
and globally. 
ORGANIZATION 
National Center for Emerging and 
Zoonotic Infectious Diseases 
National Center for HIV/AIDS. Viral 
Hepatitis, STD, and TB Prevention 
National Center for Immunization and 
Respiratory Diseases 
PRIORITIES 
Strengthen public health 
fundamentals, including infectious 
disease surveillance, laboratory 
detection, and epidemiologic 
investigation. 
Identify and implement high-impact 
public health interventions to reduce 
infectious diseases. 
Develop and advance policies to 




• Convened the Board of 
Scientific Counselors, OID, for 
external engagement in CDC's 
efforts and to monitor overall 
strategic direction. 
Convened, managed, 
and hosted international 
conferences on emerging 
infectious diseases, which 
brought together more than 
1,500 professionals from 
around the world to encourage 
the exchange of information 
on global emerging 
infectious diseases. 
Laboratory Leadership: 
• Identified gaps in 
bioinformatics resources and 
led development of AMD 
budget initiative, resulting in 
improvements that allow our 
scientists to better detect and 
respond to outbreaks. 
Facilitated the opening of the 
new Office of the Associate 
Director for Laboratory Science 
and Safety (OADLSS) and the 
enhancement of laboratory 
policy across the agency. 
Policy/Program Development: 
Supported center priorities 
by developing key 
policy documents. 
Provided leadership and 
staffing to outbreak 
response efforts. 
Improved Efficiencies: 
Coordinated across infectious 
disease programs and labs. 
• Implemented cost-saving 
strategies and shared services. 
What's Needed 
• Sustaining priority infectious disease initiatives, including advanced 
molecular detection (AMD), the Antibiotic Resistance Solutions Initiative, 
and the Global Health Security Agenda. 
• Strengthening CDC's infectious disease laboratories, including 
implementing enhanced oversight structures and systems to ensure 
effective and safe operation of CDC's infectious disease laboratories, 
and expanding CDC's capacities in advanced molecular technologies 
and bioinformatics. 
• Advancing and monitoring progress of infectious disease program 
activities that cross CDC's infectious disease programs, including initiatives 
to combat antibiotic-resistant bacteria and to prevent infections with 
human papillomavirus. 
• Enhancing work with state and local health departments and other 
partners to sustain and upgrade public health fundamentals and address 
infectious disease issues of special concern, including those above and 
chronic viral hepatitis, food safety, healthcare-associated infections, HIV/ 
AIDS, respiratory infections, safe water, vaccine-preventable diseases, and 
zoonotic and vector-borne diseases. 
Long-Term Opportunities 
In the future, OID will continue to identify and evaluate opportunities to use 
scientific advances and technical innovations to strengthen its programs 
and develop (and implement) new tools for disease detection, disease 
prevention, and outbreak response. 
A recent CDC stakeholder assessment of OID's role found that OID fulfills key 
roles as: 
• Strategic advisor. 
• Internal and external advocate. 
• Connector and convener, enhancing collaborations and increasing public 
health impact of infectious disease programs. 
• Incubator and accelerator for cutting-edge public health activities. 
• Buffer and negotiator to improve efficiencies. 
For more information visit http://www.cdc.gov/oid or call 1-800-CDC-INFO. 
NATIONAL CENTER FOR EMERGING AND 
ZOONOTIC INFECTIOUS DISEASES 
SNAPSHOT 
MISSION 
To reduce illness and death 
associated with emerging and 
zoonotic infectious diseases 
anywhere in the world and 
protect against the spread of 
infectious diseases. 
ORGANIZATION 
Division of Foodborne, Waterborne, and 
Environmental Diseases 
Division of Global Migration 
and Quarantine 
Division of Healthcare 
Quality Promotion 
Division of High-Consequence 
Pathogens and Pathology 
Division of Preparedness and 
Emerging Infections 
Division of Scientific Resources 
Division of Vector-borne Diseases 
PRIORITIES 
Antibiotic resistance. 





Advanced molecular detection. 
Infectious disease preparedness. 
Migrating populations, 
including travelers. 
Why We're Here 
The National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID) is committed to protecting people from infectious diseases 
no matter where they occur. NCEZID targets infectious diseases ranging 
from the familiar, such as foodborne illnesses and healthcare-associated 
infections, to the less common but deadly, such as anthrax and Ebola. 
NCEZID manages a broad portfolio of science-based programs that combine 
laboratory, epidemiologic, analytic, and prevention technologies with public 
health tools. NCEZID collaborates with state and local health departments, 
other U.S. government agencies, industry, and foreign ministries of health. 
Approximately 75% of emerging infectious diseases 
that affect humans (like the Zika virus, right) are 
diseases of animal (zoonotic) origin. 
How We Work 
NCEZID works globally to prevent, detect, and respond to outbreaks of 
infectious diseases—natural, accidental, or intentional. Areas the center is 
engaged in include: 
Vector-borne diseases, which are complex and common worldwide. 
Dengue virus infects as many as 400 million people worldwide each year. 
Foodborne illness: One in six Americans gets sick each year from 
contaminated foods or beverages. 
Infections spread in hospitals, nursing homes, and other healthcare 
settings: At any given time, about 1 in every 25 patients has an infection 
related to their hospital care. Healthcare-acquired infections (HAI) 
contribute to approximately $30 billion in excess healthcare costs 
per year. 
- Migration health and quarantine: Infectious diseases that emerge 
anywhere can pose a risk to populations everywhere. During the Ebola 
outbreak, CDC screened almost 340,000 travelers who were leaving a 
country with widespread transmission. 
Advanced laboratory diagnostics: Laboratory technologies based 
on next-generation gene sequencing, such as those used by CDC's 
Advanced Molecular Detection program, are more powerful and can 
detect outbreaks sooner vs. traditional methods. 
High-consequence diseases: Last year, over 600 unknown infections 
were diagnosed and investigated by CDC scientists who worked with 
more than 70 dangerous viruses and bacteria in the field or our high 
containment laboratories. 
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Key Accomplishments 
CDC's PulseNet has been the 
most effective tool for detecting 
foodborne disease outbreaks. 
Each year, PulseNet prevents an 
estimated 270,000 infections 
and saves approximately $500 
million in medical costs and lost 
productivity. More than 
1 billion pounds of contaminated 
food has been recalled since 
PulseNet was launched. 
CDC, in collaboration with FDA, 
launched the AR Isolate Bank, 
a centralized repository that 
includes more than 450,000 
antibiotic-resistant isolates and 
more than 18,000 characterized 
genomes. This bank is open to 
both public- and private-sector 
researchers to help design the 
next generation of clinical tests 
and therapeutic agents. 
CDC has excelled in developing 
new diagnostics and vaccines 
for vector-borne pathogens. 
NCEZID developed the first 
affordable rapid diagnostic test 
for plague. The test yields results 
in minutes, requires no electricity 
or refrigeration, and costs less 
than $1 to produce, making it 
a particularly effective tool in 
resource-poor settings. NCEZID 
has also invested in developing 
a dengue vaccine, which is 
currently in trials. 
CDC launched a new electronic 
platform called e-Pathology, 
which allows physicians and 
scientists from anywhere in the 
world to electronically submit 
images and scanned pathology 
slides to CDC scientists to review 
in real time. 
Increase domestic and international capacity to address antibiotic 
resistance (AR): CDC's Antibiotic Resistance Solution Initiative will expand 
our antibiotic use reporting, create a nationwide laboratory network 
to fill data gaps and inform prevention, and expand HAI/AR detection 
and response programs to all 50 states, six cities, and Puerto Rico. This 
investment will result in better tracking of and response to AR nationwide 
and could avert $7.7 billion of the direct medical costs due to infections. 
Because the scope of AR is so vast, continued financial commitment will be 
needed to reach domestic and global goals. 
Continue expansion for MOD: Since 2013, AMD has increased next-
generation gene sequencing and bioinformatics capacities. This 
technological revolution shows no signs of slowing down, and CDC will 
need to keep up with innovations at both national and state levels. In 
addition, CDC needs to fully implement whole genome sequencing to 
modernize and streamline foodborne outbreak detection and response. 
National, state, and local investment in vector-control programs: 
Diseases spread by mosquitos and ticks will continue to evolve and move 
into new areas, including the United States. Outbreaks like Zika will not 
be a one-time event. Capacity building at all levels, as well as innovation 
in diagnostics, is needed to prevent and control these outbreaks and 
understand more about the vectors. 
Long-Term Opportunities 
CDC's Antibiotic Solutions Initiative will transform how public health 
partners tackle resistant threats. Some expected outcomes include: 
» Reducing inappropriate antibiotic use by 50% in outpatient settings and by 
20% in inpatient settings. 
» Testing every Salmonella isolate available for drug resistance. 
)) Increasing the ability in 50 states to track and stop the nightmare bacteria, 
carbapenem-resistant Enterobacteriaceae (CRE). 
>> Ensuring that less than 2% of all gonorrhea infections are resistant to the 
current treatment. 
Strengthen support to state and local health departments and partners 
through CDC's Epidemiology and Laboratory Capacity grants and our 
Emerging Infections Programs. 
Accelerate implementation of and long-term support for Global Health 
Security, to prepare countries for the next epidemic or emerging infection. 
For more information visit http://www.cdc.gov/ncezid or call 1-800-CDC-INFO. 
NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, 
STD, AND TB PREVENTION 
SNAPSHOT 
MISSION 
To save lives, protect people, 
and reduce health disparities 
associated with HIV, viral 
hepatitis, STDs, and tuberculosis. 
ORGANIZATION  
Division of Adolescent and School Health 
Division of HIV/AIDS Prevention 
Division of STD Prevention 
Division of Tuberculosis Elimination 
Division of Viral Hepatitis 
PRIORITIES 
Decrease incidence of infection with 
HIV, viral hepatitis, STDs, and TB. 
Decrease illness and death from HIV, 
viral hepatitis, STDs, and TB. 
Decrease health disparities across 
groups affected by HIV, viral 
hepatitis, STDs, and TB. 
Why We're Here 
The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 
(NCHHSTP) prioritizes cost-effective, scalable programs, policies, and research 
to achieve the greatest impact on reducing the incidence of HIV, viral hepatitis, 
STDs, and tuberculosis and preventing related illness and death. These infections 
result in high personal, societal, and economic costs, both in the United States 
and around the world. NCHHSTP also works to reduce health disparities 
associated with these diseases and to help adolescents avoid infection. 
Only 57% of people living with HIV in the United States are currently 
receiving medical care for HIV infection. 
Nearly 20 million STDs occur in the United States each year, mostly among 
young persons. 
Annual hepatitis C-related mortality in 2013 surpassed the total number of 
deaths from 60 other infectious diseases combined. 
Millions of Americans are infected with the bacteria that cause TB and are at 
risk of developing active disease. 
Lesbian, gay and bisexual (LGB) adolescents have disproportionality high 
rates of health risks and negative health impacts. Twenty nine percent of 
LGB students attempted suicide in the past year compared to 6% of 
heterosexual students. 
How We Work 
HIV, viral hepatitis, STDs, and TB all share similar or overlapping characteristics: 
Risk factors such as unsafe sexual behaviors and drug use. 
Disease interactions, such as HIV increasing the risk of developing TB. 
At-risk populations, including some racial and ethnic minorities, men who 
have sex with men, adolescents, and injection drug users. 
Social, environmental, and economic determinants of health. 
NCHHSTP allocates approximately 85% of its budget for extramural funding, 
70% of which supports state and local health departments. We focus on high-
impact prevention activities to promote efficient and effective use of limited 
resources, including: 
Investing in prevention, testing, and linkage to care by health departments 
and community-based organizations. 
Expanding the use of public health and clinical data to identify populations 
and ensure access to testing and care. 
Conducting research and evaluation. 
Developing guidelines and training for healthcare providers. 
Educating the public, partners, and key populations about essential health 
information and preventive actions. 
CS2688 I 9 




STDS Nearly 20 million STDs occur in the United States each year; 
about half occur among teens and young adults. Sills can cause 
infertility, ectopic pregnancy, cancer, and increased HIV risk. The healthcare 
costs from new Sills, excluding HIV, that occur each year, are approximate-
ly 537.7 billion. 
4.4 
MILLION 
Viral Hepatitis Approximately 4.4 million people 
are living with chronic viral hepatitis infection. Viral hepatitis is the leading 
cause of liver cancer and liver transplants in the United States. Curing 
hepatitis costs 545,000 to $94,000 per person. 
MILLION 
HIV More than 1.2 million persons in the United 
States are infected with HIV. Estimated lifetime treatment 
costs are $403,000 per person using with HIV. 
014 MILLIONS AT RISK 
Tuberculosis Fewer than 10,000 cases of 
TB occur annually in the United States. Up to 13 million 
Americans are infected with the bacteria that causes TB. 
Without treatment these Americans are at risk of developing 
active TB disease. Drug-suceptible TB costs, on average, S17,000 
per year to treat, a figure that rises to $134,000 if the person has 




Increased awareness: The 
proportion of persons living with 
HIV who know their HIV status is 
at the highest level ever: 87% 
in 2014. 
Decreased HIV diagnoses: The 
number of new HIV diagnoses 
in the United States decreased 
by 19% between 2005 and 2014. 
Dramatic declines occurred 
in key populations, including 
heterosexuals, people who 
inject drugs, and 
African-American women. 
Spearheaded the first nationally 
representative study on the 
health risks of U.S. lesbian, 
gay, and bisexual high school 
students: This study helps us 
understand more about behaviors 
that can contribute to negative 
health outcomes. 
Developed the Large Outbreaks 
of Tuberculosis in the United 
States (LOTUS) surveillance 
program: This led to the 
identification of outbreaks of 10 or 
more genotype-matched TB cases. 
Updated guidelines: With 
STD experts across the country, 
we worked to preserve the last 
available effective treatment 
option for gonorrhea for as long 
as possible by updating the 
guidelines. During the past 
3 decades, $3.7 billion has been 
saved by preventing 32 million 
cases of gonorrhea. 
What's Needed 
Increasing response to viral hepatitis: Hepatitis C is common and deadly, yet 
curable. The timing is right to gain critical ground. 
Expanding use of pre-exposure prophylaxis (PrEP): The progress we've made in 
HIV prevention in the United States has been uneven. Many people living with HIV 
are not virally suppressed, and PrEP is reaching only a fraction of those who could 
benefit from it. 
Shoring up public health STD infrastructure: This critical infrastructure is eroding. 
Syphilis, gonorrhea, and chlamydia are increasing in the United States. There is also a 
growing threat from antibiotic-resistant gonorrhea. 
Preventing TB: Prevention saves lives and money. More can be done to screen and 
test for latent TB infection. 
Offering comprehensive health education in schools: More can be done to ensure 
that young people have the knowledge and skills they need to prevent infections. 
Expanding testing and treatment for infectious diseases such as HIV infection 
and hepatitis B and C among persons who inject drugs (PWID): Syringe services 
programs are an effective part of a comprehensive approach to infectious disease 
and substance use prevention among PWID. 
Long-Term Opportunities 
Support a pathway to eliminating hepatitis B and hepatitis C. Viral hepatitis is the 
leading cause of liver cancer in the United States. 
Implement comprehensive syringe services programs to test, treat, and link PWIDs 
to care in U.S. counties with the greatest needs. 
Strengthen public health STD infrastructure and continue to pursue advanced 
molecular detection approaches to syphilis and gonorrhea. 
Target investments in populations at greatest risk for acquiring HIV infection and in 
communities with high HIV prevalence. Use advanced molecular detection to identify 
and respond to outbreaks. 
Hasten progress toward TB elimination and save additional lives and money by 
finding and curing persons with latent TB infection. 
Strengthen health education and identify effective strategies for preventing initial 
substance use among children and adolescents. 
For more information visit http://www.cdc.govinchhstp or call 1-800-CDC-INFO. 
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Vaccines for Children 
20 years of protecting America's children 
The Vaccines for Children Program was 
launched in 1994 to make vaccines 
available to uninsured children. CDC 
estimates that vaccination of children 
born between 1994 and 2013 will: 
     
help avoid 
732,000 deaths 
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SNAPSHOT 
MISSION 
To prevent disease, disability, and 
death through immunization and 
by controlling respiratory and 
related diseases. 
ORGANIZATION 
Division of Bacterial Diseases 
Division of Viral Diseases 
Immunization Services Division 
Influenza Division 
Centers for Disease Control and Prevention 
NATIONAL CENTER FOR IMMUNIZATION 
AND RESPIRATORY DISEASES 
Why We're Here 
CDC protects Americans from 
infectious diseases by issuing 
recommendations and guidance 
for the prevention and control 
of vaccine-preventable diseases 
and respiratory diseases. Through 
programs such as the Vaccines 
for Children (VFC) Program, CDC 
improves access to immunization 
services for uninsured and 
underinsured U.S. populations and 
supports the scientific base for 
vaccine policy and practices. CDC 
delivers critical epidemiology and 
laboratory capacity to detect, prevent, 
and respond to vaccine-preventable 
and respiratory infectious disease 
threats and conducts preparedness 
planning for pandemic influenza. 
PRIORITIES 
Preserve core public health 
immunization infrastructure at the 
local, state, and federal levels. 
Maintain an adequate amount of 
vaccine purchase to provide a 
vaccination safety net for uninsured 
adults and respond to VPD outbreaks 
and other urgent vaccine needs. 
Improve seasonal influenza 
response and pandemic influenza 
preparedness and response. 
Ensure capacity for detecting and 
responding to emerging respiratory 
disease threats. 
How We Work 
CDC partners with state and local health agencies and private healthcare 
providers to implement a safe and effective immunization system. 
• Provides funds to build and maintain immunization programs as well as 
vaccines to protect uninsured and other priority populations and to respond 
to disease outbreaks. 
• Provides a range of support including disease surveillance, evaluation 
of vaccine effectiveness and safety, ordering and distribution systems, 
public awareness campaigns and resources, and provider education 
and tools. 
CDC partners with domestic and international partners to build 
surveillance and laboratory capacity. 
• Provides the scientific and programmatic foundation and leadership for the 
diagnosis, prevention, and control of influenza and works to build capacity 
to respond to and control seasonal and pandemic influenza. 
CDC works with federal, state, and local partners to address emerging 
and reemerging respiratory infectious disease threats. 
• Provides expertise and new innovative technologies to detect and respond 
to these emerging threats. 




In the United States 
today, we enjoy record 
high immunization 
coverage rates for most 
childhood vaccines and 
increasing coverage rates 
for adolescent and adult 




As a result, Americans have 
benefited from significant 
reductions in, and in 
some cases elimination of, 
once common and deadly 
diseases such as diphtheria, 
smallpox, measles, and 
polio. Most vaccine-
preventable diseases 
are at the lowest levels 
ever—greater than 90% 
reduction for most vaccine-
preventable diseases. 
Influenza vaccination 
coverage for children ages 
6 months through 17 years 
reached nearly 60% for the 
2015-2016 influenza season, 
compared to 44% in the 
2009-2010 influenza season. 
What's Needed 
Sustaining adequate support of the public health immunization infrastructure 
at the federal, state, and local levels. 
• Providing adequate vaccine supply to respond to VPD outbreaks and other 
urgent public health vaccine needs. 
• Addressing lagging vaccine coverage rates for some vaccines in specific 
populations (human papilloma virus [HPV]; adults; and, in certain areas, children 
living below the poverty level). 
Modernizing immunization information systems so that real-time, consolidated 
immunization data and services for all ages are available for authorized clinical, 
administrative, and public health users, as well as consumers, anytime 
and anywhere. 
• Maintaining epidemiology and laboratory capacity to respond to 
VPD outbreaks. 
• Improving seasonal influenza vaccine by improving virus characterization and 
candidate vaccine virus development. 
Responding to emerging and reemerging infectious disease threats, such as 
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and 
Legionnaires' disease. 
Long-Term Opportunities 
Decrease hospitalizations and deaths with more timely and effective seasonal 
influenza vaccines. 
Prevent HPV-related cancers by improving HPV vaccination coverage 
among adolescents. 
Better understand zoonotic risks of animal coronaviruses, like MERS-CoV, for 
emerging pathogens. 
• Improve diagnostics for early detection of emerging and reemerging 
respiratory diseases. 
• Study the effectiveness and safety of new vaccines post-licensure, such as 
that anticipated for respiratory syncytial virus (RSV). 
For more information visit http://www.cdc.govMCIRD or call 1-800-CDC-INFO. 
How We Work 
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OFFICE OF NONCOMMUNICABLE DISEASES, INJURY, 
AND ENVIRONMENTAL HEALTH  
SNAPSHOT 
MISSION 
To lead, promote, and facilitate 
science, programs, and 
policies to reduce the burden 
of noncommunicable diseases, 
disabilities, injuries, and 
environmental health hazards in 
the United States and abroad. 
ORGANIZATION 
National Center for Chronic Disease 
Prevention and Health Promotion 
National Center for Environmental 
Health / Agency for Toxic Substances 
and Disease Registry 
National Center for Injury Prevention 
and Control 
National Center on Birth Defects and 
Developmental Disabilities 
PRIORITIES 
Support priorities and strengthen 
science and program impact in the 
noncommunicable disease centers, 
Enhance integration across the 
noncommunicable disease centers, 
CDC, and within the larger public 
health community. 
Increase collaboration and innovation 
among the noncommunicable 
disease centers and 
across CDC. 
Why We're Here 
The Office of Noncommunicable Diseases, Injury, and Environmental 
Health (ONDIEH) serves as the principal advisor to the CDC director 
on issues related to the prevention and control of noncommunicable 
diseases, disabilities, injuries, and environmental health hazards. 
ONDIEH provides strategic direction and leadership for CDC's four 
noncommunicable disease national centers: NCBDDD, NCEH/ ATSDR, 
NCCDPHP, and NCIPC. 
ONDIEH is led by CDC's deputy director for Noncommunicable Diseases, 
Injury, and Environmental Health. The office works to identify, facilitate, 
and promote cross-center and cross-agency collaboration, innovation, 
and new initiatives, including those related to policy development and 
coordination, budget, programs, personnel, and scientific priorities. 
ONDIEH provides strategic leadership to CDC's four noncommunicable 
disease centers and public health programs that cross the centers, 
institutes, and offices at CDC. 
ONDIEH also serves as a home for the incubation of new public health 
initiatives. Current topics of ongoing ONDIEH work include: 
• Marijuana use and health outcomes. 
• Mental health. 
• Substance abuse. 
• Non-occupational hearing loss and its prevention. 
Key Accomplishments' 
Provided strategic leadership 
and championed the science 
and programs of CDC's 
noncommunicable 
disease centers. 
Developed strong OD 
leadership teams in each of 
the noncommunicable 
disease centers. 
Fostered incubation of new and 
cross-cutting topics: Marijuana 
use and related health outcomes, 
substance abuse, mental health, 
non-occupational hearing loss, 





centers by implementing 
lean and focused resource 
management. 
Co-located noncommunicable 
disease centers on the 
Chamblee campus which has 
resulted in: 
• Improved integration 
among centers. 
• Coordinated and 
enhanced efficiencies. 




• Sustaining the priority noncommunicable disease initiatives of the 
four noncommunicable disease centers. 
• Increasing the capacity of ONDIEH to add additional cross-cutting 
topics with current resources. 
• Transitioning new or cross-cutting topics to programmatic areas. 
ONDIEH provides guidance in 
addressing critical public health 
issues like opioid addiction. 
Long-Term Opportunities 
Moving forward, ONDIEH will: 
• Continue to advance and monitor progress of CDC's national 
noncommunicable disease centers. 
• Enhance integration among the noncommunicable disease 
centers and with other CDC centers, institutes, and offices. 
• Facilitate greater knowledge sharing among the 
noncommunicable disease centers and agency stakeholders. 
• Continue to drive strategic activities. 
• Clarify the external engagement strategy and role of the office. 
• Seek out new opportunities for additional efficiencies with the 
noncommunicable disease centers. 
For more information visit http://www.cdc.gov or call 1-800-CDC-INFO. 
MISSION 
To lead the nation's efforts to 
create expertise, information, 
and tools to support people 
and communities in preventing 
chronic diseases and promoting 
health for all. 
ORGANIZATION 
Division for Heart Disease and 
Stroke Prevention 
Division of Cancer Prevention 
and Control 
Division of Community Health 
Division of Diabetes Translation 
Division of Nutrition, Physical Activity, 
and Obesity 
Division of Oral Health 
Division of Reproductive Health 
Division of Population Health 
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Centers for Disease Control and Prevention 
NATIONAL CENTER FOR CHRONIC DISEASE 
PREVENTION AND HEALTH PROMOTION 
SNAPSHOT Why We're Here 
Chronic diseases are the main 
cause of sickness, disability, 
death, and healthcare costs. 
They are often preventable. Most 
chronic diseases are caused by a 
few risk behaviors: tobacco use, 
poor nutrition, lack of physical 
activity, and excessive alcohol 
consumption. CDC's National 
Center for Chronic Disease 
Prevention and Health Promotion 
(NCCDPHP) works to prevent these 
behaviors and support healthy 
living from birth through old age. 
What We Do to Promote Health for All Ages 
• Infants: Improve women's health before, during, and after pregnancy so 
they can have healthy babies. 
• Children and Adolescents: Support healthy communities, child care, 
and schools so children can eat well, stay active, and avoid 
risky behaviors. 
• Adults: Help adults lead healthy, active, tobacco-free lives and access 
quality preventive services like cancer screenings. 
• Older Adults: Promote quality of life and independence for people as 
they age. 
How We Work 
PRIORITIES 
Increase (healthy) life expectancy. 
Increase quality of life. 
Reduce healthcare costs.  
We work with partners to strengthen healthy behaviors and opportunities 
using four approaches: 
• 	Tracking chronic diseases and risk factors through surveys and research. 
Improving environments to make it easier for people to make 
healthy choices. 
• Strengthening the healthcare sector to deliver prevention services to 
keep people well and diagnose diseases early. 
• Connecting clinical services to community programs that help people 
prevent and manage their chronic diseases and conditions. 
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Key Accomplish 
Reducing Obesity: Obesity 
prevalence among children 
ages 2-5 years has dropped 
significantly, from 119% during 
2003-2004 to 9.4% during 
2013-2014. 
Increasing Physical Activity: 
The percentage of adults 
engaging in regular physical 
activity increased from 44% 
to 50% from 2008 to 2015. 
Helping Smokers Quit: Since 
2012 more than 5 million smokers 
have attempted to quit because 
of the TIPS campaign, and an 
estimated 400,000 smokers have 
quit for good. 
Preventing Breast Cancer 
Deaths: From 2010 through 
2013, breast cancer deaths among 
women aged 55-74 decreased 
from 58.0% to 52.3% for white 
women and from 79.3% to 73.3% 
for black women. 
What's Needed 
• Continue support for state, tribal, and territorial chronic disease 
prevention and health promotion programs. CDC supports states, 
tribes, and territories to implement evidence-based interventions that 
increase access to healthy foods, physical activity, and smoke-free 
environments; increase availability and use of electronic health records 
and team-based care to improve the management of chronic diseases; 
and availability and use of lifestyle change programs to prevent chronic 
diseases, such as type 2 diabetes. 
• Continue support for community programs, such as High Obesity in 
Rural Counties, Racial and Ethnic Approaches to Community Health 
(REACH), and funding for communities through states. For the last 
17 years, CDC has administrated community health programs to prevent 
and control chronic diseases. Through these programs, CDC promotes 
community health and reduces health disparities in communities with the 
highest burden of death, disability and illness due to chronic diseases. 
Long-Term Opportunities 
• Healthcare Delivery Transformation -The recent health insurance 
expansions and changes in payment models provide an opportunity to 
expand efforts focused on quality of patient care, especially related to 
cancer screening, and community-delivered programs like the National 
Diabetes Prevention Program. 
• As current cooperative agreements come to a close in FY 2017 and 
FY 2018, CDC has an opportunity to increase program efficiency and 
effectiveness through coordinated strategies that support healthy living 
from birth through old age. 
CDC's Tips from Former Smokers Campaign (TIPS) 
Dramatically Increased Calls to Tobacco Quitlinesi 
Ads aired 























































































































1  Number of weekly telephone calls made to 1-800-QUIT-NOW before, during, and a er CDC's 2015 Tips from Former 
Smokers campaign in the United States during March 30 - August 16, 2015. 
For more information visit http://www.cdc.qov/nccdphp or call 1-800-CDC-INFO. 
MISSION 
To protect people's health from 
environmental hazards that can 
be present in the air we breathe, 
the water we drink, and the world 
that sustains us by investigating 
relationships between 
environmental factors and health, 
developing guidance, and building 
partnerships. 
ORGANIZATION  
Division of Emergency and Environmental 
Health Services 
Division of Environmental Hazards and 
Health Effects 
Division of Laboratory Sciences 
PRIORITIES 
Ensure safe drinking water. 
Protect vulnerable populations from 
harmful environmental exposures. 
Detect and prevent environmental 
diseases and conditions. 
A 93% funding cut to 
NCEH's Lead Program in 
FY 2012 led to decreased 
testing for lead among 
children and eroded 
critical public health 
capacity, reversing 
significant gains in lead 
poisoning prevention. 
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NATIONAL CENTER FOR ENVIRONMENTAL HEALTH 
Why We're Here 
CDC protects America's health from environmental hazards that can 
be present in the air we breathe, the water we drink, and the world 
that sustains us. The National Center for Environmental Health (NCEH) 
investigates the relationship between environmental factors and health, 
develops guidance, and builds partnerships to support healthy decision-
making. These investments contribute to CDC's overall goal of keeping 
Americans safe from environmental hazards. 
How We Work 
• Track and report on trends in environmentally related diseases. 
• Collect and share environmental health data that are used to prevent 
sickness, disability, and death from harmful exposures and natural, 
chemical, and radiologic disasters and incidents. 
• Identify and disseminate the environmental health best practices that 
are the most effective at improving health and reducing medical costs. 
• Track and report on trends in environmentally related diseases. 
• Collect and share environmental health data that are used to prevent 
sickness, disability, and death from harmful exposures and natural, 
chemical, and radiologic disasters and incidents. 
• Identify and disseminate the environmental health best practices that 
are the most effective at improving health and reducing medical costs. 
• Maintain the most advanced environmental public health laboratory in 
the world. 
• Support state, tribal, territorial, and local environmental health 
programs and laboratories. 
• Prepare for and respond to natural disasters and environmental 
emergencies. 
Ann 
• Use innovative laboratory methods and environmental public health 
tracking to detect and prevent environmental diseases and conditions. 
Centers for Disease Control and Prevention 
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Significant racial disparities 
still remain in asthma 
prevalence, highlighting the 
ongoing need to implement 
comprehensive state-based 
asthma control programs 
that focus on the most 
vulnerable populations. 
Age-Adjusted Percentages of Asthma 
for U.S. Children Under 18,2014 
Ever Had Asthma 	 S II Have Asthma 




15.0% 13.0% 12.7% 




• Promising solutions that are piloted and scaled to keep water safe from 
chemicals and toxins such as per- and poly-fluoroalkyl substances (PEAS). 
• Continued vigilance to protect children from lead exposure through 
a nationwide Lead Poisoning Prevention Program and elimination of 
exposure to lead in the environment. 
• A comprehensive campaign to equip all Americans with the 
information they need to understand the impact of the environment on 
their health. 
• Expanded environmental public health tracking to strengthen the 
nationwide tracking network and integrate environmental and health 
data to drive evidence-based actions in communities. 
• More tools and methods for enabling state and local health 
departments to adapt to the effects of climate change on health and be 
prepared to take action when climate-related vector-borne diseases or 
extreme weather events strike. 
Long-Term Opportunities 
• Expand NCEH's Safe Water program by building state and local public 
health infrastructure to protect millions of people from waterborne 
contaminants, control legionellosis, and respond to water quality issues in 
drinking water distribution systems. 
• Develop and maintain a lead exposure early warning system to 
proactively identify exposures, and support a registry in Flint, Michigan, 
to follow children who were exposed to lead over time. 
• Continue exploring the benefits of incorporating electronic health records 
and emerging chemical exposures (e.g., PEAS) into environmental public 
health tracking. 
• Highlight asthma as a priority health condition through CDC's 6118 
Initiative, an effort to engage health insurance plans, businesses, and 
clinical providers in implementing evidence-based interventions targeting 
six of the most common and costly health conditions, including asthma. 
• Increase NCEH's capacity to perform biomonitoring testing to provide 
environmental chemicals exposure information by state or locality. 
Provided leadership in 
environmental health emergency 
management: NCEH led CDC's 
response to the lead contamination 
of drinking water in Flint, Michigan, 
including EOC activation, 
epidemiologic studies, and 
community outreach. 
Increased focus on prevention of 
Legionella bacteria: Legionella 
causes 66% of documented 
waterborne disease outbreaks. NCEH 
responded to outbreaks in New York 
City, Illinois, Ohio, and Texas in FY 
2016 and provided support to CDC's 
prevention and response activities 
through NCEH's Safe Water Program. 
Funded Building Resilience Against 
Climate Effects (BRACE) framework: 
BRACE helps forecast climate and 
health impacts in communities, 
identify vulnerabilities, and create 
and implement adaptation plans. 
New York City, Maine, and Michigan 
now have climate surveillance and 
modeling systems to identify people 
at risk for heat-related illness and 
death in extreme weather. 
Awarded grants to help keep water 
safe: Increased safe water protection 
knowledge and capabilities in 
14 states and 5 counties during the 
last 5 years through the Safe Water 
for Community Health (Safe WATCH) 
grant program. 
Helped prevent waterborne illness: 
Released the 2016 Model Aquatic 
Health Code to support prevention 
of waterborne illness and other 
risks in recreational water sources. 
The MAHC provides guidance on 
design, construction, operation, and 
maintenance of pools, spas, 
and hot tubs. 
Improved the public's health 
through environmental public 
health tracking: 277 data-driven 
actions were taken during the last 
5 years. 
For more information visit http://www.cdc.gov/nceh or call 1-800-CDC-INFO. 
MISSION 
To investigate environmental 
exposures to hazardous 
substances in communities 
and take action to reduce 
harmful exposures and their 
health consequences. 
ORGANIZATION 
Division of Community 
Health Investigations 
Division of Toxicology and 
Human Health Sciences 
PRIORITIES 
Reduce exposures to harmful 
chemicals in communities. 
Protect children and vulnerable 
populations from the health risks 
of harmful exposures. 
Advance environmental science 
and medicine. 
• 
AGENCY FOR TOXIC SUBSTANCES 
AND DISEASE REGISTRY 
SNAPSHOT Why We're Here 
Communities Where 
ATSDR Assessed 
Exposures and Human 
Health During 
rY 2013-2016 
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How We Work 
The Comprehensive Environmental Response, Compensation, and Liability 
Act of 1980—a.k.a., the"Superfund" Act—created the Agency for Toxic 
Substances and Disease Registry (ATSDR) to serve as a science-based public 
health agency working to address community concerns about hazardous 
waste. For 3 decades, ATSDR has kept people in more than 6,000 U.S. 
communities safe from environmental hazards. 
ATSDR protects Americans' health by preventing exposure to harmful 
contaminants in our soil, water, and air. 
ATSDR responds to requests from environmental agencies, health 
agencies, policymakers, and community members across the country 
to protect people from exposures to harmful levels of substances in 
the environment. 
• ATSDR provides funds to state health departments and supports 
environmental health professionals in regional and field offices. Along 
with Atlanta-based headquarters staff, ATSDR experts are ready 24/7 
to respond to environmental health threats from natural disasters, 
chemical spills, and other emergencies. 
p. 
• Work in communities to assess human exposures to potentially 
harmful contaminants. 
• Advise federal and state regulatory agencies and community 
members on actions needed to protect health. 
- Respond to questions about environmental exposures and 
provide guidance to healthcare providers. 
Centers for Disease Control and Prevention 
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Key Accomplishments 
Assessed more than 1 million 
people who were potentially 
at risk of harmful exposures 
to chemicals through nearly 
170 health consultations and 
assessments in FY 2015. 
Provided on-the-ground, local 
support to communities through 
the work of 400 environmental 
health professionals located in 
regional offices, state public 
health departments, and pediatric 
environmental health specialty 
units headquarters. 
Assisted the Michigan 
Department of Health 
and Human Services with 
investigating reports of new or 
worsening skin rashes in people 
exposed to Flint municipal 
water; conducted interviews and 
provided follow-up to better 
understand rash cases and make 
appropriate recommendations for 
public health interventions. 
Released new ToxProfiles that 
were used to guide public health 
decision-making by helping assess 
health effects, identify exposure 
routes and environmental sources 
of concern, and determine which 
chemicals and exposures posed 
public health risks. 
Developed guidelines, tools, and 
resources to help ensure child care 
centers are located where chemical 
hazards have been considered, 
addressed, and mitigated to best 
protect children's health. 
Reduced Amyotrophic Lateral 
Sclerosis (ALS) disease burden 
by improving identification of 
incidence, prevalence, and risk 
factors and conducting research 
leading to the launch of the 
National ALS Biorepository in 
late 2016. 
What's Needed 
Close the gap between communities' needs to protect themselves 
from harmful environmental exposures and ATSDR's current capacity to 
respond, provide assistance, and prevent harmful health effects. 
Increase understanding about the health effects of toxic exposures and 
how biomonitoring activities can lead to health improvement. 
• Expand the use of technological tools and new methods to increase 
effectiveness and timeliness in protecting communities from 
environmental hazards. 
Conduct more research to increase knowledge about how the 
combination of chemicals at hazardous waste sites affect human health 
and the ways in which toxic exposures affect vulnerable populations 
such as pregnant women and young children. 
Increase dissemination of the ToxProfiles and other toxicological 
analyses to provide data for public health action. 
Long-Term Opportunities 
Expand ATSDR's capacity to investigate harmful exposures in communities 
and recommend actions to protect health. 
• Expand the APPLETREE cooperative agreement to all 50 states and 
increase awards to enable each state to promote and implement child 
care safe-siting initiatives to protect children from health risks caused by 
placing child care and early learning facilities in hazardous locations. 
• Expand the Brownfields/Land Reuse cooperative agreements to assess 
and safely redevelop brownfields and land reuse sites. 
Create a new ATSDR Tribal Health Initiative to support investigations 
of adverse health effects in American Indian (Al) and Alaska 
Native (AN) populations. 
Continue to expand the Navajo Birth Cohort Study to investigate possible 
neonatal health effects caused by uranium exposure from past mining 
and milling operations in the Navajo Nation. 
For more information visit http://www.atsdr.cdc.gov or call 1-800-CDC-INFO. 
• k 
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PRIORITIES  
CDC-wide Priorities 
Motor vehicle injury. 
Prescription drug overdose. 
Growth Areas 
Child abuse and neglect. 
>> Older adult falls. 
Sexual violence. 
Youth sports concussion. 
NATIONAL CENTER FOR INJURY PREVENTION 
AND CONTROL 
SNAPSHOT Why We're Here 
MISSION 
To prevent violence and injuries 
and reduce their consequences. 
ORGANIZATION  
Division of Analysis, Research, and 
Practice Integration 
Division of Unintentional Injury Prevention 
Division of Violence Prevention 
As the nation's leading 
authority on violence and injury 
prevention, the National Center 
for Injury Prevention and Control 
(NCIPC) is committed to saving 
lives, protecting people, and 
lowering the social and economic 
costs of violence and injuries. 
NCIPC collects data to identify 
problems and monitor progress, 
uses research to understand what 
works, and promotes evidence-
based strategies to inform real-
world solutions. Our goal is to 
offer individuals, communities, 
and states timely, accurate 
information and useful resources 
to keep people safe where they 
live, work, play, and learn. 
Oregon: A new prevention 
plan was developed after 
NVDRS data showed that 
older adult suicides were 
3 times higher than in 
other groups. 
Arizona: Hopi Tribe saw 
36% increase in driver seat 
belt use and 32% increase 
in child safety seat use. 
Oklahoma: linked Medicaid 
and prescription monitoring 
data to identify and prevent 
high-risk patient and 
provider behaviors. 
North Carolina: Injury 
researchers are working to 
reduce head injury risks 
for athletes through 
technology and changes 
to technique. 
How We Work 
NCIPC prevents or reduces injuries in the United States and around the world by: 
• Supporting research to understand what works, including two major external 
research programs—the Injury Control Research Centers and the Youth 
Violence Prevention Centers. 
• Monitoring injuries and violent deaths to inform prevention through programs 
and activities such as: 
» National Violent Death Reporting System. 
» National Intimate Partner and Sexual Violence Survey. 
» Enhanced State Surveillance of Opioid-Involved Morbidity and Mortality. 
>> Violence Against Children Surveys. 
• Providing state and local partners with direct funding and scientific expertise 
through programs like: 
» Core State Violence and Injury Prevention Program. 
» Rape Prevention and Education Program. 
» Essentials for Childhood Framework. 
» Overdose Prevention in States Programs. 
» Striving To Reduce Youth Violence Everywhere Program. 
» Domestic Violence Prevention Enhancements and Leadership Through 
Alliances, Focusing on Outcomes for Communities United with States 
(DELTA FOCUS). 
IN= 
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VIOLENCE has lasting impacts on health. 
Consequences of violence are PREVENTABLE. 
PREVENT risk early. 
Visit cdc.gov/viotenceprevention.  






A greater capacity to anticipate, describe, and impact the instances of injury. In the 
face of complex national problems, NCIPC needs to: 
• Fully launch a national traumatic brain injury surveillance system to determine 
the incidence of sports-related concussions. 
• Start research into the causes and prevention of firearm-related violence. 
• Implement and evaluate comprehensive suicide prevention programs. 
A more robust evidence base for prevention programs. In sexual violence alone, 
additional research could help: 
• Expand the inventory of sexual violence prevention strategies with 
known effectiveness. 
• Assess the impact of approaches such as community- and society-level strategies, 
community environmental change on reducing rates of sexual violence, and the 
application of social media activities. 
Expanded monitoring of violence and injuries: 
• Growing the National Violent Death Reporting System (NVDRS). Having NVDRS 
nationwide will equip states and communities with vital information to better 
track, understand, and address the preventable characteristics of violent deaths. 
• Expanding both NVDRS and illicit opioid surveillance will increase our ability to 
track, understand, and address related injuries and help states draft prevention 
plans and programs. 
Long-Term Opportunities 
• Expand our opioid work with states, promote and disseminate the Opioid 
Prescribing Guidelines, and increase their uptake. 
• Disseminate new technical packages on youth violence, suicide, and intimate 
partner violence prevention, along with existing ones on child abuse and 
neglect and sexual violence prevention. 
• Expand our support to states to analyze data, develop state plans, and 
implement interventions that work through our Core State Violence and 
Injury Prevention Program. 
• Expand research to inform prevention strategies through programs 
such as the Injury Control Research Centers and the Youth Violence 
Prevention Centers. 
• Support the Violence Against Children Survey in additional countries, and 
then support the implementation of the INSPIRE: Seven Strategies for Ending 
Violence Against Children technical package in the countries that have 
completed the survey. 
Combatting Prescription Drug 
Overdose: NCIPC has started three 
funded programs that support 44 
states and D.C., released the Guideline 
for Prescribing Opioids for Chronic Pain, 
and engaged partner groups like 
medical schools to implement and 
disseminate the guideline. 
Improving Motor Vehicle Safety: 
NCIPC has collaborated with federal, 
state, and nongovernmental partners 
to improve safety among tribes, 
develop tool kits and resources for 
states to improve their prevention 
strategies, and educate teens on the 
importance of seat belt use. 
Preventing Traumatic Brain 
Injuries: In 2005, NCIPC launched 
HEADS UP, a series of educational 
initiatives and tool kits. HEADS UP 
improves prevention, recognition, 
and response to concussions. Studies 
show that after using the tool kit, 
77% of coaches were more easily able 
to identify concussions, and 
63% reported viewing concussions 
more seriously. HEADS UP is a strong 
brand and continues to improve 
youth sports concussion awareness 
and response. 
Reducing Child Abuse and 
Neglect: In 2016, NCIPC released 
the"Preventing Child Abuse and 
Neglect" technical package. Strategies 
in the package include those with a 
focus on preventing child abuse and 
neglect from happening in the first 
place, as well as approaches to lessen 
the harms of child abuse and neglect. 
This is a culmination of research 
done by NCIPC and the field to build 
evidence on what works. 
Implementing the Stopping Elderly 
Accidents and Deaths (STEADI) 
tool: NCIPC created STEADI to help 
primary care providers screen their 
older adult patients for falls. For every 
5,000 providers who adopt STEADI, 
over a 5-year period, more than 
6 million patients could be screened 
and over 1 million falls, and costs 
associated with treating them, could 
be prevented. 
For more information visit http://www.cdc.gov/NCIPC or call 1-800-CDC-INFO. 
ORGANIZATION 
Division of Blood Disorders 
Division of Congenital and 
Developmental Disorders 




NATIONAL CENTER ON BIRTH DEFECTS AND 
DEVELOPMENTAL DISABILITIES 
SNAPSHOT Why We're Here 
MISSION 
To study and address the causes 
of birth defects, help children 
reach their potential by 
understanding developmental 
disabilities, reduce complications 
of blood disorders, and improve 
the health of people living 
with disabilities. 
The National Center on Birth Defects and Developmental Disabilities 
(NCBDDD) prevents birth defects and developmental disorders where 
possible and enhances the health and quality of life for people who live 
with them. 
Saving babies through birth defects prevention 
and research. Birth defects afflict 1 in 33 babies 
and are a leading cause of infant death in the 
United States. More than 5,000 infants die each 
year because of birth defects. 
Helping children live to the fullest by 
understanding developmental disabilities. One 
in six children aged 3 through 17 years have one or 
more developmental disabilities. 
Protecting people and preventing 
complications of blood disorders. Blood 
disorders—such as sickle cell disease, anemia, 
and hemophilia—affect millions each year in the 
United States, cutting across the boundaries of 
age, race, sex, and socioeconomic status. 
Improving the health of people with 
disabilities. Anyone of any age can have a 
disability. An estimated 37 million to 57 million 
Americans report having some level of disability. 
Birth defects surveillance. 
Safer medications in pregnancy. 
Fetal alcohol syndrome disorders. 
Autism and other developmental 
disabilities. 
Early hearing loss detection 
and intervention. 
Attention deficit and 
hyperactivity disorder. 
Hemophilia. 
Venous thromboembolism prevention. 
Health promotion and disability. 
How We Work 
To achieve its mission, NCBDDD works to: 
Understand the problem — Characterize the occurrence and 
distribution of priority health conditions to inform public health action. 
Identify where we can intervene — Conduct research to help us 
understand the major modifiable risk factors that must be addressed 
when developing intervention and prevention programs and policies. 
Develop plans that work and take them to scale — Formulate, 
evaluate, and disseminate effective programs and policies. 
Centers for Disease Control and Prevention 
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NCBDDD conducts research 
and analysis to help families, 
providers, and public health 
partners identify and implement 
programs to address 
developmental disabilities. 
Key Accomplishments 
Established the U.S. Zika 
Pregnancy Registry to collect 
information about laboratory 
evidence of possible Zika virus 
infection among pregnant 
women. Findings will provide 
insights that may help CDC 
develop strategies to 
protect newborns. 
Provided scientific assistance to 
partners that led to a successful 
petition to FDA to.allow folic acid 
fortification of corn masa flour, 
protecting against neural tube 
defects In babies. 
Reported progress in 
identifying children with autism 
spectrum disorders (ASD) at 
younger ages. The earlier children 
are identified as having ASD, the 
sooner they can get the services 
they need to help them reach 
their full potential. 
Established an open-access 
hemophilia mutation database 
(CHAMPS) that catalogues factor 
8 and 9 mutations and developed 
a more sensitive, reproducible 
inhibitors test to use in 
clinical labs. 
Published first national 
estimating the pe, 
What's Needed 
Sustaining and recruiting epidemiology and laboratory capacity. 
Increasing the number of funded birth defects surveillance systems that 
provide quality data to conduct epidemiologic studies of birth defects 
and guide the development and evaluation of primary and secondary 
prevention efforts. 
Modernizing and improving data systems to allow for timely data 
analysis on genetic risk factors. 
Expanding effective programs and developing tools for individuals, 
families, and providers to prevent disability and promote health. 
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Become more nimble and responsive to emerging science on drugs and 
other substances that may cause birth defects (e.g., Zika) by incorporating 
the collection of biosamples into current studies and preparing 
questionnaire modules that could be rapidly implemented to respond to 
newly identified concerns. 
Expand neonatal abstinence syndrome (NAS) research, with a focus on 
understanding outcomes in affected children. 
Expand autism spectrum disorder (ASD) surveillance and research to 
include adolescents and adults to inform efforts to improve long-term 
outcomes for people with ASD. 
Publish findings from the more than 80 distinct Study to Explore Early 
Development (SEED) analyses on various maternal health and behavioral 
risk factors and provide important information on the health status of 
children with ASD. 
Expand research into gene-environment interaction risk factors for 
hemophilia complications to inform prevention. 
Expand the evidence base for interventions that currently prevent 
secondary conditions (e.g., heart disease, diabetes) in people 
with disabilities. 
For more information visit http://www.cdc.gov/NCBDDD or call 1-800-CDC-INFO. 
MISSION 
To strengthen and support the 
nation's health security to save 
lives and protect against public 
health threats. 
ORGANIZATION 
Division of Emergency Operations 
Division of Select Agents and Toxins 
Division of State and Local Readiness 
Division of Strategic National Stockpile 
PRIORITIES 
Monitor and respond to public 
health emergencies 24/7. 
Support state and local health 
department preparedness. 
Ensure critical medical supplies 
(countermeasures) are available 
and can be rapidly deployed. 
Ensure lifesaving research with 
select agents and toxins is conducted 
safely and securely. 
Support the Global Health 
Security Agenda. 
 
Centers for Disease Control and Prevention 
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OFFICE OF PUBLIC HEALTH PREPAREDNESS 
AND RESPONSE 
SNAPSHOT Why We're Here 
CDC's Office of Public Health Preparedness and Response protects the safety, 
security, and health of the United States from public health threats—foreign 
and domestic, intentional, and naturally occurring. 
We provide lifesaving response to chemical, biological, radiological, and 
nuclear threats as well as other disasters, outbreaks, and epidemics. 
In the last 7 years, CDC's 
Emergency Operations Center 
has been activated more than 
91% of the time. 
 
How We Work 
The Office of Public Health Preparedness and Response invests in state 
and local public health emergency management and response programs, 
which are the first line of defense during public health emergencies. 
We strengthen national preparedness by supporting response-ready 
state and local public health departments through CDC's Public Health 
Emergency Preparedness (PHEP) cooperative agreement. 
Our Emergency Management Program supports CDC's response to public 
health threats in the United States and around the world. We conduct real-
time monitoring of public health events, outbreaks, and hazardous agents. 
In the past 7 years, CDC's Emergency Operations Center has been activated 
more than 91% of the time. 
The Strategic National Stockpile maintains a $7 billion repository 
of lifesaving medical supplies, known as emergency medical 
countermeasures, to support state and local response to public health 
emergencies. We stand ready to deploy these assets when needed, and 
we provide training and support to state and local health departments 
preparing to receive and use countermeasures. 
We keep communities safe by overseeing and regulating laboratories that 
work with deadly pathogens and toxins. 
We support global health security, working with international partners to 
build emergency management skills programs and emergency operations 
centers capacity around the world. 
Key Accomplishments, What's Needed 
Events such as natural disasters, terrorist attacks, and pandemics stretch 
the current day-to-day public health system beyond normal capabilities. To 
address this, we need trained public health responders and infrastructure to 
handle large-scale public health emergencies at state and local levels. Being 
prepared requires: 
• Administrative flexibility to support complex responses. This includes the 
ability to rapidly move funding and people so CDC can more effectively 
respond to public health emergencies. 
• Strengthening strong partnerships to prepare against public health 
threats across the world. Continued training and exercise of response 
plans with emergency managers both at home and abroad will help to 
stop emerging health treats early and close to the source. 
• Improving the quantity, quality, and consistency of the laboratory 
inspection process to better ensure that labs working with dangerous 
pathogens do so as safely and securely as possible. 
• Continuing training and education about preparedness activities, 
opportunities, and threats. 
Long-Term Opportunities 
• Establish an emergency response fund to allow for rapid response without 
diverting critical resources. 
• Improve the public health, healthcare, and emergency management 
capabilities in the top 10 U.S. urban areas to ensure highly functioning 
response capabilities. 
• Integrate the public/private emergency medical supply chain, to ensure 
access to critical medicines and supplies when they are needed the most. 
• Build emergency management capacity in other countries as a part of 
the comprehensive Global Health Security Agenda in an effort to create 
all-hazards response capabilities that could stop or contain public health 
emergencies before they become global threats. 
Responding to public health 
emergencies: Provide 24/7 
expertise, staffing, resources, and 
coordination in response to natural 
disasters, terrorist attacks, and 
infectious disease threats like Zika 
and Ebola. 
Supporting nationwide 
capability to receive and use 
medical countermeasures: 1,661 
federal, state, territorial, and local 
responders were trained to receive, 
distribute, and dispense Strategic 
National Stockpile assets in 2015. 
Providing critical funding: PHEP 
funds supported preparedness 
activities in 50 states, 4 localities, 
and 8 territories and freely 
associated states. 
Keeping deadly pathogens safe 
and secure: Nearly 200 inspections 
of laboratories and thousands of 
assessments of those who handle 
select agents and toxins were 
conducted to keep these materials 
safe, secure, and out of the hands of 
those who would misuse them. 
Assessing readiness: A new 
review process evaluates state 
and local operational readiness 
to plan and execute a large-
scale response requiring medical 
countermeasures. 
Training emergency experts: 
Training in incident management 
systems builds emergency 
operations center capacity at home 
and around the world. 
Connecting state and local 
partners: Our efforts promote 
more effective state and local 
coordination of preparedness 
planning between the emergency 
management, public health, and 
healthcare sectors. 
For more information visit http://www.cdc.gov/phpr/ or call 1-800-CDC-INFO. 
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Surveillance Data Platform. 
CDC's Surveillance Strategy 
implementation 
How We Work 
OFFICE OF PUBLIC HEALTH SCIENTIFIC SERVICES 
SNAPSHOT 
MISSION 
To lead, promote, and facilitate 
science, standards, and policies to 
reduce the burden of diseases in 
the United States and globally. 
Why We're Here 
The Office of Public Health Scientific Services (OPHSS) leads CDC's efforts 
to improve the collection, analysis, and availability of public health data 
and information to improve America's health, safety, and security. Through 
direct supervision of the National Center for Health Statistics and the Center 
for Surveillance, Epidemiology, and Laboratory Sciences, OPHSS provides 
guidance and advice to the broader agency and advances data system 
modernization and interoperability, information innovation, and enhanced 
data analysis, synthesis, and translation. 
In 2016, OPHSS launched the 
Conversations on Public 
Health Surveillance video 
series to discuss timely issues 
around public 
health surveillance. 
Data and analytics visualization. 
• Convene and influence — OPHSS engages the CDC community, public 
health partners, private industry, vendors, and healthcare entities, as 
well as state and local health departments, to facilitate discussion of 
data challenges and solutions. 
• Provide governance — OPHSS chairs and provides support for CDC's 
Surveillance Leadership Board, which governs decisions regarding 
policy, management, and strategic direction of CDC's surveillance 
enterprise. OPHSS also co-chairs the CDC Information Resources 
Governance Council. 
• Develop innovations — OPHSS fosters innovation and facilitates sharing 
of best practices at CDC in public health surveillance, data collection 
and processing, and technology adoption. 
• Accelerate data synthesis and translation — OPHSS leads with 
technical expertise regarding new methods and provides venues to 
share and disseminate novel analysis and visualization techniques. 
Centers for Disease Control and Prevention 
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Key Accomplishments 
Initiated development of platform: 
$17 million was awarded to OPHSS 
through the Nonrecurring Expenses 
Fund to conceptualize, plan, and 
begin building a flexible data 
services platform for CDC. 
Assessed CDC's systems: 
Characterized CDC's existing 
surveillance systems and assessed 
benefits and barriers to development 
of a platform. 
Advanced data visualization across 
CDC: Places and Spaces: Mapping 
Science featured exhibits, lectures, 
and a workshop series about 
geographic information systems. 
Fostered innovation - the CDC 
Health Information Innovation 
Consortium: Awarded more than 
$1 million in $10,000 to $50,000 
increments to CDC programs to 
foster innovation in public 
health surveillance. 
Created the Hack-a-thon: Convened 
an agency-wide effort to focus on a 
technology initiative to improve data 
tools and support sharing of 
data services. 
Presented Conversations on Public 
Health Surveillance: Video series 
launched to discuss issues around 
public health surveillance at CDC 
and with partners. 
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What's Needed 
CDC's public health surveillance capabilities are essential for responding 
to public health threats. However, the system critically needs modernizing 
to be interoperable, flexible, and timely. CDC currently operates more 
than 100 separate, independent systems dedicated to specific surveillance 
activities, and multiple systems collect data from the same CDC partners. 
CDC has made progress through four key initiatives of its Surveillance 
Strategy: improving mortality reporting, notifiable disease reporting, 
syndromic surveillance, and electronic laboratory reporting. CDC is 
modernizing its surveillance enterprise by designing, developing, and 
adopting a modular, interoperable collection of shared services that 
function as an information technology platform that will enable public 








CDC's new Surveillance Data Platform Initiative will provide shared data 
services to CDC programs and public health partners. 
Long-Term Opportunities 
• Transform the agency's scientific data enterprise into an agency-wide 
shared services model through the integrated platform. 
• Dramatically enhance the agency's ability to respond to both emergency 
data needs and routine work while also reducing the burden imposed 
on states. 
(, Prepare CDC's workforce to meet the integrative needs of public health 
and modernized surveillance systems and methods. 
For more information visit https://www.cdc.gov/ophss/ or call 1-800-CDC-INFO. 
SNAPSHOT 
MISSION 
To provide scientific services to 
advance public health nationwide. 
ORGANIZATION 
Division of Health Informatics 
and Surveillance 
Division of Laboratory Systems 
Division of Public Health 
Information Dissemination 
Division of Scientific Education and 
Professional Development 
PRIORITIES 
Superb Data and Information—
Transform the public health 
system with improved systems for 
surveillance, dissemination of health 
information, access to data, and 
analytic tools. 
Excellent People—Recruit and prepare 
a dynamic public health workforce 
and its future leadership to conduct 
scientific investigations, find solutions, 
and respond to new challenges to keep 
us safe. 
Outstanding Laboratories—Enhance 
the quality and interpretation of patient 
clinical laboratory results through the 
development of guidance, standards, 
training, and systems. 
CENTER FOR SURVEILLANCE,  ;J I']:[(LOGY, 
AND LABORATORY SERVICES 
Why We're Here 
The Center for Surveillance, Epidemiology, and Laboratory Services (CSELS) 
works at the interface between CDC programs and partners in state, 
territorial, local, and tribal public health agencies. We provide scientific 
services, expertise, tools, and access to data to empower their efforts to 
promote health, prevent disease, and prepare for emerging health threats. 
CSELS leads the national surveillance strategy, operates two national 
health surveillance systems, and provides leadership for national public 
health efforts in scientific education and professional development 
through didactic training and experiential learning. CSELS strengthens the 
nation's laboratory system by continually improving quality and safety, 
informatics and data science, and the workforce through research, training, 
and the development of guidance, standards, and tools. 
How We Work 
As a new cross-cutting center that provides essential scientific services 
to others, CSELS works by building strategic partnerships and systems to 
benefit the public's health. Many of our activities (e.g., publication of the 
Morbidity and Mortality Weekly Report IMMWM, the transformation and 
provision of data through the National Notifiable Disease Surveillance 
System, operation of the CDC Library) have a long and robust history 
as flagship CDC components. Many are in the process of technological 
modernization, while other activities—like our new Laboratory Leadership 
Service created to train the nation's public health laboratorians or our effort 
to build new systems to allow electronic case reporting directly to state 
and local public health agencies from a patient's electronic health record—
reflect the changing landscape of healthcare and science. 
Centers for Disease Control and Prevention 
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DSEPD State, Tribal, Local, and Territorial Field Trainees— 9/30/2016 
Total= 202 
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• Providing resources for products and services to support state, local, and 
international efforts to protect health. 
• Collaborating across sectors and stakeholders to conduct optimal 
surveillance to improve public health action, sustain and strengthen a 
workforce of tomorrow, and enhance clinical laboratory systems. 
• Modernizing both surveillance and information dissemination systems 
and workforce education and training to support fast and effective 
detection and response to health threats. 
• Articulating the value of CSELS work as the "utility company" that 
provides essential services for the nation's public health system. 
Long-Term Opportunities 
• Modernize health data systems, connecting the electronic health record 
to public health, information dissemination procedures, and 
laboratory systems. 
• Obtain more complete and timely data on notifiable diseases and health 
conditions and improve federal, state, and local health agencies' access to 
tools for analyzing and acting on syndromic data. 
• Strengthen the knowledge and skills of the public health workforce, 
including laboratory scientists, by providing training, guidelines, and 
evidence-based recommendations. 
• Improve public health response and support through short-term 
technical assistance. 
• Expand collaboration between the healthcare and public health sectors, 
transforming the health system and leading to heathier people. 
Epidemic Intelligence Service: 
160 disease detectives serve in 
state and local health agencies and 
CDC programs to address health 
problems by conducting scientific 
investigations on a broad range of 
topics and responding to outbreaks 
and disasters. In FY16, 131 EIS officers 
conducted 52 Epi Aid investigations 
and played pivotal roles in the 
response to Zika virus infections in 
Puerto Rico, American Samoa, Brazil, 
the U.S. Virgin Islands, and Utah; the 
opioid overdose epidemic in multiple 
states; and an unprecedented 
outbreak of HIV infection in Indiana. 
Timely Information for Action: 
MMWR (the voice of CDC) worked 
tirelessly with partners to publish 
more than 40 reports on polio 
eradication, 80 on Ebola, and 40 on 
Zika virus infection to guide clinicians, 
laboratorians, travelers, and public 
health authorities during these 
emergency responses. 
Laboratory Workforce 
Development: 39,224 training 
hours were provided to 18,918 
individuals on 98 laboratory topics 
including laboratory testing, safety, 
preparedness, and bioinformatics. 
Improved Laboratory Practice: 
Disseminated over 20,000 quality 
and safety products and tools 
designed to guide quality clinical 
laboratory testing. 
Modernizing Surveillance: BioSense 
has been revitalized as a community 
focused National Syndromic 
Surveillance Program. CSELS has 
worked with SILT partners to provide 
them with cloud-based data storage 
and state-of-the-art analytic tools 
(SAS, R and ESSENCE). 
For more information visit http://www.cdc.gov/ophssicsels or call 1-800-CDC-INFO. 
SNAPSHOT 
MISSION 
To provide accurate, relevant, and 
timely statistical information and 
data to guide actions and policies 
that improve the health of the 
American people. 
ORGANIZATION 
Division of Health and Nutrition 
Examination Surveys 
Division of Health Care Statistics 
Division of Health Interview Statistics 
Division of Research and Methodology 
Division of Vital Statistics 
Office of Analysis and Epidemiology 
PRIORITIES 
Explore alternative data sources. 
Maintain survey response rates for 
vital national health programs such 
as the National Health and Nutrition 
Examination Survey (NHANES) and 
National Health Interview Survey 
(NHIS). 
Improve timeliness across 
data systems. 
Harness the potential of electronic 
health records. 
Increase data integration 
and linkages. 
Improving Timeliness: Percent of Deaths 
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NCHS efforts on 
getting cause of death 
reported more rapidly 
help identify emerging 
trends in mortality 
and strategies to 
address them. 
NATIONAL CENTER FOR HEALTH STATISTICS 
Why We're Here 
High-quality health statistics are necessary to make evidence-based decisions to 
improve health and healthcare in the United States. As one of the nation's principal 
statistical agencies, the National Center for Health Statistics (NCHS) collects, 
analyzes, and disseminates accurate, objective data to monitor long-term trends 
as well as detect short-term changes of public health importance. Leaders, health 
professionals, and an increasingly connected public look to NCHS for relevant, 
credible, and objective health information. 
How We Work 
We present a complete picture of the health of the U.S. population using a variety 
of data collection mechanisms, including: 
• Birth and death records from the 57 vital registration jurisdictions. 
• In-person household interviews on health status and health behaviors. 
• Direct physical examinations and laboratory testing. 
• Surveys of healthcare providers. 
NCHS provides credible statistics and evidence to guide policies and 
actions, including: 
• 2016 opioid prescription guidelines. 
• Tobacco use prevention and cessation programs. 
• Pediatric growth charts for American children. 
• Research on statistical methods to ensure data quality and 
promote innovation. 
 
Centers for Disease Control and Prevention 
 
 
CS2688 I 9 
Age-adjusted Suicide Rates by Sex: 
United States, 1999-2014 












For more information visit http://www.cdc.gov/NCHS or call 1-800-CDC-INFO. 
Key Accomplishments 
Strengthened the role of data 
to enhance the health and well-
being of all Americans: DHHS 
relies on NCHS data to monitor the 
implementation of health reform and 
changes in the health system, and to 
report on health insurance coverage 
at the national and state levels. 
Made significant improvements 
in the timeliness and quality of 
public health data: The percentage 
of deaths reported within 10 days 
of the event increased from 12% 
in 2012 to 48% for the first half 
of 2016, providing virtual real-
time surveillance information and 
therefore information for rapid action 
to reduce preventable deaths. 
Provided critical prescription drug 
data in the development of (DC's 
2016 Guidelines for Prescribing 
Opioids for Chronic Pain: NCHS 
data provided evidence for the new 
CDC guidelines, which are expected 
to improve patient outcomes and 
reduce adverse events and death. 
Contributed to updated 2012 
recommendations from CDC 
on children's blood lead levels: 
Contributions from NCHS data helped 
shift the focus to primary prevention 
of lead exposure. CDC will use NCHS 
data going forward to monitor and 
update recommendations to prevent 
lead exposure before it occurs and to 
promote children's health. 
Provided evidence for new national 
guidelines for diagnosing and 
treating hypertension in children 
and adolescents: NCHS data 
supported the development of 
new guidelines from the National 
Institutes of Health and the National 
High Blood Pressure Program. 
What's Needed 
New and innovative approaches for data collection and assessments of data 
quality - Survey response rates have been declining; low participation rates may 
introduce the potential for bias based on non responses in survey estimates. 
Major redesign for the National Health Interview Survey (NHIS), which will 
require support to evaluate the impact of survey changes on estimates and trends 
for critical health variables, including health insurance coverage and risk behaviors. 
Better use of existing data for evidence and evaluation - NCHS plays a critical 
role in finding ways to use administrative data across the federal system to enhance 
information for improving analytic utility. 
Appropriate statistical methods for use and analysis of electronic health 
records (EHRs) - The incorporation of EHRs into provider surveys and records 
requires refinement. An interface is needed for analyzing information from different 
EHR vendors that are not currently interoperable. 
Recruitment and retention of statisticians - Hiring and retaining skilled 
statisticians is critical for the future of NCHS as a federal statistical agency. 
Long-Term Opportunities 
Expand the value of mortality records by exploring the literal text from death 
certificates. This will improve our understanding of the contribution of different 
causes or factors to death, such as antibiotic resistance, Alzheimer's disease, and 
other conditions. 
Explore options for geocoding birth and death records to improve the national 
infrastructure for geographic information below the county level and strengthen the 
surveillance capability. 
Expand the use of electronic health records and encounters: The data being 
collected in the new National Hospital Care Survey far exceed information collected 
in previous surveys of providers, providing substantially richer information and 
detail, including information on rare events. Recent data included more than 20 
million patient visits to hospitals, outpatient facilities, and emergency rooms, and 
these numbers are increasing exponentially, providing tremendous potential for 
evidence to inform decision-making. 
Improve the use and reuse of existing data: Improvements would support 
evaluation and evidence-building for performance, policy, and decision-making, 
such as including the efforts of the Commission on Evidence-Based Policymaking. 
MISSION 
To design legislative strategies 
for complex public health issues 
and develop plans for CDC's work 
with Congress to advance CDC's 
public health goals. 
PRIORITIES 
Inform Congress about CDC's 
research, programs, and priorities. 
Track legislation. 
Provide preparation of CDC's 
Congressional testimony. 
Inform policy proposals through 
technical assistance. 
CENTERS FOR DISEASE CONTROL AND PREVENTION 
WASHINGTON OFFICE 
SNAPSHOT Why We're Here 
The CDC Washington Office (CDCW) helps position CDC in Washington 
to Congress, the Department of Health and Human Services and other 
federal agencies and partners. CDCW designs legislative strategies to 
address complex public health issues and advance CDC's work with 
Congress to improve public health. CDCW translates public health 
developments to the Washington-based policy community; provides 
strategic direction and support for CDC leadership in briefings and 




to members and their 
staff that increases 
understanding of Public 
Health issues and 
relevance to 
their constituents. 
How We Work 
CDC Washington provides the following: 
• Congressional perspectives to CDC leadership and centers 
• Expert analysis of CDC programs as they relate to Congressional and 
other policy actions 
• Technical assistance on public health policy and legislative initiatives 
• Rapid and reliable response to Administration and Congressional 
requests for information 
• Expertise in risk communication on breaking news and oversight 
• CDC materials, services, and tours of facilities for Congressional 
Members and their staff 
Regular updates for policy audiences on emerging CDC topics of 
interest 
CS268819 
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What's Needed 
• Clear communications for the Washington-based policy community on 
complex public health issues. 
• A Washington-based staff of experts in CDC priorities to represent the 
Atlanta-based agency in Washington. 




In the 114th Congress, CDCW: 
• Organized more than 20 
Congressional Member 
and staff visits to CDC 
headquarters in Atlanta, 
CDC's Fort Collins 
laboratory, and NIOSH. 
Long-Term Opportunities 
• Educate congressional offices and Washington-based partners on 
CDC's mission. 
• Highlight CDC's role in current events and outbreak response. 
• Broaden partnerships to better match the diverse activities in 
CDC's portfolio. 
• Strengthen coordination and communication between CDC and 
other federal agencies. 
• Provided technical 
assistance on legislation 
impacting CDC's work 
in Flint, MI; CDC's Global 
Health Security Agenda; and 
CDC's response to emerging 
infectious disease threats. 
 
CDC Washington works with CDC staff to ensure information presented 
in expert testimony to Congressional committees is timely, accurate 
and provides helpful scientific context to the issues being discussed. 
 
• Developed and maintained 
relationships with 
Congressional Members and 
Committee staff. 
• Developed testimony and 
prepared CDC witnesses for 
22 Congressional hearings 
(including 6 hearings 
specific to CDC's Zika 
response). 
• Prepared and staffed CDC 
leadership for more than 
500 Congressional briefings 
to educate Members and 
staff on CDC's critical work 
protecting health in their 
states and communities. 
For more information visit http://www.cdc.gov/washington or call 1-800-CDC-INFO. 
100%-.7,00. 
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OFFICE OF EQUAL EMPLOYMENT OPPORTUNITY 
SNAPSHOT 
MISSION 
To end employment discrimination 
and promote equal employment 
opportunity in the workplace. 
ORGANIZATION 
Affirmative Employment Program 
Alternative Dispute Resolution Program 
Complaints and Adjudication Section 





Why We're Here 
The Office of Equal Employment Opportunity (OEE0) is a critical partner 
in achieving CDC and ATSDR's public health goals. Our office supports the 
agency's responsibility to maintain a model equal employment opportunity 
(EEO) program and a diverse workforce. The Equal Employment Opportunity 
Commission (EEOC) guidelines state that a model EEO program effectively 
considers and addresses concerns arising under both Title VII and Section 
501 of the Rehabilitation Act. The elements of a model EEO program are 
1) leadership commitment, 2) EEO integration with the agency's strategic 
mission, 3) accountability, 4) proactive prevention of discrimination, 
5) efficiency, and 6) responsiveness and legal compliance. 
EEO is a legal requirement, 
How We Work 
°EEO is responsible for oversight of matters related to equal employment 
opportunity, affirmative employment, dispute resolution, and disabilities 
and reasonable accommodations. The impact of CDC ()EEO programs has 
national significance. OEEO organizational components consist of four 
major sections: The Complaints Processing and Adjudication Section 
(CPAS) processes and adjudicates EEO complaints. The activities performed 
are pre-complaint counseling, overseeing investigations, and coordinating 
hearing requests. The Affirmative Employment Section (AEP) generates 
annual and quarterly submissions of the Management Directive 715 
(MD-715) workforce analysis report. This report provides a barrier analysis, 
policy guidance, and standards for establishing and maintaining effective 
affirmative action and equal employment opportunity programs. The 
Alternative Dispute Resolution (ADR) program provides an opportunity 
to address and resolve workplace conflict in a neutral, confidential manner 
through the use of various creative methods, such as early intervention, 
mediation, facilitation, fact-finding, and conciliation. The Reasonable 
Accommodation Services (RA) section helps the agency establish and 
maintain a work environment in which persons with disabilities receive 
full and fair consideration for any job for which they apply and reasonable 
accommodations to perform their essential job functions. 
Centers for Disease Control and Prevention 
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OEEO is committed to fostering an inclusive culture through equity, 
opportunity, and respect. To end employment discrimination and promote 
equal employment opportunity, we need to: 
Become a model EEO program: OEEO has made significant gains in 
customer service, effectiveness, and efficiency, but continuous changes in 
the EEO landscape will require additional commitment to meet new 
EEO mandates. 
Increase training opportunities for managers and supervisors: We 
must ensure leaders have the knowledge, skills and abilities to understand 
their ADR, EEO, and RA roles and responsibilities. This knowledge can give 
CDC an advantage in recruiting and retaining a qualified and dedicated 
workforce, as well as help CDC decrease risk. 
CDC works to ensure that supervisors and managers understand EEO 
requirements and the benefits of a diverse workforce. 
Long-Term Opportunities 
As the number of complex cases and EEO changes grow, ()EEO will need to 
expand its focus from routing and handling routine complaints to civil rights 
and contract compliance. 
• Strengthening Collaborations and Partnerships: This includes more 
involvement with global initiatives involving deployed staff and the 
inherent issues associated with EEO in other countries. 
• Improving Training: Training is the most effective way to address EEO 
challenges. Dedicated regulatory and legal training would be proactive 
and effective and help CDC decrease risk. 
• Digital Tracking: All EEO components should have this capacity. With 
enhancements to its reasonable accommodation system, OEEO has an 
opportunity to help other federal agencies achieve CDC's ability to handle 
reasonable accommodation requests. 
Key Accomplishments 
The CDC EEO program has 
transformed from an at-risk program 
to a leading program within the 
federal government. 
HHS/ EEOC Best Practices: 
• From 2011 through 2016, 
EEOC cited CDC's Reasonable 
Accommodation (RA) program as 
a government-wide best practice 
and model system for use by 
other governmental agencies. 
• During 2010-2016, CDC's EEO 
program was cited by DHHS as 
having "Best in Class performance" 
for on-time compliance reporting. 
• 2011: Developed the first diversity 
and inclusion audit, cited as an 
HHS best practice. 
Program Improvements: 
Streamlined ADR, EEO, and RA 
processes to provide efficiencies and 
timely response. 
Collaborations: Implemented 
strategic alignment meetings with 
Human Resources Office, Office of 
General Counsel, union, employee 
organizations, medical review 
authority, and labor and 
employee relations. 
Training: 
• Increased EEO-related training 
opportunities agency wide for 
CDC employees worldwide. 
• Established internal mentoring 
program to assist staff in 
developing leadership skills and 
professionalism to further their 
career goals. 
• Collaborated with HHS Office 
of Civil Rights to conduct 
Title 6 Civil Rights Training 
for CDC procurement staff. 
• Established and trained three 





To advance health equity and 
women's health issues across 
the nation through CDC's science 
and programs and increase 
CDC's capacity to leverage its 
diverse workforce and engage 
stakeholders toward this end. 
ORGANIZATION 
Minority Health 
Diversity and Inclusion Management 
Office of Women's Health 
PRIORITIES 
Eliminate health disparities. 
Advance health equity. 
Protect the health and safety 
of women and girls. 
Ensure a diverse public 
health workforce. 
Programs designed 
to reduce health 
disparities 
Reducing health disparities brings us closer to reaching health equity. 
How We Work 
OFFICE OF MINORITY HEALTH AND HEALTH EQUITY 
Why We're Here 
The Office of Minority Health and Health Equity (OMHHE) aims to 
accelerate CDC's health impact and eliminate health disparities. OMHHE 
does this by facilitating implementation of science, programs, and policies 
across CDC to reduce health disparities and achieve health equity; 
advancing CDC's research, policy, and prevention initiatives to improve 
women's health; and ensuring a diverse CDC workforce that enhances 
population health outcomes. 
• Monitor and report on the health status of vulnerable populations. 
• Initiate and maintain strategic partnerships with governmental, non-
governmental, national, and regional organizations to advance science, 
practice, and workforce for eliminating health disparities. 
• Provide leadership for CDC-wide policies, strategies, action planning, 
and evaluation to eliminate health disparities. 
• Promote women's health and ensure a diverse and inclusive workforce. 
Centers for Disease Control and Prevention 
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Key Accomplishments! 
Leading CDC's efforts on health 
equity and social determinants 
of health by representing the 
agency as the co-lead of the 
Healthy People 2020 Social 
Determinants of Health topic 
area, coordinating the advisory 
committee to the director/ 
health disparities subcommittee, 
and convening the annual 
State of Health Equity at CDC 
forums to increase agency-wide 
collaboration. 
Shaping the public health 
workforce of the future through 
the CDC Undergraduate Public 
Health Scholars (CUPS) program 
and the Millennial Health 
Leaders Summits to equip the 
next generation of public health 
leaders with the tools they need to 
eliminate health disparities. 
Leading science through 
publication of CDC's first 
comprehensive reports to assess 
health disparities (the CDC Health 
Disparities & Inequalities Report), 
the first-ever CDC report on 
Hispanic Health (CDC Vital Signs), 
and a special supplement on 
health equity (Journal of Public 
Health Management and Practice) 
and through a partnership with 
Tuskegee University to host annual 
Public Health Ethics forums. 
Providing support to state, local, 
tribal, and territorial offices of 
minority health by hosting CDC's 
first-ever National Health Equity 
Leadership Academy. 
Shaping a diverse CDC workforce 
by establishing and co-leading 
CDC's Diversity and Inclusion 
Executive Steering Committee 
and by conducting two CDC-wide 
diversity culture audits. 
What's Needed 
• Increase the capacity of public health practitioners to decrease 
health disparities and health inequities through targeted national, 
regional and state level partnerships. 
• Build capacity to collect data and conduct epidemiological health 
equity studies. 
• Ensure health equity is included in the health in all policies approach. 
• Improve community health by increasing knowledge of evidence-
based strategies that work to reduce preventable morbidity and 
premature mortality in vulnerable populations. 
PAVING THE ROAD TO 
HEALTH EQUITY 
Health Equity 
is when everyone has the opportunity 
to be as healthy as possible 
Air 	 I 
Programs 
Successful health 	 Data practices to support 
equity strategies the advancement of 
health equity 
Policy 
Laws, regulations, and 




• Support evaluations of health equity and health disparities initiatives 
in the field, for example, evaluate the impacts of multi-sectoral 
collaborations. 
• Expand the Millennial Health Leaders' program by offering 3- to 12-month 
internship opportunities for graduate and medical students to engage 
with vital health equity topics. This gives OMHHE a great opportunity to 
shape the future health equity workforce and extend CDC's credibility in 
this area. 
• Increase the diversity and skills of the emerging public health workforce 
trained through the CUPS program. 
• Expand the understanding and application of SDH (i.e., SES, cultural, 
language access, health literacy, and environmental barriers) as they 
relate to Women's Health and lead CDC's centers, institutes, and offices in 
integrating related Women's Health disparities in their programs. 
For more information visit http://www.cdc.gov/minorityhealth or call 1-800-CDC-INFO. 
PRIORITIES 
Increase public trust in and credibility 
of CDC's science, research, and 
recommendations. 
Ensure delivery of health information 
that is accessible, understandable, 
and actionable. 
Maximize strategic communication 
opportunities. 




OADC extends CDC's health 
security mission by providing 
timely and accurate information 
needed to save lives and protect 
people. 
ORGANIZATION 
Why We're Here 
The Office of the Associate Director for Communication provides agency-
level communication strategy and advice, reporting to the CDC director. 
OADC works alongside agency programs to harmonize CDC communication 
efforts and maximize their impact. OADC also coordinates awareness 
with HHS on media issues and prepares the CDC director as a public 
health thought leader on multiple media platforms. Whether speaking to 
international partners, presenting on the Hill, giving interviews to top-tier 
reporters on complex issues, or motivating CDC staff and leaders, OADC 




Keeping America Safe, 
Healthy, and Secure.' 
OADC developed 24/7 
messaging to remind those 
who CDC serves of the 
agency's commitment to 
resprving health security. 
Office of Communication Science 
Division of Communication Services 
Division of Public Affairs 
How We Work 
Whether responding to a public health emergency such as Zika or Ebola 
or confronting epidemics like prescription drug overdose, CDC is America's 
front line of defense against threats to our nation's health security. As 
the centralized leader of communication at CDC, OADC provides critical 
support to CDC's centers, institutes, and offices to disseminate life-saving 
information that people need to make decisions to protect their health 
and that of their families and communities. 
OADC achieves its mission through a determined focus on providing 
accurate, clear health information when, where, and how people need to 
see it. OADC provides expertise and services supporting CDC programs in 
the areas of crisis and risk communication, health literacy, graphic design, 
video production, public affairs, employee communication, digital media, 
language translation, CDC INFO, CDC Museum, and communication 
research and evaluation. OADC works to expand CDC's health 
communication capacity and contributes to the field of communication 
across the country and around the world. 
Centers for Disease Control and Prevention 
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Digital Acceleration: 
OADC has led the 
way in government 
communication 
by expanding and 
integrating digital 
strategies into CDC's 
health communication 
and public affairs work. 
4.1)1 Best practices in content 
GA 	syndication, social 
media, and responsive 
design ensure that 
CDC's health and 
science information is 
easily accessible when 
and where people seek 
information. 
Clear Communication: 
The CDC Clear 
Communication Index is 
a research-based tool to 
help develop and assess 
public communication. 
It has been used to 
train more than 700 
CDC staff, grantees, and 
partners, as well as staff 
from other agencies. 
HOW THE PUBLIC VIEWS CDC 
CDC is ranked as 3rd  most 
favorably viewed federal 
agency (71%). Fewer than 
1 in 5 U.S. ci zens express 
a nega ve view of CDC. 
Pew Research Center, Sept 2015 
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Vital Signs: CDC's Vital Signs is 
a monthly digital publication 
that reaches, on average, 
nearly 1.2 billion people 
monthly with important public 
health messages. OADC leads 
communication support and 
production of all issues relating 
to Vital Signs. 
What's Needed 
Today's communication landscape is characterized by fast-paced 
technological changes that require CDC to remain on the cutting edge 
of innovations in communication science in order to effectively reach 
priority audiences. OADC works to build the capacity for enabling agency 
communicators to succeed. To continue meeting new communication 
challenges, OADC must focus efforts on: 
• Adapting to newly emerging communication technologies. 
• Addressing demographic trends that point to wider cultural changes in 
communication behaviors and preferences. 
- Maintaining tools for segments of the population that still prefer or 
require traditional or adaptive modes of communication. 
Long-Term Opportunities 
Help people see themselves in CDC's messages: OADC provides leadership 
and direct support to CDC programs that work to place scientific findings in 
plain language and reviewed for cultural competence. When appropriate, 
they are translated into other languages and/or told through 
compelling stories. 
Increase data-driven communication: OADC uses information collected 
from its communication channels (web, media releases, (DC-INFO, social 
media) to tailor health information and delivery methods to specific 
audiences for their needs. 
Use communication science to enhance two-way communication: CDC 
is a leader in the use of tools for engagement with our audiences, which the 
public increasingly expects. 
Workforce development: Shifts in U.S. demographics, information-seeking 
behaviors, technology, and expectations for 24/7 engagement, while also 
maintaining traditional, science-based communication practices, demand 
a savvy communication and public affairs workforce with specialized skills 
and experience. OADC works to expand and prepare the communication 
workforce both within CDC and among its partners. 
For more information visit http://www.cdc.gov/about/24-7 or call 1-800-CDC-INFO. 
Centers for Disease Control and Prevention 
ORGANIZATION 
Office of Laboratory Safety 
Office of Laboratory Science 
PRIORITIES 
OFFICE OF THE ASSOCIATE DIRECTOR FOR 
LABORATORY SCIENCE AND SAFETY 
SNAPSHOT 
MISSION 
To strengthen the CDC culture 
of laboratory science and safety 
through leadership, collaboration, 
training, and continuous quality 
improvement. 
Why We're Here 
The Associate Director for Laboratory Science and Safety (ADLSS) serves 
as the key point of oversight and accountability for laboratory quality 
and safety at CDC.The Office of the ADLSS (OADLSS) was established 
in 2015 to centralize oversight and leadership of laboratory safety and 
quality following widely publicized laboratory safety incidents in 2014. 
Congress remains deeply interested in CDC's laboratory safety reforms. 
OADLSS's core functions are to ensure laboratory safety compliance, build 
a well-trained CDC laboratory workforce, and improve the quality of CDC's 
laboratory science. 
CDC's guiding principles for laboratory 
work are to ensure the safety of all 
staff and the community and be as 
transparent as possible about our work 
as we conduct high-quality scientific 
research to protect people in this 
country and around the world. 4. ••• ...... 	.11 Ilh 
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Strengthen the culture of laboratory 
safety and quality. 
Improve laboratory safety and quality. 
Work to build a strong cadre of junior 
and senior leaders with particular 
expertise in laboratory management. 
Focus consistent attention 
on obtaining and maintaining 
appropriate accreditation. 
Engage and train 
laboratory scientists. 
How We Work 
The creation of OADLSS represents a major success in transforming 
laboratory quality and safety oversight at the agency. By centralizing 
all laboratory quality and safety functions under a single point of 
accountability, OADLSS merged the scientific and safety priorities of its 
diverse laboratories and established a framework for effective leadership of 
CDC's laboratories. 
OADLSS's ultimate goals are to strengthen the culture of safety at every level 
of the agency; foster the culture of quality, where CDC laboratories meet the 
highest standards of accuracy, reliability, and timeliness; and ensure CDC 
laboratories strive for continuous improvement to scientific rigor and safety. 
OADLSS comprises an Office of Laboratory Safety and an Office of 
Laboratory Science. The Office of Laboratory Safety provides comprehensive 
safety oversight of CDC laboratories, including compliance with biosecurity 
regulations under the Federal Select Agent Program, biosafety inspections, 
and chemical and radiation safety. The Office of Laboratory Science 
provides leadership of laboratory quality initiatives at the agency and the 
implementation of quality management systems in CDC laboratories. 
IMP 
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LLS trains fellows to 
integrate safety and 
quality into every aspect 
of laboratory practice 
while working to protect 
the public's health, safety, 
and security. 
Long-Term Opportunities 
External Accreditation of CDC Laboratories: OADLSS is implementing 
an agency-wide laboratory quality program that requires CDC laboratories 
to undergo external assessment. External assessment presents an 
invaluable opportunity to strengthen and promote scientific excellence in 
CDC's laboratories. 
Reinvigorate Laboratory Training: Creating new laboratory safety and 
quality training is an ongoing priority for OADLSS. Continued efforts 
and investments are needed to create comprehensive safety and quality 
training across the workforce. 
  
Key Accomplishments What's Needed 
  
Strengthening the safety culture and long-established practices in 
every laboratory group in the agency is a challenging and ongoing task. 
Congressional oversight committees and the media remain intensely 
interested in CDC laboratory safety, which is both an opportunity and a 
challenge to ensure that CDC clearly communicates the progress of its 
reforms and is transparent about potential safety issues. 
OADLSS has advanced laboratory quality and safety significantly since its 
creation in 2015. Its continued success requires buy-in from agency and CIO 
leadership as well as bench-level laboratory staff. There are two key initiatives 
needed to further advance laboratory safety and excellence at the agency. 
The first includes the successful implementation of a laboratory quality 
program to help CDC laboratories obtain external accreditation and ensure 
scientific excellence. The second is a major investment in CDC's laboratory 
training programs, including creating new laboratory safety and quality 
trainings and running a new laboratory training facility in Building 15 on the 
CDC Roybal campus. 
Laboratory Safety Review Board 
(LSRB): Established in 2015, the 
LSRB is charged with reviewing 
and approving every protocol for 
the transfer of biological materials 
out of Biosafety Level 3 (BSL-3) 
and BSL-4 laboratories to lower 
levels of containment, a key issue 
in the 2014 laboratory incidents. 
The LSRB reviews all new and 
amended protocols for these 
transfers and conducts annual 
reviews of existing protocols. The 
LSRB has authority to suspend any 
protocol that it finds is not being 
conducted appropriately. 
Creation of the Laboratory 
Leadership Service: CDC 
established the Laboratory 
Leadership Service, or LLS, a 
fellowship program that prepares 
early-career laboratory scientists 
to become future laboratory 
leaders. LLS is modeled after the 
Epidemic Intelligence Service, 
and it combines competency-
based public health laboratory 
training with practical, applied 
investigations and service. LLS 
fellows are deployed to help 
investigate laboratory incidents 
and near misses to understand 
what happened and what steps 
are needed to prevent safety 
lapses in the future. 
Laboratory Quality Council 
(LQC): Established in 2016, the 
LQC is charged with improving 
the quality of CDC laboratory 
operations by providing guidance 
and establishing policies for 
the agency. The council advises 
on strategic planning and 
provides recommendations for 
harmonizing quality systems 
across CDC laboratories. 




PUBLIC HEALTH—HEALTHCARE COLLABORATION 
Snenuthen public health and healthcare collaboration 
LEADING CAUSES UF DEATH 
Better prevent the leading 
causes or illness, injury. 
disability, and death 
HEALTH SECURITY 
trpprwe health security 
at !tome and mound 
die winld 
Centers for Disease Control and Prevention 
OFFICE OF THE ASSOCIATE DIRECTOR FOR POLICY 
SNAPSHOT 
MISSION 
To identify and advance 
opportunities to use policy, 
leverage health system 
transformation, and engage 
other sectors to improve the 
public's health. 
ORGANIZATION 
Office of Health System Collaboration 
Policy, Research, Analysis, and 
Development Office 
PRIORITIES 
Support public health and healthcare 
sector collaboration. 
Identify high-value public 
health policies. 
Increase use of evidence that 
demonstrates prevention's impact. 
Conduct economic and policy 
analyses to inform decisions. 
Why We're Here 
The Office of the Associate Director for Policy (OADP) supports CDC policy 
activities and leads CDC's strategic priority to strengthen the public health 
and healthcare sector collaboration. OADP ensures that CDC speaks with 
a consistent policy voice and supports the agency's capacity for economic 
and policy analyses. It effectively engages the healthcare delivery system 
through its 6118 initiative and its proposal of 18 health-promoting and 
cost-effective interventions. OADP also collaborates with public health 
agencies through its Health Impact in 5 Years (Hl-5) initiative, which 
identifies 14 evidence-based community-wide interventions. In addition, 
OADP provides technical assistance on health reform topics and manages 
CDC's relationships with the Center for Medicare and Medicaid Services 
(CMS) and other stakeholders. 
How We Work 
OADP includes the Office of the Policy Director (OD), the Office of Health 
System Collaboration (OHSC), and the Policy Research, Analysis, and 
Development Office (PRADO). 
• OD supports linkages with the Health and Human Services Secretariat, 
CMS and other federal agencies, the Office of the Surgeon General, and 
the Domestic Policy Council. 
• OHSC leads CDC's public health—healthcare collaboration strategy; 
builds partnerships with public and private insurers, healthcare systems, 
and clinicians to increase access to health-promoting interventions; 
summarizes and shares CDC's evidence base on effective clinical 
interventions; and builds public health capacity to productively engage 
in health system transformation activities. 
• PRADO analyzes the policy, economic, and budgetary impacts of 
preventive interventions, establishes guidance and standards for 
conducting policy analyses, analyzes the evidence associated with 
phases of the policy process, strengthens the policy analytic capacity of 
CDC employees through technical assistance and trainings, maintains 
and conducts CDC's regulatory and "policy awareness and review 
process," hosts the chief regulatory officer, and translates CDC science 
for use in informing decisions to improve public health. 
CS2688I 9 




Innovative Clinical 	Total Population 
Prevention Prevention Community-wide Prevention 
 
HEALTHCARE 	 PUBLIC HEALTH 
 
Key Accomplishments 
Support for public health and 
healthcare sector collaboration: 
Established partnerships with 
state Medicaid and public health 
programs to implement 6118 
interventions. Also established 
partnerships with CMS and 
commercial health insurance 
companies. Developed the 
Community Health Improvement 
Navigator, a tool that helps 
hospitals conduct community 
health needs assessments. 
High-value public health 
policies: Led the development 
and implementation of the 
National Prevention Strategy. 
Developed the 6118 and Health 
Impact in 5 Years (HI-5) initiatives. 
Published white papers on 
emerging healthcare finance 
models. 
Use of evidence that 
demonstrates prevention's 
impact: Established CDC-wide 
policy community of practice and 
policy review process. Increased 
capacity in health system literacy 
and created innovative Web tools, 
trainings, and resources. 
Economic and policy analyses 
used to inform decisions: 
Established core economic and 
budgetary impact indicators. 
Published seminal AJPM 
supplement on "The Use of 
Economics in Informing U.S. 
Public Health Policy." Developed 
public health economic 
modeling calculators. 
What's Needed 
• Improving the identification, development, implementation, and 
evaluation of various policy approaches to address critical public 
health problems. 
• Identifying and communicating the economic and health impacts 
of public health initiatives to policymakers and leaders in the health, 
business, and other sectors. 
• Integrating the buckets of prevention framework into public health 
practice to promote meaningful collaboration between public health 
and healthcare. 
• Developing and sharing tools and resources to help public health 
stakeholders more effectively partner with the healthcare delivery 
system on prevention measures. 
Long-Term Opportunities 
• Create and support sustainable partnerships between the public health 
and healthcare sectors that result in practice changes that prioritize and 
institutionalize evidence-based prevention. 
• Improve access to and use and quality of clinical prevention services and 
community-wide prevention interventions. 
• Improve health and cost outcomes for high-burden, high-cost health 
conditions and total community or population health. 
• Apply evidentiary criteria to expand HI-5 and 6118 initiatives, policy 
analyses, and economic analyses for high-burden conditions in locales 
that are ready to implement them. 
For more information visit http://www.cdc.gov/policy or call 1-800-CDC-INFO. 
How We Work 
OFFICE OF THE ASSOCIATE DIRECTOR FOR SCIENCE 
2017 SNAPSHOT 	Why We're Here 
MISSION 
To provide CDC/ATSDR with 
scientific vision, advice, and 
leadership in promoting quality and 
integrity of CDC science and serve 
as the advocate for the application 
of science to solve important public 
health problems. 
ORGANIZATION 
Office of Scientific Integrity 
Office of Science Quality 
Office of Technology and Innovation 
Special Projects Activity 
PRIORITIES 
Promote and protect the welfare 
of human subjects and laboratory 
animals involved in CDC-sponsored 
research. 
Promote and improve public access to 
CDC scientific data and publications. 
Promote and improve technology 
transfer to private industry, and foster 
and support innovation at CDC for 
improving the effectiveness of public 
health practice. 
The Office of the Associate Director for Science (OADS) includes the 
Offices of Scientific Integrity (051), Science Quality (OSQ), Technology and 
Innovation (OTI), and the Special Projects Activity (SPA). The OADS vision 
is to be the catalyst for science integrity, quality, and relevance to translate 
CDC science into action. OSI exists to provide efficient services that will 
streamline the processes for demonstrating regulatory compliance, 
ensuring CDC science is timely and current. The OSQ mission is to provide 
leadership, guidance, and support to agency scientists to enhance 
the impact of CDC research and science while OTI is the champion for 
innovative science and technologies at CDC/ATSDR. 
OSI is the focal point for achieving scientific integrity by meeting federal 
regulatory compliance responsibilities and protecting the rights and welfare 
of research subjects. OSI works to streamline processes, procedures, and 
guidance to improve intramural and extramural research, and reduce 
administrative burdens placed on CDC scientists and collaborators. 
OSQ works to increase the impact of CDC research and science by 
promoting standards and recommended practices for scientific quality, 
relevance, credibility, and transparency within the agency and throughout 
the public health community. 
OTI works to encourage, foster, and develop innovative science, 
technologies, processes, and policies that support the agency. OTI supports 
scientific outreach, training, and collaboration in research and development 
activities, and technology transfer that advance CDC's mission and engage 
other agencies, global partners, academia, innovators, and consumers. 
SPA works within OADS to provide oversight and leadership in major or 
cross-cutting scientific activities through internal and external collaboration 
and partnerships. Cross-cutting impact is achieved by participation on high-
level internal and external scientific activities and groups. 
Centers for Disease Control and Prevention 
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Long-Term Opportunities 
For more information visit http://www.cdc.goviod/science or call 1-800-CDC-INFO. 
Key Accomplishments 
The Animal Care and Use 
Program Office (ACUPO) was 
awarded full re-Accreditation by 
the Association for Assessment 
and Accreditation of Laboratory 
Animal Care (AAALAC). ACUPO 
held inspections of CDC animal 
laboratories to maintain highest 
standards of welfare for our 
laboratory animals. 
The mandatory Scientific 
Integrity and Quality Overview 
Course was launched through the 
HHS Learning Portal. Over 7,500 
CDC staff have enrolled. 
The public access to 
publications repository system 
has been launched across CDC. 
CDC public access publications 
have been downloaded more 
than 3 million times. 
Since its inception in 2011, 
the iFund has supported and 
financed over 60 mission-driven 
projects. For FY2016, OTI received 
82 proposals. 
CDC Technology Transfer Office 
facilitated robust distribution 
of Zika virus specimens for 
emergency R&D purposes in 
response to the current outbreak. 
To date, 146 material transfer 
agreements have been executed. 
Launched "We Were There" 
series to provide insight into the 
rich past and impact of CDC and 
to share first-hand accounts from 
the frontline responders. 
What's Needed 
• Developing an IT system that will efficiently and effectively automate scientific 
processes, replace legacy systems, and provide information and reports on 
agency research and investigations. 
• Resolving the appropriateness of the 12-month embargo of federal employee 
publications via discussions with the White House Office of Science and 
Technology Policy and other HHS Operating Divisions. 
• Fostering a culture of innovation in support of the processes and 
communications necessary to enable technology transfer to the private sector 
for advancing public health. 
• Managing and tracking projects and outcomes across CDC to enable 
evaluation and reporting of the impact and added value of the Academic 
Partnerships Program. 
• Encouraging consistency across the agency for data management plans, 
and data management to make public health data discoverable, accessible, 
and usable. 
2015 iFund Awardee 
developed an inexpensive 
dry method for rapid 
field decontamination of 
firefighters. System can be 
used while the firefighter is 
still wearing a self-contained 
breathing apparatus (SCBA) 
and enables gear to be ready 
for immediate reuse. 
• Support the expansion of public access to publications to make other 
document collections publicly available. 
• Update, expand, and offer OADS training in the HHS Learning Portal. 
• Increase recognition for CDC scientists who create inventions to improve 
public health. 
• Explore partnership opportunities with local accelerators or incubators to 
further build, design, engineer, or manufacture CDC inventions. 
• Grow commonalities among HHS OPDIVs, such as the finalization of the 
Common Rule. 
• Establish an accredited Institutional Review Board at CDC. 
• Expand the Academic Partnerships program to more universities in Georgia 
and neighboring states. 
• Grow the impact of public health research and non-research data through a 
more consistent approach to data accessibility. 
Centers for Disease Control and Prevention 
OFFICE OF THE CHIEF OF STAFF 
MISSION 
To provide strategic direction 
and advice to the CDC director 
and agency senior leadership for 
coordination, synchronization, and 
implementation of agency-wide 
priorities, policies, and programs, 
ORGANIZATION 
Budget and Operations Management 
Team 
Division of Issues Management, Analysis, 
and Coordination 
Meeting and Advance Team 
Public—Private Partnerships Team 
PRIORITIES 
Strategically advise the CDC director. 
Maintain internal and external 
relations. 
Provide information management 
with Executive Branch across 
the agency. 
Conduct proactive issues 
management. 
Coordinate and synchronize 
leadership activities. 
Why We're Here 
CDC's Office of the Chief of Staff (0CoS) brings together the critical 
functions of a nimble knowledge management asset in support of 
the director and leadership team. The office allows the agency to 
anticipate, prepare for, and respond to emerging issues while remaining 
focused on accomplishing long-term priorities. 0CoS works across the 
department and the entire agency to ensure decisions are timely and 
resources are aligned with priorities. 
How We Work 
• Meeting and Advance Team: Deliver full-spectrum, direct support 
to the agency director, deputy director, and chief of staff, inclusive of 
executive and special assistance, for scheduling, high-profile visits, 
meeting and event management, and logistics. 
• Division of Issues Management, Analysis, and Coordination: 
Provide strategic advice and information to the CDC director for 
informed decision-making on critical issues, serve as Executive 
Secretariat and coordinate review of policy documents, lead forecasting 
and management of critical issues, and provide strategic coordination of 
the regulatory agenda and all Government Accountability Office (GAO) 
and Office of the Inspector General (01G) engagements. 
• Budget and Operations Management Team: Serve as the 
Management Official for all OD offices, including financial management; 
executive recruitment and human resources; purchasing; and safety, 
security, and asset information management. 
• Public—Private Partnerships Team: Establish and sustain partnerships, 
including those with the CDC Foundation, as the hub of external 
relations with the private sector on behalf of the director and agency. 
Provide technical support for partnership teams across the agency, 
including conflict of interest guidance and review of gifts, and 
deliberately form and sustain relationships on behalf of the director 
and agency. 
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The knowledge management function relies on strong relationships with 
the centers, institutes, and offices that make up the agency. Our ability to 
fully support the director and leadership team relies on maintaining the 
expectation that the systems and procedures will be used. This includes 
forecasting, reviewing and clearing requests for information, receiving 
and responding to congressional correspondence, processing invitations 
for the director, maintaining relationships with the CDC Foundation, and 
coordinating communications and information sharing among the other 
OD offices. 
Driving CDC Priorities 
Strategic Positioning 
with Stakeholders 
GAO- 262 total 
engagements; 216 
closed, 46 ongoing 
H11 
01G- 91 total 
engagements; 71 
closed, 20 ongoing 
348 trips, including 
62 international, 
across 33 countries 
tfr 43 dignitary visits 
to CDC 
57 CDC rule 
makings; removed 
one rule from the 
Code of Federal 
Regulations 
Leveraging CDC Partners 
ENGAGEMENT WITH PARTNERS BY INDUSTRY 
66 BIOTECH/ DIAGNOSTICS 
El 42 PHARMACEUTICAL 
20 HEALTH/SOCIAL SERVICES 
dip 15 HOSPITALITY 
8 ARTS/ENTERTAINMENT/RECREATION 
8 HEALTH & INFORMATION TECHNOLOGY 
8 INFORMATION TECHNOLOGY 
7 mum 
plik 6 HEALTHCARE SYSTEM 
6 VETERINARY 
5 BUSINESS/ECONOMIC DEVELOPMENT 
W --11 5 OTHER 
5 PHILANTHROPY 
CIII 
	RETAIL & HEALTHCARE 
  
Key Accomplishme' What's Needed 
  
Formalized and Centralized 
Issues Management: 
Launched Forecasting Portal, 
a searchable repository of 
upcoming CDC activities 
feeding multiple recurring 
reports, and centralized 
coordination of CDC's regulatory 
and Federal Register activities, 
Established Public—Private 
Partnerships activities within 
and outside of CDC: 
• Conducted 129 conflict of 
interest reviews in 
22 months. 
• 571 Corporate Medical 
Officials registered and 
attended six Business Health 
Executive Calls during 
2015-2016. 
• $58 million to CDC 
Foundation Domestic and 
International Emergency 
Funds for Ebola and 
Zika responses. 
Full Service Advance Team: 
Provided executive assistance, 
scheduling, travel and event 
advance planning and logistics, 
meeting and event planning 
and management, and protocol 
and VIP visit coordination. 
Long-Term Opportunities 
• Review CDC regulatory agenda for priority setting in 2017. 
• Engage select high-impact corporate health groups to champion public 
health priorities. 
• Institutionalize conflict of interest and transparency practices across 
agency for partnerships. 
• Coordinate visits for transition team members and new 
leadership teams. 
• Coordinate all executive-level recruitments for leadership positions 
within the agency, including hiring, onboarding, and relocation 
of personnel. 
For more information visit http://www.cdc.goviod or call 1-800-CDC-INFO. 
From human resources to finance to IT to safety and wellness, OCOO provides 
more than 100 services to CDC staff. 
SNAPSWIT 
VISION 
To be partners in protecting 
health through exemplary 
business service, innovative 
practice, and continuous 
workforce development, 
ORGANIZATION 
Office of the Director: 
• Business Integrity and Strategic 
Management (BISM) Unit 
• Executive Officer (EO) 
• Working Capital Fund (WCF) 
Human Resources Office (HRO) 
Office of Financial Resources (OFR) 
Office of Safety, Security, and Asset 
Management (OSSAM) 
Office of the Chief Information 
Officer (OCIO) 
PRIORITIES 
Customer Service: Provide high-quality 
services and solutions that are timely, 
accurate, and meet mission needs. 
Efficiency: Implement business practices 
and cost-effective strategies that 
ensure OCOO is a model for efficient 
government operations. 
Effectiveness: Provide compliant, high-
quality services. 
Healthy Enterprise: Be a desired 
employer that attracts, develops, and 
retains a skilled and diverse workforce. 
OFFICE OF THE CHIEF OPERATING OFFICER 
Why We're Here 
The Office of the Chief Operating Officer (0000) provides oversight and 
support for all of CDC's centralized business operations. Led by the chief 
operating officer, OCOO ensures that CDC employees and contractors have the 
tools and resources they need in a safe, secure, and healthy workplace as they 
strive to fulfill CDC's mission. 
How We Work 
OCOO's business services offices administer CDC's budget, grants, facilities, 
physical security, workforce health and wellness, human resources, and 
information technology programs. In 2014, CDC began working under 
a working capital fund (WCF), which seeks to achieve greater efficiency, 
transparency, and accountability for business services support. BSOs provide 
services to CDC programs and the WCF bills programs for the services consumed 
based on preestablished rates. 
Human Resources Office (HRO): Leads human capital management activities, 
delivers agencywide training and workforce development services, advises and 
assists agency hiring managers with recruitment and workforce needs, and 
manages and oversees ethics and compliance activities. 
Office of Financial Resources (OFR): Leads CDC's financial management 
activities, manages budget formulation, integration, and execution, oversees 
a system of internal budget, financial, and payment processes and systems, 
and leads and directs CDC's contract and grant activities. 
Office of the Chief Information Officer (0C10): Leads CDC's IT program, 
including capital planning, enterprise architecture, project management, 
employee IT services, business systems and analytics, information security, 
and other management services. 
Office of Safety, Security, and Asset Management (OSSAM): Provides a safe, 
secure, and healthy workplace for CDC staff, manages facilities and ensures 
environmental stewardship, runs a model workforce wellness program, and 
provides transportation services. 







fo! 230,000 FOIA pages provided 
23,000 travel orders 
issued, including 4,500 
international orders 
10,000 employees 11110",,. 
trained in more than 
500 classes 
4IN 





, certificates issued 





22,700 email accounts 
maintained 
20,700 contract 
and grant actions 
processed 
8,000 personnel awards 
processed 
5,500 flu shots 
administered to staff 
What's Needed 
Human Resources: Improve time to hire and other personnel practices 
by expanding CDC's Partnering 2 Win recruitment and hiring 
transformation program. 
Enterprise Risk Management: Implement an enterprise risk management 
framework to provide a holistic risk management approach that addresses 
strategic, reputational, operational, financial, and compliance risks. 
Facilities: Support repairs to and replacement of aging CDC facilities. 
Rapid Response for Public Health Emergencies: Establish authorities and 
mechanisms to quickly support emergency public health responses to help CDC 
save lives and money. 
Business Services Funding as a Percentage 
of CDC's Total Budget* 
IF'S Working Capital Fund 
All Business Services 
Sources 
—Total CDC Budget 
3.4% 	3.5% 	3.5% 	4 	 3.5% 	3.4% w-4 rm 
FY 2010 	1V2021 	FY 2012 	FY 2013 	FY 2014 	FY 2015 	FY 2016 
*Dollars in millions; WCF total is operating budget only (reserves excluded); CDC budget includes mandatory, discretionary, and transfer amounts. 
Key Accomplishments 
• Completed organizational and leadership changes to streamline and 
improve service. 
• Implemented the CDC's Working Capital Fund. 
• Implemented major new systems for travel (Concur Government Edition), 
grants (GrantSolutions), and financial management (Unified Financial 
Management System). 
• Enhanced systems and processes to reduce Freedom of Information Act 
request backlog. 
• Enhanced communications, including a services and operations portal 
and intra net sites designed to meet CDC program needs. 
• Enhanced IT, including the design and implementation of a high-speed 
research network for genomics big data, Wi-Fi access on all CDC domestic 
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Thomas R. Frieden, MD, MPH 
Director, Centers for Disease Control and Prevention 
Administrator, Agency for Toxic Substances and Disease Registry (ATSDR) 
Thomas R. Frieden, MD, MPH, became Director of the Centers for Disease Control and Prevention (CDC) in June 
2009. Dr. Frieden has worked to control health threats from infectious diseases, respond to emergencies, and 
battle the leading causes of suffering and death in our nation and around the world. 
As the director of our nation's health protection agency, he is leading CDC to address these challenging health 
priorities. 
1. Improving health security at home and around the world — by preparing for, detecting, rapidly 
responding to and preventing health threats 24/7 to save lives and safeguard communities. These include 
global disease threats, antimicrobial resistance, foodborne illness and health care-acquired infections. 
2. Reducing the leading causes of death and illness — by focusing on reducing disease that sap the quality of 
life and longevity of Americans, including tobacco, uncontrolled blood pressure, diabetes, obesity, 
physical inactivity, motor vehicle safety, prescription drug overdoses, and HIV/AIDS. 
3. Strengthening public health & health care collaboration - by aligning, coordinating and integrating public 
health and health care to improve health outcomes. 
Dr. Frieden has intensified the agency's 24/7 work to save lives and protect people, including: 
• Establishing more effective responses to outbreaks and other health threats at state, local and global 
levels, including the global effort to eradicate polio forever. 
• Preventing infections from food and in health care facilities with new programs and guidance. 
• Helping Americans to quit smoking, reducing childhood obesity, prevent diabetes, and saving teens and 
others lives from car crashes through focused programs. 
• Extending life-saving treatment, disease prevention and infection control in more than 50 countries to 
save lives globally and protect Americans from health threats outside our borders. 
Career Highlights 
• As a CDC EIS officer disease detective from 1990-1992, Dr. Frieden conducted many epidemiologic 
investigations, including outbreaks of measles, typhoid, cryptosporidium, and multidrug-resistant 
tuberculosis. 
• From 1992-1996, as a CDC assignee, he led New York City's program that rapidly controlled tuberculosis, 
including reducing cases of multidrug-resistant tuberculosis by 80 percent. 
• While working in India for five years as a CDC assignee to the World Health Organization, he assisted with 
national tuberculosis control efforts. The program in India has treated more than 10 million patients and 
has saved more than three million lives. 
• As Commissioner of the New York City Health Department from 2002-2009, he directed the city's effort 
that reduced the number of smokers by 350,000, and reduced teen smoking by half. 
• New York City also became the first place in the United States to eliminate trans-fats from restaurants, 
leading more than 50 national chains to eliminate transfat from their menus, and require certain 
restaurants to post calorie information prominently. 
• The New York City health department also established the largest community electronic health records 
project in the country. It became the model to expand electronic health record use across the nation. 
• Immediately upon his appointment as CDC Director in 2009, Dr. Frieden led the nation's response to the 
2009 H1N1 influenza virus pandemic. 
• Dr. Frieden launched the first-ever national paid anti-tobacco media campaign, CDC's Tips from Former 
Smokers, projected to help more than 100,000 smokers quit, saving money and preventing tens of 
thousands of deaths. 
• He also prioritized CDC's efforts to reduce infections in healthcare settings, cutting some life-threatening 
infections by a third or more. 
• Dr. Frieden created CDC's Vital Signs, a monthly clear-language publication, pointing out today's most 
critical health problems, and guiding the public health community and clinical providers to actionable 
solutions. 
A physician with training in internal medicine, infectious diseases, public health, and epidemiology, Dr. Frieden is 
especially known for his expertise in tuberculosis control. Dr. Frieden worked for CDC from 1990 until 2002. He 
began his career at CDC as an Epidemic Intelligence Service (EIS) Officer at the New York City Health 
Department. 
Dr. Frieden speaks Spanish and graduated from Oberlin College. He received both his medical degree and 
master's of public health degree from Columbia University and completed infectious disease training at Yale 
University. He has received many awards and honors and has published more than 200 scientific articles. 
Anne Schuchat, MD (RADM, USPHS) 
Principal Deputy Director 
Anne Schuchat, M.D. has been Principal Deputy Director for CDC since September 2015. 
Dr. Schuchat began her public health career in 1988 when she came to CDC as an Epidemic Intelligence Service 
Officer. She was director of CDC's National Center for Immunization and Respiratory Diseases from 2006-2015. 
Other CDC leadership posts include: acting director of the National Center for Infectious Diseases (NCID) and the 
Center for Global Health; chief of the Respiratory Diseases Branch and Chief Health Officer for CDC's 2009 H1N1 
pandemic influenza response. Schuchat was the initial medical director of ABCs - the Active Bacterial Core 
surveillance of the Emerging Infections Program Network and spearheaded prevention of newborn infection 
from group B streptococcal disease in the 1990s. She also served as CDC's interim deputy director for Science 
and Program in early 2009. She was promoted to Rear Admiral in the United States Public Health Service in 2006 
and earned a second star in 2010. Schuchat was elected to the Institute of Medicine of the National Academy of 
Sciences in 2008. 
John Auerbach, MBA 
Associate Director for Policy 
Deputy Director, CDC (Acting) 
Director, Office for State, Tribal, Local, and Territorial Support (OSTLTS) (Acting) 
John Auerbach is the associate director for policy at the Centers for Disease Control and Prevention (CDC), and 
the acting director of the Office for State, Tribal, Local and Territorial Support (OSTLTS), He oversees the Office 
of the Associate Director for Policy, which focuses on the promotion of public health and prevention as 
components of health care and payment reform and health system transformation. As acting director of OSTLTS, 
he oversees key activities and technical assistance that support the nation's health departments and the public 
health system. 
Previously, he was a distinguished professor of practice in health sciences and director of the Institute on Urban 
Health Research and Practice at Northeastern University from 2012 to 2014. 
Auerbach was the commissioner of public health for the Commonwealth of Massachusetts from 2007 to 2012. 
Under his leadership, the department developed innovative programs to address racial and ethnic disparities, 
promote wellness (including the Mass in Motion campaign), combat chronic disease, and support the successful 
implementation of the state's healthcare reform initiative. 
Prior to that, Auerbach was the executive director of the Boston Public Health Commission for nine years during 
which health equity, emergency preparedness, and tobacco prevention became priorities. In addition to 
Boston's public health programs, he oversaw its emergency medical, homeless, and substance abuse services. 
Auerbach worked at the state health department for a decade, first as chief of staff and later as an assistant 
commissioner overseeing the HIV/AIDS Bureau during the early years of the epidemic. 
Sherri A. Berger, MSPH 
Chief Operating Officer 
Sherri Berger, MSPH, became Chief Operating Officer of the Centers for Disease Control and Prevention (CDC), 
one of 10 major operating divisions of the Department of Health and Human Services (HHS), in August 2011. As 
COO, she oversees management, facilities, and operations at the Atlanta-based public health agency. She 
provides substantial strategic direction for CDC's 10,000 employees, 5,000 contractors, and $13 billion budget — 
while ensuring CDC has proper resources to fulfill its critical work to save lives and protect people from health 
threats. 
Specifically, Berger manages CDC's budget; oversees facilities design, maintenance, security, management 
analysis, and safety and personnel security; leads acquisitions, contractual assistance and grants; manages 
information technology and security; and directs human resources strategy, training, and workplace 
development. 
Berger's oversight and management as Chief Operating Officer has intensified CDC's business services by: 
• Transitioning the agency's business services offices from a direct appropriation to the Working Capital 
Fund 
• Consolidating the agency's financial management functions into a single Office of Financial Resources to 
ensure fiscal accountability, oversight, and ensure compliance with external and internal controls 
• Consolidating five offices responsible for a broad portfolio of crosscutting services, including safety and 
security, to effectively deliver a safe, secure functional, and healthy workplace for CDC staff 
• Ensuring the agency's information technology portfolio is current and state-of-the art with a customer-
driven focus 
• Serving as a champion for the Federal Employee Viewpoint Survey, using results to drive agency 
improvements to better serve CDC staff and the public they serve 
Berger is a manager with extensive experience at both the program and senior leadership level. Berger worked 
as an epidemiologist at the community level until moving to CDC headquarters in Atlanta to serve as a principal 
epidemiologic investigator. As a result of her management at the program level, she was nominated to 
participate in the Senior Executive Service Candidate Development Program, where she expanded her career 
into business management. Berger has held several leadership positions at CDC, including associate director for 
formulation, evaluation, and analysis in CDC's Financial Management Office, deputy director of one of CDC's 
national centers, and director of the agency's Recovery Act Coordination Unit. Berger received her bachelor's in 
political science from the University of Florida and a master's of science in public health with a concentration in 
epidemiology from the University of South Florida. 
Harold W. Jaffe, MD, MA 
Associate Director for Science 
Harold W. Jaffe, MD, MA, received his undergraduate degree in genetics from the University of California, 
Berkeley, and his medical degree from the University of California, Los Angeles. He trained in internal medicine 
at the UCLA Medical Center and in infectious diseases at the University of Chicago hospitals. 
He served as an Epidemic Intelligence Officer at the U.S. Centers for Disease Control (CDC). In 1981, he joined a 
CDC task force investigating a new disease, soon to become known as AIDS. He led the first national case-control 
study to determine risk factors for the disease and the first natural history study of HIV. Over the next 2 
decades, he served in leadership positions in CDC's expanding HIV/AIDS programs and in 2001 became Director 
of the National Center for HIV, STD, and TB Prevention. He also spent a sabbatical year at The Institute of Cancer 
Research in London, UK. 
In 2004, Dr. Jaffe accepted a position as Fellow of St Cross College and Head of the Department of Public Health 
at the University of Oxford. At Oxford, he established a new master's degree program in Global Health Science. 
The course has trained more than 130 students, half of whom come from developing countries. In June 2010, he 
returned to CDC to become the Associate Director of Science. 
Dr. Jaffe is a member of the Institute of Medicine of The National Academies, the Infectious Diseases Society of 
America, and has been a Fellow of the UK Faculty of Public Health. His research interests include a focus on 
HIV/AIDS and global health. 
Leandris Liburd, PhD, MPH, MA 
Director, Office of Minority Health and Health Equity (OMHHE) 
Leandris Liburd, PhD, MPH, MA, is the Director of the Office of Minority Health and Health Equity at the Centers 
for Disease Control and Prevention (CDC). In this role, she oversees the work of CDC's Offices of Minority Health  
& Health Equity and Women's Health, and of Diversity & Inclusion Management. In addition, she provides 
agency leadership, direction, and accountability for CDC's policies and programs to ensure they are effective in 
improving women's and minority health. She also serves as the agency's principal advisor on health equity issues 
with the Department of Health and Human Services, other federal agencies, national organizations, academic 
institutions, and the public. 
Dr. Liburd is a respected public health leader who has over the course of her career championed community 
health promotion, chronic disease prevention, community engagement, eliminating health disparities, and 
addressing the social determinants of health. She has worked in public health at the local, state, and federal 
levels, and has held a variety of leadership positions at CDC since joining the agency in 1987. Dr. Liburd has 
published extensively on community-based public health approaches to chronic disease prevention and control, 
the influence of culture and gender on health beliefs and behaviors, and racial and ethnic health disparities. In 
2010, she published her first edited volume Diabetes and Health Disparities: Community-Based Approaches for 
Racial and Ethnic Populations which serves as a key resource for those interested in socio-ecological approaches 
to reducing diabetes disparities. 
Dr. Liburd holds a Bachelor of Arts degree from the University of Michigan at Ann Arbor, a Master of Public 
Health in health education from the University of North Carolina at Chapel Hill, and a Master of Arts in cultural 
anthropology and a Doctor of Philosophy degree in medical anthropology from Emory University. 
Katherine Lyon Daniel, PhD 
Associate Director for Communication 
Katherine Lyon Daniel, PhD, is the Centers for Disease Control and Prevention's Associate Director for 
Communication. She leads the agency's external and internal communication aimed at putting the best 
information available into the hands of people who need it to protect their health or the health of others. Dr. 
Daniel combines her experience in strategic communication and behavioral science to advance CDC's mission of 
saving lives and protecting people. 
Integrated communication - When she stepped into her agency-wide role in 2011, Dr. Daniel had already 
identified a need for CDC's information to be available more broadly and through more channels. With the aim 
of developing communication that would help everyone within CDC understand how their work fits into the 
overall mission by creating a clear, concise summary of the agency's mission: CDC 24/7. Saving Lives. Protecting 
People. She led the integration of digital and traditional media so that agency information appears 
simultaneously on multiple platforms, and she folded the work of the agency's broadcast and graphics units into 
the overall communication strategy. 
Accessible information - Under Dr. Daniel's leadership, CDC has adopted a Clear Communication Index that 
guides authors in developing materials that meet an agency-wide accessibility and readability standard. Earlier, 
as deputy director of CDC's National Center for Health Marketing, she helped accelerate the agency's eHealth 
movement. She supported the migration of CDC's flagship Morbidity and Mortality Weekly Report to electronic 
distribution and the inclusion of interactive features. And she continues to push the agency's adoption of health 
literacy, plain language, and clear communication. 
Strategic communication - Throughout her CDC career, Dr. Daniel has championed the need to think ahead 
about what may happen next and to plan communication interventions for those events. She supported 
research and a proactive focus to help the agency become more effective in helping people. For example, in her 
early CDC career she initiated the development of the agency's parenting and pregnancy portals. These portals 
connect parents and others not only to the topic they first seek, but also to other topics that are part of their 
total health needs. 
Digital media - Use of digital media has increased substantially, reaching more than 11 million people through 
the agency's YouTube channel, 13 blogs, 18 Facebook profiles, and 50 Twitter profiles. Dr. Daniel supports 
communicators throughout the agency with services that help them select and integrate the multiple channels 
most appropriate to their audiences and messages. 
Gateways to health information - In addition to the parenting and pregnancy portals, Dr. Daniel originated 
CDC's Gateway to Health Communication and Social Marketing Practice. This encyclopedia for health 
communication and public health professionals collects communication planning resources in a single location to 
help support more effective outreach to populations needing reliable health information. She was a key player 
in the development of CDC's national conference on Health Communication, Media, and Marketing that 
convenes university scholars, public health researchers, and practitioners from the government and private 
sectors for cross-disciplinary dialogue. 
Campaigns for health behavior change - Dr. Daniel initiated the government's first communication campaign to 
support early autism screening. The "Learn the Signs. Act Early" campaign that has improved early identification 
of developmental delay and disability by engaging parents, public health and healthcare partners, so that 
families get the services and support they need as early as possible. She also led CDC's landmark communication 
campaign to increase awareness of folic acid consumption among women of child-bearing age. 
Dr. Daniel earned a B.A. in Psychology from the University of Virginia, and the Ph.D. in Social Ecology from the 
University of California at Irvine. Her dissertation research focused on communicating long-term health risks to 
the US Senate. She has conducted and published research on risk perception and understanding risk behavior. 
She has authored or co-authored more than a dozen scientific articles. In 2010-2011, she completed the 
National Preparedness Leadership Initiative at Harvard University. She has received numerous professional 
communication awards, including two HHS Secretary's Awards for Distinguished Service, the International 
Academy of Arts and Sciences Questar Grand award, the MarCom Creative Gold award, and the Public Relations 
Society of America's prestigious Silver Anvil award. 
As a mother, Dr. Daniel's aim is to empower moms—or anyone who cares for others—to be the best advocates 
for their families' health by putting the information they need at their fingertips. As a communication and 
behavioral science professional, she seeks to extend CDC's ability to promote and improve health by putting the 
most reliable, helpful information possible in the best places for those who need it. 
Reginald R. Mebane, MS 
Director, Office of Equal Employment Opportunity 
Reginald R. Mebane, MS, is currently the Director of CDC's Office of Equal Employment Opportunity (OEE0). As 
Director, Mr. Mebane is responsible for advising and counseling CDC's executive leadership team on a variety of 
equal employment opportunity, diversity management, civil rights and human resources issues impacting the 
agency's complex and diverse global workforce. His key responsibilities include but are not limited to matters 
related to Affirmative Employment(AEP), Disability, Reasonable Accommodation(RA), Alternative Dispute 
Resolution(ADR), Special Emphasis Programs(SEP), and EEO Complaints Processing and Settlements for all CDC 
centers, institutes and offices. He is also responsible for the design and direction of programs, policies and 
procedures based on the Equal Employment Opportunity Commission's(EE0C) rules, regulations, laws and 
Executive Orders governing equal opportunity, diversity management, civil rights, and human resources that 
further ensure prevention of individual and systematic discrimination across the enterprise. As the agency's EEO 
Director, he is the officer with direct liaison responsibility to the EEOC, Health and Human Services (HHS), Office 
of General Counsel (OGC) and all other respective internal and external customers and stakeholders regarding 
employment and civil rights regulatory matters. "Our overarching strategy is to make CDC a world class model 
EEO program." 
Mr. Mebane joined CDC in February 2005 as Chief Management Officer of CDC's Coordinating Center for 
Infectious Diseases (CCID). In this role, he had direct authority for the management of the estimated $4.0B CCID 
budget which included business operations, human capital, information technology, grants, facilities, and 
administrative services for the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; National 
Center for Immunization and Respiratory Diseases; National Center for Preparedness, Detection, and Control of 
Infectious Diseases; and National Center for Zoonotic, Vector-Borne and Enteric Diseases. Under his leadership, 
CCID grew in size and scope to $7B, comprising over half the agency's programs, assets, people and EEO 
activities. 
Prior to working at CDC, Mr. Mebane spent over 23 years at FedEx. After starting his career with the company in 
1981, Mr. Mebane was promoted from dock worker, to manager, to the Director of International Operations. In 
2001, Mr. Mebane moved to Buffalo, New York, to become the Chief Operating Officer for a $2.0B company that 
FedEx acquired. In addition to his management duties at FedEx, Mr. Mebane was the corporate lead for the 
Diversity training curriculum for the corporation from 1995 to 1997 where he became part of the critically 
acclaimed Fed Ex Leadership Institute. While there he taught leadership, diversity and management practices to 
FedEx employees from around the world. 
Outside of his corporate work, Mr. Mebane has served on the faculty of the University of Memphis, the 
University of Buffalo and Georgia Tech. He also worked as a psychotherapist and psychiatric case manager in 
Memphis during the national crises associated with homelessness and the de-institutionalization of the severely 
mentally ill. As a result of this experience, he was inspired to later become Chairman of the Memphis Health, 
Education & Housing Finance Facility Board (1994-2001). The restructuring of this board under his chairmanship 
is his legacy to Memphis in making housing affordable and sustainable for moderate income families. 
Since joining CDC, Mr. Mebane has been very active in serving others and the community as a proud graduate of 
Leadership Atlanta, CDC's Speakers Bureau and the Office of Equal Employment Opportunity's (OEE0) monthly 
mentoring circles in addition to serving on the board of directors for Georgia's Visiting Nurse Association and 
Sisters of Mercy Health System headquartered in St. Louis. 
Steve Monroe, PhD 
Associate Director for Laboratory Science and Safety 
Steve Monroe, PhD, is the Associate Director for Laboratory Science and Safety (ADLSS) at the Centers for 
Disease Control and Prevention (CDC). He oversees the Office of the Associate Director for Laboratory Science 
and Safety (OADLSS) which provides high-level oversight and coordination of critical laboratory policies and 
operations, particularly those associated with laboratory safety and quality management programs at all CDC 
campuses. 
He was the Deputy Director of the National Center for Emerging and Zoonotic Infectious Diseases. He previously 
served as director of the Division of High-Consequence Pathogens and Pathology at the National Center for 
Zoonotic, Vector-borne, and Enteric Diseases, and before then he was director of the Division of Viral and 
Rickettsial Diseases. 
Dr. Monroe began his career at CDC in 1987 as a National Research Council fellow in the Viral Gastroenteritis 
Section in DVRD. He spent the next 17 years studying the biology and molecular epidemiology of enteric viruses, 
particularly astrovirus and norovirus. He was instrumental in defining the properties that led to the formal 
classification of astroviruses as a new virus family and served as chair of the first Astroviridae Study Group of the 
International Committee on Taxonomy of Viruses. Dr. Monroe pushed the development and implementation of 
real-time polymerase chain reaction (RT-PCR) assays for detecting and characterizing noroviruses and provided 
formal and informal hands-on training to numerous collaborators in state health department laboratories. In 
1998, he received the Pekka Halonen Award in diagnostic virology. 
Dr. Monroe received a PhD in molecular biology from Washington University in St. Louis and a bachelor of 
science degree in biochemistry from Iowa State University. He completed a post-doctoral fellowship in virology 
at the University of Wisconsin prior to moving to CDC. Dr. Monroe has been the co-author of more than 130 
scientific manuscripts and book chapters and co-author of more than 130 scientific manuscripts and holds two 
patents. 
Dena S. Morris, MPP 
Director, CDC Washington Office 
Dena Morris is the Director of the CDC Washington Office (CDCW), which serves as a critical link between CDC 
and the Washington policy community. CDCW translates CDC's critical work to Members of Congress and 
identifies opportunities for CDC to engage in important public health policy developments on Capitol Hill. 
Dena's extensive experience on Capitol Hill provides a strong foundation to guide CDC's legislative strategy and 
strengthen the bridges between the agency and Congress, the Administration, and Washington-based public 
health partners. For eight years, Dena served as legislative director for a senior member of Senate leadership. In 
addition to helping guide major US policy issues, Dena played a key role in public health issues such as food 
safety, pandemic influenza, smoking cessation, and childhood obesity. Before working in the Senate, Dena was 
senior vice president of FaegreBD, a Washington-based consulting firm where she helped strengthen 
relationships between non-profit organizations and Congress. 
Dena has a bachelor's degree from Indiana University in political science, and a master's degree in public policy 
from Georgetown University's Graduate Public Policy Institute. 
Carmen Villar, MSW 
Chief of Staff 
Carmen Villar is Chief of Staff for the Centers for Disease Control and Prevention (CDC) and is responsible for 
managing day-to-day operations of the Office of the Director. She resolves issues that cross organizational lines, 
coordinates decision-making processes, and ensures that CDC focuses on its highest priority initiatives. She has 
exemplary expertise in public health management and makes a visible impact on staff morale throughout the 
agency. 
Before becoming Chief of Staff in 2010, Ms. Villar was Deputy Director of CDC's Nigeria office. In this capacity, 
Ms. Villar served as the principal advisor to the Country Director on policy and program development. She 
oversaw the management and operations of the approximately $200 million portfolio of public health activities 
including The President's Emergency Plan for AIDS Relief (PEPFAR); avian influenza surveillance; and the Field 
Epidemiology and Laboratory Training Program. As a member of the USG interagency senior management team, 
Ms. Villar exercised strategic planning and diplomatic skills that increased collaboration and coordination with 
the government of Nigeria and improved public health across the country. 
Prior to joining the CDC-Nigeria team, Ms. Villar served as both Acting Director and Deputy Director for the CDC-
Zambia program. She has a strong passion for global health and frequently shares fond memories and lessons 
learned from her 5 years serving abroad for CDC's Division of Global HIV/AIDS. 
Before moving overseas, Ms. Villar served as Acting Deputy Director for Management and Operations (DDMO) 
for CDC's Division of HIV/AIDS Prevention (DHAP), where she oversaw the administration and management of a 
$630 million budget, nearly 400 cooperative agreements, and 700 staff. Her experience in managing and guiding 
research, program, HIV prevention community planning, and capacity building activities in various positions 
throughout DHAP and the Bioterrorism Preparedness and Response Program refined her management skills and 
prepared her for senior leadership roles both domestically and internationally. 
Ms. Villar joined CDC in 1997 as a Presidential Management Intern, where she completed policy rotations in the 
National Center for HIV, STD, and TB Prevention, the Division of Cancer Prevention and Control, the Financial 
Management Office, and the Health Resources and Services Administration's HIV/AIDS Bureau. Ms. Villar's 
interest in HIV/AIDS and government was apparent early on in her career. Prior to joining the federal 
government, she gained policy experience working for the California State Assembly and as the Government 
Affairs Coordinator for the AIDS Healthcare Foundation in Los Angeles. Ms. Villar completed both her Bachelor 
of Arts in anthropology and Master of Social Welfare at the University of California at Berkeley. 
She has received numerous awards in recognition of her work in government including the HHS Secretary's 
Award for Distinguished Service and the State Department's Meritorious Honor Award. 
John Howard, MD, MPH, JD, LLM 
Director, National Institute for Occupational Safety and Health (NIOSH) 
John Howard, MD, MPH, JD, LLM serves as the Director of the National Institute for Occupational Safety and 
Health and the Administrator of the World Trade Center Health Program the U.S. Department of Health and 
Human Services in Washington, D.C. He first served as NIOSH director from 2002 through 2008, and again from 
2009 to the present. In 2015, Dr. Howard was re-appointed to an unprecedented third six-year term by Dr. 
Thomas Frieden, the Director of the Centers for Disease Control and Prevention. 
Prior to his appointment as Director of NIOSH, Dr. Howard served as Chief of the Division of Occupational Safety 
and Health in the California Department of Industrial Relations, Labor and Workforce Development Agency, 
from 1991 through 2002. 
Dr. Howard received his Doctor of Medicine from Loyola University of Chicago, his Master of Public Health from 
the Harvard School of Public Health, his Doctor of Law from the University of California at Los Angeles, and his 
Master of Law in Administrative Law and his Master of Business Administration in Healthcare Management from 
the George Washington University in Washington, D.C. 
Dr. Howard is board-certified in internal medicine and occupational medicine. He is admitted to the practice of 
medicine and law in the State of California and in the District of Columbia, and he is a member U.S. Supreme 
Court bar. He has written numerous articles on occupational health law and policy and serves as a professorial 
lecturer in environmental and occupational health in the Milken Institute School of Public Health at The George 
Washington University in Washington, D.C. 
Rebecca Martin, PhD 
Director, Center for Global Health (CGH) 
Rebecca Martin, PhD, is the Director of the Center for Global Health (CGH) at the US Centers for Disease Control 
and Prevention (CDC). Since 2012, Dr. Martin has served as the Director for the Global Immunization Division, in 
CGH, which leads CDC's global polio eradication efforts, accelerated disease control for vaccine-preventable 
diseases, introduction of new and underutilized vaccines, and the strengthening of immunization systems. 
Dr. Martin began her career with CDC in 1997 in the National Immunization Program, Epidemiology and 
Surveillance Division, and has held positions both domestically and globally in immunization and 
HIV/AIDS. Prior to joining CDC, Rebecca worked at the Maryland Department of Hygiene and Mental Health in 
Baltimore Maryland as the immunization program epidemiologist leading efforts to increase vaccination 
coverage, conducting outbreak investigations, coordinating the development and introduction of Maryland's 
immunization registry, and supporting the state's Vaccines for Children Program. She also has worked at the 
Montgomery County Health Department in Maryland in HIV/AIDS programs for high-risk populations. 
Since 1991, Dr. Martin has worked in the global health arena in Haiti, and has had CDC assignments in Kenya, 
Tanzania, and Denmark (2002-2011). Over the past 15 years, she has collaborated with multilateral 
organizations, including the World Health Organization (WHO) and UNICEF, and development partners, and has 
worked closely with ministries of health and non-governmental organizations. 
Prior to her current position as director of GID, Rebecca was detailed to the WHO European Regional Office as 
the Regional Advisor for Immunization (2008-2011) for its 53 member states, where she spearheaded regional 
efforts to strengthen immunization and surveillance systems, provide evidence for the introduction of new 
vaccines, achieve the goal of measles and rubella elimination, and maintain the region's polio-free status. From 
2006-2008, Dr. Martin served as Program Director for Strategic Information and Human Resources for Health 
with the CDC Country Office in Tanzania. She led and implemented studies, in partnership with the ministry of 
health, to measure and evaluate the HIV/AIDS epidemic and strengthen national capacity. Rebecca was 
detailed to the WHO African Regional Office from 2002-2006, based in Kenya as the senior epidemiologist in the 
inter-country immunization program office for the eight east African countries; she served as the team lead from 
2005-2006. 
She received her Doctorate of Philosophy from the Johns Hopkins Bloomberg School of Public Health in 
international health and infectious disease epidemiology, conducting her research in Haiti on high-titer measles 
vaccines. Dr. Martin serves as a technical advisor on global advisory groups to WHO and GAVI Alliance. She has 
co-authored manuscripts and global guidelines on immunization strategies, vaccine-preventable diseases and 
surveillance methods. 
Stephen C. Redd, MD, (RADM, USPHS) 
Director, Office of Public Health Preparedness and Response (OPHPR) 
Stephen Redd, MD (RADM, USPHS), is the Director of the Office of Public Health Preparedness and Response 
(PHPR) at the Centers for Disease Control and Prevention (CDC). This office is responsible for all of CDC's public 
health preparedness and response activities. 
Before coming to PHPR, Dr. Redd served as director of CDC's Influenza Coordination Unit. During the H1N1 
pandemic, he served as Incident Commander for the nearly year-long response. 
A Rear Admiral and Assistant Surgeon General in the United States Public Health Service, Dr. Redd has served 29 
years as a Commissioned Officer. He has investigated outbreaks such as Legionnaires' Disease, developed 
strategies to control malaria, and worked to eliminate measles in the US. A graduate of Princeton and Emory 
universities, he received his medical degree with honors and trained in medicine at Johns Hopkins. Rear Admiral 
Redd has authored more than 120 scientific publications and received numerous awards, including the Public 
Health Service Distinguished Service Medal and the Meritorious Service Medal. 
Robin M. Ikeda, MD, MPH (RADM, USPHS) 
Deputy Director, CDC 
Director, Office of Noncommunicable Diseases, Injury and Environmental Health (ONDIEH) 
Robin M. Ikeda, MD, MPH, (RADM, USPHS), is the Director for the Office of Noncommunicable Diseases, Injury 
and Environmental Health (ONDIEH). In this position, she is responsible for providing guidance and leadership to 
the CDC's scientific and programmatic portfolios. Previously, she served as Acting Director for the National 
Center for Injury Prevention and Control (NCIPC) from January to November 2010, while also serving as Deputy 
Director. 
Prior to these appointments, from April 2006 to September 2009, Dr. Ikeda served as NCIPC's Associate Director 
for Science. From 2003 to 2006, she held the position as Associate Director for Science within CDC's 
Epidemiology Program Office and the Office of Workforce and Career Development. During 1993 —2006, she 
held a range of positions within NCIPC, including Team Leader and staff epidemiologist, and worked on a 
number of injury prevention issues including youth violence, suicide, and motor-vehicle related crashes. She 
began her career at CDC as an Epidemic Intelligence Service Officer assigned to the Bureau of Communicable 
Disease Control at the New York State Department of Health. 
Dr. Ikeda holds a B.A. from Stanford University, a M.D. from Cornell University Medical College, and a M.P.H. 
(Epidemiology) from the Emory University Rollins School of Public Health. She is board-certified in both Internal 
Medicine and Preventive Medicine and holds the rank of Rear Admiral in the United States Public Health Service. 
Coleen A. Boyle, PhD, MSHyg 
Director, National Center on Birth Defects and Developmental Disabilities (NCBDDD) 
Coleen Boyle serves as Director of the National Center on Birth Defects and Developmental Disabilities 
(NCBDDD) at CDC. Dr. Boyle began her career at CDC in 1984 as part of a large effort to study the adverse health 
effects of exposure to Agent Orange, a herbicide used during the Vietnam War. Following that project, Dr. Boyle 
joined CDC's work in birth defects and developmental disabilities holding various positions of increasing 
responsibility until her appoint as Center Director in 2010. 
Dr. Boyle's interest and expertise span a number of areas related to child health and development. She directed 
a major public health response on cochlear implants and risk of meningitis, resulting in the product recall of 
particular implant device. She contributed widely to the field of newborn screening guiding CDC's work in 
newborn hearing and congenital heart disorder screening and has served on the HHS Secretary's Advisory 
committee on Heritable Disorders in Newborn and Children. She has lead the development of CDC's autism 
research and surveillance activities that have documented the changing prevalence of autism in the United 
States. 
Dr. Boyle has twice received CDC's highest award for scientific excellence, the Charles C. Shepard Award for 
outstanding scientific publication and has authored or co-authored many peer-reviewed and other scientific 
publications. 
Ursula E. Bauer, PhD, MPH 
Director, National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) 
Ursula Bauer, PhD, MPH, is the director of the National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP), a position she assumed on January 4, 2010. Prior to becoming director of NCCDPHP, Dr. 
Bauer held various chronic disease prevention leadership positions at the New York State Department of Health, 
the Florida Department of Health, and the Louisiana Office of Public Health, where she was stationed as an 
Epidemic Intelligence Service Officer. 
As NCCDPHP Director, Dr. Bauer sets the strategic direction for the center's portfolio, focused on surveillance 
and epidemiology to move data into action; policy and environmental improvements to support health and 
healthful behaviors; health care system collaboration to strengthen effective delivery of clinical and other 
preventive services; and links between community and clinic to improve self-management of chronic conditions 
and enhance quality of life. Together, these strategies drive improvements in health status, including reductions 
in morbidity, mortality and health care costs related to heart disease, cancer, stroke, diabetes, tobacco use, 
obesity and many other conditions and risk factors. 
NCCDPHP has an annual budget of about $1.2 billion and more than 1,000 staff dedicated to preventing chronic 
diseases and promoting health across the life span, in key settings, and with attention to the primary chronic 
disease risk factors. Under Dr. Bauer's leadership, the center takes a coordinated, collaborative approach to 
investing its resources, working across divisions and programs and with grantees and partners to offer a more 
seamless, mutually reinforcing approach to advancing population health. 
Dr. Bauer received a PhD in epidemiology from Yale University, an MPH in family health from Columbia 
University, and a master's degree in political science from Rutgers University. 
Pat Breysse, PhD 
Director, National Center for Environmental Health (NCEH)/Agency for Toxic Substances and Disease Registry 
(ATSDR) 
Pat Breysse, PhD, joined CDC in December 2014 as the Director of NCEH/ATSDR. Dr. Breysse leads CDC's efforts 
to investigate the relationship between environmental factors and health. He came to CDC from the Johns 
Hopkins University where he served as Associate Chair for Educational Programs within the Department of 
Environmental Health Sciences, Program Director for the Industrial Hygiene Training Program, and co-director of 
the Johns Hopkins Center for Childhood Asthma in the Urban Environment. 
During his 30 years at Johns Hopkins, Dr. Breysse established a long-standing expertise in environmental health 
as well as a strong record as a leader in the field. He has published over 200 peer-reviewed journal articles and 
has presented at more than 25 scientific meetings in just the past 5 years. His research has focused on the 
evaluation and control of chemical, biological, and physical factors that can affect health, with a particular 
concentration on risk and exposure assessment. 
Dr. Breysse received his PhD in Environmental Health Engineering from Johns Hopkins University in 1985 and 
completed postdoctoral training at the British Institute for Occupational Medicine in Edinburgh, Scotland. He is 
also a board certified Industrial Hygienist and an editorial review board member for the Journal of Exposure 
Science and Environmental Epidemiology. 
Debra Houry, MD, MPH 
Director, National Center for Injury Prevention and Control (NCIPC) 
Debra Houry, MD, MPH, is the Director of the National Center for Injury Prevention and Control (NCIPC) at CDC. 
In this role, Dr. Houry leads innovative research and science-based programs to prevent injuries and violence 
and to reduce their consequences. She joined the CDC in October 2014. She has previously served as Vice-Chair 
and Associate Professor in the Department of Emergency Medicine at Emory University School of Medicine and 
as Associate Professor in the Departments of Behavioral Science and Health Education and in Environmental 
Health at the Rollins School of Public Health. Dr. Houry also served as an Attending Physician at Emory University 
Hospital and Grady Memorial Hospital and as the Director of Emory Center for Injury Control. Her prior research 
has focused on injury and violence prevention in addition to the interface between emergency medicine and 
public health, and the utility of preventative health interventions and screening for high-risk health behaviors. 
She has received several national awards for her work in the field of injury and violence prevention. 
Dr. Houry received the first Linda Saltzman Memorial Intimate Partner Violence Researcher Award from the 
Institute on Violence, Abuse, and Trauma and the Academy of Women in Academic Emergency Medicine's 
Researcher Award. She is past president of the Society for Academic Emergency Medicine, the Society for 
Advancement of Violence and Injury Research, and Emory University Senate. Dr. Houry has served on numerous 
other boards and committees within the field of injury and violence prevention. She has authored more than 90 
peer-reviewed publications and book chapters on injury prevention and violence. Dr. Houry received her MD 
and MPH degrees from Tulane University and completed her residency training in emergency medicine at 
Denver Health Medical Center. 
Rima Khabbaz, MD 
Deputy Director, CDC 
Director, Office of Infectious Diseases (01D) 
Rima Khabbaz, MD, is the CDC Deputy Director for Infectious Diseases and the Director of the Office of 
Infectious Diseases (01D). As such, she provides leadership to the efforts of CDC's infectious disease national  
centers and helps to advance the Agency's cross-cutting infectious disease priorities including the integration of 
advanced molecular detection (AMD) technologies into public health. 
Previous CDC positions include acting director of the National Center for Immunization and Respiratory Diseases 
(NCIRD), acting director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), 
director of the National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID); 
director, acting deputy director, and associate director for epidemiologic science in the National Center for 
Infectious Diseases (NCID); and deputy director and associate director for science in the Division of Viral and 
Rickettsia! Diseases (DVRD). 
Her first job at CDC was an Epidemic Intelligence Service (EIS) Officer in NCID's Hospital Infections Program. She 
later served as a medical epidemiologist in NCID's Retrovirus Diseases Branch, where she made major 
contributions to defining the epidemiology of the non-HIV retroviruses, specifically human T lymphotropic 
viruses (HTLV) I and II, in the United States and to developing guidance for counseling HTLV—infected 
persons. Following the hantavirus pulmonary syndrome outbreak in the southwestern United States in 1993, 
she led CDC's efforts to set up national surveillance for this syndrome. She also played a key role in developing 
and coordinating CDC's blood safety and food safety programs related to viral diseases. 
She has served in leadership positions during many of CDC's responses to outbreaks of new and/or reemerging 
infections, including Nipah, Ebola, West Nile virus, SARS, and monkeypox, and she led the CDC field team to the 
nation's capital during the public health response to the anthrax attacks of 2001. 
Dr. Khabbaz is a graduate of the American University of Beirut in Lebanon, where she obtained both her 
bachelor's degree in science (biology/chemistry) and her medical doctorate degree. She trained in internal 
medicine and completed a fellowship in infectious diseases at the University of Maryland in Baltimore. In 
addition to her CDC position, she serves as clinical adjunct professor of medicine (infectious diseases) at Emory 
University. 
Dr. Khabbaz is a fellow of the Infectious Diseases Society of America (IDSA), a member of the American 
Epidemiological Society, and a member of the American Society for Microbiology and of the American Society 
for Tropical Medicine and Hygiene. She is a graduate of the Public Health Leadership Institute at the University 
of North Carolina and the National Preparedness Leadership Initiative at Harvard University. She served on 
IDSA's Annual Meeting Scientific Program Committee and serves on the society's Public Health Committee. She 
also is a member of the Institute of Medicine's Forum on Microbial Threats. 
Nancy Messonnier, MD (CAPT, USPHS) 
Director, National Center for Immunization and Respiratory Diseases (NCIRD) 
Dr. Nancy Messonnier (CAPT, USPHS) is the Director for the National Center for Immunization and Respiratory 
Diseases (NCIRD), Since beginning her public health career in 1995 as an Epidemic Intelligence Service Officer in 
the National Center for Infectious Diseases (NCID), Dr. Messonnier has held a number of leadership posts across 
CDC and within NCIRD. She brings strong management and leadership skills, commitment to staff mentoring and 
development, and a passion for immunization and infectious disease prevention. 
Dr. Messonnier has played critical roles in several successful public health initiatives including the vaccination of 
millions of people living in the African Meningitis Belt with MenAfriVac; serving on anthrax response teams 
during the 2001 intentional anthrax release; leading the evaluation of an anthrax vaccine and post-exposure 
antibiotic; overseeing a family of studies exploring resurgence of pertussis; championing for prevention and 
control of bacterial meningitis in the U.S; and providing vital leadership to CDC's cross-cutting laboratory, global 
health, and surveillance initiatives. She has written more than 140 articles and chapters and received numerous 
awards. 
Dr. Messonnier received her BA from the University of Pennsylvania and MD from the University of Chicago 
School of Medicine. She completed internal medicine residency training at the University of Pennsylvania. 
Beth P. Bell, MD, MPH 
Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) 
Beth P. Bell, MD, MPH, is the director of the National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID). She provides leadership for the prevention and control of a broad spectrum of infectious diseases, 
including rare but deadly diseases like Ebola and anthrax, and more common conditions like foodborne diseases 
and healthcare-associated and antibiotic-resistant infections. In addition, Dr. Bell provides oversight for a 
diverse portfolio of science-based programs that promote water safety, global health and the health of 
migrating populations, and the identification and control of diseases transmitted by animals and insects. She is 
responsible for providing leadership and direction for NCEZID's world-class laboratories, which are developing 
new tests, vaccines, and, since the 2014 launch of Advanced Molecular Detection, next-generation sequencing 
to enable faster diagnosis and more effective prevention and control of infectious diseases. 
Since Dr. Bell assumed the position in 2010, she has led NCEZID's response to several major infectious disease 
threats, including the largest Ebola epidemic in history affecting multiple countries in West Africa, chikungunya 
spreading throughout the Americas, a multistate outbreak of fungal meningitis that exposed thousands of 
patients who had received contaminated steroid injections, the second-largest outbreak of West Nile virus 
disease in the United States, the worst cholera outbreak in recent history that caused more than 8,000 deaths in 
Haiti, and dozens of outbreaks of foodborne disease that occur each year. 
Throughout her tenure at CDC, Dr. Bell has worked in multiple roles requiring medical, public health, scientific, 
and management expertise. She joined CDC in 1992 as an Epidemic Intelligence Service officer assigned to the 
Washington State Department of Health, where she was the lead officer in the seminal investigation of 
Escherichia coil 0157:H7 infections from contaminated hamburgers. She joined the Hepatitis Branch in the 
Division of Viral and Rickettsial Diseases and later served as chief of the Epidemiology Branch in the Division of 
Viral Hepatitis. She then moved on to several center leadership positions, serving as the associate director for 
epidemiologic science, acting deputy director, and acting director at the National Center for Immunization and 
Respiratory Diseases. Dr. Bell has made numerous contributions in the epidemiology and prevention of viral 
hepatitis and also held leadership roles during CDC responses to the 2001 anthrax attacks, Hurricane Katrina, 
and the 2009 H1N1 influenza pandemic. The author/co-author of more than 135 scientific publications, Dr. Bell 
has received many awards for her work, including the Alexander Langmuir Prize and the lain Hardy Award. 
Dr. Bell received a BA from Brown University, an MD from Yale University, and an MPH from the University of 
Rochester School of Medicine. She is a Fellow of the Infectious Diseases Society of America, the American 
Academy of Family Medicine, and the American Academy of Preventive Medicine. 
Jonathan Mermin, MD, MPH (RADM, USPHS) 
Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) 
Jonathan Mermin, MD, MPH (RADM, USPHS), is the Director of the National Center for HIV/AIDS, Viral Hepatitis, 
STD, and TB Prevention (NCHHSTP). 
From 2009-2013, Dr. Mermin served as Director of the Division of HIV/AIDS Prevention, NCHHSTP. Under his 
leadership, the Division spearheaded a new approach to HIV prevention, called High Impact Prevention, that 
aligned funding with epidemiology and ensured program and research activities had the greatest effect on 
reducing incidence and improving health equity. Dr. Mermin also served as Director of CDC-Kenya and HHS 
Public Health Attaché for the U.S. Embassy from 2006-2009, where he oversaw CDC's largest country office, 
implementing programs and research involving a broad range of infectious diseases, including HIV, malaria, 
tuberculosis, and emerging infections. From 1999-2006, he was Director of CDC-Uganda where he oversaw 
CDC's HIV prevention and care programs, including implementation of the first antiretroviral treatment program 
funded by CDC outside of the United States, and the development of a basic care package that was incorporated 
into PEPFAR and World Health Organization guidelines. 
Dr. Mermin began his career at CDC in 1995 as an EIS officer with the Foodborne and Diarrhea! Diseases Branch. 
He completed an internal medicine residency at San Francisco General Hospital and a preventive medicine 
residency at CDC and the California Department of Health Services. He is a graduate of Harvard College and 
Stanford University School of Medicine, and received his MPH from Emory University. He has co-authored more 
than 150 scientific articles. He currently serves as an Adjunct Professor at Emory University School of Public 
Health. 
Chesley Richards, MD, MPH, FACP 
Deputy Director, CDC 
Director, Office of Public Health Scientific Services 
In these two roles, Dr. Richards is a key advisor to the CDC Director and oversees the National Center for Health 
Statistics (NCHS) and the Center for Surveillance, Epidemiology and Laboratory Services (CSELS) with activities 
that include the MMWR, Vital Signs publications, the Epidemic Intelligence Service and other scientific training 
programs, the Guide to Community Preventive Services, and a broad range of cross cutting epidemiology, public 
health surveillance, and laboratory services. 
Dr. Richards earned his M.D. from the Medical University of South Carolina, an M.P.H. in Health Policy and 
Administration from University of North Carolina at Chapel Hill and is a graduate of the Epidemic Intelligence 
Service (EIS) at CDC, the Cancer Control Education Fellowship at UNC Lineberger Cancer Center and the Program 
on Clinical Effectiveness at Harvard School of Public Health. He completed Internal Medicine (Medical College of 
Georgia), Geriatric Medicine (Emory University) and General Preventive Medicine and Public Health (UNC Chapel 
Hill). 
Michael F. lademarco, MD, MPH (CAPT. USPHS) 
Director, Center for Surveillance, Epidemiology, and Laboratory Services (CSELS) 
Dr. Michael lademarco is Director of the Center for Surveillance, Epidemiology, and Laboratory Services (CSELS) 
at the U.S. Centers for Disease Control and Prevention (CDC). His expertise as a physician-scientist and 
laboratorian provides a strong foundation to lead CDC's efforts to track America's health, strengthen laboratory 
networks, and help public health officials identify urgent health threats. 
CSELS provides scientific service, expertise, skills, and tools in support of CDC's mission. CSELS contains many of 
CDC's core scientific services and products, including the Morbidity and Mortality Weekly Report (MMWR), The 
Community Guide, Epi lnfoTM,  the Epidemic Intelligence Service, the CDC Learning Connection, Stephen B. 
Thacker CDC Library, and crucial national disease surveillance systems. 
Prior to this appointment, Dr. lademarco served as Laboratory Branch Chief of CDC's Division of Tuberculosis 
Elimination, where he oversaw clinical laboratory referral services and helped strengthen laboratory capacity 
building. From 2006 to 2010, he was the Department of Health and Human Services Health Attaché at the U.S. 
Mission in Vietnam, where he coordinated U.S. health activities for the Embassy and was the in-country 
representative for the Office of the Secretary. In 2011, Dr. lademarco was awarded a Government of Vietnam 
medal by the country's prime minister in part for his work against HIV/AIDS. In addition, he served as Associate 
Director for Science for the Division of Tuberculosis Elimination, where he oversaw the issuance of major TB 
guidelines. 
Dr. lademarco obtained his undergraduate degree from Franklin & Marshall College, medical degree from the 
University of Virginia, and master's degree in public health from Saint Louis University. He trained clinically and 
in research at Temple University Hospital in internal medicine and Barnes-Jewish Hospital in pulmonary 
medicine. Prior to joining CDC, he was a faculty member of Washington University in St. Louis. Currently, he is an 
adjunct faculty member of Emory University and serves as an attending physician at the Atlanta Veterans 
Administration Medical Center Medical Intensive Care Unit. 
Charles J. Rothwell, MBA, MS 
Director, National Center for Health Statistics (NCHS) 
Charles J. Rothwell, MBA, MS, serves as the director for the National Center for Health Statistics (NCHS). He 
came to Federal government service in 1987 as Associate Director of NCHS responsible for IT and information 
services of the Center. In 2003, he became the Director of the Division of Vital Statistics. 
Before entering Federal service, Mr. Rothwell spent thirteen years in the State Health Department in North 
Carolina and while there developed the position and became the first director of the State Center for Health 
Statistics. He was responsible for health statistics, public health IT and statewide public health planning 
activities, and served as an adjunct assistant professor of biostatistics at the University of North Carolina, School 
of Public Health, and the University of North Carolina, Health Services Research Center. 
Over the years he has been an advisor to the Agency for the International Development (AID) and the United 
Nations (U.N.) for automating Peru's national statistical activities; served as a member of a U.S. multi-
disciplinary scientific team providing on-site consultative services to East Germany, and U.S. representative to a 
U.N. technical advisory committee that helped develop electronic data transmission standards between 
countries, U.N. affiliates and the U.N. He was a past member of the Robert Wood Johnson Advisory Committee 
on Information Technology for state governments. He helped to develop the National Science Foundation's 
(NSF) digital government initiative to build partnerships between computer science academia and non-defense 
federal agencies and was a member of the IT Board of National Institute of Standards and Technology (NIST) 
Advanced Technology Program and NSF Computer Science Large Systems selection committee. 
He also served on a peer review team for the Library of Congress for their National Digital Information 
Infrastructure and Preservation Program (NDIIPP). For a change of pace he also served as a legislative assistant 
for Senator Lieberman, working primarily on bipartisan health care reform legislation and as the lead legislative 
staffer on education issues. 
Mr. Rothwell served as an officer in the U.S. Marine Corps, reaching the rank of captain. He attended the 
Virginia Military Institute in Lexington, Virginia, majoring in physics, minor in mathematics and received a 
bachelor of science. He received his master of science in operations research and systems analysis, from the 
University of North Carolina at Chapel Hill, North Carolina, and his master of business administration from the 
University of Maryland, College Park, Maryland. 
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Centers for Disease Control and Prevention's 
Strategic Framework FY 2016-FY 2020 
CDC works 24/7 to protect the health, safety, and security of Americans. CDC fights disease whether it starts at home or abroad, is 
infectious or not, occurs naturally, by accident, or from a deliberate attack. CDC promotes the health and well-being of Americans 
of all ages—doing all it can to prevent infections, injuries, and illnesses from ever occurring. 
CDC protects the nation and the world by: 
• Detecting, responding to, and stopping new and emerging 
health threats. 
• Preventing injuries, illnesses, and premature deaths. 
• Discovering new ways to protect and improve the public's 
health through science and advanced technology. 
With an annual budget of more than $13 billion and more 
than 15,000 staff, CDC supports communities throughout the 
U.S. and protects Americans by working in more than 60 coun-
tries around the world. Almost 85% of CDC's domestic funding 
is provided directly to state and local entities to detect and 
control disease, prevent the leading causes of death, and pre-
pare for health threats. 
Strategic Priority #1: Improve health security 
at home and around the world. 
CDC's expertise in preparedness, rapid detection, and re-
sponse saves lives and safeguards communities from health 
threats. We are employing faster, more advanced ways to 
find, stop, and prevent infectious disease outbreaks here and 
abroad. The spread of infectious diseases in the U.S. not only 
causes suffering and death, it also has a substantial impact 
on healthcare costs and our economy. Foodborne illnesses 
alone account for roughly 48 million illnesses and more than 
$15.5 billion in costs per year. About 2 million people become 
infected with antibiotic-resistant bacteria each year, and 
roughly 23,000 die of these infections. And each year, 75,000 
Americans with healthcare-associated infections die while 
hospitalized. Building a skilled workforce, using proven inter-
vention strategies, and strengthening laboratory networks 
across the U.S. and throughout the world provide the strong 
systems needed to protect the public's health. 
Increase access to high-quality laboratory testing, including 
the use of advanced molecular detection (AMD) technologies. 
• By employing new, cutting-edge AMD technologies in CDC 
and partner laboratories across the country and around 
the world, we now have the ability to more quickly detect, 
identify, and respond to emerging and antibiotic-resistant 
infectious disease outbreaks. 
• As technologies advance, CDC continues to help state and 
local laboratories—which are at the frontlines in preparing 
for and responding to health threats—to implement 
modern, high-quality testing for infectious diseases. 
• CDC's Environmental Health Laboratory provides service, 
standardization, and quality assurance to laboratories 
testing for newborn disorders, life-threatening diseases, 
nutrition status, and environmental exposures. 
• CDC's laboratories serve as global reference centers 
solving new disease mysteries and preparing for annual 
influenza vaccines. CDC has 23 programs designated as 
WHO global collaborating centers, providing our expertise 
and capabilities to protect Americans at home from threats 
abroad. 
Enhance Global Health Security by building and sustaining 
capacity to detect and respond to disease threats such 
as polio, influenza, Ebola, the Middle East Respiratory 
Syndrome (MERS) virus, and insect-borne threats such as 
the Zika virus. 
We are accelerating progress toward a world safe and secure 
from infectious disease threats and promoting global health 
security by increasing countries' capacity to: 
• Prevent and reduce the likelihood of outbreaks—natural, 
accidental, or intentional. 
• Detect threats early to save lives. 
• Respond rapidly and effectively using multisector, 
international coordination and communication. 
Enhance state and local abilities to prevent, detect, and 
respond to health threats. 
• CDC supports state and local preparedness systems to 
increase molecular diagnostic testing capacity. 
• CDC's select agent registry keeps Americans safer by 
tracking possession and use of pathogenic and toxic 
agents to prevent accidental or intentional misuse. 
• By developing new tools such as the medical 
countermeasure operational readiness review, we make 
sure states can rapidly dispense medicines to reduce 
disease and death during a crisis. 
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• Our National Syndromic Surveillance Program (NSSP)—a 
partnership among local, state, and national public health 
programs—enables partners to detect and characterize 
disease outbreaks, other hazardous events, or conditions of 
public health concern to strengthen regional and national 
situational awareness. 
• CDC supports state and local rapid, population-based 
surveillance of microcephaly and other adverse outcomes 
possibly linked to Zika virus infection. 
Some recent strategic priority accomplishments: 
• The 2014-2016 Ebola epidemic in West Africa 
demonstrated the importance of readiness and remaining 
prepared for Ebola and other health threats to the United 
States. More than 4,000 CDC staff protected people in the 
U.S. and helped stop the spread of Ebola in Guinea, Sierra 
Leone, and Liberia through surveillance, contact tracing, 
laboratory testing, community engagement, infection 
prevention and control, and vaccine evaluation. CDC's 
field laboratory in Bo, Sierra Leone, operated for 421 days 
in a row, testing more than 27,000 specimens. At the 
height of the response, more than 200 CDC staff worked 
in the field in West Africa and 400 staff worked on Ebola 
at CDC's Atlanta headquarters. CDC investments in health 
infrastructure also prevented widespread transmission in 
other West African countries. For example, the substantial 
investment for polio eradication programs in Nigeria 
ensured that responders there were prepared for Ebola, 
enabling Lagos to rapidly stop its outbreak. If Ebola had 
not been stopped in Lagos, it likely would have spread 
for months or years to other parts of Nigeria and Africa, 
killing hundreds of thousands of people and setting back a 
decade of progress in saving lives. 
• CDC also played a critical role protecting the United States 
from Ebola by aiding state and local health departments in 
their preparedness activities. Together with international, 
federal, and state partners, CDC established airport risk 
assessments for travelers leaving affected countries and 
entering the U.S., monitored travelers and other potentially 
exposed persons for 21 days, and helped hospitals across 
the country prepare to manage possible cases of Ebola or 
other hemorrhagic disease through intensive training and 
preparedness activities. 
• CDC continues to work to improve laboratory safety. In the 
past 10 years, CDC performed 2,072 laboratory inspections 
and restricted 338 people from accessing select agents and 
toxins. 
• Lifesaving medical countermeasures from CDC's Strategic 
National Stockpile can be delivered in 12 hours or less to 
anywhere in the U.S. For example, CDC provided 50 vials 
of botulinum antitoxin to the Ohio Department of Health 
within 10 hours for an outbreak in April 2015. 
• Since adoption of advanced molecular detection 
technologies, including whole genome sequencing (WGS), 
we are able to solve outbreaks more quickly and prevent 
illness and death that would have otherwise occurred. 
For example, more than 95% of tuberculosis isolates in 
the nation were tested for drug resistance, and molecular 
testing identified multiple outbreaks. 
• During the past 10 years, CDC has deployed 294 pathogen-
specific tests in 59 countries, helping to find and stop 
spread of disease at the source. In addition, CDC and our 
in-country collaborators discovered 61 pathogens that 
were new to the region in which they were discovered and 
12 new pathogens identified for the first time anywhere in 
the world. 
• CDC supports more than 50 partner countries as well 
global partners to rapidly identify and share novel 
influenza strains. Sharing strains improves vaccine virus 
selection and enhances pandemic preparedness and 
provides the basis for response capacity for other infectious 
diseases such as MERS and Ebola. 
• Since CDC and partners began to work towards 
eradication, polio cases have decreased from more than 
350,000 per year in 1988 to 74 in 2015 and 19 through the 
first half of 2016. Following CDC surges in India and then 
Nigeria, India was declared polio-free in March 2014, and 
Africa completed a year with no wild poliovirus cases when 
Nigeria was verified to be polio-free in 2015, leaving only 
Afghanistan and Pakistan with continuing transmission. 
• Provided more than 107 million rapid diagnostic tests and 
243 million treatments for malaria since 2006 as part of the 
President's Malaria Initiative. 
• In 2016, CDC rapidly identified the link between Zika 
virus and microcephaly in newborns and implemented 
prevention strategies appropriate to different parts of the 
United States. 
Strategic Priority #2: Better prevent the leading 
causes of illness, injury, disability, and death. 
The stakes are high—the top 10 leading causes of death ac-
count for nearly 75% of all deaths in the U.S., with cardiovascu-
lar disease, stroke, and cancer accounting for more than half of 
all deaths and more than $472 billion in healthcare costs. 
Provide timely, quality data on priority health and health-
care issues at the national, state, and local levels to better 
monitor and improve the health of Americans. 
• CDC's gold-standard health surveys and public-use 
data sets provide accurate, timely, and comprehensive 
information on health and healthcare issues. 
• We continue to lead the nation in conducting high-
quality research related to the public's health, including 
population health surveillance and epidemiology at 
national and state levels and building the science basis for 
decision-making on public health programs, policies, and 
services. 
• We are building and improving information systems, which 
will enable enhanced data exchange to improve internal 
and external information sharing. 
• CDC is a trusted source of information for consumers 
and healthcare professionals through a variety of 
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communication platforms including scientific publications, 
emergency health alerts for practicing clinicians, a 
comprehensive internet presence, and news and social 
media outreach. 
Work with communities to prevent injury, disease, and disability. 
• Vaccination programs, including the Vaccines for Children 
Program (VFC) provide half of all childhood vaccines in the 
U.S., in addition to epidemiology and laboratory capacity 
to detect and respond to vaccine preventable diseases. 
Childhood immunization saves $3 in direct costs and $10 in 
direct and indirect costs for every $1 spent. 
• We prevent heart attacks, strokes, cancer, diabetes, and 
other diseases that are the leading causes of illness and 
premature death by helping reduce tobacco use, improve 
physical activity and nutrition, and reduce obesity. For 
example, our scientific research shows increasing access 
to tobacco-free environments, improving access to 
fluoridated water, and providing children with healthier 
food options in schools result in better health. We also 
work to ensure that tools for healthy living are accessible 
for people with disabilities. 
• Our proven approaches to injury and violence prevention 
help reduce deaths due to motor vehicle crashes, still 
a leading cause of death and injuries in the U.S., with 
effective interventions to increase use of restraints and 
reduce speeding and alcohol-impaired driving. We focus 
on vulnerable populations, including American Indians 
and Alaska natives and older Americans. We also apply 
our scientific expertise to help reduce deaths from 
the opioid overdose epidemic by supporting states to 
implement effective strategies, and equipping healthcare 
providers with the tools they need to improve safe opioid 
prescribing. 
• We work to help children thrive by preventing child abuse 
and neglect, improving asthma management, increasing 
early identification of developmental disabilities such 
as autism spectrum disorder, improving treatment of 
children with Attention Deficit and Hyperactivity Disorder 
(ADE-1Di, and preventing harms that include birth defects 
from maternal exposures such as medication use during 
pregnancy. 
• We prevent work-related injuries, illnesses, and fatalities 
due to hazardous exposures and falls. 
Support doctors, nurse practitioners, nurses, pharmacists, 
and other health professionals by increasing workforce 
capacity at the state and local levels. 
We help build and train the public health workforce through 
financial and technical support to states and localities. Fellow-
ship programs such as the Public Health Associate Program  
(PHAP), the Laboratory Leadership Service(LLS), and the 
Epidemic Intelligence Service (EIS)  assign more than 500 CDC-
trained public health workers and disease detectives to state, 
local, tribal, and territorial health departments. 
Some recent strategic priority accomplishments: 
• Most vaccine-preventable disease case counts are at their 
lowest levels ever, with greater than 90% coverage for 
many vaccines. Vaccination of children born in the U.S. 
between 1994 and 2013 prevented 322 million illnesses, 
avoided 732,000 deaths, and will save nearly $1.4 trillion 
in societal costs. Influenza vaccination alone prevented 
1.9 million illnesses and 67,000 hospitalizations during the 
2014-2015 flu season. 
• Although more than 35 million Americans still smoke 
cigarettes, adult cigarette-smoking rates decreased to a 
new low of 15.1% in 2015, representing an estimated 10 
million fewer smokers than in 2009. 
• The Tips from Former Smokers (TIPS) campaign has helped 
at least 400,000 smokers quit for good since 2012.TIPS 
costs just $393 to save a year of life and less than $3,000 
per life saved; it is a public health best buy. 
• There was a 9% decrease in HIV diagnoses between 2010 
and 2014. 
• Providers using CDC's new HIV testing algorithm can detect 
acute infection just 4 days after RNA positivity. 
• CDC released its STEAD! (Stopping Elderly Accidents, 
Deaths, and Injuries) Initiative, which gives healthcare 
providers evidence-based tools and guidance needed to 
address and prevent falls among their patients. 
• CDC data and research paved the way for a 2016 U.S. 
Food and Drug Administration (FDA) decision to permit 
fortification of corn masa flour with folic acid, which could 
reduce neural tube defects—severe birth defects of the 
brain and spine—particularly among the nation's Hispanic 
population. 
• CDC's National Institute for Occupational Safety and Health 
(NIOSH) conducted a health-hazard evaluation study 
that found a high rate of carpal tunnel syndrome among 
workers at a poultry-processing plant that employed 
workers from an underserved population. These findings 
led to safer working conditions and updated industry 
guidelines. 
• Encouraging widespread adoption of directly observed 
therapy for tuberculosis and increased support to local 
health departments have helped prevent tens of thousands 
of tuberculosis cases in the United States since 1993. 
• EIS officers conduct more than 200 investigations per year, 
ranging from assessing the effectiveness of a vaccination 
campaign to preventing meningococcal disease in 
university students to determining risk factors for 
healthcare-associated infections. 
• More than 350 Public Health Associate Program (PHAP) 
associates are assigned to public health agencies in 
44 states, one territory, and the District of Columbia in 
addition to 34 Career Epidemiology Field Officers (CEF05) 
in 27 state, territorial, or local public health programs. 
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Strategic Priority #3: Strengthen public health 
and healthcare collaboration. 
We have a unique opportunity to increase the value of our na-
tion's health investments by better aligning public health and 
healthcare. 
Leverage partnerships with clinicians and healthcare 
organizations to decrease healthcare-associated and 
antibiotic-resistant infections and prevent prescription drug 
overdoses. 
• CDC has invested in practical and proven efforts to counter 
the threat of untreatable antibiotic-resistant infections. 
In 2014, the Chicago Prevention Epicenter completed 
a multicenter evaluation of a new prevention package 
in four long-term acute care hospitals, demonstrating a 
56% reduction in deadly antibiotic-resistant carbapenem-
resistant Enterobacteriaceae (CRE) infections. 
• Our 6/18 Initiative increases use of proven prevention 
practices. CDC provides partners with rigorous evidence 
and practical information on implementation to 
address high-burden health conditions and associated 
interventions to inform their decisions so they have the 
greatest health and cost impact. Multiple state Medicaid 
programs, commercial payers, and large employers are 
adapting their covered benefits to provide access to 
specific 6/18 interventions. 
• The CDC Guideline for Prescribing Opioids for Chronic  
Pain provides recommendations for the prescribing of 
opioid pain medication for patients 18 or older in primary 
care settings outside of active cancer treatment, palliative 
care, and end-of-life care. Improving the way opioids are 
prescribed through clinical practice guidelines can ensure 
patients have access to safer, more effective chronic pain 
treatment while reducing the number of people who 
overdose or die of these drugs, as well as reducing rates of 
neonatal opioid withdrawal syndrome. 
Increase ability of public health and healthcare systems to 
reduce disease threats and improve health by increasing 
prevention through the use of community, clinical, and 
laboratory services, 
• Our cancer programs increase access to recommended 
preventive screening to reduce mortality. 
• Partnerships among community and clinical care providers 
help improve blood pressure and cholesterol control and 
help people stop smoking. 
• Our community and school-based programs reduce the risk 
that teens develop HIV, STDs, and unintended pregnancy. 
Use emerging data sources, existing surveys, and innovative 
information delivery to inform clinical care systems to 
improve population health. 
• CDC links our national surveys with Medicaid enrollment 
and claims records collected from the Centers for Medicare 
and Medicaid Services (CMS) to better understand and 
improve changes in health status and healthcare use, 
including among low-income families with children, the 
elderly, and people with disabilities. 
• Through the National Health Interview Survey (NHIS), CDC 
increased the number of states with accurate estimates of 
health insurance coverage, from 32 states in 2011 to all 50 
states and Washington, D.C., in 2014. 
• CDC has expanded the number of states and territories in 
the National Violent Death Reporting System (NVDRS) and 
has used this data to identify circumstances and prevention 
strategies for suicide. 
• In FY 2015, CDC Vital Signs electronic media had a total 
potential reach of 6.6 million people. 
• Annual mortality data are being reported more quickly 
than ever. We released final 2014 mortality data in early 
December 2015 and preliminary 2015 data in June 2016. 
In 2015, CDC received 38% of death records within 10 days 
of the event, a proportion which more than doubled since 
2013. 
• Specialized websites, such as the Community Health  
Improvement Navigator and Sortable Stats assist states, 
local communities, tribes, and territories with data, useful 
information and tools. 
Some recent strategic priority accomplishments: 
• The combination of CDC data systems, guidelines, and 
programs has contributed to significant reductions 
of healthcare-associated infections, including a 50% 
reduction in central line-associated bloodstream infections 
between 2008 and 2014. 
• As of 2015, the Million Hearts' Hypertension Control  
Challenge recognized nearly 60 public and private 
healthcare practices and systems that reach more than 
12 million adult patients in 29 states for achieving blood 
pressure control for at least 70% of their patients with 
hypertension. 
• By September 30, 2015, the World Trade Center (WTC) 
Health Program had enrolled 73,199 eligible responders 
and survivors. In FY 2015, the WTC Health Program paid 
claims for eligible treatment, including medication, for 
more than 22,100 of these responders and survivors. 
• Provided timely guidance to healthcare providers 
and the public in the U.S. and globally to prevent Zika 
virus infection and its effects, including immediately 
communicating with the American and global public about 
the importance of travel avoidance for pregnant women 
to avoid Zika virus infection following determination of its 
effects on pregnancy. 
Paq€ 4 of 4 
Attachment E: CDC's performance overview from the FY 2017 Congressional 
Justification 
Page 156 
CDC FY 2017 Congressional Justification 
OVERVIEW OF PERFORMANCE 
As the nation's prevention agency and a leader in improving health around the world, CDC is committed to 
reducing the leading causes of death, disability and injury. CDC staff work 24/7 around the world to save lives, 
protect people, and save money through prevention. To achieve maximum public health impact, CDC conducts 
research; implements strategic, evidence-based programs; and monitors results through ongoing data 
collection. 
CDC's priorities form the core of its public health programs. These programs require the scientific excellence and 
leadership of our highly trained staff, who are dedicated to 
high standards of quality and ethical practice. The agency's 
priorities are: 
• Strengthen public health and clinical linkages. 
• Protect Americans from infectious diseases. 
• Prevent the leading causes of disease, disability, and 
death. 
• Ensure global disease protection. 
• Keep Americans safe from environmental and work-
related hazards. 
• Protect Americans from natural and bioterrorism 
threats. 
• Monitor health and ensuring laboratory excellence. 
Performance in each of these areas and in all of CDC's work is 
strengthened through the use of rigorous and ongoing 
performance metrics and program evaluation data to monitor program effectiveness and compare performance 
to established targets. The accomplishments described below highlight the importance of investing in public 
health, preventing disease, and protecting health. 
Strengthen Public Health and Clinical Linkages and Protect Americans from Infectious Diseases 
• Healthcare facilities monitor and prevent healthcare-associated infections (HAI) through CDC's National 
Healthcare Safety Network (NHSN). As of December 2015, over 18,000 healthcare facilities, including 
nearly all US hospitals, participate in NHSN for quality improvement. The number of acute care hospitals 
currently reporting antibiotic use data in NHSN increased from 64 (in FY 2014) to 130 facilities. In 
addition, 500 long- term acute care hospitals (LTACHs) began reporting Clostridium difficile and 
Methicillin-resistant Staphylococcus aureus (MRSA) infections this year. Since 2008, the combination of 
CDC data systems, guidelines and programs has contributed to significant reductions of HAls in 
healthcare settings, including: 
o 50% reduction in central line-associated bloodstream infections (since 2008). 
o 13% reduction in laboratory identified healthcare-associated MRSA bloodstream infections 
(since 2011). 
o 11% reduction in catheter-associated urinary tract infections for LTACHs (since 2014). 
• In January 2015, CDC added the Targeted Assessment for Prevention (TAP) report NHSN. TAP allows 
NHSN users to review data for the facilities and facility locations they have access to in order to identify 
where excess infections are occurring. Since being introduced, NHSN TAP reports for hospitals have 
been used on average every 20 minutes. TAP reports are currently available for central line-associated 
bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), and Clostridium 
As we continue to expand and 
strengthen our collection and use of 
data, we gain greater knowledge and 
insight about the extent of our biggest 
health problems, which populations are 
most affected by them, and what we 
need to do to solve them. Information is 
power — and this power makes it 
possible for us to implement programs 
that fulfill our promise to keep 
Americans healthy and our nation 
strong. 
— Dr. Tom Frieden, Director, CDC 
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difficile infections. State health departments), and nine Centers for Medicare and Medicaid Services 
(CMS) Quality Improvement Networks (QIN) representing 26 states have already used these reports to 
reduce HAI infections and focus their Clostridium difficile prevention efforts. 
• CDC has invested in practical interventions to counter the threat of untreatable antibiotic resistant 
infections. In 2014, the Chicago Prevention Epicenter completed a multicenter evaluation of a novel 
prevention package bundle in four long-term acute care hospitals, which demonstrated a 56% reduction 
in carbapenem-resistant Enterobacteriaceae (CRE) infections. An important antibiotic resistance 
prevention strategy, the prevention package included improved patient screening, CRE positive patient 
isolation, daily chlorhexidine bathing, and enhanced healthcare worker training and monitoring. 
• CDC has expanded its HIV testing efforts, especially focusing on communities that have a high burden of 
HIV infection among African Americans and Latinos. CDC-supported health departments performed 
nearly 3.2 million HIV tests in 2014, with more than 12,000 people newly identified as HIV positive. 
• In 2015, Indiana activated its emergency operations center to investigate and respond to an outbreak of 
HIV and hepatitis C infections among persons who inject drugs. Previous planning and exercising 
required by CDC's Public Health Emergency Preparedness (PHEP) cooperative agreement enabled the 
state health department to rapidly establish an Incident Command System structure to support the 
outbreak and leverage other state agencies to address transportation needs, Medicaid issues, and other 
healthcare concerns, This included integrating 49 Disease Intervention Specialists (DIS) from other state 
programs who identified infected persons, connected them to care, and contained the outbreak. 
• CDC has improved its ability to detect large TB outbreaks in the U.S. by establishing surveillance for 
outbreaks of .1.0 genotype-matched TB cases related by recent transmission. CDC detected 18 
suspected large outbreaks in the U.S. from April 2014-March 2015. Most (78%) of these suspected 
outbreaks were initially identified by CDC, instead of solely relying on CDC-funded TB programs. This 
novel surveillance system can provide data to better understand the epidemiology of large outbreaks, 
inform advocacy and policy initiatives, and lead to quicker and more efficient public health responses. 
Ensure Global Disease Protection 
• During FY 2015, 138 Epidemic Intelligence Service (EIS) officers had an EOC-coordinated deployment for 
CDC's Ebola response, either domestically or internationally. These 138 EIS officers deployed for a total 
of 5,798 days during FY 2015. 
• CDC's direct technical assistance to PEPFAR-supported countries significantly contributed to 9.1 million 
voluntary medical male circumcision procedures performed in 14 PEPFAR countries in 2014. This 
represents a 22% increase in procedures from 2013 and a 750% increase from 2010. This one-time 
intervention has a lifelong benefit of reducing the risk of HIV infection to uninfected men. 
• •In 2015, CDC and its partners published study results on the efficacy and safety of strategies for 
prevention and treatment of malaria in pregnancy. These findings were critical in revising the World 
Health Organization recommendations on the use of intermittent preventative treatment in pregnancy 
(IPTp), which were released in November 2015. Since October 2014, PHEP awardees have actively 
monitored more than 21,500 travelers from countries in West Africa with widespread Ebola cases. This 
includes daily monitoring for a 21-day incubation period for every traveler. PHEP resources and guidance 
enabled the establishment of active monitoring procedures in only 10 days within the 62 PHEP 
jurisdictions. As an example, within one week, IT and epidemiology staff in one state collaborated to 
rapidly develop a novel electronic Ebola monitoring surveillance system, increased its call center 
capacity, and hired Ebola duty officers to work seven days a week to successfully monitor more than 125 
travelers a day. 
• CDC began a presumptive treatment and vaccination pilot program in 2013, partnering with the 
International Organization for Migration (IOM) and the bureau of Population, Refugees, and Migration 
(PRM). After only two years of implementation in countries with high rates of U.S. bound refugees, 60% 
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now receive at least one round of ACIP recommended vaccines, and 74 percent receive appropriate 
antiparasitic and antimalarial treatment. Current interventions in refugee groups have reduced 
imported malaria cases by 98 percent, and intestinal parasite infections by 81 percent. 
Prevent the Leading Causes of Illness, Injury, Disability, and Death 
• In 2015, CDC launched the Tips from Former Smokers national education campaign with a series of 
powerful new ads. The ads highlighted health conditions such as colorectal cancer and macular 
degeneration, the benefits of quitting for smokers' loved ones, and the importance of quitting smoking 
completely. This continues the long-running success of the Tips campaign, which has helped hundreds of 
thousands of Americans quit smoking for good. The campaign has proven to be a "best buy" in public 
health by costing just $393 to save a year of life (well under the widely accepted limit for the cost-
effectiveness of a public health program of $50,000 per year of life saved). 
• CDC's surveillance of emerging tobacco products and their use highlighted critical national trends—
particularly the rapid increase in e-cigarettes use among youth. Hookah smoking roughly doubled for 
middle and high school students from 2013-2014; e-cigarette use now surpasses use of every other 
tobacco product overall, including conventional cigarettes. 
• As of 2015, through the National Diabetes Prevention Program (DPP), evidence-based lifestyle change 
programs have been delivered to approximately 32,000 people at high risk for type 2 diabetes in 49 
states and the District of Columbia, and over 7,463 lifestyle coaches have been trained. The National 
DPP helped secure coverage for diabetes prevention for over 1 million employees in eight states. 
• CDC's Breast and Cervical Cancer Early Detection Program provided breast and cervical cancer screening 
to 451,209 low-income, uninsured and underinsured women in 2014, diagnosing 5,312 women with 
breast cancer and 3,220 women with invasive cervical cancer or high-grade premalignant lesions. 
• The 2014 Million Hearts® Hypertension Control Challenge recognized 30 public and private health care 
practices and systems for achieving blood pressure control for at least 70% of their patients with 
hypertension, reaching over 3.5 million adult patients in 19 different states. One 2014 Champion, the 
Peninsula Community Health Center in Bremerton, WA, increased their blood pressure control rate from 
78% to 84% within one year. 
• In 2013-2014, nearly 88,000 children received sealants through CDC-sponsored school-based sealant 
programs. Over nine years, school-based sealant programs prevented 8.5 cavities per every 10 children 
sealed. 
• In 2014, several states, including Tennessee and Iowa, increased water access in schools by providing 
water bottle filling stations for students to use during the school day and at lunch, replacing less healthy 
beverage options, increasing students' overall water consumption, and maintaining hydration. Adequate 
hydration may improve cognitive function in children and adolescents. 
• CDC investments assist U.S. hospitals in becoming Baby-Friendly, a designation based on adherence to 
the evidence-based Ten Steps to Successful Breastfeeding. As of November 2015, CDC's promotion of 
Baby-Friendly hospitals contributed to 14.8% of all U.S. births (-590,000 babies per year) occurring at 
Baby-Friendly hospitals (306hospitals across 48 states), more than double the percent of 2012 births at 
Baby Friendly hospitals. 
• CDC's Division of Reproductive Health supports state Perinatal Quality Collaboratives (PQC) to improve 
pregnancy outcomes for women and newborns using continuous quality improvement methods. 
Between 2010 and December 2013 the California PQC has shown a 57% decrease in the percentage of 
elective deliveries (37-38 weeks gestation); the New York PQC has shown a 92% decrease in elective 
deliveries (36-38 weeks gestation), including an 86% decrease in labor inductions and a 94% decrease in 
scheduled C-sections without a medical indication. From September 2008 to March 2014, the Ohio PQC 
has seen an estimated cost savings of over $27,789,000 associated with a shift of 48,400 births to 39 
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weeks gestation or greater and a 68% decline in the rate of deliveries less than 39 weeks without a 
medical indication. 
• A large, regional healthcare provider began integrating CDC's Elderly fall's prevention initiative (STEADI) 
into its primary care practices in 2012, modifying its electronic health records (EHR) to incorporate 
STEADI and providing point-of-care clinical decision support. As of 2015, 17 of its primary care practices 
and 74 clinicians are presently using the EHR-based tools. Among practices that have implemented 
STEADI more than 70% of patients aged 65+ were screened for falls. Over 75% of those patients 
screened also underwent assessments. 
Keep Americans safe from environmental and work-related hazards, and natural and bioterrorism threats 
• In February 2015, PHEP-funded staff quickly responded to a train derailment in West Virginia that spilled 
3 million gallons of crude oil, contaminating the area's primary water source. Public health response 
staff rapidly mobilized the public health emergency management system, enabling the health 
department to provide the 2,000 affected residents with clean, alternative sources of water and the 
information needed to appropriately treat the water once the water system was re-established. 
• In FY 2015, the CDC-funded Louisiana Healthy Homes and Childhood Lead Poisoning Prevention Program 
piloted blood-lead testing at Women, Infants, and Children (WIC) clinics in four Louisiana parishes. The 
partnership with WIC demonstrated WIC clinics are an efficient place to screen children ages 12 to 24 
months who are at risk for lead poisoning and who would not otherwise be tested. The program 
reached an additional 581 children, 79% of whom had never before been tested. 
• CDC's National Institute of Occupational Safety and Health (NIOSH) conducted a Health Hazard 
Evaluation study that found a high rate of carpal tunnel syndrome in a poultry processing plant 
employing workers from an underserved population. The findings received national media attention and 
helped support OSHA activities, including expanded enforcement and updated guidelines for the 
industry. 
• CDC distributed more than 1,189 radiation emergency tool kits in FY 2015 to public health professionals 
and clinicians. Recent evaluation research has found that the toolkits were valuable resources for 
planning (pre-event) and just-in-time (intra-event) use. Since the creation of the toolkits in 2005, CDC 
has provided more than 29,200 kits to professionals across the nation and internationally to assist 
clinicians in developing plans and response capacity for radiation emergencies. 
Monitor health and ensuring laboratory excellence 
• States continue to show progress in electronic lab reporting (ELR) implementation, which is vital to 
increasing notifiable disease reporting to health departments and improving disease surveillance. In FY 
2015, over 40 jurisdictions (of 55 total) increased the volume of lab reports received electronically, with 
more than 20 jurisdictions increasing their volume of electronic reports by over 10%. 
• In response to the Ebola outbreak, Laboratory Preparedness training courses saw a 151% increase in 
successful course completions among global public health and clinical laboratories in FY 2015. More 
than 4,200 laboratory professionals successfully completed training and qualified for mandated 
certification necessary to safely package and ship infectious agents such as Ebola. 
• In 2015, CDC's STD lab discovered gonorrhea in vitro that is susceptible to a novel antibiotic inhibits DNA 
biosynthesis. This antibiotic demonstrated a high level of antimicrobial activity against gonorrhea, 
including isolates with decreased susceptibility or resistance to currently available agents. 
• CDC recently identified two novel viruses, Heartland and Bourbon, which were isolated from fatal 
human cases. Evidence suggests that ticks transmit these viruses. To support surveillance and diagnosis 
of these pathogens, CDC produced diagnostic reagents and designed assays to test for the viruses. With 
CDC reagents, cases that would have remained undiagnosed are now being confirmed. 
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• CDC now has almost two years of data on the impact of Advanced Molecular Detection (AMD) 
technologies (specifically, whole genome sequencing, or WGS) on foodborne listeriosis. Since the 
adoption of WGS, the number of outbreaks detected has increased by 50% while the number of cases 
per outbreak has decreased by 50%. Outbreaks are being detected earlier and the number of cases 
linked to specific food sources has increased 15-fold. 
• From 2014-2015, CDC Enhanced EHR-Immunization Information System interoperability at 8,400 
practice sites through standardized data transport protocols, tools to aid HL7 messaging, and patient-
level de-duplication best practices and test cases. 
Other CDC Accomplishments 
• In June 2015, CDC released the first federal estimates of 2014 health insurance coverage for the civilian 
noninstitutionalized U.S. population using the National Health Interview Survey (NHIS). For the first 
time, the NHIS produced estimates for 50 states and the District of Columbia, allowing for comparisons 
of coverage before and after implementation of the Health Insurance Marketplaces and Medicaid 
expansion. Typically, the NHIS produces health insurance coverage estimates for about 20 states; a 
sample increase of nearly 10,000 made it possible to expand the number of states for which reliable 
estimates could be made. 
• In FY 2015, CDC Vital Signs electronic media reach was 6.6 million potential viewings, almost doubling 
the annual year-end goal of 3.9 million. The significant increase in reach was driven by increased traffic 
to the CDC Vital Signs website, which readers use to access information about each monthly release. 
During FY 2015, CDC published over 250 MMWR Weekly and Serial publications and increased total 
electronic media reach by eight percent since FY 2013 from 21.4 million to 23.0 million during FY 2015. 
During the year, MMWR Weekly was also ranked as the number one epidemiology journal by Google  
Scholar, based on citations, with multiple Vital Signs publications represented among the most often 
cited MMWR reports. 
• CDC supported health departments in increasing the capacity and performance of the public health 
system: 
o Currently 45% of the US population is being served by an accredited health department. As of 
November 2015, 84 local and 12 state health departments have achieved public health 
accreditation, and another 250 health departments have formally applied. Eighty-six percent 
(86%) of states and 45% of local health departments indicate they have applied or are preparing 
to apply for accreditation. 
o Among 79 local and tribal health departments funded through Accreditation Support Initiatives 
60% have applied for accreditation and 19% have since been accredited. Results indicate that 
even small investments ($4,000-$40,000) can have significant impact and accelerate a health 
department's ability to meet these national consensus standards. As of December 2015, CDC 
funded an additional 33 local, tribal and territorial health departments for accreditation 
readiness activities. 
• As of November 2015, CDC.gov's satisfaction score of 82 continues its rank as a "top performer" among 
100 participating federal websites, maintaining high customer satisfaction scores as measured by the 
American Customer Satisfaction Index. 
• CDC completed its Roybal Campus Water Study in May of 2015. Since completion of the study and its 
remediation actions, CDC estimates a reduction of at least 85 million gallons of water use per year, 
totaling almost 45% of water used on the Roybal campus. This has resulted in savings of over 
$2,000,000. 
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Agency Performance Planning and Management 
CDC conducts continuous quality improvement through priority and goal setting, performance measurement, 
and program evaluation. CDC collects information on program priorities, measurable outcomes, strategies, and 
progress through annual updates. 
The CDC awards nearly 80 percent of its budget through grants and contracts to help accomplish its mission to 
promote health and quality of life by preventing and controlling disease, injury, and disability. Contracts procure 
goods and services used directly by the agency, and grants assist other health-related and research 
organizations that contribute to CDC's mission through health information dissemination, preparedness, 
prevention, research, and surveillance. 
Many CDC grant announcements require applicants to assess the health burden of their region, state or 
community. CDC surveillance systems often serve as the basis for the data used in applications. Data systems at 
CDC provide data at various levels depending upon data collection methodology, including national, state, 
regional and county level data. While CDC strives to have more health burden data available at the county level, 
the methodology can be costly and as such, currently a subset of health burden data is available across on the 
3,100 counties in the United States. CDC has recently re-launched the Community Health Status Indicators 
website (http://wwwn.cdc.gov/CommunityHealth) where community level health data can be accessed easily by 
grantees, health departments and the general public to be used in grant applications as well as for planning 
purposes. Users can examine health data for their county and compare their county with comparable counties 
around the nation matched on a variety of demographic and predictive factors (i.e. population, educational 
attainment, housing factors, income, poverty, urbanicity). 
CDC considers all data submitted in grant applications during the application review process. Actual award 
amount may be based off of grantee burden levels in some CDC grants (i.e. higher burden=more money). Once 
funding is awarded, data submitted by a grantee is used to monitor finances and grantee performance 
throughout the life of the award period. 
Agency use of evaluation and evidence 
CDC fully supports the use of evidence and evaluation. CDC supports scientific advances and the use of evidence 
and data to support program design and budget decisions. CDC continues to focus on the development and use 
of evidence to enhance all aspects of the Agency's mission. 
CDC builds evidence regarding effective programs through its own evaluation, through systematic reviews of 
existing literature (Community Guide), through the use of rigorous methods to develop vaccination 
recommendations (ACIP's GRADE), and by finding innovative ways to make data accessible for public health 
decision making (Data Warehouse, Sortable Stats, Prevention Status Reports, National Health Report). 
CDC promotes evidence-based prevention interventions in our grant announcements, shares best practices 
through websites, searchable databases and other means, and is exploring additional strategies for promoting 
the use of evidence in practice such as performance-based grant making and recognition awards (Million 
Hearts). 
CDC is increasing its internal capacity to oversee and conduct program evaluation by expanding and enhancing 
the evaluation training available to employees through CDC University, developing an evaluation fellowship to 
expand program evaluation expertise, recruiting external subject matter planning and evaluation experts to 
"coach" CDC programs on related challenges, and by putting standard program evaluation guidelines and 
recommendations into place. CDC has also adapted an 10M framework to measure the impact of CDC science 
and gauge its scientific influence on subsequent events and actions that lead to health improvements. 
Alignment to Administration Priorities and Initiatives 
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CDC is committed to supporting the national priorities set by the Administration. For example, CDC has 
supported the implementation of the President's National HIV/AIDS Strategy (NHAS) goals of reducing the 
number of new HIV infections, increasing access to care for people living with HIV, and reducing HIV-related 
health disparities through domestic HIV programs. 
CDC is a key implementer of the Global Health Security (GHS) Agenda because of the agency's unmatched 
technical expertise, existing country platforms, and strong government-to-government relationships—unique 
assets critical for successful implementation. Through full implementation of the GHS Agenda, CDC can further 
accelerate and expand efforts with partner countries and other partners to accelerate progress toward a world 
safe and secure from infectious disease threats. 
CDC is providing support for full implementation of its surveillance, prevention, and stewardship activities to 
advance the goals of the White House's National Strategy for Combating Antibiotic-Resistant Bacteria (CARB). 
Through its "detect and protect" strategy, CDC is building a more robust network to "detect" our most serious 
AR threats and "protect" patients and communities. 
In alignment with the First Lady's Let's Move Initiative to combat the childhood obesity epidemic and the 
President's Task Force on Childhood Obesity, CDC funds school health programs to improve food and beverage 
options and increase physical activity. 
CDC is committed to HHS Sustainability Efforts in construction of new facilities designed and built to meet 
Guiding Principles. Moreover, Guiding Principle compliance is embedded in Repairs & Improvements projects 
for existing facilities across CDC. 
In support of the National Prevention, Public Health, and Health Promotion Council (National Prevention 
Council) chaired by the Surgeon General, CDC helped lead the implementation of the National Prevention 
Strategy by providing technical and content expertise, participating in stakeholder engagement, and assisting in 
the development and review of recommendations and actions. 
CDC is a co-founding partner of The Million Hearts initiative, a national public-private initiative designed to 
prevent one million heart attacks and strokes by January 2017. CDC provides leadership and communications 
support for the initiative, which includes a number of complementing public and private strategies. 
CDC also provides substantial support to Healthy People (HP) 2020. CDC is committed to the success of the 
Healthy People process and to assisting in prioritizing and achieving HP 2020 goals and objectives, as well as 
supplying the bulk of the data used to measure progress. Through engagement in the development process and 
CDC's integration of HP 2020 measures into our strategic and operational planning efforts, CDC is strategically 
aligned with and making major contributions to the health objectives for the nation. 
CDC actively supports the HHS Action Plan to Reduce Racial and Ethnic Health Disparities by helping to eliminate 
persistent health disparities in the leading causes of death and disability through effective and scalable public 
health interventions. 
CDC leads key activities for 19 measures in the FY 2017 HHS performance plan. These include: 
• improving health care quality and patient safety 
• strengthening public health surveillance and epidemiology 
• enhancing support of the public health infrastructure at the state, tribal, local, and territorial levels 
• addressing obesity through childhood nutrition, food labeling, and physical fitness 
• protecting Americans in public health emergencies 
• increasing impact in global health 
• preventing and controlling tobacco use 
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• enhancing food safety 
• mitigating and preventing infectious and chronic diseases 
Building on CDC's contributions to prior Agency Priority Goals, CDC plays a significant role in four Agency Priority 
Goals for FY 2016-2017, contributing our expertise in surveillance and promotion of evidence-based practices in 
accomplishing these goals: 
• preventing adult tobacco consumption 
• combating antibiotic resistance bacteria 
• improving food safety in the United States 
• reducing opioid-related morbidity and mortality 
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EXECUTIVE SUMMARY 
An update to the first CDC Winnable Battles Progress Report released in November 2013, this document captures 
recent data and contributions across each CDC Winnable Battle: Tobacco, Nutrition / Physical Activity / Obesity, 
Food Safety, Healthcare-Associated Infections, Motor Vehicle Injuries, Teen Pregnancy, and HIV. CDC Winnable 
Battles utilize evidence-based, cost-effective strategies to tackle specific health challenges working together with 
partners in public health. 
Notable in this update is the continued progress of several Winnable Battles. Teen birth rates continue to fall. 
Fatalities due to motor vehicle crashes are fewer. The percentage of adults who smoke is decreasing, and the 
percent of youth who smoke has declined past the 2015 Winnable Battles target. Some healthcare-associated 
infections, including methicillin-resistant Staphylococcus aureus (MRSA) and central line-associated blood stream 
infections (CLABSI) have declined. And, the percent of people living with HIV who know their status is increasing. 
Rates of breastfeeding, which helps protect against childhood obesity and other illnesses, continue to climb. While 
not yet evident in the data, indications of progress are emerging in other areas as well. Better, more focused use 
of food safety data to inform agencies who have oversight of food industries is poised to help prevent foodborne 
illness and outbreaks. 
Despite these gains, much work remains. For instance, new potential health threats such as e-cigarettes are 
emerging and need evaluation to determine how they may affect our health. 
Together with our partners, we are having a positive impact on health by focusing on what works now. We've made 
progress in most areas, but still have more to do to meet our 2015 goals. The Winnable Battles were chosen based 
on the magnitude of the health problems and the ability of CDC and its public health partners to make significant 
progress to improve outcomes. There are evidence-based strategies available now to address the critical health 
challenges presented by each of the Winnable Battles areas. By continuing to work closely with our public health 
partners and educating stakeholders about these evidence-based strategies, we can achieve our Winnable Battles 
goals. 
NUTRITION, 
PHYSICAL ACTIVITY, 	 HEALTHCARE-ASSOCIATED 
TOBACCO 
	
OBESITY & FOOD SAFETY INFECTIONS 
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TARGETS 
A comprehensive set of indicators establishes baselines and targets for all Winnable Battle areas. These indicators 
help us measure the impact of programs and policies on our nation's health, and support the Department of Health 
and Human Services' strategic plan and other priorities. Derived from Healthy People 2020 and other established 
measures, the related targets are ambitious yet achievable, evidence-based, and specific to the priorities and 
opportunities within each of these health areas. 
This dashboard gives a snapshot of each indicator by comparing recent data trends to the 2015 Winnable Battle 
targets. 
• Red = Not on track to reach 2015 target 
Yellow = Progress is being made, but overall progress is limited or slow 
• Green = On track to reach 2015 target 
Green Checkmark= Exceeded 2015 target 
2015 Targets 	 Progress 
Tobacco 
Decrease the percent of adults who smoke cigarettes by 17.5% • 
Decrease the percent of youth who smoke cigarettes by 12% 1 
Increase the proportion of the U.S. population covered by smoke-free laws by 59% 
Nutrition, Physical Activity, and Obesity 
Reduce the proportion of children and adolescents age 2-19 who are obese by 8% 
Increase the proportion of infants who are breastfed at 6 months by 35% 
Food Safety 
Reduce foodborne illness caused by Salmonella by 14.5% 
Reduce foodborne illness caused by Shiga toxin-producing Escherichia coli (STEC) 
0157:H7 by 29% 
• 
Healthcare-associated Infections (HAls) 
Reduce central line-associated blood stream infections (CLABSI) in hospitals by 60% • 
Reduce healthcare-associated invasive methicillin-resistant Staphylococcus aureus 
(MRSA) by 60% 
• 
Reduce surgical site infections (SSI) in hospitals by 30% • 
Reduce catheter-associated urinary tract infections (CAUTI) in hospitals by 30% 0 
Motor Vehicle Safety 
Reduce fatalities due to motor vehicle crashes by 31% • 
Teen Pregnancy 
Decrease teen birth rates by 20% 1 
HIV 
Reduce the number of new HIV infections by 25% • 
Increase the percent of people living with HIV who know their status by 11% • 
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TOBACCO 
Prevent the initiation of tobacco use, promote quitting, and ensure 
smoke-free environments 
Key Strategies 
• Monitor tobacco use and prevention policies 
• Protect people from secondhand smoke 
• Offer help to quit tobacco use 
• Warn about the dangers of tobacco 
• Enforce bans on tobacco advertising, promotion and 
sponsorship 
• Raise taxes on tobacco 
Key Highlights 2014 
• 2014 Surgeon General's Report: The Health Consequences of Smoking —50 Years of Progress was released in 
January 2014. The new report concluded that that despite progress, smoking and exposure to tobacco smoke 
are responsible for more than 480,000 premature deaths annually, as well as at least $289 billion in health care 
expenses and other economic costs each year. 
• The evidence-based guide Best Practices for Comprehensive Tobacco Control Programs was updated and 
released in 2014. The report describes an integrated programmatic structure for implementing interventions 
proven to be effective and provides levels of state investment to prevent and reduce tobacco use in each state. 
The report includes expanded information on health equity from the previous versions of Best Practices. 
• In 2014, CDC launched the third Tips from Former Smokers campaign, focusing on health conditions such as 
premature birth, periodontal (gum) disease and tooth loss, and HIV complications. The campaign resulted in 80% 
call volume increase to 1-800-QUIT-NOW and a more than 1,000% increase in average weekly unique visitors to the 
TIPS website. 
• Two states and the District of Columbia increased tobacco taxes in 2014, a proven strategy to reduce tobacco 
use. Additionally, 63 jurisdictions around the country acted to protect the public from secondhand smoke by 
implementing smoke free ordinances. 
• CDC staff examined poison control calls related to e-cigarettes for the first time. The analysis assessed total 
monthly poison center calls related to e-cigarettes or conventional cigarettes, and found the proportion of 
e-cigarette calls jumped from 0.3 percent in September 2010 to 41.7 percent in February 2014. More than half of 
the calls related to e-cigarettes were for children five years of age or younger. 
• CDC researchers found that prohibiting smoking in subsidized housing would yield annual cost savings of $496.82 
million, including $310.48 million in secondhand smoke-related care, $133.77 million in renovation expenses, and 
$52.57 million in smoking-attributable fire loses. By state, annual overall cost savings ranged from $0.58 million in 
Wyoming to $124.68 million in New York. See King, B.A., Peck, R.M. and Babb, S.D., National and State Cost Savings 
Associated with Prohibiting Smoking in Subsidized and Public Housing in the United States, Preventing Chronic 
Disease, October, 2014. 
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TOBACCO 
Progress to Date 
Trends in percentage of adults who smoke cigarettes, 2006-2013 
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2015 CDC Target 
20% - 
.17% 







2006 2007 2008 2009 2010 2011 2012 2013 2015* 
Years 
Source: National Health Interview Service MOS) 	 "data anticipated June 2016 
Trends in percentage of youth who smoke cigarettes, 2005-2013 
250,0 





2006 2007 2008 2009 2010 2015* 
Years 
Source: Youth Risk Behavior Surveillance System (YRBSS) 	 data anticipated June 2016 
Trends in proportion of U.S. population covered by comprehensive 
state and/or local laws making workplaces, including restaurants 
and bars, smoke-free, 2007-2014 
100% 












2007 2008 2009 2010 2011 2012 2013 2014 2015* 
Years 
Source: Americans for Nonsmokers' Rights lANRS, CDC 	 'data anticipated March 2016 
Published April 11,2015 	 5 
Winnable Battles 2010-2015 Progress Report 
NUTRITION, PHYSICAL ACTIVITY, & OBESITY 
Support all Americans in achieving optimal health by making nutritious foods and physical 
activity easy, attractive, and affordable choices 
Key Strategies 
• Promote healthy eating and physical activity in child 	• Increase breastfeeding support in early care settings, 
care centers, schools, hospitals, workplaces, 	 hospitals, worksites, and communities 
and communities 	 • Reduce consumption of calories from added sugars 
• Eliminate artificial trans fat in the food supply 
• Reduce sodium in the food supply 
Key Highlights 2014 
Illustrating the extent of the U.S. obesity burden, the State Adult Obesity Prevalence and Maps were released in 
September 2014. 
• Today, 11% of all births in the U.S. occur at Baby-Friendly hospitals, up from less than 2% in 2007. This achievement 
surpasses the Healthy People 2020 goal of 8.1%, The CDC funded Best Fed Beginnings project contributed to 
the acceleration of Baby-Friendly designated U.S. hospitals. Nearly one third of all hospitals earning designation 
as Baby-Friendly in 2014 and early 2015 enrolled in Best Fed Beginnings, a nationwide effort to make quality 
improvements to maternity care to better support mothers and babies to be able to breastfeed. 
• Breastfeeding rates continue to rise, according to the 2014 Breastfeeding Report Card. Professional breastfeeding 
support can help mothers start and continue breastfeeding to meet personal goals and national health 
recommendations; the Report Card tracks such support. From 2006 through 2013, the number of International 
Board Certified Lactation Consultants increased from 2.1 to 3.5 per 1,000 live births. 
• Released in July 2014, The State Indicator Report on Physical Activity presents state-level information on physical 
activity behaviors and on environmental and policy supports for physical activity. 
• The Comprehensive School Physical Activity Program (CSPAP) Guide was developed to assist schools and school 
districts to develop, implement, and evaluate comprehensive physical activity programs. For example, teachers 
that participated in a CSPAP training in Monroe County, Tennessee changed academic testing days to coincide 
with mornings that students had before-school physical activities because teachers noticed a positive difference in 
student behavior. 
• Participation in Let's Move Child Care by early care and education providers increased from 11,981 to 15,963 
providers, who serve over 910,000 children. In 2014, learning collaboratives were launched in California (Los 
Angeles), Kentucky, and Virginia (in addition to 6 states in 2013), and thousands of additional ECE providers across 
the nation pledged to meet best practices for food, beverages, breastfeeding support, physical activity, and screen 
time through participation in Let's Move Child Care. 
• Through the Sodium Reduction in Communities Program (SRCP), ten grantees across the country are working 
with partners to increase access to and accessibility of healthier food options, focusing on lower sodium products. 
Each community is working with a combination of independent restaurants, distributive food programs and/or 
governmental and non-governmental organizations that sell and serve food. Communities are seeing quantifiable 
success in reducing sodium. For example Philadelphia, a SRCP awardee, is working with multiple partners to 
reduce sodium content in meals in Chinese take-out Restaurants. As of January 2015, 185 restaurants were 
enrolled in the initiative. Over 24 months, significant reductions in sodium content in three main dishes were seen, 
ranging from 13% to 34%. 
• As of August 2014, 100% of the U.S. General Services Administration-managed cafeteria's contracts include the 
HHS/GSA Health and Sustainability guidelines in the National Capital Regions, moving toward increased adoption 
of the Food Service Guidelines. 
• Promote food service guidelines in cafeterias, 
concessions, vending, restaurants, grocery stores, 
and markets 
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NUTRITION, PHYSICAL ACTIVITY, & OBESITY 
Progress to Date 
Trends in the prevalence of obesity among U.S. children and adolescents, 
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FOOD SAFETY 
Keep America's food supply safe by preventing and responding to foodborne illness 
Key Strategies 
• Drive policy and prevention with data and analyses 
• Investigate outbreaks to stop current and prevent 
future foodborne outbreaks 
• Address challenges of culture-independent 
diagnostic testing with advanced technologies, 
• Support state and local public health and other 
partners to fulfill their primary roles in addressing 
food safety priorities. 
• Improve environmental public health practice to 
prevent foodborne illness outbreaks at restaurants. 
Key Highlights 2014 
• Available for hands-on web access for the first time, the Atlas of Salmonella in the United States, 1968-2011 
summarizes surveillance data on 32 types of Salmonella isolates from people, animals, and other sources. The 
information is organized by demographic, geographic and other categories. The Atlas enables the reader to 
compare trends in Salmonella serotypes by following their spread or decline over time and location. This could lead 
to tailored prevention efforts targeted at specific serotypes. 
• Since CDC began applying advanced molecular detection (AMD) and enhanced epidemiology methods for 
nationwide surveillance of Listeria infections, CDC has been able to detect seven clusters of illness that would not 
have been detected by the older methods. The percentage of Listeria clusters for which a food source was found 
increased from 6% in FY 2013 to 21% in FY 2014. One example of a success is a Listeria outbreak that affected 
at least 32 people in 11 states between October and December 2014. Seven of those people died. Using whole 
genome sequencing, CDC was able to identify the illnesses as a cluster one week faster than would have occurred 
with the older methods. CDC worked with state and local health departments, the Food and Drug Administration, 
and food industries to identify prepackaged caramel apples as the source of the outbreak. Investigation partners 
were then able to take action to inform the public and get caramel apples off the shelves to keep more people 
from becoming ill. 
• The country's largest grocery retailer is partnering with CDC to decrease pathogens such as Salmonella and 
Campylobacter in chicken products provided by its suppliers. The new program, announced in December 2014, 
requires the retailer's poultry suppliers to implement holistic controls from farm to final product and is designed 
to significantly reduce potential contamination levels, in fresh whole chickens and chicken parts. It also requires 
suppliers to validate that the measures they have implemented are effective through specialized testing. All 
poultry suppliers of this grocery retailer must be in compliance with the new requirements by June 2016. 
• CDC released the 2012 National Antimicrobial Resistant Monitoring System (NARMS) Annual Human Isolates 
Report to aid in better understanding trends in antibiotic resistance, which helps doctors prescribe effective 
treatment and helps public health officials investigate outbreaks faster. 
• Researchers provided evidence for the importance of kitchen manager certification in restaurant food safety 
through a CDC-funded study on "Restaurant manager and worker food safety certification and knowledge" 
(December 2014 Foodbome Pathogens and Disease). Findings from this study and others indicate certified 
managers have better food safety knowledge with improvement in food safety practices. 
• Researchers also identified gaps in restaurant policies and practices concerning ill workers (e.g., lack of policies 
requiring sick workers to stay home), that if addressed, could help prevent foodborne illness outbreaks, according 
to a CDC-funded study on "Managerial practices regarding workers working while ill" (January 2015 Journal of Food 
Protection). 
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• The National Voluntary Environmental Assessment and Information System (NVEAIS), launched in April 2014, 
is a national effort to systematically collect, analyze, interpret, and disseminate environmental factor data from 
foodborne illness outbreak investigations. More than half of all foodborne illness outbreaks are associated with 
restaurants, banquet halls, and schools and other institutions. The environmental factor data collected through 
NVENS will be used to help determine the causes of outbreaks in these settings, improve outbreak response 
efforts, and prevent future outbreaks. 8 state and 3 local health departments have registered for NVEAIS since its 
launch, and 44 outbreaks have been reported by sites in NVEAIS. 
• CDC's e-Learning on Environmental Assessment of Foodborne Illness Outbreaks is new, free virtual training that 
teaches state, local, territorial and tribal environmental health professionals how to collect environmental factor 
data during foodborne illness outbreak investigations. Over 1,100 people from 48 states and 282 localities across 
the nation have participated in the e-Learning course since its April 2014 launch. 
FOOD SAFETY 
Progress to Date 
Trends in the rate of infections caused by Salmonella, 2006-2013 
20 
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HEALTHCARE-ASSOCIATED INFECTIONS (HAI) 
Ensure safe healthcare for all Americans by eliminating healthcare-associated infections 
Key Strategies 
• Promote use of National Healthcare Safety Network (NHSN) data to target prevention 
• Expand collaborations and partnerships to promote and implement proven HAI prevention practices 
• Develop innovative approaches to prevent HAls across the healthcare system 
Key Highlights 2014 
• National Healthcare Safety Network (NHSN)—the nation's most widely used HAI tracking system—became the first 
fully automated system that electronically captures antibiotic prescriptions and drug susceptibility test results that 
show which antibiotics work on specific bacteria. This feature is now available to over 15,000 facilities which will 
contribute to improved physician, pharmacy and laboratory decision making around antibiotic use. CDC continues 
working to extend the use of the Antimicrobial Use and Resistance (AUR) reporting options nationally. 
• A new approach to using data for action to protect patients from HAls, CDC's Targeted Assessment for Prevention 
(TAP) strategy allows state agencies, hospitals, and other NHSN users to focus prevention efforts on facilities and 
units within facilities with excess infections. A pilot of seven Quality Improvement Organizations partnering with 
CDC to focus catheter-associated urinary tract infections (CAUTI) prevention in low-performing facilities showed 
early success generating TAP reports and using facility assessment tools. 
• CDC released updated estimates of the national HAI burden in acute care hospitals following a multistate 
prevalence survey of HAls and antibiotic use which estimated the full spectrum of HAls, identifying where to 
focus prevention efforts. CDC also released the National and State Healthcare-Associated Infection Progress 
Report showing how each state and the country as a whole are doing in eliminating six of the most common HAls. 
CDC continues to promote these data to inform national, state, and local efforts to protect patients across the 
healthcare spectrum. 
• As a part of the effort to promote stewardship to fight antibiotic resistance, CDC issued Vital Signs: Improving 
Antibiotic Use Among Hospitalized Patients as a call to action and is working with partners to help hospitals 
establish stewardship programs through practical implementation tools that include Core Elements of Hospital 
Antibiotic Stewardship Programs and a self-assessment checklist. 
• CDC continues to promote the role of health departments to assist healthcare facilities in detecting and preventing 
the spread of HAls and AR pathogens. In 2014, CDC supported implementation of the regional collaborative 
approach in 12 states (i.e. Illinois, Vermont, Wisconsin) to control the spread of healthcare-associated multidrug-
resistant organisms (MDRO) between healthcare facilities. The Wisconsin/Milwaukee Health Department 
prevention activity used NHSN to track AR data and focus prevention in all acute care and long term care facilities 
in the state. 
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Healthcare-Associated Infections (HAI) 
Progress to Date 
Trends in central line-associated blood stream infections 
(CLABSI) in hospitals, 2006-2013 
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Trends in healthcare-associated invasive methilicillin-resistant 
Staphylococcus aureus (MRSA) infections, 2007-2013 
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Healthcare-Associated Infections (HAI) 
Progress to Date 
Trends in surgical site infections (SSI) in hospitals, 2006-2013 
1.2 
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Trends in catheter-associated urinary tract infections (CAUTI) 
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MOTOR VEHICLE SAFETY 
Keep people safe on the road — everyday 
Key Strategies 
• Improve proper restraint use (including seat belts, 
car seats, and booster seats) 
• Prevent crashes and injuries among vulnerable 
populations, including teens, older adults, American 
Indians and Alaska Natives 
• Reduce alcohol-impaired driving 
• Develop and communicate occupational 
motor vehicle injury prevention and protection 
information to manufacturers, employers, workers, 
and others who need it 
Key Highlights 2014 
• Released in October 2014, MV PICCS (Prioritizing Interventions and Cost Calculator for States) is an on-line 
interactive calculator that can help state decision makers prioritize and select motor vehicle injury prevention 
strategies from a suite of 12 effective interventions that are not in widespread use. MV PICCS calculates the 
expected number of injuries prevented and lives saved at the state level, as well as the costs of implementation, 
while taking into account the state's available resources. 
• State specific fact sheets on restraint use and drunk driving were created and broadly disseminated. The fact 
sheets detail the state-level public health burden for both topics and successful strategies for reducing the burden. 
• Employer and worker information was prepared and broadly disseminated on motor vehicle safety to employers 
and workers at high risk for motor vehicle crashes. Information included a pamphlet to inform truckers on the 
importance of quality sleep to prevent drowsy driving, and an article that describes how employers can develop 
effective motor vehicle safety programs using a consensus-based standard influenced by CDC science. 
• Four new standards were developed with partners to enhance safety in ambulance compartments to better 
withstand crashes and protect emergency medical service workers and patients. 
• CDC worked to expand work with tribal nations to identify specific risk behaviors associated with motor vehicle 
fatalities and to focus on opportunities to improve motor vehicle safety, decrease crashes, and reduce motor 
vehicle related fatalities. Video and online resources were created and updated. 
• An estimated 2,519,471 Emergency Department visits resulted from nonfatal crash injuries, which resulted in 
188,833 hospitalizations and an estimated $18.4 billion in lifetime medical costs and $32.9 billion in lifetime work 
loss costs, according to CDC Vital Signs on motor vehicle crash injuries released in October 2014. Primary seat belt 
laws, child passenger restraint laws, ignition interlocks to prevent alcohol impaired driving, sobriety checkpoints, 
and graduated driver licensing (GDL) systems have demonstrated effectiveness for reducing motor vehicle crashes 
and injuries. To date, no state has implemented all of these safety measures in accordance with evidence and 
expert recommendation. 
• Motor vehicle crash deaths among children age 12 and younger decreased by 43% from 2002-2011; however, 
still more than 9,000 children died in crashes during that period, according to CDC Vital Signs released on child 
passenger safety in February 2014. Of children who died in a crash, one in three was not buckled up, and more 
black and Hispanic children were not buckled compared with white children. CDC recommends that states and 
communities consider using proven strategies to increase car seat, booster seat, and seat belt use and reduce child 
motor vehicle deaths. 
• Sobriety checkpoint programs are effective, according to a systematic review released in conjunction with the 
Community Guide. However, in looking at the overall use of all sobriety checkpoints (not just those that are 
publicized or part of a program), 12 states do not allow them at all, and only one-third of the other states use them 
regularly. 
• Re-launched in October 2014, Parents Are the Key campaign provides information and tools for parents, 
pediatricians, and communities that focus on reducing teen driving-related injuries and deaths. Motor vehicle 
crashes are the leading cause of death among teens. Over 100,000 people have accessed the website and 40,000 
materials have been downloaded. 
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MOTOR VEHICLE SAFETY 
Progress to Date 
Trends in motor vehicle-related fatalities, 2007-2013 
15 
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TEEN PREGNANCY 
Reduce teen pregnancy and its contribution to the cycle of poverty for teens and 
their families 
Key Strategies 
• Monitor teen pregnancy/birth rates and prevention 
policies 
• Promote the delay of sexual initiation through 
evidence-based programs and social norm changes 
• Strengthen clinical services and improve the 
quality of care 
• Promote the use of effective contraceptive methods, 
including long-acting reversible contraception, by 
sexually active teens 
Key Highlights 2014 
• Recommendations for Providing Quality Family Planning (QFP) Services gives all providers of reproductive health 
services access to national, evidence-based guidance on family planning service delivery, including specific 
recommendations for serving adolescent clients. The recommendations were released in April 2014. 
• Working with partners, CDC developed and disseminated provider tools to support widespread understanding 
and use of the QFP Services, and the Medical Eligibility Criteria and Selected Practice Recommendations for 
Contraceptive Use. A training course for pediatricians to ensure they have the knowledge, skills and motivation to 
screen adolescents for sexual activity, and to counsel patients about contraception and other reproductive health 
matters, was developed and piloted with the America Academy of Pediatricians. 
• CDC worked to disseminate information and provide learning opportunities to support removing barriers to the 
use of Long Acting Reversible Contraceptives (LARC) including efforts to clarify the safety and effectiveness of 
LARC use among adolescent females and Medicaid reimbursement for immediate postpartum insertion of LARC. 
• CDC, in partnership with the Office of Adolescent Health (DAH), is providing funding to nine grantees to 
implement a community-wide initiative to reduce teen pregnancy and births in communities with the highest 
rates. Grantees have: 
• Reached over 19,000 youth with evidence-based interventions to prevent teen pregnancy, representing a 
four-fold increase from 2012. This exceeded the year three goal of 12,500. 
• Provided contraceptive and reproductive health services to over 50,000 individual adolescents through 
63 partner clinics. 
• Increased LARC coverage by 80% from 2011 among adolescent clients served by health center partners, 
particularly among African American and White adolescents between 15 and 19 years of age. 
• In January 2014, CDC initiated a systematic review to examine the body of evidence documenting observed 
health, economic, and social consequences of teenage pregnancy through systematic review and meta-analytic 
techniques. CDC met with economic experts and policy leaders (August 2014) to discuss and review the 
systematic review protocol. The review is expected to be completed in 2016. 
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TEEN PREGNANCY 
Progress to Date 
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HIV INFECTION 
Prevent new HIV infections and ensure quality health care for persons living with HIV 
• Educate all Americans about the threat of HIV and 
how to prevent it 
Key Strategies 
• Intensify HIV prevention efforts in communities 
where HIV is most heavily concentrated 
• Improve data monitoring, dissemination, and 
feedback 
• Maximize the proportion of people with HIV who 
have suppressed viral load by improving diagnosis, 
linkage and retention in care, and antiretroviral 
provision and adherence 
• Expand targeted efforts to prevent HIV infection 
using a combination of effective, evidence-based 
approaches for persons living with HIV and those at 
high risk of infection 
Key Highlights 2014 
• Released in 2014, the State HIV Prevention Progress Report (SPR) is the first annual report highlighting six HIV 
prevention and care indicators by providing state-level baseline information, baseline national average, and 2015 
national goals. The SPR provides an important opportunity to reflect on states' individual progress. It shows that 
the nation's HIV goals are achievable, but closing gaps between states will be critical. The next SPR is due to be 
released in fall 2015. 
• In April 2014, CDC released new resources to support the Data to Care strategy, which uses surveillance data to 
identify HIV-diagnosed people who are not engaged in care, to link or re-engage them with care and support the 
goal of viral suppression among all persons living with HIV. Included is a new Data to Care website which provides 
technical information to support state and local public health jurisdictions in their use of HIV surveillance data to 
support continuous, high-quality care for persons living with HIV. 
• In May 2014, the US Public Health Service and CDC released the first comprehensive clinical practice guidelines for 
pre-exposure prophylaxis (PrEP), which is a way for people who do not have HIV but who are at substantial risk of 
getting it to prevent HIV infection by taking a pill every day. 
• In June 2014, CDC and the Association of Public Health Laboratories (APHL) issued the Laboratory Testing for 
the Diagnosis of HIV Infection or HIV Testing Algorithm, which updates recommendations for HIV testing by 
laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and 
to public health authorities. 
• In December 2014, CDC, in collaboration with the HIV/AIDS Bureau at the Health Resources and Services 
Administration (HRSA), the National Institutes of Health (NIH), and five participating CDC partner organizations 
(American Academy of HIV Medicine, Association of Nurses in AIDS Care, International Association of Providers of 
AIDS Care, the National Minority AIDS Council, and Urban Coalition for HIV/AIDS Prevention Services), published 
Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States, 2014 which 
update and expand recommendations from 2003. The updated recommendations address recent advances in 
biomedical, behavioral and structural interventions and are directed to a broad range of health professionals and 
organizations focused on optimizing health outcomes for people with HIV and reducing their risk of exposing 
others to HIV. 
• Through its Act Against AIDS (MA) initiative, CDC raises awareness among patients, providers, and the public 
about HIV. Collectively, AAA efforts have reached millions of people through extensive ad placement, social media 
engagement, provider information kits and meetings, conferences and trainings. The following campaigns were 
launched in 2014: 
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▪ HIV Treatment Works is the first national communication campaign focused exclusively on encouraging 
treatment and care for people living with HIV (PLWH). 
• One Conversation at a Time is a national communication campaign that encourages Hispanics/Latinos to 
talk openly about HIV/AIDS with their families, friends, partners, and communities. 
I. 	Start Talking. Stop HIV seeks to reduce new HIV infections among gay, bisexual and other men who have 
sex with men (MSM) by encouraging open discussion about a range of HIV prevention strategies and related 
sexual health issues between sex partners. 
HIV INFECTION 
Progress to Date 
Trends in the number of new HIV infections, 2006-2010 
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RESOURCES UPDATE 
• Winnable Battles Web Site: Updated presentations with national and state data as well as recommended 
approaches and initiatives. Subscribers to the Winnable Battles web site receive a periodic "News You Can Use" 
eNews Blast that shares innovative practices, tools and strategies to inform public health work. 
• CDC Vital Signs: Each month, the CDC Vital Signs Program releases a call-to-action about an important public 
health topic, typically one of the Winnable Battles focus areas. Vital Signs uses the most recent CDC data on 
health behaviors and outcomes to create materials for key partners and the public and includes scientific papers, 
infographics, short videos, key messages and more. Vital Signs on Winnable Battles topics can be found at http:// 
www.cdc.gov/vitalsigns/ or www.cdc.gov/winnablebattles. The resources are free and available for download or 
print. 
• Virtual Town Hall Meetings: All public health professionals are invited to a town hall teleconference on the latest 
CDC Vital Signs report on the second Tuesday of each month at 2-3 pm (ET). Featuring informative subject matter 
experts and health department officials, the teleconferences are designed to provide a forum for health officials to 
broaden the conversation, build momentum, and carry out evidence-based, effective programs within the public 
health areas covered by Vital Signs. 
• Did You Know? (DYK): These quick bullet points are emailed to about 30,000 subscribers weekly to inform public 
health professionals and move CDC data and recommendations into action. Readers use DYK to educate their 
constituents; start, change, evaluate, or support programs, policies, and practices; and share with staff, community 
organizations, boards of health, leaders and decision makers, and others. DYK is also CDC's most popular 
syndicated content. 
• National Health Report: A dedicated web site at www.cdc.gov/healthreport offers a snapshot of our nation's 
health, highlighting recent successes and challenges in fighting critical health problems in the United States (U.S.). 
Up-to-date dashboards, resources, videos and printable fact sheets and infographics are available to assist in 
Winnable Battles work. 
• Prevention Status Report: In 2013, CDC released the second set of Prevention Status Reports (PSR) for all 50 
states and the District of Columbia, with information on key indicators of public health status, practice, and policy 
for each Winnable Battle area. Through the PSR, CDC is helping advance evidence-based policy and practice 
by sharing with health officials and other policy makers each state's status on key public health indicators and 
performance on key policy indicators. Public health leaders can use the PSRs to support public health planning, 
priority setting, and communications. Although the PSRs include data about public health problems, their primary 
focus is on policies and practices that can prevent or reduce health risk behaviors and lead to improved health 
outcomes. Posted at www.cdc.gov/psr, the free reports are available by topic or state. The next PSR is slated for 
release in 2015. 
• Sortable Stats: Free and available online, Sortable Stats is an interactive data set comprised of behavioral risk 
factors and health indicators. The online tool is used as a resource in the promotion of policy, system, and 
environmental changes. Its data set compiles state-level data for the 50 states, DC, and U.S. territories from various 
published CDC and federal sources into a format that allows users to view, sort, and analyze data at state, regional, 
and national levels. Sortable Stats recently expanded to include data on youth marijuana use and cancer deaths. 
http://wwwn.cdc.gov/sortablestats/  
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• Collaboration with partners: To maximize the impact of the Winnable Battles initiative, CDC works with partners at 
the national, state, and local levels, including the National Conference of State Legislatures (NCSL), the Association 
of State and Territorial Health Officials (ASTHO), and the National Association of County and City Health Officials 
(NACCHO). For example: 
• CDC supports and works with NCSL and ASTHO to bring together state policy makers to learn about 
Winnable Battles and share evidence-based interventions to address them. CDC also collaborated with NCSL 
to develop a Winnable Battle "toolkit" for states that outlines each Winnable Battle and includes examples 
of proven or promising strategies, policy options, and programs that have been effective in addressing 
Winnable Battles in other jurisdictions. 
• CDC works with NACCHO in support of Winnable Battles through overall product dissemination, technical 
assistance, evaluation, and communications. Working with CDC, NACCHO has developed messages and 
materials that assist local health departments in understanding their role in choosing and promoting 
Winnable Battles and provides communication and dissemination strategies for Winnable Battles materials 
and products. NACCHO developed a Winnable Battles web portal on its site, naccho.org, which features 
progress on a Winnable Battle each month. NACCHO also provides Winnable Battles-related resources, 
programs, tools, and policy guidelines via short articles in Public Health Dispatch and publicizes Winnable 
Battles-related news, information, and resources via e-communications and social media outlets, including 
NACCHO's blog, NACCHO Voice. 
For more information about Winnable Battles, visit http://www.cdc.gov/winnablebattles/.  
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This report offers practical dashboards that highlight 
America's recent progress in combatting the leading 
causes of death and key risk and protective factors 
impacting our nation's health. Progress for each 
indicator was assessed based on year-to-year (trend) 
data and the annualized percent change, though only 
baseline and the most current data are reported in the 
tables. Indicators with fewer than three data points 
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I. 	Progress in the Leading Causes of Death 
Since 2005, the rate of death has declined for all leading causes of death, except suicide. 
Trends in Age-Adjusted Death Rates (per 100,000 persons), 2005-2012 




1. Heart disease 216.8 170.5 
2. Cancers 185.1 166.5 
3. Chronic lower respiratory diseases 43.9 41.5 
4. Stroke 48.0 36.9 
5. Unintentional injuries 39.5 39.1 
6. Alzheimer's disease 24.0 23.8 
7. Diabetes 24.9 21.2 
8. Pneumonia and influenza 21.0 14.4 
9. Kidney disease 14.7 13.1 
10. Suicide 10.9 12.6 
Trend in wrong direction 
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Percentage of Deaths by Cause, 2012 
• Heart disease 
• Cancer 









The ten leading causes of death are responsible for three-quarters of all deaths in the U.S. 


































































Life Expectancy and Premature Death 
We have reached an all-time-high life expectancy in the U.S., due in part to improvements in the prevention and 
control of key diseases. Americans are living longer, with declines in premature mortality across most of the 
leading causes of death. 
Trends in Key Indicators of Life Expectancy and Premature Death, 2005-2012 





Life expectancy at birth, in years 77.6 78.8 
Premature Death 
Number of premature deaths (before age 80) 1,365,816 1,389,330 
Years of Potential Life Lost' 
Total years of potential life lost before age 75 
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Trends in Life Expectancy and Years of Potential Life Lost (YPLL) 
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Life Expectancy 	 YPLL 
Years of potential life lost (YPLL) is a measure of the extent of premature mortality in a population. This estimate is based on the 
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II. 	Focus on the Top Five Leading Causes of Death 
1. 	Heart Disease (#1) and Stroke (#4) 
Every hour in the U.S., about 83 Americans die from heart disease and stroke. More than a quarter of these 
deaths could have been prevented or delayed with better control of key risk factors (below) and health-promoting 
behaviors, including physical activity, healthy diet and avoiding tobacco use (see Sections V.1 and V.2). 
Trends in Heart Disease, Stroke and Key Risk and Protective Factors 
Key Indicator Baseline Status 
Heart Disease 2005 2012 
Age-adjusted death rate from heart disease 216.8 170.5 
Stroke 2005 2012 
Age-adjusted death rate from stroke 48.0 36.9 
Select Risk Factors 2006 2012* 
Aspirin Use: Percent of high-risk adults (post event/ 






Blood Pressure Control: Percent of adults with high blood 
pressure who have it controlled (<140/90) 
Cholesterol Control: Percent of adults with 
high LDL-Cholesterol who have it controlled 
Sodium Intake: Daily amount of sodium (mg) consumed 
in food, per person (ages 2+) 3,436 3,463 (2010) 
Progress 
• 
El Trend in wrong direction 
* Unless otherwise noted. 
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2. Cancer 
Recent years have brought advances in the prevention and control of cancers, including a first-ever vaccine 
against HPV-related cancers. Yet vaccine coverage levels fall well below that of other countries and other 
routine adolescent vaccines in the U.S., putting future generations at risk. At the same time, declining rates of 
recommended cancer screenings among women are cause for concern. 
Trends in Cancer and Related Protective Factors 
Key Indicator 	 Baseline 	Status 	 Progress 
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Percent of women (ages 50-74) receiving a 
mammogram, past 2 years (age-adjusted) 
81.6% 
Percent of adults (ages 50-75) receiving recommended 	60.9% 
colorectal cancer screening (age-adjusted) 	 (2008) 
Percent of women (ages 21-65) receiving a Pap test, 











2008 	 2013 
Percent of adolescent girls (13-15years) receiving 3 
doses of HPV vaccine 
16.6% 	32.7% 
Trend in wrong direction 
'Unless otherwise noted. 
Insufficient Progress 	 Progress 
Missed Opportunities in Cancer Prevention 
• • • 	 people at-risk for colon 4 . 
linj  cancer are not getting 
recommended screening 
women at-risk for breast 
1in5  cancer are not getting recommended screening 
women at-risk for cervical 
cancer are not getting 
recommended screening 
• • • 	 teen girls have not 
2in3 received full HPV vaccine series 
If current trends continue, cancer will soon surpass heart disease as the leading cause of death in the U.S. 
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3. Chronic Lower Respiratory Diseases 
Chronic lower respiratory diseases, primarily chronic obstructive pulmonary diseases (CORD) such as 
emphysema and chronic bronchitis, became the 3rd leading cause of death in 2008. 
Trends in Chronic Lower Respiratory Diseases and Select Risk Factors 
Key Indicator Baseline 
2005 
Status 	 Progress 
2012* 
Age-adjusted death rate (per 100,000) from 
chronic lower respiratory diseases 
43.9 41.5 
Select Risk Factors 
Number of hospitalizations for asthma 489,000 439,000 (2010) 
25.2% Percent of adults who are current smokers 
(cigarettes/cigars/pipes) 
28.0% 
MI Trend in wrong direction 	 Insufficient Progress 
	
Progress 
* Unless otherwise noted. 
Despite slightly declining death rates, the number of deaths from these conditions is on the rise, as our nation's 
older population grows. It will remain a concern in the years to come. 
COIN)" 
by 2020: 
expected cost of medical 
care for adults with COPD 
will be more than 
$90 BILLION „ 
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4. Unintentional Injuries 
While we have made great progress in reducing motor-vehicle fatalities in recent years, deaths from other types 
of injury have been on the rise. Drug overdoses, particularly from prescription painkillers, now kill as many 
as 46 people each day in the U.S. Deaths from falls among older persons have also increased, as our aging 
population grows. Together, drug poisonings (of any intent) and older-adult falls claimed more than 18,500 
additional lives in 2012, compared to 2005. 
Trends in Unintentional Injuries 




All unintentional injuries (motor-vehicle crashes, falls 
among older adults, and drug poisonings) 
39.5 39.1 
• Motor vehicle 15.2 11.4 
• Drug poisonings (any intent) 10.1 13.1 
• Older adult falls (age 65+) 42.3 55.3 
11 Trend in wrong direction 	 Insufficient Progress 
	 411, Progress 
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III. Other Leading Causes of Death 
Each of these five diseases or conditions accounts for 3% or less of all deaths, but together they claimed 
the lives of nearly 300,000 people in 2012 alone. We have effective prevention and control strategies for 
most of these conditions, but they must be adopted by populations most in need. We can do better in helping 
individuals control key risk factors for diabetes and kidney disease (see Sections 111.1, V.1 and V.2), and get 
vaccinated against flu. 
Trends in Other Leading Causes of Death and Related Risk and Protective Factors 




6. Alzheimer's Disease 








Percent of adults with diabetes with an Al c value >9% 
(age-adjusted) 17.9% (2008) 21.0% 
8. Pneumonia and Influenza 
Age-adjusted death rate (per 100,000 persons) from 
pneumonia and influenza 
21.0 14.4 
Influenza Vaccination 
Percent of children ages 6 months-17 years receiving 
>1 dose of influenza vaccine per influenza season 43.7% (2009) 56.6% 
Percent of adults receiving influenza vaccination 






Percent of health-care personnel receiving influenza 







9. Kidney Disease 
Age-adjusted death rate (per 100,000 persons) from 
kidney disease 
10. Suicide 
Age-adjusted death rate (per 100,000 persons) from 
suicide 
IllTrend in wrong direction 
	
Insufficient Progress 	 . Progress 





















Percent of adults who are current cigarettes, 
cigars, or pipe smokers (age-adjusted) 
Percent of high school students who are current 
cigarette smokers 














IV. 	KEY CONTRIBUTORS TO THE NATION'S HEALTH 
1. Tobacco Use 
Smoking is the leading preventable cause of disease and death in the U.S., responsible for about 1 in every 5 
deaths. It puts smokers and those exposed to secondhand smoke at risk for serious health problems, including 
heart attack, stroke, lung cancer and many other cancers. Although fewer Americans are smoking and they are 
smoking less than in previous years, continued efforts are needed, when as many as one-quarter of adults and 
nearly 1 in 6 youth are still smoking. 
Trends in Tobacco Use and Exposure 
II Trend in wrong direction 
	
Insufficient Progress 	 40 Progress 
* Unless otherwise noted. 
SMOKIN 
Human immunodeficiency virus (HIV) 
Illegal drug use 
Alcohol use 
Motor vehicle injuries 
causes more dea s eac year 	Microbial agents 
than all of these combined: 	Toxic agents 




Pulmonary blood clots 
	• Heart disease 
Diabetes 
Abnormal lipid profile 
High blood pressure 
Pancreatitis Liver disease 
Fatty liver 
Cirrhosis 













	• Inflamed veins. 
often with blood clots 
	• Gout 





Medical Complications of Obesity 
Sleep apneas 	• Stroke 
and snoring 
9 
2. Healthy Weight 
Obesity puts individuals at risk for many of the leading causes of death, including heart disease, stroke, some 
types of cancer, respiratory diseases, diabetes and kidney disease. Despite progress in some areas, our nation 
falls far short of healthy physical-activity and dietary-consumption levels, leaving more than a third of adults 
obese. Obesity costs the U.S. about $147 billion in medical expenses each year. 
Trends in Obesity and Key Risk and Protective Factors 




Percent of adults (ages 20+) who are obese 34.3% 34.9% 
Percent of youth (ages 2-19) who are obese 15.4% 16.9% 
Behavioral Risk or Protective Factors 
Physical Activity 2005 2013 
Percent of adults who met the federal physical activity 
guidelines 
16.6% 20.7% 
Percent of high school students who are physically 
active at least 1 hour a day, seven days a week 
17.9% 27.1% 
Nutrition 2006 2010 
Average daily fruit intake (per 1,000 calories 
consumed) per person (ages 2+) 
0.5 cups 0.6 cups 
Average daily vegetable intake (per 1,000 calories 
consumed) per person (ages 2+) 
0.8 cups 0.8 cups 
3. Maternal and Child Health 
We have reached historically low infant-mortality and teen-birth rates in the U.S. and made great strides in 
increasing infant vaccination and breastfeeding rates. Yet half of infants are still not breastfed and as many as 
1 in 16 new mothers in the U.S. are teens, putting the health of future generations at risk. 
Trends in Maternal and Child Health, Risk and Protective Factors 





Infant Death Rate (< 1 year) 6.9 
28,440 
6.0 
23,629 Number of Infant Deaths 
Teen Births 
Rate of teen births among females ages 15 to 19 








Percent of children (19-35 months) receiving universally 
recommended doses of vaccines (DTaP, polio, MMR, Hib, 






Number of children ages 1 to 5 with blood lead levels greater 









III Trend in wrong direction 
	
Insufficient Progress 	 •Progress 
* Unless otherwise noted. 
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4. Infectious Diseases 
a. 	Sexually Transmitted and Bloodbome Infections 
Despite progress in curbing HIV transmission, nearly 50,000 people still acquire HIV each year, and 1 in 6 
persons who have it are unaware of their infection. Chlamydia and Hepatitis C tend to be under-diagnosed, but 
increased screening efforts have identified more cases in recent years, leading to higher case rates. Despite 
this, deaths from hepatitis C are expected to rise in the coming decades, as many individuals (who remain 
undiagnosed and untreated) grow older and develop serious complications. 
Trends in Select Sexually Transmitted and Bloodborne Infections 
Key Indicator B4sellrie 
HIV 2006 2010 
Number of new HIV infections in the U.S. 






Rate of HIV transmission among adolescents and 
adults (per 100 persons, age 13+, who have HIV) 
Percent of people living with HIV who know their 
serostatus (persons ages 13+) 
84.2% 
Chlamydia 2005 2012 
Rate of chlamydia in women ages 15-19 
(per 100,000 population) 
2733 3291.5 
Rate of chlamydia in women ages 20-24 
(per 100,000 population) 
2667.9 3695.5 
Hepatitis C 2005 2011* 
Number of new cases of hepatitis C 694 1,778 (2012) 
17,721 Number of hepatitis C deaths 11,849 
• Trend in wrong direction 
	
Insufficient Progress 	 Progress 
" Unless otherwise noted. 
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people in the U.S. 
are living with HIV 
do not know 
1  in6  they are infected 
11 









estimated annual cost 
of preventable health 
care expenditures from 
healthcare-associated 
infections 
b. 	Healthcare-Associated Infections 
Healthcare-associated infections affect about 1 in 25 hospital patients, resulting in roughly 75,000 deaths 
each year. Whereas improvements have been made in reducing many infections, most notably surgical-site 
and central line-associated bloodstream infections; catheter-associated urinary tract infections (CAUTIs) have 
reached historically high rates, signaling a need for more aggressive and focused CAUTI prevention measures. 









Central line-associated blood stream infection 
(CLABSI), standardized infection ratio (SIR)1  








Hospital admission and readmission due to 
surgical-site infections (SSI), SIR 
Hospital onset of Clostridium difficile 
(C. difficile), SIR 
Incidence of healthcare-associated invasive 
Meth icill in-resistant Staphylococcus aureus 
(MRSA) infections (rate per 100,000 persons) 
	
1.00 	 0.8 
	
40 
1.00 (2011) 	 0.98 	 N/A 
27.08 	 18.74 
	 • 
MI Trend in wrong direction 	 Insufficient Progress 
	
•  Progress 
* Unless otherwise noted. 
' The Standardized Infection Ratio (SIR) is calculated by dividing the actual (observed) infections by the expected infections using data 
gathered through the CDC National Healthcare Safety Network (NHSN). 
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c. 	Foodbome Illnesses 
Each year, there are about 1,000 foodborne illness outbreaks caused by foods contaminated with bacteria 
such as Listeria, Salmonella and E. co/i. These illnesses sicken 1 out of 6 Americans and cause 3,000 deaths 
annually. Despite progress in reducing Listeria infections, there have been slight increases in Salmonella and 
E. coil infections — signaling the need for more work in these areas. 
Trends in Food-Borne Illnesses 
Key Indicator 	 2005 	 2013* 	Progress 
Rate of Listeria infection in the population 
(cases per 100,000 population)  
Rate of Salmonella infection in the population 
(cases per 100,000 population) 
Rate of Salmonella serotype Enteritidis (SE) infection 
in the population (cases per 100,000 population) 
Rate of Shiga toxin-producing Escherichia coil 
(STEC) 0157 infection in the population 







11 Trend in wrong direction 
	
Insufficient Progress 	 • Progress 
* 2013 data are preliminary and reflects the most currently available data, unless otherwise noted. 
Antibiotic Resistance Threatens our Ability to Fight Infectious Diseases 
0.29 0.26 
Each year, antibiotic 
resistance causes 
more than 
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Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry 
FY 2008-2018 Non-Pay Obligations by Program 
FY 2008 	FY 2009 	FY 2010 	FY 2011 	FY 2012 	FY 2013 FY 2014 
	
FY 2015 FY 2016 FY 2018 
  
(b)(6) 
SS,D57_I 1 	..3Q0.5i38 	55,36E1.1* S5,104936 .i5,?/.)5,a39 	S5,4134.2.45 	$5,362,779 	.12.5-,egE 	5:5-13S.4 
1. Immunization & Respiratory 
Diseases 
21 - 21 - Travel & Transportation of 
N/A N/A N/A N/A 	$515,274 	$500,778 	$701,929 	$722,398 	$722,398 
Persons 	 N/A 	N/A 	N/A 	N/A 	$3,280 	$2,600 	$2,901 	$2,859 	$2,859 
22- Transportation of Things 
	
N/A 	N/A 	N/A 	N/A 	$782 	$818 	$624 	$794 	$794 
23 - Rent, Telecommunication, 
Other Comm & Utilities 
	
N/A 	N/A 	N/A 	N/A 	$6,962 	$3,326 	$3,006 	$1,428 	$1,428 
24- Printing & Reproduction 	 N/A 	N/A 	N/A 	N/A 	$156 	$56 	$60 	$62 	$62 
25 - Consulting & Other Services 	N/A 	N/A 	N/A 	N/A 	$115,022 	$97,014 	$228,727 	$226,503 	$226,503 
26- Supplies & Materials 	 N/A 	N/A 	N/A 	N/A 	$95,535 	$109,858 	$97,410 	$86,053 	$86,053 
31 - Equipment 	 N/A 	N/A 	N/A 	N/A 	$2,022 	$3,314 	$3,914 	$5,494 	$5,494 
41 - Grants 	 N/A 	N/A 	N/A 	N/A 	$291,515 	$283,792 	$365,286 	$399,205 	$399,205 
42 - Insurance Claims 	 N/A 	N/A 	N/A 	N/A 	$ - 	$ - 	$20 	$0 	 $0 
2. HIV/AIDS, Viral Hepatitis, 
Sexually Transmitted Diseases & TB 
Prevention 	 N/A 	N/A 	N/A 	N/A 	$937,203 	$881,732 	$950,631 	$950,133 	$950,133 
21 - Travel & Transp. of Persons 	N/A 	N/A 	N/A 	N/A 	$4,304 	$3,330 	$3,481 	$3,763 	$3,763 
22- Transportation of Things 	 N/A 	N/A 	N/A 	N/A 	$592 	$599 	$582 	$583 	$583 
23 - Rent, Comm & Utilities 	 N/A 	N/A 	N/A 	N/A 	$1,483 	$916 	$793 	$674 	$674 
24- Printing & Reproduction 	 N/A 	N/A 	N/A 	N/A 	$503 	$486 	$418 	$386 	$386 
25 - Consulting & Other Services 	N/A 	N/A 	N/A 	N/A 	$147,655 	$136,639 	$191,977 	$185,367 	$185,367 
26- Supplies & Materials 	 N/A 	N/A 	N/A 	N/A 	$5,036 	$4,406 	$5,629 	$4,457 	$4,457 
31 - Equipment 	 N/A 	N/A 	N/A 	N/A 	$1,988 	$3,062 	$7,087 	$5,744 	$5,744 
41 - Grants 	 N/A 	N/A 	N/A 	N/A 	$775,629 	$732,258 	$740,664 	$749,059 	$749,059 
42 - Insurance Claims 	 N/A 	N/A 	N/A 	N/A 	$14 	$36 	$ - 	$100 	$100 
3. Emerging & Zoonotic Infectious 
Diseases 	 N/A 	N/A 	N/A 	N/A 	$146,222 	$141,390 	$279,008 	$300,225 	$451,225 
21 - Travel & Transp. of Persons 	N/A 	N/A 	N/A 	N/A 	$3,564 	$3,386 	$3,349 	$3,859 	$3,859 
22- Transportation of Things 	 N/A 	N/A 	N/A 	N/A 	$987 	$880 	$923 	$960 	$960 
23 - Rent, Comm & Utilities 	 N/A 	N/A 	N/A 	N/A 	$1,300 	$928 	$1,040 	$1,029 	$1,029 
24- Printing & Reproduction 	 N/A 	N/A 	N/A 	N/A 	$521 	$305 	$250 	$412 	$412 
Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry 
FY 2008-2018 Non-Pay Obligations by Program 
FY 2008 	FY 2009 	P12010 	FY 2011 	P12012 	FY 2013 	FY 2014 	P12015 	FY 2016 	FY 2018 
(b)(6) 
25 - Consulting & Other Services 
	
N/A N/A N/A N/A $59,276 $53,220 $132,070 	$137,969 	$168,969 














$12,271 	$14,005 	$14,005 














$11,917 	$7,743 	$7,743 














$117,188 	$134,139 	$254,139 












$ - 	$110 	$110 
4. Chronic Disease Prevention & 
Health Promotion 	 N/A 	N/A 	N/A 	N/A 	$647,043 	$626,369 	$1,059,235 $1,066,253 	$1,066,253 
21- Travel & Transp. of Persons 	N/A 	N/A 	N/A 	N/A 	$3,158 	$2,412 	$2,649 	$2,914 	$2,914 
22- Transportation of Things 	 N/A 	N/A 	N/A 	N/A 	$153 	$180 	$210 	$101 	$101 
23 - Rent, Comm & Utilities 	 N/A 	N/A 	N/A 	N/A 	$1,816 	$349 	$349 	$364 	$364 
24- Printing & Reproduction 	 N/A 	N/A 	N/A 	N/A 	$548 	$427 	$436 	$318 	$318 
25 - Consulting & Other Services 	N/A 	N/A 	N/A 	N/A 	$119,816 	$119,575 	$288,946 	$301,095 	$301,095 
26- Supplies & Materials 	 N/A 	N/A 	N/A 	N/A 	$1,213 	$975 	$852 	$901 	$901 
31 - Equipment 	 N/A 	N/A 	N/A 	N/A 	$2,758 	$1,159 	$2,016 	$2,472 	$2,472 
41 - Grants 	 N/A 	N/A 	N/A 	N/A 	$517,579 	$501,279 	$763,771 	$757,471 	$757,471 
42- Insurance Claims 	 N/A 	N/A 	N/A 	N/A 	$1 	 $12 	$5 	 $615 	$615 
5. Birth Defects, Developmental 
Disabilities, Disabilities & Health 	N/A 	N/A 	N/A 	N/A 	$106,740 	$98,551 	$101,746 	$103,236 	$103,236 
21 - Travel & Transp. of Persons 	N/A 	N/A 	N/A 	N/A 	$748 	$626 	$554 	$543 	$543 
22- Transportation of Things 	 N/A 	N/A 	N/A 	N/A 	$36 	$29 	$48 	$48 	$48 
23 - Rent, Comm & Utilities 	 N/A 	N/A 	N/A 	N/A 	$126 	$77 	$79 	$88 	$88 
24- Printing & Reproduction 	 N/A 	N/A 	N/A 	N/A 	$253 	$207 	$226 	$482 	$482 
25 - Consulting & Other Services 	N/A 	N/A 	N/A 	N/A 	$27,375 	$24,607 	$37,077 	$35,753 	$35,753 
26- Supplies & Materials 	 N/A 	N/A 	N/A 	N/A 	$589 	$426 	$300 	$602 	$602 
31 - Equipment 	 N/A 	N/A 	N/A 	N/A 	$205 	$336 	$196 	$242 	$242 
41 - Grants 	 N/A 	N/A 	N/A 	N/A 	$77,408 	$72,243 	$63,268 	$65,477 	$65,477 
6. Environmental Health 	 N/A 	N/A 	N/A 	N/A 	$70,354 	$65,046 	$138,545 	$136,180 	$136,180 
21- Travel & Transp. of Persons 	N/A 	N/A 	N/A 	N/A 	$880 	$675 	$741 	$1,065 	$1,065 
22- Transportation of Things 	 N/A 	N/A 	N/A 	N/A 	$176 	$168 	$208 	$230 	$230 
23 - Rent, Comm & Utilities 	 N/A 	N/A 	N/A 	N/A 	$595 	$85 	$82 	$99 	$99 
Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry 
FY 2008-2018 Non-Pay Obligations by Program 
  
   
FY 2008 	FY 2009 	FY 2010 	FY 2011 	FY 2012 	FY 2013 	FY 2014 	FY 2015 	FY 2016 	FY 2018 
24- Printing & Reproduction 
	
N/A N/A 	N/A 	N/A 	$46 	$37 	$19 	$16 
	
$16 




N/A 	N/A 	N/A 	$24,568 	$23,162 	$56,333 	$57,122 
	
$57,122 




N/A 	N/A 	N/A 	$3,053 	$3,801 	$4,048 	$4,169 
	
$4,169 




N/A 	N/A 	N/A 	$6,569 	$4,401 	$8,415 	$5,510 
	
$5,510 




N/A 	N/A 	N/A 	$ - 	$ - 	$ - 	$24 
	
$24 




N/A 	N/A 	N/A 	$34,466 	$32,712 	$68,699 	$67,875 
	
$67,875 




N/A 	N/A 	N/A 	$ - 	$4 	 $ - 	$70 
	
$70 




N/A 	N/A 	N/A 	$110,612 	$102,633 	$121,266 	$138,722 
	
$200,322 




N/A 	N/A 	N/A 	$632 	$497 	$539 	$600 
	
$600 




N/A 	N/A 	N/A 	$30 	$18 	$13 	$17 
	
$17 




N/A 	N/A 	N/A 	$144 	$91 	$105 	$92 
	
$92 




N/A 	N/A 	N/A 	$260 	$176 	$173 	$97 
	
$97 




N/A 	N/A 	N/A 	$26,794 	$22,996 	$31,652 	$38,726 
	
$45,726 




N/A 	N/A 	N/A 	$161 	$101 	$130 	$143 
	
$143 




N/A 	N/A 	N/A 	$128 	$142 	$730 	$644 
	
$644 




N/A 	N/A 	N/A 	$82,463 	$78,611 	$87,916 	$98,402 
	
$153,002 




N/A 	N/A 	N/A 	$ - 	$ - 	$6 	 $ - 
	 0 




N/A 	N/A 	N/A 	$220,257 	$218,495 	$296,418 	$296,198 	$296,198 




N/A 	N/A 	N/A 	$3,096 	$2,697 	$3,199 	$3,770 	$3,770 




N/A 	N/A 	N/A 	$398 	$404 	$464 	$619 	$619 




N/A 	N/A 	N/A 	$4,804 	$6,374 	$5,888 	$5,293 	$5,293 




N/A 	N/A 	N/A 	$648 	$557 	$489 	$418 	$418 




N/A 	N/A 	N/A 	$149,414 	$147,637 	$223,416 	$226,243 	$226,243 




N/A 	N/A 	N/A 	$1,408 	$951 	$971 	$1,127 	$1,127 




N/A 	N/A 	N/A 	$2,935 	$7,530 	$6,363 	$5,362 	$5,362 




N/A 	N/A 	N/A 	$57,541 	$52,346 	$55,609 	$53,181 	$53,181 
42 - Insurance Claims 	 N/A 	N/A 	N/A 	N/A 	$12 	$ - 	$20 	$185 	$185 
9. National Institute for 
Occupational Safety & Health 	 N/A 	N/A 	N/A 	N/A 	$166,303 	$158,677 	$204,870 	$205,275 	$205,275 
 
(b)(6) 
Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry 
FY 2008-2018 Non-Pay Obligations by Program 
FY 2008 P12009 P12010 FY 2011 P12012 FY 2013 P12014 P12015 FY 2016 P12018 
21 - Travel & Transp. of Persons N/A N/A N/A N/A $4,050 $3,626 $3,466 $3,902 $3,902 (b)(6) 
22- Transportation of Things N/A N/A N/A N/A $800 $747 $713 $808 $808 
23 - Rent, Comm & Utilities N/A N/A N/A N/A $4,369 $3,611 $3,723 $3,955 $3,955 
24 - Printing & Reproduction N/A N/A N/A N/A $239 $176 $71 $114 $114 
25 - Consulting & Other Services N/A N/A N/A N/A $45,661 $44,497 $86,985 $86,422 $86,422 
26- Supplies & Materials N/A N/A N/A N/A $5,131 $5,040 $4,617 $4,830 $4,830 
31 - Equipment N/A N/A N/A N/A $8,296 $7,650 $7,247 $8,424 $8,424 
41 - Grants N/A N/A N/A N/A $97,754 $93,331 $98,049 $96,819 $96,819 
42 - Insurance Claims N/A N/A N/A N/A $2 $0 $0 $1 $1 
10. Global Health N/A N/A N/A N/A $226,144 $210,464 $261,661 $313,804 $313,804 
21 - Travel & Transp. of Persons N/A N/A N/A N/A $15,840 $13,051 $12,632 $21,443 $21,443 
22 - Transportation of Things N/A N/A N/A N/A $3,283 $2,255 $2,285 $3,152 $3,152 
23 - Rent, Comm & Utilities N/A N/A N/A N/A $7,872 $7,989 $5,185 $6,298 $6,298 
24 - Printing & Reproduction N/A N/A N/A N/A $88 $75 $347 $108 $108 
25 - Consulting & Other Services N/A N/A N/A N/A $45,514 $38,299 $75,331 $101,032 $101,032 
26- Supplies & Materials N/A N/A N/A N/A $3,452 $2,858 $2,746 $3,175 $3,175 
31 - Equipment N/A N/A N/A N/A $3,525 $1,912 $2,431 $4,478 $4,478 
32 - Land & Structure N/A N/A N/A N/A $ 	- $162 $10 $ 	- $ 	- 
41 - Grants N/A N/A N/A N/A $146,572 $143,854 $160,688 $174,109 $174,109 
42 - Insurance Claims N/A N/A N/A N/A $ 	- $11 $7 $9 $9 
11. Public Health Preparedness & 
Response N/A N/A N/A N/A $1,171,885 $1,151,563 $1,297,036 $1,248,739 $1,248,739 
21 - Travel & Transp. of Persons N/A N/A N/A N/A $3,886 $3,332 $3,549 $3,470 $3,470 
22- Transportation of Things N/A N/A N/A N/A $5,386 $2,752 $8,915 $3,471 $3,471 
23 - Rent, Comm & Utilities N/A N/A N/A N/A $2,006 $2,185 $2,245 $2,492 $2,492 
24- Printing & Reproduction N/A N/A N/A N/A $221 $119 $168 $189 $189 
25 - Consulting & Other Services N/A N/A N/A N/A $128,422 $163,766 $272,118 $272,553 $272,553 
26- Supplies & Materials N/A N/A N/A N/A $387,213 $370,767 $377,417 $326,427 $326,427 





































Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry 
FY 2008-2018 Non-Pay Obligations by Program 
FY 2008 	P12009 	FY 2010 	FY 2011 	P12012 	FY 2013 	P12014 	P12015 	FY 2016 	FY 2018 
(b)(6) 
N/A 	N/A 	N/A 	N/A 	$638,230 	$604,206 	$626,810 	$632,843 	$632,843 
N/A 	N/A 	N/A 	N/A 	$0 	 $2 
$5,092,113 $5,300,588 $5,366,336 $5,109,936 $1,430,825 $953,892 $390,717 
	
$44,151 	$54,529 	$54,750 	$46,349 	$10,827 	$11,263 	$12,211 
22- Transportation of Things 	 $21,689 	$13,849 	$13,905 	$13,864 	$7,356 	$4,715 	$1,121 
23 - Rent, Comm & Utilities 	 $23,340 	$68,676 	$97,793 	$55,310 	$40,711 	$41,588 	$7,274 
24- Printing & Reproduction 	 $9,418 	$8,320 	$8,768 	$4,903 	$464 	$427 	$426 
25 - Consulting & Other Services 	$1,231,450 $1,188,126 	$1,193,002 	$1,361,443 $600,273 	$406,326 	$152,436 
26- Supplies & Materials 	 $548,439 	$493,357 	$756,854 	$475,815 	$129,139 	$82,579 	$25,868 
31 - Equipment 	 $72,738 	$57,254 	$57,486 	$55,836 	$52,046 	$30,788 	$9,649 
32 - Land & Structure 	 $106,842 	$8,620 	$8,654 	$7,701 	$12,923 	$10,935 	$24 
41 - Grants 	 $3,033,943 $3,407,804 	$3,175,071 	$3,088,417 $577,069 	$365,044 	$181,691 
42 - Insurance Claims 	 $103 	$53 	$53 	$298 	$17 	$227 	$17 
13. Buildings and Facilities 	 N/A 	N/A 	N/A 	N/A 	$5,978 	$35,375 	$17,620 
22- Transportation of Things 	 N/A 	N/A 	N/A 	N/A 	$ - 	$2 	 $0 
23 - Rent, Comm & Utilities 	 N/A 	N/A 	N/A 	N/A 	$91 	$ - 	$22 
25 - Consulting & Other Services 	N/A 	N/A 	N/A 	N/A 	$3,720 	$26,799 	$10,792 
26- Supplies & Materials 	 N/A 	N/A 	N/A 	N/A 	$ - 	$24 	$55 
31- Equipment 	 N/A 	N/A 	N/A 	N/A 	$6 	 $565 	$2,256 
32 - Land & Structure 	 N/A 	N/A 	N/A 	N/A 	$2,161 	$7,985 	$4,495 
15. Toxic Substances & Disease 
Registry 	 N/A 	N/A 	N/A 	N/A 	$51,497 	$39,279 	$42,076 	$44,905 	$44,905 
21 - Travel & Transp. of Persons 	N/A 	N/A 	N/A 	N/A 	$713 	$394 	$409 	$522 	$522 
22- Transportation of Things 	 N/A 	N/A 	N/A 	N/A 	$25 	$52 	$26 	$37 	$37 
23 - Rent, Comm & Utilities 	 N/A 	N/A 	N/A 	N/A 	$263 	$4,568 	$111 	$126 	$126 
24 - Printing & Reproduction 	 N/A 	N/A 	N/A 	N/A 	$8 	 $12 	$7 	 $7 	 $7 
25 - Consulting & Other Services 	N/A 	N/A 	N/A 	N/A 	$29,318 	$16,506 	$22,654 	$25,124 	$25,124 
26 - Supplies & Materials 	 N/A 	N/A 	N/A 	N/A 	$321 	$361 	$183 	$104 	$104 
31 - Equipment 	 N/A 	N/A 	N/A 	N/A 	$784 	$1,025 	$367 	$317 	$317 
41 - Grants 
42 - Insurance Claims 
12. CDC Wide Activities and 
Program Support 
21 - Travel & Transp. of Persons 
Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry 
FY 2008-2018 Non-Pay Obligations by Program 
P12008 FY 2009 FY 2010 P12011 P12012 FY 2013 FY 2014 FY 2015 FY 2016 
32 - Land & Structure N/A N/A N/A N/A $ 	- $ 	- $ 	- $24 $24 
(b)(6) 
41 - Grants N/A N/A N/A N/A $20,057 $16,359 $18,320 $18,548 $18,548 
42 - Insurance Claims N/A N/A N/A N/A $9 $1 $ 	- $95 $95 
CDC/ATSDR Discretionary Total $5,092,113 $5,300,588 $5,366,336 $5,109,936 $5,806,339 $5,184,245 $5,862,779 $5,925,896 $6,138,496 
21 - Travel & Transp. of Persons $44,151 $54,529 $54,750 $46,349 $54,978 $47,889 $49,679 $59,240 $59,240 
22 - Transportation of Things $21,689 $13,849 $13,905 $13,864 $20,004 $13,620 $16,133 $12,601 $12,601 
23 - Rent, Comm & Utilities $23,340 $68,676 $97,793 $55,310 $72,540 $72,087 $29,901 $28,729 $28,729 
24 - Printing & Reproduction $9,418 $8,320 $8,768 $4,903 $3,955 $3,058 $3,088 $3,003 $3,003 
25 - Consulting & Other Services $1,231,450 $1,188,126 $1,193,002 $1,361,443 $1,522,828 $1,321,043 $1,810,513 $1,873,789 $1,911,789 
26- Supplies & Materials $548,439 $493,357 $756,854 $475,815 $643,322 $594,041 $532,499 $469,794 $469,794 
31 - Equipment $72,738 $57,254 $57,486 $55,836 $91,096 $69,256 $68,367 $61,250 $61,250 
32 - Land & Structure $106,842 $8,620 $8,654 $7,701 $15,084 $19,082 $4,529 $2,578 $2,578 
41 - Grants $3,033,943 $3,407,804 $3,175,071 $3,088,417 $3,382,434 $3,043,876 $3,347,959 $3,413,668 $3,588,268 
42 - Insurance Claims $103 $53 $53 $298 $98 $294 $111 $1,246 $1,246 
fi A 4,i.311,2fiC .'::.3,-str SSG .C. rCI 	1 C4.  
16. VACCINES FOR CHILDREN (VFC) 
PROGRAM N/A N/A N/A N/A $3,984,701 $3,590,899 $3,539,659 $3,828,163 $3,828,163 
21 - Travel & Transp. of Persons N/A N/A N/A N/A $99 $277 $293 $229 $229 
22 - Transportation of Things N/A N/A N/A N/A $163 $36 $17 $22 $22 
23 - Rent, Comm & Utilities N/A N/A N/A N/A $25,275 $9,908 $24 $114 $114 
24- Printing & Reproduction N/A N/A N/A N/A $19 $65 $61 $56 $56 
25 - Consulting & Other Services N/A N/A N/A N/A $84,782 $72,274 $96,089 $100,879 $100,879 
26- Supplies & Materials N/A N/A N/A N/A $3,791,324 $3,421,661 $3,356,793 $3,636,186 $3,636,186 
31 - Equipment N/A N/A N/A N/A $2 $1,411 $981 $9 $9 
32 - Land & Structure N/A N/A N/A N/A $ 	- $265 $ 	- $ 	- $ 	- 
41 - Grants N/A N/A N/A N/A $83,038 $85,002 $85,400 $90,669 $90,669 
17. Energy Employees Occupational 
Illness Compensation Program N/A N/A N/A N/A $47,652 $44,641 $47,584 $44,569 $44,569 
21 - Travel & Transp. of Persons N/A N/A N/A N/A $406 $247 $263 $298 $298 
22- Transportation of Things N/A N/A N/A N/A $9 $4 $4 $5 $5 
FY 2018 
Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry 
FY 2008-2018 Non-Pay Obligations by Program 
FY 2008 	P12009 	P12010 	FY 2011 	P12012 	FY 2013 	FY 2014 	P12015 	FY 2016 	FY 2018 
(b)(6) 
23 - Rent, Comm & Utilities 
	













































































18. WORLD TRADE CENTER HEALTH 


















































CDC/ATSDR Discretionary and 
Mandatory Level 	 $10,044,604 $9,073,141 	$9,708,299 	$10,085,314 $10,297,914 
Prior to FY 2012, CDC Discretionary funding was appropriated in a single account (annual 0943). For FY2008-2011, all discretionary obligations by object class are grouped in the "CDC 
Wide Activities and Program Support" account. 
2 Prior to FY 2012, CDC Mandatory funding data is not readily available. For FY 2016-2018, obligations are assume to remain level. 
Attachment I: List of testimony since 2009 
Page 212 
CDC Congressional Testimony 
Date 	 Testimony Title 	 Witness 	 Committee 




Senate Foreign Relations 
Subcommittee on Western 
Hemisphere, Transnational 
Crime, Civilian Security, 
Democracy, Human Rights, and 
Global Women's Issues 
    
6/14/2016 Combatting Superbugs. U.S. Public 	Beth Bell, MD, 	House Energy and Commerce 
Health Responses to Antibiotic 	 MPH 	 Subcommittee on Oversight and 
Resistance 	 Investigations 
4/14/2016 The Federal Perspective on the State of 




Senate Homeland Security and 
Governmental Affairs 
       
3/23/2016 CDC 24/7: On the Front Lines of 





Subcommittee on Labor, Health 
and Human Services, Education 
and Related Agencies 
      
3/2/2016 Examining the U.S. Public Health 
	
Thomas Frieden, House Energy and Commerce 




Committee, Subcommittee on 
Oversight and Investigations 
2/24/2016 The Zika Virus: Coordination of a Multi- 	Anne Schuchat, 	House Oversight and 
Agency Response 	 MD (RADM, 	Government Reform 
USPHS) 	 Subcommittee on 
Transportation and Public Assets 
2/24/2016 Zika Virus: Addressing_the Growing 




Senate Health, Education, Labor 
and Pensions Committee 
2/11/2016 Emerging health threats and the Zika 
supplemental request 
2/10/2016 The Global Zika Epidemic  
Thomas Frieden, Senate Committee on 
MD, MPH 	Appropriations, Subcommittee 
on Labor, Health and Human 
Services, Education and Related 
Agencies 
Thomas Frieden, House Foreign Affairs Joint 
MD, MPH 	Hearing of the Subcommittee on 
Africa, Global Health, Global 
Human Rights, and International 
Organizations, and the 





House Energy and Commerce 
Subcommittee on Health 
Thomas Frieden, Senate Committee on Homeland 
MD, MPH 	Security and Governmental 
Affairs 
12/8/2015 Drug Resistant Tuberculosis: The Next 
Global Health Crisis? 
11/19/2015 U.S. Public Health Preparedness for 
Seasonal Influenza: Has the Response 
Improved?  
5/1/2015 CDC's Role in the Federal Approach to 
Opioid Overdose Prevention  
4/15/2015 Update on the U.S. Public Health 
Response to the Ebola Outbreak  
3/25/2015 CDC 24/7: Keeping Americans Healthy, 
Safe, and Competitive 
2/26/2015 Medical and Public Health Preparedness 
and Response: Are We Ready for Future  
Threats?  
2/10/2015 The Reemergence of Vaccine-
Preventable Diseases: Exploring the 


















House Foreign Affairs 
Committee, Subcommittee on 
Africa, Global Health, Global 
Human Rights, and International 
Organizations 
House Energy and Commerce 
Committee, Subcommittee on 
Oversight and Investigations 
House Energy and Commerce 
Committee, Subcommittee on 
Oversight and Investigations 
House Committee on 
Appropriations, Subcommittee 
on Labor, Health and Human 
Services, Education and Related 
Agencies 
House Committee on 
Appropriations, Subcommittee 
on Labor, Health and Human 
Services, Education and Related 
Agencies  
Senate Health, Education, Labor 
and Pensions Committee 
Senate Health, Education, Labor 
and Pensions Committee 
2/3/2015 Examining the U.S. Public Health 




House Energy and Commerce 
Committee, Subcommittee on 
Oversight and Investigations 
   
11/19/2014 Examining Medical Product 
Development in the Wake of the Ebola 
Epidemic 
11/19/2014 Preparedness and Response to Public 
Health Threats: How Ready Are We?  
11/18/2014 Update on the U.S. Public Health 
Response to the Ebola Outbreak 
Thomas Frieden, House Energy and Commerce 
MD, MPH 	Committee, Subcommittee on 
Oversight and Investigations 
   
10/16/2014 Public Health Response to Ebola Thomas Frieden, House Energy and Commerce 
   
MD, MPH 
	
Committee Subcommittee on 
Oversight and Investigations 
Beth Bell, MD, 
MPH 












9/17/2014 Global Efforts to Fight Ebola  
9/16/2014 Ebola in West Africa: A Global Challenge 
and Public Health Threat 
8/7/2014 Combating the Ebola Threat 
7/22/2014 Coal Miners' Struggle for Justice: How 
Unethical Legal and Medical Practices 
Stack the Deck Against Black Lung 
Claimants 
7/16/2014 Review of CDC Anthrax Lab Incident 
5/15/2014 Ending Tobacco Use in the United States 
- Our Past, Present and Future 
5/7/2014 The President's Fiscal Year 2015 Budget 
4/29/2014 Examining the Growing Problems of 
Prescription Drug and Heroin Abuse 
11/6/2013 Aging, Transportation and Health  
House Committee on Foreign 
Affairs, Subcommittee on Africa, 
Global Health, Global Human 
Rights, and International 
Organizations 
Senate Committees on 
Appropriations and Health, 
Education, Labor and Pensions 
House Committee on Foreign 
Affairs, Subcommittee on Africa, 
Global Health, Global Human 
Rights, and International 
Organizations 
Subcommittee on Employment, 
Workplace Safety - Committee 
on Health, Education, Labor and 
Pensions — United States Senate 
House Energy and Commerce 
Subcommittee on Oversight and 
Investigations 
Senate Health, Education, Labor 
and Pensions Committee 
Dr. Tom Frieden Senate LHHS Appropriations 
Subcommttee 
Daniel Sosin, 	House Energy and Commerce 
MD, MPH., FACP Subcommittee on Oversight and 
Investigations 
Grant Baldwin, 	Special Committee on Aging U.S. 
PhD, MPH 	Senate 
Beth Bell, MD, 
MPH 
5/22/2013 Food and Drug Safety, Public Health, and Anne Schuchat, 
the Environment in China 	 MD (RADM, 
USPHS) 
9/24/2013 CDC's Portfolio to Detect Healthcare-
associated Infections and Protect 
Patients and Communities 
Health, Education, Labor and 
Pensions Committee - United 
States Senate 
Congressional-Executive 
Commission on China 
4/26/2013 Review of Federal Hydraulic Fracturing 
Research Activities  
Robin M. Ikeda, 
MD, MPH 
(RADM, USPHS) 
Subcommittees on Energy and 
Environment Committee on 
Science, Space and Technology 
U.S. House of Representatives 
   
4/23/2013 Meeting the Challenge of Drug-Resistant Thomas R. 
Diseases in Developing Countries 	Frieden, MD, 
MPH 
3/5/2013 CDC 24/7: Keeping Americans Healthy, 	Thomas R. 




Committee on Foreign Affairs 
Subcommittee on Africa, Global 
Health, Human Rights, & 
International Organizations 
United States House of 
Representatives 
Committee on Appropriations 
Subcommittee on Labor, Health 
and Human Services, Education 
and Related Agencies 
2/13/2013 Influenza: Perspective on Current 




Committee on Energy and 
Commerce Subcommittee on 
Oversight and Investigations, 
United States House of 
Representatives  
    
2/5/2013 The CDC investigation of Legionnaires' 
disease among patients at the VA 
Pittsburgh Healthcare System  
Lauri Hicks, DO House Committee on Veterans' 
Affairs Subcommittee on 
Oversight and Investigations, 
United States House of 
Representatives 
11/30/2012 Autism Spectrum Disorder 
 
Coleen A. Boyle, Committee on Oversight and 
PhD 	 Government Reform, United 
States House of Representatives 
11/15/2012 The CDC and Public Health Response to 	Beth Bell, MD, 
the 2012 Fungal Meningitis and Other MPH 
Infections Outbreak  
Health, Education, Labor, and 
Pensions Committee, United 
States Senate 
        
        
3/27/2012 Learning From the Upper Big Branch 	Jeffery L. Kohler, Committee on Education and 
Tragedy 	 PhD 	 the Workforce United States 
House of Representatives 
Christopher J. 
Portier, PhD 
William H. Dietz, 
MD, PhD 
Ali S. Khan, MD, 
MPH 
12/6/2011 Health Issues Associated with 
Contaminated Drywall 
10/12/2011 Food Marketing: Can "Voluntary"  
Government Restrictions Improve 
Children's Health?  
5/12/2011 Strengthening our Nation's Public Health 
Security through Medical  
Countermeasures and the Strategic 
National Stockpile  
5/3/2011 Sacred Obligation: Restoring Veteran 
Trust and Patient Safety 
Subcommittee on Consumer 
Protection, Product Safety, and 
Insurance Committee on 
Commerce, Science, and 
Transportation 
United States Senate 
Subcommittee on Health and 
Subcommittee on Commerce, 
Manufacturing, and Trade 
Committee on Energy & 
Commerce U.S. House of 
Representatives 
Subcommittee on Emergency 
Preparedness, Response and 
Communications Committee on 
Homeland Security U.S. House 
of Representatives 
Michael Bell, 	Committee on Veterans Affairs 
MD 	 U.S. House of Representatives 
9/29/2010 PEPFAR: From Emergency to  
Sustainability and Advances Against 
HIV/AIDS 
Thomas Frieden, Committee on Foreign Affairs, 
MD, MPH 	U.S. House of Representatives 
9/16/2010 Camp Leieune: Contamination and  




9/14/2010 Pending Public Health Legislation Ileana Arias, 
PhD 
9/8/2010 Protecting School—age Athletes From 
Sports-Related Concussion Injury 
Vikas Kapil, DO, 
MPH, FACOEM 
Subcommittee on Investigations 
and Oversight; Committee on 
Science and Technology United 
States House of Representatives 
Subcommittee on Health; 
Committee on Energy and 
Commerce United States House 
of Representatives 
Subcommittee on Health; 
Committee on Energy & 
Commerce U.S. House of 
Representatives 
7/21/2010 Are Agencies Playing It Safe and Secure:  
An Examination of Worker Protections  
Pre- and Post-Injury 
John Howard, 
MD, MPH, JD, 
LLM 
Subcommittee on Federal 
Workforce, Postal Service, and 
the District of Columbia 
Committee on Oversight and 
Government Reform — US House 
of Representatives 
    
6/29/2010 Examining the Continuing Needs of 
Communities Affected by 9/11  
John Howard, 	Committee on Health, 
MD, MPH, JD, Education, Labor and Pensions — 
LLM 	 United States Senate 
   
6/23/2010 Worker Health and Safety from the Oil 
Rig to the Shoreline 
6/16/2010 HHS Actions to Identify and Address 
Health Effects of the BP Oil Spill  
6/15/2010 Evaluating the Health Impacts of the 
Gulf of Mexico Oil Spill  
John Howard, 	Committee on Education and 
MD, MPH, JD, Labor U.S. House of 
LLM 	 Representatives 
John Howard, 	Subcommittee on Health; 
MD, MPH, JD, Committee on Energy and 
LLM 	 Commerce U.S. House of 
Representatives 
John Howard, 	Subcommittee on Health; 
MD, MPH, JD, Committee on Health, 
LLM 	 Education, Labor and Pensions 
United States Senate 
7/14/2010 Antibiotic Resistance and the Use of 
Antibiotics in Animal Agriculture 
All Khan, MD, 	Subcommittee on Health; 
MPH 	 Committee on Energy & 
Commerce U.S. House of 
Representatives 
   
7/1/2010 The Battle Against Diabetes: Progress 
Made, Challenges Unmet 
Ann Albright, 
PhD, RD 
Subcommittee on Health; 
Committee on Energy and 
Commerce United States House 
of Representatives 
    
6/15/2010 Lead Exposure in D.C.: Prevention, 	Ileana Arias, 	Subcommittee on Federal 
Protection, and Potential Prescriptions 	PhD 	 Workforce, Postal Service, and 
the District of Columbia 
Committee on Oversight and 
Government Reform U.S. House 
of Representatives 
5/20/2010 Preventing Harm—Protecting Health:  
Reforming CDC's Environmental Public 
Health Practices 
Robin M. Ikeda, 
MD, MPH 
Subcommittee on Investigations 
and Oversight; Committee on 
Science and Technology 
United States House of 
Representatives 
    
5/20/2010 Investing in Mine Safety: Preventing 	John Howard, 	Appropriations Committee; 
Another Disaster 	 MD, MPH, JD, Subcommittee on Labor, Health 
LLM 	 and Human Services, Education, 
and Related Agencies U.S. 
Senate 
5/12/2010 Prematurity and Infant Mortality: What 	William M. 	Subcommittee on Health 
Happens When Babies Are Born Too Callaghan, MD, 	Committee on Energy and 
Early? 	 MPH 	 Commerce United States House 
of Representatives 
5/11/2010 Safe Patient Handling & Lifting 
Standards for a Safer American 
Workforce  
4/28/2010 Antibiotic Resistance and the Threat to 
Public Health 
4/22/2010 The Environment and Human Health: 	Henry Falk, MD, 
The Role of HHS 	 MPH 
4/14/2010 Smokeless Tobacco: Impact on the 
	
Terry F. 
Health of our Nation's Youth and Use in 
	
Pechacek, PhD 
Major League Baseball  
Subcommittee on Employment 
and Workplace Safety 
Committee on Health, 
Education, Labor and Pensions 
United States Senate 
Committee on Energy and 
Commerce Subcommittee on 
Health United States House of 
Representatives 
Subcommittee on Investigations 
and Oversight; Committee on 
Science and Technology United 
States House of Representatives 
Subcommittee on Health, 
Committee on Energy and 








2/25/2010 Biosurveillance: Smart Investments for 
	
Daniel M. Sosin, Subcommittees on Homeland 
Early Warning 
	
MD, MPH, FACP Security Committee on 
Appropriations United States 
House of Representatives 
12/16/2009 Innovative Childhood Obesity Practices William H. Dietz, 
MD, PhD 
  
11/18/2009 H1N1 Preparedness: An Overview of 
Vaccine Production and Distribution 
11/17/2009 H1N1 Flu: Getting the Vaccine to Where Anne Schuchat, 
It Is Most Needed 	 MD (RADM, 
USPHS)  
Subcommittee on Health 
Committee on Energy and 
Commerce U.S. House of 
Representatives 
Subcommittees on Health, and 
Oversight and Investigations; 
Committee on Energy and 
Commerce, United States House 
of Representatives 
Committee on Homeland 
Security and Governmental 




11/17/2009 Protecting Employees, Employers and  




Committee on Education and 
Labor, U.S. House of 
Representatives 
   




Subcommittee on Commerce, 
Trade and Consumer Protection; 
Committee on Energy and 
Commerce, United States House 
of Representatives 
    
5/15/2009 Benefits of Farm-to-School Projects,  
Healthy Eating and Physical Activity for 
School Children  
William H. Dietz, Senate Committee on 
MD, PhD 	Agriculture, Nutrition & Forestry 
5/14/2009 Protecting the Protectors: An  
Assessment of Front-line Federal  
Workers in Response to the 2009-H1N1 
Influenza Outbreak 
5/7/2009 CDCs Response to a Novel 2009-H1N1  






Subcommittee on the Federal 
Workforce, Postal Service and 
the District of Columbia 
House Committee on Education 
and Labor 
11/10/2009 The Cost of Being Sick: H1N1 and Paid 	Anne Schuchat, Subcommittee on Children and 
Sick Days 	 MD (RADM, 	Families; 
USPHS) 	Committee on Health, 
Education, Labor and Pensions, 
United States Senate 
11/5/2009 Preventing Child Abuse and Improving 	Rodney 	Subcommittee on Healthy 
Responses to Families in Crisis 	 Hammond, PhD 	Families &Communities; 
Committee on Education & 
Labor U.S. House of 
Representatives 
9/29/2009 Responding to the 2009-2010 Influenza 	Thomas Frieden, Oversight and Government 
Season 	 MD, MPH 	Reform United States House of 
Representatives 
9/9/2009 Preparing Small Businesses for the 
Challenges of 2009-H1N1 Influenza 
Anne Schuchat, 	Committee on Small Business, 
MD (RADM, 	United States House of 
USPHS) 	 Representatives 
  
6/24/2009 Protecting Older Adults During Public 
Health Emergencies 
Richard Besser, 	Committee on Aging, United 
MD 	 States Senate 
5/20/2009 State and Local Pandemic Preparedness 	Daniel Sosin, 	House Committee on Oversight 
MD, MPH, FACP and Government Reform 
5/6/2009 U.S. Global Health Response to a Novel 	Anne Schuchat, Subcommittee on Africa and 
2009-H1N1 Influenza Virus 	 MD (RADM, 	Global Health, House 
USPHS) 	 Committee on Foreign Affairs 
4/30/2009 U.S. Health Response to a Novel 2009 
H1N1 Influenza Virus 
Anne Schuchat, 	Subcommittee on Health, House 
MD (RADM, 	Committee on Energy & 
USPHS) 	 Commerce 
4/29/2009 U.S. Health Response to a Novel 2009 	Richard Besser, 	Senate Committee on Health, 
H1N1 Influenza Virus MD 	 Education, Labor & Pensions 
   
4/29/2009 U.S. Health Response to a Novel 2009 




Senate Committee on Homeland 
Security & Governmental Affairs 
   
3/31/2009 Making Health Care Work for American 	Richard Besser, 	Testimony Before the 
Families: The Role of Public Health 	MD 	 Subcommittee on Health 
Committee on Energy & 
Commerce 
United States House of 
Representatives  
3/26/2009 Current Status and Activities to Decrease William H. Dietz, Testimony before the 
the Prevalence of Obesity Among U.S. 	MD, PhD 	Committee on Agriculture 
Children and Adolescents 	 Subcommittee on Department 
Operations, Oversight, Nutrition 
and Forestry United States 
House of Representatives 
3/12/2009 Scientific Oversight and Management of Howard 	 Testimony before the Senate 
the Agency for Toxic Substances and 	Frumkin, MD, 	Committee on Science and 
Disease Registry 	 DrPH 	 Technology Subcommittee on 
Investigations and Oversight 
2/25/2009 Update on the Latest Global Warming 	Howard 	 Testimony before the Senate 
Science 	 Frumkin, MD, 	Committee on Energy and Public 
DrPH 	 Works 
United States Senate 
2/5/2009 CDC Response to the Multistate 	 Ali Khan, MD, 	Testimony before the Senate 
Outbreak of Salmonella Typhimurium 	MPH 	 Committee on Agriculture, 
Nutrition, and Forestry 
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• CDC Quarantine Stations 



















CDC HAS RESEARCH, DETECTION, AND RESPONSE 
UNITS AROUND THE COUNTRY 
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CDC CAMPUSES IN ATLANTA 
- CDC Owned 
0 - CDC Leased 
CDC's global presence 
• Global Disease 
Detection Center 
* Global Immunizations 
- Measles/Polio 
(7.) Influenza experts 
deployed 
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CDC HAS RESEARCH, DETECTION, AND RESPONSE 
UNITS AROUND THE WORLD 
